|
Name |
Accession |
Description |
Interval |
E-value |
| DCL_NRPS-like |
cd19536 |
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal ... |
1360-1776 |
1.25e-139 |
|
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal fungal CT domains and Dual Epimerization/Condensation (E/C) domains; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type [D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L))], which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380459 [Multi-domain] Cd Length: 419 Bit Score: 442.27 E-value: 1.25e-139
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1360 AYPMTSLQQGMLLQSEAS-GDPRLLHNVVLHeVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQVPLQWVHPatAVAA 1438
Cdd:cd19536 1 MYPLSSLQEGMLFHSLLNpGGSVYLHNYTYT-VGRRLNLDLLLEALQVLIDRHDILRTSFIEDGLGQPVQVVHR--QAQV 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1439 EVPVHDLCGldGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDER-RFALGVAEHHSVLDGWSLQSLVDELLAVYA 1517
Cdd:cd19536 78 PVTELDLTP--LEEQLDPLRAYKEETKIRRFDLGRAPLVRAALVRKDEReRFLLVISDHHSILDGWSLYLLVKEILAVYN 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1518 DLLAGvvAREAEAPAVGFRDYVALEREAEANAASALFWLDYLAGARYRPLPGLAE---EGPRRMAAVRVDVPADSLSrlR 1594
Cdd:cd19536 156 QLLEY--KPLSLPPAQPYRDFVAHERASIQQAASERYWREYLAGATLATLPALSEavgGGPEQDSELLVSVPLPVRS--R 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1595 ALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPEE-PGADRLLGLFLNTLPCRLSASV-DLLDSARRAFDYE 1672
Cdd:cd19536 232 SLAKRSGIPLSTLLLAAWALVLSRHSGSDDVVFGTVVHGRSEEtTGAERLLGLFLNTLPLRVTLSEeTVEDLLKRAQEQE 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1673 RASLEHRRHPLAAIRRRNR-ELRLDSLFNFVDFHQDDAAPA-----GVRHGGILDQVVVDVDVPLAVDFEvaGERLEVGF 1746
Cdd:cd19536 312 LESLSHEQVPLADIQRCSEgEPLFDSIVNFRHFDLDFGLPEwgsdeGMRRGLLFSEFKSNYDVNLSVLPK--QDRLELKL 389
|
410 420 430
....*....|....*....|....*....|
gi 15597498 1747 QYAAGRFPAERAEALAGAYREALLALLGDP 1776
Cdd:cd19536 390 AYNSQVLDEEQAQRLAAYYKSAIAELATAP 419
|
|
| A_NRPS |
cd05930 |
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain ... |
462-910 |
6.38e-135 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341253 [Multi-domain] Cd Length: 444 Bit Score: 430.03 E-value: 6.38e-135
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 462 PQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMR 541
Cdd:cd05930 1 PDAVAVVDGDQSLTYAELDARANRLARYLRERGVGPGDLVAVLLERSLEMVVAILAVLKAGAAYVPLDPSYPAERLAYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 542 EAGGIVFALADAEcagrareafagacldlstlplagsgmslpapggrDAAYMIFTSGTSGQPKGVVVEHASALNLSQALA 621
Cdd:cd05930 81 EDSGAKLVLTDPD----------------------------------DLAYVIYTSGSTGKPKGVMVEHRGLVNLLLWMQ 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 622 RTVYanvVGEGLRVTVNAPFSFDSSIKQIL-QLLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGL 700
Cdd:cd05930 127 EAYP---LTPGDRVLQFTSFSFDVSVWEIFgALLAGATLVVLPEEVRKDPEALADLLAEEGITVLHLTPSLLRLLLQELE 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 701 DDAHPALpGRILVGGERFdeaSWEVAAGWR----RCQVFNLYGPTEATVNASLARVAEH----ARPTIGRALANVDLHVV 772
Cdd:cd05930 204 LAALPSL-RLVLVGGEAL---PPDLVRRWRellpGARLVNLYGPTEATVDATYYRVPPDdeedGRVPIGRPIPNTRVYVL 279
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 773 DGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRI 852
Cdd:cd05930 280 DENLRPVPPGVPGELYIGGAGLARGYLNRPELTAERFVPNPFGPGERMYRTGDLVRWLPDGNLEFLGRIDDQVKIRGYRI 359
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 15597498 853 ELGEIRSALLEHPAVGEAAVLTDEADAAEPgadrRIVAFVTAAEETADE-----SWLEVDLPS 910
Cdd:cd05930 360 ELGEIEAALLAHPGVREAAVVAREDGDGEK----RLVAYVVPDEGGELDeeelrAHLAERLPD 418
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
3-1261 |
3.07e-127 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 436.21 E-value: 3.07e-127
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 3 ASEDLQSAVQPAASEALEGFPLSPLQTRAWRRHAERPENTVVGVRLHAPADPVATLERLRRALDGEAQLRVAYRTMPGMS 82
Cdd:COG1020 2 AAAAAAALPPAAAAAPLPLSAAQQRLWLLLLLLLGSAAYNLALALLLLGLLLVAALLLLAALLARRRRALRTRLRTRAGR 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 83 LPVQVLDGRAADLLVERLPGDGDWAGRFARESARLAASPLGGEGQPVLALGLLLDAAGETLQGLLLAAPAFVVDAASLVA 162
Cdd:COG1020 82 PVQVIQPVVAAPLPVVVLLVDLEALAEAAAEAAAAAEALAPFDLLRGPLLRLLLLLLLLLLLLLLLALHHIISDGLSDGL 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 163 LLRRGLGPAGQASADEGDE----ALLFQHFSEWANEALAGEDGESASGYWREQAAVAAESPLALADDLGEGEWTAR---- 234
Cdd:COG1020 162 LLAELLRLYLAAYAGAPLPlpplPIQYADYALWQREWLQGEELARQLAYWRQQLAGLPPLLELPTDRPRPAVQSYRgarv 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 235 -RLLPRALLERLAA----NGLPEAAALL-AWTQVAGQFQGDE----GLPlemarlVSGRLFNEFAELAGPFAGVAPLCLE 304
Cdd:COG1020 242 sFRLPAELTAALRAlarrHGVTLFMVLLaAFALLLARYSGQDdvvvGTP------VAGRPRPELEGLVGFFVNTLPLRVD 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 305 NVRAGSVGERLDALQAAILA------------QEEAAALRDPfaPDWPLAELGFAWLAGELDGAGVAELDCRQPPLGG-- 370
Cdd:COG1020 316 LSGDPSFAELLARVRETLLAayahqdlpferlVEELQPERDL--SRNPLFQVMFVLQNAPADELELPGLTLEPLELDSgt 393
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 371 ---FLELQVLPHGEGRLASLRVRRDH-DGTLAGRLLDAWVECLESIAADRQLPLAGLPLIGAAERERY-QAWQGERVEPA 445
Cdd:COG1020 394 akfDLTLTVVETGDGLRLTLEYNTDLfDAATIERMAGHLVTLLEALAADPDQPLGDLPLLTAAERQQLlAEWNATAAPYP 473
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 446 PVESLVAAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVY 525
Cdd:COG1020 474 ADATLHELFEAQAARTPDAVAVVFGDQSLTYAELNARANRLAHHLRALGVGPGDLVGVCLERSLEMVVALLAVLKAGAAY 553
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 526 TPVNPEFPAARVERMREAGGIVFALADAECAGRAREaFAGACLDLSTLPLAGSGMSLPAPGGR--DAAYMIFTSGTSGQP 603
Cdd:COG1020 554 VPLDPAYPAERLAYMLEDAGARLVLTQSALAARLPE-LGVPVLALDALALAAEPATNPPVPVTpdDLAYVIYTSGSTGRP 632
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 604 KGVVVEHASALNLSQALARTvYAnvVGEGLRVTVNAPFSFDSSIKQIL-QLLSGHCLVLVPQEVRSDPQRMLGFLEERRI 682
Cdd:COG1020 633 KGVMVEHRALVNLLAWMQRR-YG--LGPGDRVLQFASLSFDASVWEIFgALLSGATLVLAPPEARRDPAALAELLARHRV 709
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 683 DVLDCTPSLFRLLLQAGLDDAHPalPGRILVGGERFDEASWE-VAAGWRRCQVFNLYGPTEATVNASLARV----AEHAR 757
Cdd:COG1020 710 TVLNLTPSLLRALLDAAPEALPS--LRLVLVGGEALPPELVRrWRARLPGARLVNLYGPTETTVDSTYYEVtppdADGGS 787
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 758 PTIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWPGSG-RLYRSGDLVRWRADGCLE 836
Cdd:COG1020 788 VPIGRPIANTRVYVLDAHLQPVPVGVPGELYIGGAGLARGYLNRPELTAERFVADPFGFPGaRLYRTGDLARWLPDGNLE 867
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 837 FLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLTDEadaaEPGADRRIVAFVTAAEETADESWLE----------- 905
Cdd:COG1020 868 FLGRADDQVKIRGFRIELGEIEAALLQHPGVREAVVVARE----DAPGDKRLVAYVVPEAGAAAAAALLrlalalllppy 943
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 906 -----------------VDLPSGHRVAGLNLNETEYVYQEIFVDEVYSRDGIVLPPDAVVLDVGANIGLFSLYIASRAPR 968
Cdd:COG1020 944 mvpaavvlllplpltgnGKLDRLALPAPAAAAAAAAAAPPAEEEEEEAALALLLLLVVVVGDDDFFFFGGGLGLLLLLAL 1023
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 969 ARVVAFEPLAPIRRRLEANLGRYAPQVEVFGIGLSDAEREETFTYYPGYSTFSGIAEYADASGERDVIRRYLSNQGEEGG 1048
Cdd:COG1020 1024 ARAARLLLLLLLLLLLFLAAAAAAAAAAAAAAAAAAAAPLAAAAAPLPLPPLLLSLLALLLALLLLLALLALLALLLLLL 1103
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1049 ANLLLDNIDEILDDRLRAEAHRCRLRRLDQVIGELGLERIDLLKIDVQRAEMDVLLGLDDAALAKVRQIVLEVHDKRDGA 1128
Cdd:COG1020 1104 LLLLLLALLLLLALLLALLAALRARRAVRQEGPRLRLLVALAAALALAALLALLLAAAAAAAELLAAAALLLLLALLLLA 1183
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1129 TAGRADALSDLLRRHGFEVSIRQDALLEGTDRYNCYAVRPGYAESLAERIDWRALAPRPAAALGGELSEQALRGFLEARL 1208
Cdd:COG1020 1184 LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLAAAAAALLALALLLALLALAALLALAALAALAAALLALA 1263
|
1290 1300 1310 1320 1330
....*....|....*....|....*....|....*....|....*....|...
gi 15597498 1209 PAYMLPSRIARVERLPLTAEGKLDRRALLAALAAEAAAQTLEAPANATEAALL 1261
Cdd:COG1020 1264 LALLALALLLLALALLLPALARARAARTARALALLLLLALLLLLALALALLLL 1316
|
|
| AA-adenyl-dom |
TIGR01733 |
amino acid adenylation domain; This model represents a domain responsible for the specific ... |
494-872 |
2.01e-108 |
|
amino acid adenylation domain; This model represents a domain responsible for the specific recognition of amino acids and activation as adenylyl amino acids. The reaction catalyzed is aa + ATP -> aa-AMP + PPi. These domains are usually found as components of multi-domain non-ribosomal peptide synthetases and are usually called "A-domains" in that context. A-domains are almost invariably followed by "T-domains" (thiolation domains, pfam00550) to which the amino acid adenylate is transferred as a thiol-ester to a bound pantetheine cofactor with the release of AMP (these are also called peptide carrier proteins, or PCPs. When the A-domain does not represent the first module (corresponding to the first amino acid in the product molecule) it is usually preceded by a "C-domain" (condensation domain, pfam00668) which catalyzes the ligation of two amino acid thiol-esters from neighboring modules. This domain is a subset of the AMP-binding domain found in Pfam (pfam00501) which also hits substrate--CoA ligases and luciferases. Sequences scoring in between trusted and noise for this model may be ambiguous as to whether they activate amino acids or other molecules lacking an alpha amino group.
Pssm-ID: 273779 [Multi-domain] Cd Length: 409 Bit Score: 352.72 E-value: 2.01e-108
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 494 GVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALADAECAGRARE-AFAGACLDLST 572
Cdd:TIGR01733 21 GVGPGDRVAVLLERSAELVVAILAVLKAGAAYVPLDPAYPAERLAFILEDAGARLLLTDSALASRLAGlVLPVILLDPLE 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 573 LPLAGSGMSLPAP----GGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARtvyANVVGEGLRVTVNAPFSFDSSIK 648
Cdd:TIGR01733 101 LAALDDAPAPPPPdapsGPDDLAYVIYTSGSTGRPKGVVVTHRSLVNLLAWLAR---RYGLDPDDRVLQFASLSFDASVE 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 649 QIL-QLLSGHCLVLVPQEVRSDPQRMLGFL-EERRIDVLDCTPSLFRLLLQAglddAHPALPG--RILVGGERFDEAswe 724
Cdd:TIGR01733 178 EIFgALLAGATLVVPPEDEERDDAALLAALiAEHPVTVLNLTPSLLALLAAA----LPPALASlrLVILGGEALTPA--- 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 725 VAAGWRR----CQVFNLYGPTEATVNASLARVAEHARP-----TIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVA 795
Cdd:TIGR01733 251 LVDRWRArgpgARLINLYGPTETTVWSTATLVDPDDAPrespvPIGRPLANTRLYVLDDDLRPVPVGVVGELYIGGPGVA 330
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 15597498 796 RGYAGDAGEAAGRFVEEGWPGS--GRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV 872
Cdd:TIGR01733 331 RGYLNRPELTAERFVPDPFAGGdgARLYRTGDLVRYLPDGNLEFLGRIDDQVKIRGYRIELGEIEAALLRHPGVREAVV 409
|
|
| A_NRPS_Bac |
cd17655 |
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of ... |
454-910 |
2.22e-102 |
|
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetases 1, 2, and 3 (BA1, also known as ATP-dependent cysteine adenylase or cysteine activase, BA2, also known as ATP-dependent lysine adenylase or lysine activase, and BA3, also known as ATP-dependent isoleucine adenylase or isoleucine activase) in Bacilli. Bacitracin is a mixture of related cyclic peptides used as a polypeptide antibiotic. This family also includes gramicidin synthetase 1 involved in synthesis of the cyclic peptide antibiotic gramicidin S via activation of phenylalanine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341310 [Multi-domain] Cd Length: 490 Bit Score: 338.53 E-value: 2.22e-102
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 454 FDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFP 533
Cdd:cd17655 3 FEEQAEKTPDHTAVVFEDQTLTYRELNERANQLARTLREKGVGPDTIVGIMAERSLEMIVGILGILKAGGAYLPIDPDYP 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 534 AARVERMREAGGIVFALADAECAgrAREAFAGACLDLSTLPL-AGSGMSLPAPG-GRDAAYMIFTSGTSGQPKGVVVEHA 611
Cdd:cd17655 83 EERIQYILEDSGADILLTQSHLQ--PPIAFIGLIDLLDEDTIyHEESENLEPVSkSDDLAYVIYTSGSTGKPKGVMIEHR 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 612 SALNLSQALARTVYanvVGEGLRVTVNAPFSFDSSIKQILQ-LLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPS 690
Cdd:cd17655 161 GVVNLVEWANKVIY---QGEHLRVALFASISFDASVTEIFAsLLSGNTLYIVRKETVLDGQALTQYIRQNRITIIDLTPA 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 691 LFRLLLQAGLDDAHPALpgRILVGGErfdEASWEVAAGW-----RRCQVFNLYGPTEATVNASL----ARVAEHARPTIG 761
Cdd:cd17655 238 HLKLLDAADDSEGLSLK--HLIVGGE---ALSTELAKKIielfgTNPTITNAYGPTETTVDASIyqyePETDQQVSVPIG 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 762 RALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRI 841
Cdd:cd17655 313 KPLGNTRIYILDQYGRPQPVGVAGELYIGGEGVARGYLNRPELTAEKFVDDPFVPGERMYRTGDLARWLPDGNIEFLGRI 392
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 15597498 842 DEQVKINGYRIELGEIRSALLEHPAVGEAAVLTDEADAAEPgadrRIVAFVTAAEETADE---SWLEVDLPS 910
Cdd:cd17655 393 DHQVKIRGYRIELGEIEARLLQHPDIKEAVVIARKDEQGQN----YLCAYIVSEKELPVAqlrEFLARELPD 460
|
|
| A_NRPS_Ta1_like |
cd12116 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A ... |
462-899 |
3.16e-101 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A polyketide synthase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the myxovirescin (TA) antibiotic biosynthetic gene in Myxococcus xanthus; TA production plays a role in predation. It also includes the salinosporamide A polyketide synthase which is involved in the biosynthesis of salinosporamide A, a marine microbial metabolite whose chlorine atom is crucial for potent proteasome inhibition and anticancer activity.
Pssm-ID: 341281 [Multi-domain] Cd Length: 470 Bit Score: 334.26 E-value: 3.16e-101
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 462 PQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMR 541
Cdd:cd12116 1 PDATAVRDDDRSLSYAELDERANRLAARLRARGVGPGDRVAVYLPRSARLVAAMLAVLKAGAAYVPLDPDYPADRLRYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 542 EAGGIVFALADAECAGRAREAFAGACLDLSTLPLAGSGmSLPAPGGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALA 621
Cdd:cd12116 81 EDAEPALVLTDDALPDRLPAGLPVLLLALAAAAAAPAA-PRTPVSPDDLAYVIYTSGSTGRPKGVVVSHRNLVNFLHSMR 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 622 RTVyanVVGEGLRVTVNAPFSFDSSIKQIL-QLLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGL 700
Cdd:cd12116 160 ERL---GLGPGDRLLAVTTYAFDISLLELLlPLLAGARVVIAPRETQRDPEALARLIEAHSITVMQATPATWRMLLDAGW 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 701 DDAHPAlpgRILVGGERFDEaswEVAAGW--RRCQVFNLYGPTEATVNASLARVAEHARP-TIGRALANVDLHVVDGLGR 777
Cdd:cd12116 237 QGRAGL---TALCGGEALPP---DLAARLlsRVGSLWNLYGPTETTIWSTAARVTAAAGPiPIGRPLANTQVYVLDAALR 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 778 RKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWPGSG-RLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGE 856
Cdd:cd12116 311 PVPPGVPGELYIGGDGVAQGYLGRPALTAERFVPDPFAGPGsRLYRTGDLVRRRADGRLEYLGRADGQVKIRGHRIELGE 390
|
410 420 430 440
....*....|....*....|....*....|....*....|...
gi 15597498 857 IRSALLEHPAVGEAAVLTDeadaaEPGADRRIVAFVTAAEETA 899
Cdd:cd12116 391 IEAALAAHPGVAQAAVVVR-----EDGGDRRLVAYVVLKAGAA 428
|
|
| A_NRPS_Srf_like |
cd12117 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis ... |
452-909 |
1.32e-99 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis termination module Surfactin (SrfA-C); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the adenylation domain of the Bacillus subtilis termination module (Surfactin domain, SrfA-C) which recognizes a specific amino acid building block, which is then activated and transferred to the terminal thiol of the 4'-phosphopantetheine (Ppan) arm of the downstream peptidyl carrier protein (PCP) domain.
Pssm-ID: 341282 [Multi-domain] Cd Length: 483 Bit Score: 330.32 E-value: 1.32e-99
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 452 AAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPE 531
Cdd:cd12117 1 ELFEEQAARTPDAVAVVYGDRSLTYAELNERANRLARRLRAAGVGPGDVVGVLAERSPELVVALLAVLKAGAAYVPLDPE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 532 FPAARVERMREAGGIVFALADAECAGRAREafaGACLDLSTLPLAGSGMSLPAPGGR--DAAYMIFTSGTSGQPKGVVVE 609
Cdd:cd12117 81 LPAERLAFMLADAGAKVLLTDRSLAGRAGG---LEVAVVIDEALDAGPAGNPAVPVSpdDLAYVMYTSGSTGRPKGVAVT 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 610 HASALnlsqALARTVYANVVGEGLRVTVNAPFSFDSSIKQIL-QLLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCT 688
Cdd:cd12117 158 HRGVV----RLVKNTNYVTLGPDDRVLQTSPLAFDASTFEIWgALLNGARLVLAPKGTLLDPDALGALIAEEGVTVLWLT 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 689 PSLFRLLLQAGLDdahpALPG--RILVGGERFDEASweVAAGWRRC---QVFNLYGPTEATVNASLARVAEHARPT---- 759
Cdd:cd12117 234 AALFNQLADEDPE----CFAGlrELLTGGEVVSPPH--VRRVLAACpglRLVNGYGPTENTTFTTSHVVTELDEVAgsip 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 760 IGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLG 839
Cdd:cd12117 308 IGRPIANTRVYVLDEDGRPVPPGVPGELYVGGDGLALGYLNRPALTAERFVADPFGPGERLYRTGDLARWLPDGRLEFLG 387
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 15597498 840 RIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLTDEADaaepGADRRIVAFVTAAEETADE---SWLEVDLP 909
Cdd:cd12117 388 RIDDQVKIRGFRIELGEIEAALRAHPGVREAVVVVREDA----GGDKRLVAYVVAEGALDAAelrAFLRERLP 456
|
|
| A_NRPS_VisG_like |
cd17651 |
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) ... |
454-900 |
3.62e-98 |
|
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes virginiamycin S synthetase (VisG) in Streptomyces virginiae; VisG is involved in virginiamycin S (VS) biosynthesis as the provider of an L-pheGly molecule, a highly specific substrate for the last condensation step by VisF. This family also includes linear gramicidin synthetase B (LgrB) in Brevibacillus brevis. Substrate specificity analysis using residues of the substrate-binding pockets of all 16 adenylation domains has shown good agreement of the substrate amino acids predicted with the sequence of linear gramicidin. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341306 [Multi-domain] Cd Length: 491 Bit Score: 326.22 E-value: 3.62e-98
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 454 FDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFP 533
Cdd:cd17651 1 FERQAARTPDAPALVAEGRRLTYAELDRRANRLAHRLRARGVGPGDLVALCARRSAELVVALLAILKAGAAYVPLDPAYP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 534 AARVERMREAGGIVFALADAECAGR-AREAFAGACLDLSTLPLAGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVVEHAS 612
Cdd:cd17651 81 AERLAFMLADAGPVLVLTHPALAGElAVELVAVTLLDQPGAAAGADAEPDPALDADDLAYVIYTSGSTGRPKGVVMPHRS 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 613 ALNLSQALARtvyANVVGEGLRVTVNAPFSFDSSIKQILQ-LLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSL 691
Cdd:cd17651 161 LANLVAWQAR---ASSLGPGARTLQFAGLGFDVSVQEIFStLCAGATLVLPPEEVRTDPPALAAWLDEQRISRVFLPTVA 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 692 FRLLLQAGldDAHPALPGR---ILVGGERF--DEASWEVAAGWRRCQVFNLYGPTEATVNASL---ARVAEH-ARPTIGR 762
Cdd:cd17651 238 LRALAEHG--RPLGVRLAAlryLLTGGEQLvlTEDLREFCAGLPGLRLHNHYGPTETHVVTALslpGDPAAWpAPPPIGR 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 763 ALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRID 842
Cdd:cd17651 316 PIDNTRVYVLDAALRPVPPGVPGELYIGGAGLARGYLNRPELTAERFVPDPFVPGARMYRTGDLARWLPDGELEFLGRAD 395
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*...
gi 15597498 843 EQVKINGYRIELGEIRSALLEHPAVGEAAVLTDEadaaEPGADRRIVAFVTAAEETAD 900
Cdd:cd17651 396 DQVKIRGFRIELGEIEAALARHPGVREAVVLARE----DRPGEKRLVAYVVGDPEAPV 449
|
|
| A_NRPS_AB3403-like |
cd17646 |
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or ... |
451-902 |
6.02e-95 |
|
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341301 [Multi-domain] Cd Length: 488 Bit Score: 316.91 E-value: 6.02e-95
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 451 VAAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNP 530
Cdd:cd17646 1 HALVAEQAARTPDAPAVVDEGRTLTYRELDERANRLAHLLRARGVGPEDRVAVLLPRSADLVVALLAVLKAGAAYLPLDP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 531 EFPAARVERMREAGGIVFALADAECAGRAREAFAGACLDLSTLPLAGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVVEH 610
Cdd:cd17646 81 GYPADRLAYMLADAGPAVVLTTADLAARLPAGGDVALLGDEALAAPPATPPLVPPRPDNLAYVIYTSGSTGRPKGVMVTH 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 611 ASALNlsqALARTVYANVVGEGLRVTVNAPFSFDSSIKQIL-QLLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTP 689
Cdd:cd17646 161 AGIVN---RLLWMQDEYPLGPGDRVLQKTPLSFDVSVWELFwPLVAGARLVVARPGGHRDPAYLAALIREHGVTTCHFVP 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 690 SLFRLLLQAGLDDAHPALPgRILVGGErfdEASWEVAAGWRR---CQVFNLYGPTEATVNASLARVAEHARPT---IGRA 763
Cdd:cd17646 238 SMLRVFLAEPAAGSCASLR-RVFCSGE---ALPPELAARFLAlpgAELHNLYGPTEAAIDVTHWPVRGPAETPsvpIGRP 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 764 LANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRIDE 843
Cdd:cd17646 314 VPNTRLYVLDDALRPVPVGVPGELYLGGVQLARGYLGRPALTAERFVPDPFGPGSRMYRTGDLARWRPDGALEFLGRSDD 393
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*....
gi 15597498 844 QVKINGYRIELGEIRSALLEHPAVGEAAVLTDEAdaaePGADRRIVAFVTAAEETADES 902
Cdd:cd17646 394 QVKIRGFRVEPGEIEAALAAHPAVTHAVVVARAA----PAGAARLVGYVVPAAGAAGPD 448
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
400-1804 |
4.85e-94 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 342.32 E-value: 4.85e-94
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 400 RLLDAWVECLESIAADRQLPLAGLPLIGAAERERY-QAWQGERVEPAPVESLVAAFDLRAALQPQAPALLDAHGSLDFAT 478
Cdd:PRK12316 462 RMARHWQNLLRGMVENPQARVDELPMLDAEERGQLvEGWNATAAEYPLQRGVHRLFEEQVERTPEAPALAFGEETLDYAE 541
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 479 LRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALADAECAGR 558
Cdd:PRK12316 542 LNRRANRLAHALIERGVGPDVLVGVAMERSIEMVVALLAILKAGGAYVPLDPEYPAERLAYMLEDSGVQLLLSQSHLGRK 621
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 559 AREAFAGACLDLSTLPLAGSGMSLPAPG----GRDAAYMIFTSGTSGQPKGVVVEHASALNLSQAlARTVYANVVGEglR 634
Cdd:PRK12316 622 LPLAAGVQVLDLDRPAAWLEGYSEENPGtelnPENLAYVIYTSGSTGKPKGAGNRHRALSNRLCW-MQQAYGLGVGD--T 698
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 635 VTVNAPFSFDSSIKQI-LQLLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPALPgRILV 713
Cdd:PRK12316 699 VLQKTPFSFDVSVWEFfWPLMSGARLVVAAPGDHRDPAKLVELINREGVDTLHFVPSMLQAFLQDEDVASCTSLR-RIVC 777
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 714 GGERFDEASWE-VAAGWRRCQVFNLYGPTEATVNAS-LARVAEHAR-PTIGRALANVDLHVVDGLGRRKTRGASGELWIG 790
Cdd:PRK12316 778 SGEALPADAQEqVFAKLPQAGLYNLYGPTEAAIDVThWTCVEEGGDsVPIGRPIANLACYILDANLEPVPVGVLGELYLA 857
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 791 GAGVARGYAGDAGEAAGRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEA 870
Cdd:PRK12316 858 GRGLARGYHGRPGLTAERFVPSPFVAGERMYRTGDLARYRADGVIEYAGRIDHQVKLRGLRIELGEIEARLLEHPWVREA 937
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 871 AV-------------LTDEADA---------------------------------------AEPGADRRIVAFVTAAEET 898
Cdd:PRK12316 938 AVlavdgkqlvgyvvLESEGGDwrealkahlaaslpeymvpaqwlalerlpltpngkldrkALPAPEASVAQQGYVAPRN 1017
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 899 ADESWLEV---DLPSGHRVaGLNLNETEYVYQEIFVDEVYSR---DGIVLPPDavvlDVGANIGLFSLYIASRAPRA--- 969
Cdd:PRK12316 1018 ALERTLAAiwqDVLGVERV-GLDDNFFELGGDSIVSIQVVSRarqAGIQLSPR----DLFQHQTIRSLALVAKAGQAtaa 1092
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 970 ---RVVAFEPLAPIRRRL--EANLGRY--------APQVEVFGIGLSDAEREETFTYYPGYSTFSGIAE-----YADASG 1031
Cdd:PRK12316 1093 dqgPASGEVALAPVQRWFfeQAIPQRQhwnqslllQARQPLDPDRLGRALERLVAHHDALRLRFREEDGgwqqaYAAPQA 1172
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1032 ERDVIRRYLSNQG------EEGGANLLLDNiDEILDDRLRAEAHRCRlrRLDQVIGELGLERID--LLKIDVQRAEMDVL 1103
Cdd:PRK12316 1173 GEVLWQRQAASEEellalcEEAQRSLDLEQ-GPLLRALLVDMADGSQ--RLLLVIHHLVVDGVSwrILLEDLQRAYADLD 1249
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1104 LGLD---------DAALAKVRQIVLEVHDKRDGATAGRADAL------SDLLRRHGFEVSIRQDA--------------- 1153
Cdd:PRK12316 1250 ADLPartssyqawARRLHEHAGARAEELDYWQAQLEDAPHELpcenpdGALENRHERKLELRLDAertrqllqeapaayr 1329
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1154 ------LLEGTDRYNC-YAVRP-------GYA-ESLAERID------WRALAPRPAAALGGELSE------QALRGFLEA 1206
Cdd:PRK12316 1330 tqvndlLLTALARVTCrWSGQAsvlvqleGHGrEDLFEDIDlsrtvgWFTSLFPVRLTPAADLGEsikaikEQLRAVPDK 1409
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1207 RLPAYML-----PSRIARVERLP-----LTAEGKLDRRALLAALAAEAAAQTLeapANATEAALLEIWKSvlkrpaigvs 1276
Cdd:PRK12316 1410 GIGYGLLrylagEEAAARLAALPqpritFNYLGQFDRQFDEAALFVPATESAG---AAQDPCAPLANWLS---------- 1476
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1277 dnffqvggdsirlIQMQVMAREAGLAFTL-RDVFNHQSIRELAR-----LLAAPASPADALGTSAPQSLEPFALLSAAER 1350
Cdd:PRK12316 1477 -------------IEGQVYGGELSLHWSFsREMFAEATVQRLADdyareLQALIEHCCDERNRGVTPSDFPLAGLSQAQL 1543
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1351 KRLP---EGLDDAYPMTSLQQGMLLQS---EASGDprlLHNVVLHEVHGrLDGELLARAWAILIGRHAILRTGFDLHGG- 1423
Cdd:PRK12316 1544 DALPlpaGEIADIYPLSPMQQGMLFHSlyeQEAGD---YINQLRVDVQG-LDPDRFRAAWQATVDRHEILRSGFLWQDGl 1619
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1424 QVPLQWVHPATavaaEVPVHDLCGLDGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGW 1503
Cdd:PRK12316 1620 EQPLQVIHKQV----ELPFAELDWRGREDLGQALDALAQAERQKGFDLTRAPLLRLVLVRTGEGRHHLIYTNHHILMDGW 1695
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1504 SLQSLVDELLAVYAdllagvvAREAEAPAVGFRDYVA-LEREAEanAASALFWLDYLAgaryrplpglAEEGPRRMA-AV 1581
Cdd:PRK12316 1696 SNAQLLGEVLQRYA-------GQPVAAPGGRYRDYIAwLQRQDA--AASEAFWKEQLA----------ALEEPTRLAqAA 1756
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1582 RVDVP------------ADSLSRLRALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPEE-PGADRLLGLFL 1648
Cdd:PRK12316 1757 RTEDGqvgygdhqqlldPAQTRALAEFARAQKVTLNTLVQAAWLLLLQRYTGQETVAFGATVAGRPAElPGIEQQIGLFI 1836
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1649 NTLP--CRLSASVDLLDSARRAFDYERASLEHRRHPLAAIRR---RNRELRLDSLFNFVDFHQDDA----APAGVRHGGI 1719
Cdd:PRK12316 1837 NTLPviAAPRPDQSVADWLQEVQALNLALREHEHTPLYDIQRwagQGGEALFDSLLVFENYPVAEAlkqgAPAGLVFGRV 1916
|
1530 1540 1550 1560 1570 1580 1590 1600
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1720 LDQVVVDVDVPLAVDFevaGERLEVGFQYAAGRFPAERAEALAGAYREALLALLGDPVQPPAAAQAEDSVELRRVLKVLS 1799
Cdd:PRK12316 1917 SNHEQTNYPLTLAVTL---GETLSLQYSYDRGHFDAAAIERLDRHLLHLLEQMAEDAQAALGELALLDAGERQRILADWD 1993
|
....*
gi 15597498 1800 RVLGR 1804
Cdd:PRK12316 1994 RTPEA 1998
|
|
| A_NRPS_Cytc1-like |
cd17643 |
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation ... |
462-900 |
3.28e-91 |
|
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Streptomyces sp. cytotrienin synthetase (CytC1), a relatively promiscuous adenylation enzyme that installs the aminoacyl moieties on the phosphopantetheinyl arm of the holo carrier protein CytC2. Also included are Streptomyces sp Thr1, involved in the biosynthesis of 4-chlorothreonine, Pseudomonas aeruginosa pyoverdine synthetase D (PvdD), involved in the biosynthesis of the siderophore pyoverdine and Pseudomonas syringae syringopeptin synthetase, where syringpeptin is a necrosis-inducing phytotoxin that functions as a virulence determinant in the plant-pathogen interaction. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341298 [Multi-domain] Cd Length: 450 Bit Score: 304.62 E-value: 3.28e-91
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 462 PQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMR 541
Cdd:cd17643 1 PEAVAVVDEDRRLTYGELDARANRLARTLRAEGVGPGDRVALALPRSAELIVALLAILKAGGAYVPIDPAYPVERIAFIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 542 EAGGIVFALADAEcagrareafagacldlstlplagsgmslpapggrDAAYMIFTSGTSGQPKGVVVEHASALNLsqaLA 621
Cdd:cd17643 81 ADSGPSLLLTDPD----------------------------------DLAYVIYTSGSTGRPKGVVVSHANVLAL---FA 123
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 622 RTVYANVVGEGLRVTVNAPFSFDSSIKQI-LQLLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGL 700
Cdd:cd17643 124 ATQRWFGFNEDDVWTLFHSYAFDFSVWEIwGALLHGGRLVVVPYEVARSPEDFARLLRDEGVTVLNQTPSAFYQLVEAAD 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 701 DDAHPALPGRILV-GGERFDEA---SWEVAAGWRRCQVFNLYGPTEATVNASLARV-----AEHARPTIGRALANVDLHV 771
Cdd:cd17643 204 RDGRDPLALRYVIfGGEALEAAmlrPWAGRFGLDRPQLVNMYGITETTVHVTFRPLdaadlPAAAASPIGRPLPGLRVYV 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 772 VDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEE--GWPGSgRLYRSGDLVRWRADGCLEFLGRIDEQVKING 849
Cdd:cd17643 284 LDADGRPVPPGVVGELYVSGAGVARGYLGRPELTAERFVANpfGGPGS-RMYRTGDLARRLPDGELEYLGRADEQVKIRG 362
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|.
gi 15597498 850 YRIELGEIRSALLEHPAVGEAAVLTDEadaAEPGaDRRIVAFVTAAEETAD 900
Cdd:cd17643 363 FRIELGEIEAALATHPSVRDAAVIVRE---DEPG-DTRLVAYVVADDGAAA 409
|
|
| A_NRPS_CmdD_like |
cd17652 |
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) ... |
462-899 |
7.22e-89 |
|
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes phosphinothricin tripeptide (PTT, phosphinothricylalanylalanine) synthetase, where PTT is a natural-product antibiotic and potent herbicide that is produced by Streptomyces hygroscopicus. This adenylation domain has been confirmed to directly activate beta-tyrosine, and fluorinated chondramides are produced through precursor-directed biosynthesis. Also included in this family is chondramide synthase D (also known as ATP-dependent phenylalanine adenylase or phenylalanine activase or tyrosine activase). Chondramides A-D are depsipeptide antitumor and antifungal antibiotics produced by C. crocatus, are a class of mixed peptide/polyketide depsipeptides comprised of three amino acids (alanine, N-methyltryptophan, plus the unusual amino acid beta-tyrosine or alpha-methoxy-beta-tyrosine) and a polyketide chain ([E]-7-hydroxy-2,4,6-trimethyloct-4-enoic acid).
Pssm-ID: 341307 [Multi-domain] Cd Length: 436 Bit Score: 297.63 E-value: 7.22e-89
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 462 PQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMr 541
Cdd:cd17652 1 PDAPAVVFGDETLTYAELNARANRLARLLAARGVGPERLVALALPRSAELVVAILAVLKAGAAYLPLDPAYPAERIAYM- 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 542 eaggivfaLADAecagrareafaGACLDLSTlplagsgmslpapgGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALA 621
Cdd:cd17652 80 --------LADA-----------RPALLLTT--------------PDNLAYVIYTSGSTGRPKGVVVTHRGLANLAAAQI 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 622 RtvyANVVGEGLRVTVNAPFSFDSSIKQILQ-LLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGL 700
Cdd:cd17652 127 A---AFDVGPGSRVLQFASPSFDASVWELLMaLLAGATLVLAPAEELLPGEPLADLLREHRITHVTLPPAALAALPPDDL 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 701 DDAHpalpgRILVGGErfdEASWEVAAGW-RRCQVFNLYGPTEATVNASLARVAE-HARPTIGRALANVDLHVVDGLGRR 778
Cdd:cd17652 204 PDLR-----TLVVAGE---ACPAELVDRWaPGRRMINAYGPTETTVCATMAGPLPgGGVPPIGRPVPGTRVYVLDARLRP 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 779 KTRGASGELWIGGAGVARGYAGDAGEAAGRFVEE--GWPGSgRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGE 856
Cdd:cd17652 276 VPPGVPGELYIAGAGLARGYLNRPGLTAERFVADpfGAPGS-RMYRTGDLARWRADGQLEFLGRADDQVKIRGFRIELGE 354
|
410 420 430 440
....*....|....*....|....*....|....*....|...
gi 15597498 857 IRSALLEHPAVGEAAVLTDEadaaEPGADRRIVAFVTAAEETA 899
Cdd:cd17652 355 VEAALTEHPGVAEAVVVVRD----DRPGDKRLVAYVVPAPGAA 393
|
|
| A_NRPS_ApnA-like |
cd17644 |
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the ... |
454-897 |
6.26e-88 |
|
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Planktothrix agardhii anabaenopeptin synthetase (ApnA A1), which is capable of activating two chemically distinct amino acids (Arg and Tyr). Structural studies show that the architecture of the active site forces Arg to adopt a Tyr-like conformation, thus explaining the bispecificity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341299 [Multi-domain] Cd Length: 465 Bit Score: 295.88 E-value: 6.26e-88
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 454 FDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFP 533
Cdd:cd17644 6 FEEQVERTPDAVAVVFEDQQLTYEELNTKANQLAHYLQSLGVKSESLVGICVERSLEMIIGLLAILKAGGAYVPLDPNYP 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 534 AARVERMREAGGIVFALADAEcagrareafagacldlstlplagsgmslpapggrDAAYMIFTSGTSGQPKGVVVEHASA 613
Cdd:cd17644 86 QERLTYILEDAQISVLLTQPE----------------------------------NLAYVIYTSGSTGKPKGVMIEHQSL 131
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 614 LNLSQALARTVYANvvgEGLRVTVNAPFSFDSSIKQILQ-LLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLF 692
Cdd:cd17644 132 VNLSHGLIKEYGIT---SSDRVLQFASIAFDVAAEEIYVtLLSGATLVLRPEEMRSSLEDFVQYIQQWQLTVLSLPPAYW 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 693 RLLLQAGLDD--AHPALPGRILVGGERFDEASWE--VAAGWRRCQVFNLYGPTEATVNASLARV-----AEHARPTIGRA 763
Cdd:cd17644 209 HLLVLELLLStiDLPSSLRLVIVGGEAVQPELVRqwQKNVGNFIQLINVYGPTEATIAATVCRLtqlteRNITSVPIGRP 288
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 764 LANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWPGS--GRLYRSGDLVRWRADGCLEFLGRI 841
Cdd:cd17644 289 IANTQVYILDENLQPVPVGVPGELHIGGVGLARGYLNRPELTAEKFISHPFNSSesERLYKTGDLARYLPDGNIEYLGRI 368
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*.
gi 15597498 842 DEQVKINGYRIELGEIRSALLEHPAVGEAAVLTDEadaaEPGADRRIVAFVTAAEE 897
Cdd:cd17644 369 DNQVKIRGFRIELGEIEAVLSQHNDVKTAVVIVRE----DQPGNKRLVAYIVPHYE 420
|
|
| A_NRPS_TlmIV_like |
cd12114 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including ... |
462-897 |
2.17e-84 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Streptoalloteichus tallysomycin biosynthesis genes; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the TLM biosynthetic gene cluster from Streptoalloteichus that consists of nine NRPS genes; the N-terminal module of TlmVI (NRPS-5) and the starter module of BlmVI (NRPS-5) are comprised of the acyl CoA ligase (AL) and acyl carrier protein (ACP)-like domains, which are thought to be involved in the biosynthesis of the beta-aminoalaninamide moiety.
Pssm-ID: 341279 [Multi-domain] Cd Length: 477 Bit Score: 286.09 E-value: 2.17e-84
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 462 PQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMR 541
Cdd:cd12114 1 PDATAVICGDGTLTYGELAERARRVAGALKAAGVRPGDLVAVTLPKGPEQVVAVLGILAAGAAYVPVDIDQPAARREAIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 542 EAGGIVFALADAECAgrareAFAGACLDLSTLPLAGSGMSLPAPGGR----DAAYMIFTSGTSGQPKGVVVEHASALNLS 617
Cdd:cd12114 81 ADAGARLVLTDGPDA-----QLDVAVFDVLILDLDALAAPAPPPPVDvapdDLAYVIFTSGSTGTPKGVMISHRAALNTI 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 618 QALARtvyANVVGEGLRVTVNAPFSFDSSIKQILQLLS-GHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLL 696
Cdd:cd12114 156 LDINR---RFAVGPDDRVLALSSLSFDLSVYDIFGALSaGATLVLPDEARRRDPAHWAELIERHGVTLWNSVPALLEMLL 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 697 QAGLDDAHPALPGR-ILVGGErfdeasW-------EVAAGWRRCQVFNLYGPTEATVNASLARVAEH--ARPTI--GRAL 764
Cdd:cd12114 233 DVLEAAQALLPSLRlVLLSGD------WipldlpaRLRALAPDARLISLGGATEASIWSIYHPIDEVppDWRSIpyGRPL 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 765 ANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEgwPGSGRLYRSGDLVRWRADGCLEFLGRIDEQ 844
Cdd:cd12114 307 ANQRYRVLDPRGRDCPDWVPGELWIGGRGVALGYLGDPELTAARFVTH--PDGERLYRTGDLGRYRPDGTLEFLGRRDGQ 384
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|...
gi 15597498 845 VKINGYRIELGEIRSALLEHPAVGEAAVLtdeaDAAEPGaDRRIVAFVTAAEE 897
Cdd:cd12114 385 VKVRGYRIELGEIEAALQAHPGVARAVVV----VLGDPG-GKRLAAFVVPDND 432
|
|
| A_NRPS_PvdJ-like |
cd17649 |
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal ... |
462-905 |
8.15e-83 |
|
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes pyoverdine biosynthesis protein PvdJ involved in the synthesis of pyoverdine, which consists of a chromophore group attached to a variable peptide chain and comprises around 6-12 amino acids that are specific for each Pseudomonas species, and for which the peptide might be first synthesized before the chromophore assembly. Also included is ornibactin biosynthesis protein OrbI; ornibactin is a tetrapeptide siderophore with an l-ornithine-d-hydroxyaspartate-l-serine-l-ornithine backbone. The adenylation domain at the N-terminal of OrbI possibly initiates the ornibactin with the binding of N5-hydroxyornithine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341304 [Multi-domain] Cd Length: 450 Bit Score: 280.41 E-value: 8.15e-83
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 462 PQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMR 541
Cdd:cd17649 1 PDAVALVFGDQSLSYAELDARANRLAHRLRALGVGPEVRVGIALERSLEMVVALLAILKAGGAYVPLDPEYPAERLRYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 542 EAGGIVFALADaecagrareafagacldlstlplagsgmslpapGGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALA 621
Cdd:cd17649 81 EDSGAGLLLTH---------------------------------HPRQLAYVIYTSGSTGTPKGVAVSHGPLAAHCQATA 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 622 RtVYAnvVGEGLRVTVNAPFSFDSSIKQILQ-LLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPS-LFRLLLQAG 699
Cdd:cd17649 128 E-RYG--LTPGDRELQFASFNFDGAHEQLLPpLICGACVVLRPDELWASADELAEMVRELGVTVLDLPPAyLQQLAEEAD 204
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 700 LDDAHPALPGRILV-GGERFdeaSWEVAAGWRRCQV--FNLYGPTEATVNASLARVAEH-----ARPTIGRALANVDLHV 771
Cdd:cd17649 205 RTGDGRPPSLRLYIfGGEAL---SPELLRRWLKAPVrlFNAYGPTEATVTPLVWKCEAGaaragASMPIGRPLGGRSAYI 281
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 772 VDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWPGSG-RLYRSGDLVRWRADGCLEFLGRIDEQVKINGY 850
Cdd:cd17649 282 LDADLNPVPVGVTGELYIGGEGLARGYLGRPELTAERFVPDPFGAPGsRLYRTGDLARWRDDGVIEYLGRVDHQVKIRGF 361
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*.
gi 15597498 851 RIELGEIRSALLEHPAVGEAAVLtdeadaAEPGA-DRRIVAFVTAAEETADESWLE 905
Cdd:cd17649 362 RIELGEIEAALLEHPGVREAAVV------ALDGAgGKQLVAYVVLRAAAAQPELRA 411
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
394-895 |
8.32e-82 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 301.69 E-value: 8.32e-82
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 394 DGTLAGRLLDAWVECLESIAADRQLPLAGLPLIGAAERER-YQAWQGERVEPAPvESLVAAFDLRAALQPQAPALLDAHG 472
Cdd:PRK12467 458 EATTIERLATHWRNLLEAIVAEPRRRLGELPLLDAEERAReLVRWNAPATEYAP-DCVHQLIEAQARQHPERPALVFGEQ 536
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 473 SLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALAD 552
Cdd:PRK12467 537 VLSYAELNRQANRLAHVLIAAGVGPDVLVGIAVERSIEMVVGLLAVLKAGGAYVPLDPEYPQDRLAYMLDDSGVRLLLTQ 616
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 553 AECAGRAR--EAFAGACLDLSTLPLAGSGMSLPAP--GGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARtvyANV 628
Cdd:PRK12467 617 SHLLAQLPvpAGLRSLCLDEPADLLCGYSGHNPEValDPDNLAYVIYTSGSTGQPKGVAISHGALANYVCVIAE---RLQ 693
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 629 VGEGLRVTVNAPFSFDSSIKQIL-QLLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDdAHPAL 707
Cdd:PRK12467 694 LAADDSMLMVSTFAFDLGVTELFgALASGATLHLLPPDCARDAEAFAALMADQGVTVLKIVPSHLQALLQASRV-ALPRP 772
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 708 PGRILVGGERFdeaSWEVAAGWRR----CQVFNLYGPTEATVNASLARVAEHARPT----IGRALANVDLHVVDGLGRRK 779
Cdd:PRK12467 773 QRALVCGGEAL---QVDLLARVRAlgpgARLINHYGPTETTVGVSTYELSDEERDFgnvpIGQPLANLGLYILDHYLNPV 849
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 780 TRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGW-PGSGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIR 858
Cdd:PRK12467 850 PVGVVGELYIGGAGLARGYHRRPALTAERFVPDPFgADGGRLYRTGDLARYRADGVIEYLGRMDHQVKIRGFRIELGEIE 929
|
490 500 510
....*....|....*....|....*....|....*...
gi 15597498 859 SALLEHPAVGEAAVLtdeadaAEPG-ADRRIVAFVTAA 895
Cdd:PRK12467 930 ARLLAQPGVREAVVL------AQPGdAGLQLVAYLVPA 961
|
|
| DltA |
cd05945 |
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes ... |
458-908 |
1.22e-78 |
|
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes D-alanyl carrier protein ligase DltA and aliphatic beta-amino acid adenylation enzymes IdnL1 and CmiS6. DltA incorporates D-ala in techoic acids in gram-positive bacteria via a two-step process, starting with adenylation of D-alanine that transfers D-alanine to the D-alanyl carrier protein. IdnL1, a short-chain aliphatic beta-amino acid adenylation enzyme, recognizes 3-aminobutanoic acid, and is involved in the synthesis of the macrolactam antibiotic incednine. CmiS6 is a medium-chain beta-amino acid adenylation enzyme that recognizes 3-aminononanoic acid, and is involved in the synthesis of cremimycin, also a macrolactam antibiotic. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341267 [Multi-domain] Cd Length: 449 Bit Score: 268.35 E-value: 1.22e-78
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 458 AALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARV 537
Cdd:cd05945 1 AAANPDRPAVVEGGRTLTYRELKERADALAAALASLGLDAGDPVVVYGHKSPDAIAAFLAALKAGHAYVPLDASSPAERI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 538 ERMREAGGIVFALADaecagrareafagacldlstlplagsgmslpapgGRDAAYMIFTSGTSGQPKGVVVEHASALN-L 616
Cdd:cd05945 81 REILDAAKPALLIAD----------------------------------GDDNAYIIFTSGSTGRPKGVQISHDNLVSfT 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 617 SQALARtvyaNVVGEGLRVTVNAPFSFDSSIKQIL-QLLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLL 695
Cdd:cd05945 127 NWMLSD----FPLGPGDVFLNQAPFSFDLSVMDLYpALASGATLVPVPRDATADPKQLFRFLAEHGITVWVSTPSFAAMC 202
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 696 LQAGLDDA--HPALPGrILVGGERFDEAsweVAAGWRRC----QVFNLYGPTEATVNASLARV-----AEHARPTIGRAL 764
Cdd:cd05945 203 LLSPTFTPesLPSLRH-FLFCGEVLPHK---TARALQQRfpdaRIYNTYGPTEATVAVTYIEVtpevlDGYDRLPIGYAK 278
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 765 ANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFV-EEGWPGsgrlYRSGDLVRWRADGCLEFLGRIDE 843
Cdd:cd05945 279 PGAKLVILDEDGRPVPPGEKGELVISGPSVSKGYLNNPEKTAAAFFpDEGQRA----YRTGDLVRLEADGLLFYRGRLDF 354
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 15597498 844 QVKINGYRIELGEIRSALLEHPAVGEAAVLTDEADAAEPgadrRIVAFVTAaeETADESWLEVDL 908
Cdd:cd05945 355 QVKLNGYRIELEEIEAALRQVPGVKEAVVVPKYKGEKVT----ELIAFVVP--KPGAEAGLTKAI 413
|
|
| A_NRPS_PpsD_like |
cd17650 |
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation ... |
462-898 |
5.28e-78 |
|
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetase 1 (BacA) in Bacillus licheniformis, tyrocidine synthetase in Brevibacillus brevis, plipastatin synthase (PpsD, an important antifungal protein) in Bacillus subtilis and mannopeptimycin peptide synthetase (MppB) in Streptomyces hygroscopicus. Plipastatin has strong fungitoxic activity and is involved in inhibition of phospholipase A2 and biofilm formation. Bacitracin, a mixture of related cyclic peptides, is used as a polypeptide antibiotic while function of tyrocidine is thought to be regulation of sporulation. MppB is involved in biosynthetic pathway of mannopeptimycin, a novel class of mannosylated lipoglycopeptides. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341305 [Multi-domain] Cd Length: 447 Bit Score: 266.64 E-value: 5.28e-78
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 462 PQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMR 541
Cdd:cd17650 1 PDAIAVSDATRQLTYRELNERANQLARTLRGLGVAPGSVVGVCADRSLDAIVGLLAVLKAGGAYVPIDPDYPAERLQYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 542 EAGGIVFALADAEcagrareafagacldlstlplagsgmslpapggrDAAYMIFTSGTSGQPKGVVVEHASALNLSQALA 621
Cdd:cd17650 81 EDSGAKLLLTQPE----------------------------------DLAYVIYTSGTTGKPKGVMVEHRNVAHAAHAWR 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 622 RtVYAnVVGEGLRVTVNAPFSFDSSIKQILQ-LLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLL---- 696
Cdd:cd17650 127 R-EYE-LDSFPVRLLQMASFSFDVFAGDFARsLLNGGTLVICPDEVKLDPAALYDLILKSRITLMESTPALIRPVMayvy 204
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 697 QAGLDdaHPALpgRILVGGERFDEASWEVAAGWR---RCQVFNLYGPTEATVNAS-----LARVAEHARPTIGRALANVD 768
Cdd:cd17650 205 RNGLD--LSAM--RLLIVGSDGCKAQDFKTLAARfgqGMRIINSYGVTEATIDSTyyeegRDPLGDSANVPIGRPLPNTA 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 769 LHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRIDEQVKIN 848
Cdd:cd17650 281 MYVLDERLQPQPVGVAGELYIGGAGVARGYLNRPELTAERFVENPFAPGERMYRTGDLARWRADGNVELLGRVDHQVKIR 360
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|
gi 15597498 849 GYRIELGEIRSALLEHPAVGEAAVLTDEADaaepGADRRIVAFVTAAEET 898
Cdd:cd17650 361 GFRIELGEIESQLARHPAIDEAVVAVREDK----GGEARLCAYVVAAATL 406
|
|
| A_NRPS_SidN3_like |
cd05918 |
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); ... |
454-902 |
8.81e-78 |
|
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family of siderophore-synthesizing NRPS includes the third adenylation domain of SidN from the endophytic fungus Neotyphodium lolii, ferrichrome siderophore synthetase, HC-toxin synthetase, and enniatin synthase. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341242 [Multi-domain] Cd Length: 481 Bit Score: 267.10 E-value: 8.81e-78
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 454 FDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFP 533
Cdd:cd05918 5 IEERARSQPDAPAVCAWDGSLTYAELDRLSSRLAHHLRSLGVGPGVFVPLCFEKSKWAVVAMLAVLKAGGAFVPLDPSHP 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 534 AARVERMREAGGIVFALADAECagrareafagacldlstlplagsgmslpapggrDAAYMIFTSGTSGQPKGVVVEHASA 613
Cdd:cd05918 85 LQRLQEILQDTGAKVVLTSSPS---------------------------------DAAYVIFTSGSTGKPKGVVIEHRAL 131
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 614 LNLSQALARTVYanvVGEGLRVTVNAPFSFDSSIKQIL-QLLSGHCLVLVPQEVRsdPQRMLGFLEERRIDVLDCTPSLF 692
Cdd:cd05918 132 STSALAHGRALG---LTSESRVLQFASYTFDVSILEIFtTLAAGGCLCIPSEEDR--LNDLAGFINRLRVTWAFLTPSVA 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 693 RLLlqaglddaHPA-LPG--RILVGGERfdeASWEVAAGW-RRCQVFNLYGPTEATVNASLARVAEHARP-TIGRALANV 767
Cdd:cd05918 207 RLL--------DPEdVPSlrTLVLGGEA---LTQSDVDTWaDRVRLINAYGPAECTIAATVSPVVPSTDPrNIGRPLGAT 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 768 dLHVVDGLGRRKT--RGASGELWIGGAGVARGYAGDAGEAAGRFVE-------EGWPGSGRLYRSGDLVRWRADGCLEFL 838
Cdd:cd05918 276 -CWVVDPDNHDRLvpIGAVGELLIEGPILARGYLNDPEKTAAAFIEdpawlkqEGSGRGRRLYRTGDLVRYNPDGSLEYV 354
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 15597498 839 GRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVltdeADAAEP---GADRRIVAFVTAAEETADES 902
Cdd:cd05918 355 GRKDTQVKIRGQRVELGEIEHHLRQSLPGAKEVV----VEVVKPkdgSSSPQLVAFVVLDGSSSGSG 417
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
381-907 |
2.17e-77 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 287.44 E-value: 2.17e-77
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 381 EGRLASLRVRRD-HDGTLAGRLLDAWVECLESIAADRQLPLAGLPLIGAAERER-YQAWQGERVEPAPVESLVAAFDLRA 458
Cdd:PRK12467 1505 EGLQASLTYATDlFEASTIERLAGHWLNLLQGLVADPERRLGELDLLDEAERRQiLEGWNATHTGYPLARLVHQLIEDQA 1584
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 459 ALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVE 538
Cdd:PRK12467 1585 AATPEAVALVFGEQELTYGELNRRANRLAHRLIALGVGPEVLVGIAVERSLEMVVGLLAILKAGGAYVPLDPEYPRERLA 1664
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 539 RMREAGGIVFALADAECAGR--AREAFAGACLDLSTLPLAGSGMSLPA--PGGRDAAYMIFTSGTSGQPKGVVVEHASAL 614
Cdd:PRK12467 1665 YMIEDSGIELLLTQSHLQARlpLPDGLRSLVLDQEDDWLEGYSDSNPAvnLAPQNLAYVIYTSGSTGRPKGAGNRHGALV 1744
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 615 NLSQALaRTVYANVVGEGlrVTVNAPFSFDSSIKQIL-QLLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFR 693
Cdd:PRK12467 1745 NRLCAT-QEAYQLSAADV--VLQFTSFAFDVSVWELFwPLINGARLVIAPPGAHRDPEQLIQLIERQQVTTLHFVPSMLQ 1821
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 694 LLLQAGLDDAHPALPGRILVGGERFDEAS---WEVAAGWRrcQVFNLYGPTEATVNASLaRVAEHARPT------IGRAL 764
Cdd:PRK12467 1822 QLLQMDEQVEHPLSLRRVVCGGEALEVEAlrpWLERLPDT--GLFNLYGPTETAVDVTH-WTCRRKDLEgrdsvpIGQPI 1898
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 765 ANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEE--GWPGsGRLYRSGDLVRWRADGCLEFLGRID 842
Cdd:PRK12467 1899 ANLSTYILDASLNPVPIGVAGELYLGGVGLARGYLNRPALTAERFVADpfGTVG-SRLYRTGDLARYRADGVIEYLGRID 1977
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 15597498 843 EQVKINGYRIELGEIRSALLEHPAVGEAAVLtdeadAAEPGADRRIVAFVTaaeeTADESWLEVD 907
Cdd:PRK12467 1978 HQVKIRGFRIELGEIEARLREQGGVREAVVI-----AQDGANGKQLVAYVV----PTDPGLVDDD 2033
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
409-906 |
2.04e-76 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 284.36 E-value: 2.04e-76
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 409 LESIAADRQLPLAGLPLIGAAERER-YQAWQGERVEPAPVESLVAAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVA 487
Cdd:PRK12467 3055 LQAMLNNPAARLGELPTLAAHERRQvLHAWNATAAAYPSERLVHQLIEAQVARTPEAPALVFGDQQLSYAELNRRANRLA 3134
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 488 EALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALADAECAGRAREAFAGAC 567
Cdd:PRK12467 3135 HRLIAIGVGPDVLVGVAVERSVEMIVALLAVLKAGGAYVPLDPEYPRERLAYMIEDSGVKLLLTQAHLLEQLPAPAGDTA 3214
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 568 LDLSTLPLAGSGMSLPAP--GGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARtvyANVVGEGLRVTVNAPFSFDS 645
Cdd:PRK12467 3215 LTLDRLDLNGYSENNPSTrvMGENLAYVIYTSGSTGKPKGVGVRHGALANHLCWIAE---AYELDANDRVLLFMSFSFDG 3291
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 646 SIKQIL-QLLSGHCLVLVPQEVRsDPQRMLGFLEERRIDVLDCTPSLFRLLLQ-AGLDDAHPAlpGRILVGGERFDEASW 723
Cdd:PRK12467 3292 AQERFLwTLICGGCLVVRDNDLW-DPEELWQAIHAHRISIACFPPAYLQQFAEdAGGADCASL--DIYVFGGEAVPPAAF 3368
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 724 E-VAAGWRRCQVFNLYGPTEATVNASLARVAEHARPT-----IGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARG 797
Cdd:PRK12467 3369 EqVKRKLKPRGLTNGYGPTEAVVTVTLWKCGGDAVCEapyapIGRPVAGRSIYVLDGQLNPVPVGVAGELYIGGVGLARG 3448
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 798 YAGDAGEAAGRFVEEGWPGSG-RLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLtde 876
Cdd:PRK12467 3449 YHQRPSLTAERFVADPFSGSGgRLYRTGDLARYRADGVIEYLGRIDHQVKIRGFRIELGEIEARLLQHPSVREAVVL--- 3525
|
490 500 510
....*....|....*....|....*....|
gi 15597498 877 adAAEPGADRRIVAFVTAAEETADesWLEV 906
Cdd:PRK12467 3526 --ARDGAGGKQLVAYVVPADPQGD--WRET 3551
|
|
| AMP-binding |
pfam00501 |
AMP-binding enzyme; |
454-847 |
4.85e-76 |
|
AMP-binding enzyme;
Pssm-ID: 459834 [Multi-domain] Cd Length: 417 Bit Score: 259.55 E-value: 4.85e-76
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 454 FDLRAALQPQAPALL-DAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEF 532
Cdd:pfam00501 1 LERQAARTPDKTALEvGEGRRLTYRELDERANRLAAGLRALGVGKGDRVAILLPNSPEWVVAFLACLKAGAVYVPLNPRL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 533 PAARVERMREAGGIVFALADAEC-AGRAREAFA------------------GACLDLSTLPLAGSGMSLPAPGGRDAAYM 593
Cdd:pfam00501 81 PAEELAYILEDSGAKVLITDDALkLEELLEALGklevvklvlvldrdpvlkEEPLPEEAKPADVPPPPPPPPDPDDLAYI 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 594 IFTSGTSGQPKGVVVEHASALNLSQALAR-TVYANVVGEGLRVTVNAPFSFDSSIK--QILQLLSGHCLVLVPQEVRSDP 670
Cdd:pfam00501 161 IYTSGTTGKPKGVMLTHRNLVANVLSIKRvRPRGFGLGPDDRVLSTLPLFHDFGLSlgLLGPLLAGATVVLPPGFPALDP 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 671 QRMLGFLEERRIDVLDCTPSLFRLLLQAGlDDAHPALPG--RILVGGERFDEASWEVAAGWRRCQVFNLYGPTEATVNAS 748
Cdd:pfam00501 241 AALLELIERYKVTVLYGVPTLLNMLLEAG-APKRALLSSlrLVLSGGAPLPPELARRFRELFGGALVNGYGLTETTGVVT 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 749 LAR---VAEHARPTIGRALANVDLHVVD-GLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgsgrlYRSG 824
Cdd:pfam00501 320 TPLpldEDLRSLGSVGRPLPGTEVKIVDdETGEPVPPGEPGELCVRGPGVMKGYLNDPELTAEAFDEDGW------YRTG 393
|
410 420
....*....|....*....|...
gi 15597498 825 DLVRWRADGCLEFLGRIDEQVKI 847
Cdd:pfam00501 394 DLGRRDEDGYLEIVGRKKDQIKL 416
|
|
| A_NRPS_Sfm_like |
cd12115 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene ... |
447-899 |
2.53e-75 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene cluster from Streptomyces lavendulae; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the saframycin A gene cluster from Streptomyces lavendulae which implicates the NRPS system for assembling the unusual tetrapeptidyl skeleton in an iterative manner. It also includes saframycin Mx1 produced by Myxococcus xanthus NRPS.
Pssm-ID: 341280 [Multi-domain] Cd Length: 447 Bit Score: 258.79 E-value: 2.53e-75
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 447 VESLVAAFdlrAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYT 526
Cdd:cd12115 1 LHDLVEAQ---AARTPDAIALVCGDESLTYAELNRRANRLAARLRAAGVGPESRVGVCLERTPDLVVALLAVLKAGAAYV 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 527 PVNPEFPAARVErmreaggivFALADAECAgrareafagacldlstlplagsgmsLPAPGGRDAAYMIFTSGTSGQPKGV 606
Cdd:cd12115 78 PLDPAYPPERLR---------FILEDAQAR-------------------------LVLTDPDDLAYVIYTSGSTGRPKGV 123
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 607 VVEHASALNLSQALARTVYANVVGEGLRVTvnaPFSFDSSIKQILQLLS-GHCLVLVpqevrSDPQRMLGFLEERRIDVL 685
Cdd:cd12115 124 AIEHRNAAAFLQWAAAAFSAEELAGVLAST---SICFDLSVFELFGPLAtGGKVVLA-----DNVLALPDLPAAAEVTLI 195
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 686 DCTPSLFRLLLQAgldDAHPALPGRILVGGERF-DEASWEVAAGWRRCQVFNLYGPTEATVNASLARVAEHAR--PTIGR 762
Cdd:cd12115 196 NTVPSAAAELLRH---DALPASVRVVNLAGEPLpRDLVQRLYARLQVERVVNLYGPSEDTTYSTVAPVPPGASgeVSIGR 272
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 763 ALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRID 842
Cdd:cd12115 273 PLANTQAYVLDRALQPVPLGVPGELYIGGAGVARGYLGRPGLTAERFLPDPFGPGARLYRTGDLVRWRPDGLLEFLGRAD 352
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*..
gi 15597498 843 EQVKINGYRIELGEIRSALLEHPAVGEAAVLTDEaDAAepgADRRIVAFVTAAEETA 899
Cdd:cd12115 353 NQVKVRGFRIELGEIEAALRSIPGVREAVVVAIG-DAA---GERRLVAYIVAEPGAA 405
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
409-896 |
8.42e-75 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 275.38 E-value: 8.42e-75
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 409 LESIAADRQLPLAGLPLIGAAERERYQAWQGERVePAPVESLVAAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAE 488
Cdd:PRK10252 420 IAQFAADPALLCGDVDILLPGEYAQLAQVNATAV-EIPETTLSALVAQQAAKTPDAPALADARYQFSYREMREQVVALAN 498
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 489 ALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALADAECAGRAREAFAGACL 568
Cdd:PRK10252 499 LLRERGVKPGDSVAVALPRSVFLTLALHAIVEAGAAWLPLDTGYPDDRLKMMLEDARPSLLITTADQLPRFADVPDLTSL 578
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 569 DLSTLPLAGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALaRTVYAnvVGEGLRVTVNAPFSFDSSIK 648
Cdd:PRK10252 579 CYNAPLAPQGAAPLQLSQPHHTAYIIFTSGSTGRPKGVMVGQTAIVNRLLWM-QNHYP--LTADDVVLQKTPCSFDVSVW 655
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 649 QI-LQLLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQA----GLDDAHPALPgRILVGGERFDEA-- 721
Cdd:PRK10252 656 EFfWPFIAGAKLVMAEPEAHRDPLAMQQFFAEYGVTTTHFVPSMLAAFVASltpeGARQSCASLR-QVFCSGEALPADlc 734
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 722 -SWEvaaGWRRCQVFNLYGPTEATVNAS--------LARVAEHARPtIGRALANVDLHVVDGLGRRKTRGASGELWIGGA 792
Cdd:PRK10252 735 rEWQ---QLTGAPLHNLYGPTEAAVDVSwypafgeeLAAVRGSSVP-IGYPVWNTGLRILDARMRPVPPGVAGDLYLTGI 810
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 793 GVARGYAGDAGEAAGRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV 872
Cdd:PRK10252 811 QLAQGYLGRPDLTASRFIADPFAPGERMYRTGDVARWLDDGAVEYLGRSDDQLKIRGQRIELGEIDRAMQALPDVEQAVT 890
|
490 500
....*....|....*....|....*.
gi 15597498 873 LTDE--ADAAEPGADRRIVAFVTAAE 896
Cdd:PRK10252 891 HACVinQAAATGGDARQLVGYLVSQS 916
|
|
| GrsT |
COG3208 |
Surfactin synthase thioesterase subunit [Secondary metabolites biosynthesis, transport and ... |
1880-2114 |
1.90e-74 |
|
Surfactin synthase thioesterase subunit [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442441 [Multi-domain] Cd Length: 237 Bit Score: 247.84 E-value: 1.90e-74
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1880 SAQPRLRLIALPPAGGNAGTFRGWDARLPADVELLAIQYPGRQERQDEPFVTDVEAMLCAIDDALLPLLDRPFALIGASL 1959
Cdd:COG3208 2 RPDARLRLFCFPYAGGSASAYRPWAAALPPDIEVLAVQLPGRGDRLGEPPLTSLEELADDLAEELAPLLDRPFALFGHSM 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1960 GGMLAYELAARLESLHGLRARQLFVISSRAPGPDLEYPRFHAMGDAELLRTLREYDVLPLEVLDDPELREISLATLRADS 2039
Cdd:COG3208 82 GALLAFELARRLERRGRPLPAHLFVSGRRAPHLPRRRRPLHDLSDAELLAELRRLGGTPEEVLADPELLELFLPILRADF 161
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 15597498 2040 RLAADYRYRPREPLAIPITAILGEQDPGVSRVAIDGWRRHASR-YELETLAGGHGLVVTAAEEVCAILRQRLAPDV 2114
Cdd:COG3208 162 RLLETYRYTPGPPLDCPITALGGDDDPLVSPEELAAWREHTTGpFRLRVFPGGHFFLRDHPAELLALIRAALAALA 237
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
196-897 |
5.07e-74 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 276.45 E-value: 5.07e-74
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 196 LAGEDGESASGYWREQAAvAAESPLALADDL-------GEGEWTARRLLPRALLERLAA---------NGLPEAAALLAW 259
Cdd:PRK12316 4273 LQRQDAAASEAFWREQLA-ALDEPTRLAQAIaradlrsANGYGEHVRELDATATARLREfartqrvtlNTLVQAAWLLLL 4351
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 260 TQVAGQFQGDEGLPlemarlVSGRL--FNEFAELAGPFAGVAPLCLENVRAGSVGERLDALQAAILAQEEAAALrdPFAP 337
Cdd:PRK12316 4352 QRYTGQDTVAFGAT------VAGRPaeLPGIEGQIGLFINTLPVIATPRAQQSVVEWLQQVQRQNLALREHEHT--PLYE 4423
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 338 DWPLAELGFAWLAGEL---DGAGVAELDCRQPPlGGFLELQVLPHGEGR----LA-----SLRVR----RDH-DGTLAGR 400
Cdd:PRK12316 4424 IQRWAGQGGEALFDSLlvfENYPVSEALQQGAP-GGLRFGEVTNHEQTNypltLAvglgeTLSLQfsydRGHfDAATIER 4502
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 401 LLDAWVECLESIAADRQLPLAGLPLIGAAERERY-QAWQGERVE-PAP--VESLVAAfdlRAALQPQAPALLDAHGSLDF 476
Cdd:PRK12316 4503 LARHLTNLLEAMAEDPQRRLGELQLLEKAEQQRIvALWNRTDAGyPATrcVHQLVAE---RARMTPDAVAVVFDEEKLTY 4579
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 477 ATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALADAECA 556
Cdd:PRK12316 4580 AELNRRANRLAHALIARGVGPEVLVGIAMERSAEMMVGLLAVLKAGGAYVPLDPEYPRERLAYMMEDSGAALLLTQSHLL 4659
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 557 GRAREAFAGACLDLS-TLPLAGSGMSLPAPG--GRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARtvyANVVGEGL 633
Cdd:PRK12316 4660 QRLPIPDGLASLALDrDEDWEGFPAHDPAVRlhPDNLAYVIYTSGSTGRPKGVAVSHGSLVNHLHATGE---RYELTPDD 4736
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 634 RVTVNAPFSFDSSIKQILQLLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPALPGRILV 713
Cdd:PRK12316 4737 RVLQFMSFSFDGSHEGLYHPLINGASVVIRDDSLWDPERLYAEIHEHRVTVLVFPPVYLQQLAEHAERDGEPPSLRVYCF 4816
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 714 GGERFDEASWEVAagWRRCQV---FNLYGPTEATVNASLARVAEHARPT-----IGRALANVDLHVVDGLGRRKTRGASG 785
Cdd:PRK12316 4817 GGEAVAQASYDLA--WRALKPvylFNGYGPTETTVTVLLWKARDGDACGaaympIGTPLGNRSGYVLDGQLNPLPVGVAG 4894
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 786 ELWIGGAGVARGYAGDAGEAAGRFVEE--GWPGsGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLE 863
Cdd:PRK12316 4895 ELYLGGEGVARGYLERPALTAERFVPDpfGAPG-GRLYRTGDLARYRADGVIDYLGRVDHQVKIRGFRIELGEIEARLRE 4973
|
730 740 750
....*....|....*....|....*....|....
gi 15597498 864 HPAVGEAAVLtdeadAAEPGADRRIVAFVTAAEE 897
Cdd:PRK12316 4974 HPAVREAVVI-----AQEGAVGKQLVGYVVPQDP 5002
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
196-909 |
9.78e-74 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 275.68 E-value: 9.78e-74
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 196 LAGEDGESASGYWREQAAvAAESPLALADDL-------GEGEW-------TARRLLPRALLERLAANGLPEAAALLAWTQ 261
Cdd:PRK12316 1727 LQRQDAAASEAFWKEQLA-ALEEPTRLAQAArtedgqvGYGDHqqlldpaQTRALAEFARAQKVTLNTLVQAAWLLLLQR 1805
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 262 VAGQfqgdegLPLEMARLVSGRLfnefAELAGP------FAGVAPLCLENVRAGSVGERLDALQAAILAqeeaaaLRDpf 335
Cdd:PRK12316 1806 YTGQ------ETVAFGATVAGRP----AELPGIeqqiglFINTLPVIAAPRPDQSVADWLQEVQALNLA------LRE-- 1867
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 336 APDWPLAEL-GFAWLAGE--------LDGAGVAELDCRQPPLG-GFLELQV-------LPHGEGRLASLRV-----RRDH 393
Cdd:PRK12316 1868 HEHTPLYDIqRWAGQGGEalfdsllvFENYPVAEALKQGAPAGlVFGRVSNheqtnypLTLAVTLGETLSLqysydRGHF 1947
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 394 DGTLAGRLLDAWVECLESIAADRQLPLAGLPLIGAAERERYQAWQGERVEPAPVESLV-AAFDLRAALQPQAPALLDAHG 472
Cdd:PRK12316 1948 DAAAIERLDRHLLHLLEQMAEDAQAALGELALLDAGERQRILADWDRTPEAYPRGPGVhQRIAEQAARAPEAIAVVFGDQ 2027
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 473 SLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALAD 552
Cdd:PRK12316 2028 HLSYAELDSRANRLAHRLRARGVGPEVRVAIAAERSFELVVALLAVLKAGGAYVPLDPNYPAERLAYMLEDSGAALLLTQ 2107
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 553 AECAGRAREAFAGACLDLST-LPLAGSGMSLPAP--GGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTVYanvV 629
Cdd:PRK12316 2108 RHLLERLPLPAGVARLPLDRdAEWADYPDTAPAVqlAGENLAYVIYTSGSTGLPKGVAVSHGALVAHCQAAGERYE---L 2184
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 630 GEGLRVTVNAPFSFDSSIKQILQ-LLSGHCLVLVPQEVRsDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPALP 708
Cdd:PRK12316 2185 SPADCELQFMSFSFDGAHEQWFHpLLNGARVLIRDDELW-DPEQLYDEMERHGVTILDFPPVYLQQLAEHAERDGRPPAV 2263
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 709 GRILVGGERFDEASWE-VAAGWRRCQVFNLYGPTEATVNASL--ARVAE---HARPTIGRALANVDLHVVDGLGRRKTRG 782
Cdd:PRK12316 2264 RVYCFGGEAVPAASLRlAWEALRPVYLFNGYGPTEAVVTPLLwkCRPQDpcgAAYVPIGRALGNRRAYILDADLNLLAPG 2343
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 783 ASGELWIGGAGVARGYAGDAGEAAGRFVEEGWPGSG-RLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSAL 861
Cdd:PRK12316 2344 MAGELYLGGEGLARGYLNRPGLTAERFVPDPFSASGeRLYRTGDLARYRADGVVEYLGRIDHQVKIRGFRIELGEIEARL 2423
|
730 740 750 760 770
....*....|....*....|....*....|....*....|....*....|...
gi 15597498 862 LEHPAVGEAAVLtdeadAAEPGADRRIVAFV---TAAEETADE--SWLEVDLP 909
Cdd:PRK12316 2424 QAHPAVREAVVV-----AQDGASGKQLVAYVvpdDAAEDLLAElrAWLAARLP 2471
|
|
| A_NRPS_ACVS-like |
cd17648 |
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV ... |
462-909 |
4.71e-73 |
|
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV synthetase (ACVS, EC 6.3.2.26; also known as N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase or delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase) is involved in medically important antibiotic biosynthesis. ACV synthetase is active in an early step in the penicillin G biosynthesis pathway which involves the formation of the tripeptide 6-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine (ACV); each of the constituent amino acids of the tripeptide ACV are activated as aminoacyl-adenylates with peptide bonds formed through the participation of amino acid thioester intermediates. ACV is then cyclized by the action of isopenicillin N synthase.
Pssm-ID: 341303 [Multi-domain] Cd Length: 453 Bit Score: 252.32 E-value: 4.71e-73
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 462 PQAPALLDAHGSLDFATLRARSEAVAEALLAAG-VRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVErm 540
Cdd:cd17648 1 PDRVAVVYGDKRLTYRELNERANRLAHYLLSVAeIRPDDLVGLVLDKSELMIIAILAVWKAGAAYVPIDPSYPDERIQ-- 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 541 reaggivFALADAEcagrAReafagacldlstLPLAGSgmslpapggRDAAYMIFTSGTSGQPKGVVVEHASALNLSQAL 620
Cdd:cd17648 79 -------FILEDTG----AR------------VVITNS---------TDLAYAIYTSGTTGKPKGVLVEHGSVVNLRTSL 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 621 ARtVYANVVGEGLRVTVNAPFSFDSSIKQI-LQLLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAG 699
Cdd:cd17648 127 SE-RYFGRDNGDEAVLFFSNYVFDFFVEQMtLALLNGQKLVVPPDEMRFDPDRFYAYINREKVTYLSGTPSVLQQYDLAR 205
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 700 LDDAHpalpgRILVGGERFDEASWEVAAGWRRCQVFNLYGPTEATVNASLARVAEHAR--PTIGRALANVDLHVVDGLGR 777
Cdd:cd17648 206 LPHLK-----RVDAAGEEFTAPVFEKLRSRFAGLIINAYGPTETTVTNHKRFFPGDQRfdKSLGRPVRNTKCYVLNDAMK 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 778 RKTRGASGELWIGGAGVARGYAGDAGEAAGRFV-------EEGWPGS-GRLYRSGDLVRWRADGCLEFLGRIDEQVKING 849
Cdd:cd17648 281 RVPVGAVGELYLGGDGVARGYLNRPELTAERFLpnpfqteQERARGRnARLYKTGDLVRWLPSGELEYLGRNDFQVKIRG 360
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 15597498 850 YRIELGEIRSALLEHPAVGEAAVLT-DEADAAEPGADRRIVAFVTAAEETADES----WLEVDLP 909
Cdd:cd17648 361 QRIEPGEVEAALASYPGVRECAVVAkEDASQAQSRIQKYLVGYYLPEPGHVPESdllsFLRAKLP 425
|
|
| A_NRPS_GliP_like |
cd17653 |
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of ... |
453-913 |
1.49e-72 |
|
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of nonribosomal peptide synthases (NRPS) gliotoxin biosynthesis protein P (GliP), thioclapurine biosynthesis protein P (tcpP) and Sirodesmin biosynthesis protein P (SirP). In the filamentous fungus Aspergillus fumigatus, NRPS GliP is involved in the biosynthesis of gliotoxin, which is initiated by the condensation of serine and phenylalanine. Studies show that GliP is not required for invasive aspergillosis, suggesting that the principal targets of gliotoxin are neutrophils or other phagocytes. SirP is a phytotoxin produced by the fungus Leptosphaeria maculans, which causes blackleg disease of canola (Brassica napus). In the fungus Claviceps purpurea, NRPS tcpP catalyzes condensation of tyrosine and glycine, part of biosynthesis of an unusual class of epipolythiodioxopiperazines (ETPs) that lacks the reactive thiol group for toxicity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341308 [Multi-domain] Cd Length: 433 Bit Score: 250.30 E-value: 1.49e-72
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 453 AFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEF 532
Cdd:cd17653 2 AFERIAAAHPDAVAVESLGGSLTYGELDAASNALANRLLQLGVVPGDVVPLLSDRSLEMLVAILAILKAGAAYVPLDAKL 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 533 PAARVERMREAggivfaladaecagrareafAGACLDLSTlplagsgmslpaPGGRDAAYMIFTSGTSGQPKGVVVEHAS 612
Cdd:cd17653 82 PSARIQAILRT--------------------SGATLLLTT------------DSPDDLAYIIFTSGSTGIPKGVMVPHRG 129
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 613 ALNLSQALARTVYanvVGEGLRVTVNAPFSFDSSIKQILQLLS-GHCLVLvpqevrSDPQRMLGFLeERRIDVLDCTPSL 691
Cdd:cd17653 130 VLNYVSQPPARLD---VGPGSRVAQVLSIAFDACIGEIFSTLCnGGTLVL------ADPSDPFAHV-ARTVDALMSTPSI 199
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 692 FRLLLQAGLDDAHpalpgRILVGGErfdEASWEVAAGW--RRCqVFNLYGPTEATVNASLARVAEHARPTIGRALANVDL 769
Cdd:cd17653 200 LSTLSPQDFPNLK-----TIFLGGE---AVPPSLLDRWspGRR-LYNAYGPTECTISSTMTELLPGQPVTIGKPIPNSTC 270
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 770 HVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEG-WPGSgRLYRSGDLVRWRADGCLEFLGRIDEQVKIN 848
Cdd:cd17653 271 YILDADLQPVPEGVVGEICISGVQVARGYLGNPALTASKFVPDPfWPGS-RMYRTGDYGRWTEDGGLEFLGREDNQVKVR 349
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 849 GYRIELGEIRS-ALLEHPAVGEAAVLTDEAdaaepgadrRIVAFVTAaeETAD----ESWLEVDLPSGHR 913
Cdd:cd17653 350 GFRINLEEIEEvVLQSQPEVTQAAAIVVNG---------RLVAFVTP--ETVDvdglRSELAKHLPSYAV 408
|
|
| A_NRPS_LgrA-like |
cd17645 |
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This ... |
454-909 |
2.00e-69 |
|
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes linear gramicidin synthetase (LgrA) in Brevibacillus brevis. LgrA has a formylation domain fused to the N-terminal end that formylates its substrate for linear gramicidin synthesis to proceed. This formyl group is essential for the clinically important antibacterial activity of gramicidin by enabling head-to-head gramicidin dimers to make a beta-helical pore in gram-positive bacterial membranes, allowing free passage of monovalent cations, destroying the ion gradient and killing bacteria. This family also includes bacitracin synthetase 1 (known as ATP-dependent cysteine adenylase or BA1); it activates cysteine, incorporates two D-amino acids, releases and cyclizes the mature bacitracin, an antibiotic that is a mixture of related cyclic peptides that disrupt gram positive bacteria by interfering with cell wall and peptidoglycan synthesis. Also included is surfactin synthetase which activates and polymerizes the amino acids Leu, Glu, Asp, and Val to form the antibiotic surfactin.
Pssm-ID: 341300 [Multi-domain] Cd Length: 440 Bit Score: 241.30 E-value: 2.00e-69
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 454 FDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFP 533
Cdd:cd17645 4 FEEQVERTPDHVAVVDRGQSLTYKQLNEKANQLARHLRGKGVKPDDQVGIMLDKSLDMIAAILGVLKAGGAYVPIDPDYP 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 534 AARVERMREAGGIVFALADAEcagrareafagacldlstlplagsgmslpapggrDAAYMIFTSGTSGQPKGVVVEHASA 613
Cdd:cd17645 84 GERIAYMLADSSAKILLTNPD----------------------------------DLAYVIYTSGSTGLPKGVMIEHHNL 129
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 614 LNLSQaLARTVYAnvVGEGLRVTVNAPFSFDSSIKQIL-QLLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLdctpslf 692
Cdd:cd17645 130 VNLCE-WHRPYFG--VTPADKSLVYASFSFDASAWEIFpHLTAGAALHVVPSERRLDLDALNDYFNQEGITIS------- 199
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 693 rlLLQAGLDDAHPALPGR----ILVGGE---RFDEASWevaagwrrcQVFNLYGPTEATVNASLARV-AEHARPTIGRAL 764
Cdd:cd17645 200 --FLPTGAAEQFMQLDNQslrvLLTGGDklkKIERKGY---------KLVNNYGPTENTVVATSFEIdKPYANIPIGKPI 268
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 765 ANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRIDEQ 844
Cdd:cd17645 269 DNTRVYILDEALQLQPIGVAGELCIAGEGLARGYLNRPELTAEKFIVHPFVPGERMYRTGDLAKFLPDGNIEFLGRLDQQ 348
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 15597498 845 VKINGYRIELGEIRSALLEHPAVGEAAVLTDEadaaEPGADRRIVAFVTAAEETADE---SWLEVDLP 909
Cdd:cd17645 349 VKIRGYRIEPGEIEPFLMNHPLIELAAVLAKE----DADGRKYLVAYVTAPEEIPHEelrEWLKNDLP 412
|
|
| MenE/FadK |
COG0318 |
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid ... |
450-901 |
2.77e-69 |
|
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) is part of the Pathway/BioSystem: Menaquinone biosynthesis
Pssm-ID: 440087 [Multi-domain] Cd Length: 452 Bit Score: 241.25 E-value: 2.77e-69
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 450 LVAAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVN 529
Cdd:COG0318 1 LADLLRRAAARHPDRPALVFGGRRLTYAELDARARRLAAALRALGVGPGDRVALLLPNSPEFVVAFLAALRAGAVVVPLN 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 530 PEFPAARVERMreaggivfaLADAECAgrareafagACLdlstlplagsgmslpapggrdAAYMIFTSGTSGQPKGVVVE 609
Cdd:COG0318 81 PRLTAEELAYI---------LEDSGAR---------ALV---------------------TALILYTSGTTGRPKGVMLT 121
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 610 HASALNLSQALARTVYanvVGEGLRVTVNAPFSFDSSIKQILQ--LLSGHCLVLVPqevRSDPQRMLGFLEERRIDVLDC 687
Cdd:COG0318 122 HRNLLANAAAIAAALG---LTPGDVVLVALPLFHVFGLTVGLLapLLAGATLVLLP---RFDPERVLELIERERVTVLFG 195
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 688 TPSLFRLLLQAgLDDAHPALPG--RILVGGERFDEASWEVAAGWRRCQVFNLYGPTEATVNASLARVAEHARP--TIGRA 763
Cdd:COG0318 196 VPTMLARLLRH-PEFARYDLSSlrLVVSGGAPLPPELLERFEERFGVRIVEGYGLTETSPVVTVNPEDPGERRpgSVGRP 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 764 LANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFvEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDE 843
Cdd:COG0318 275 LPGVEVRIVDEDGRELPPGEVGEIVVRGPNVMKGYWNDPEATAEAF-RDGW------LRTGDLGRLDEDGYLYIVGRKKD 347
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 15597498 844 QVKINGYRIELGEIRSALLEHPAVGEAAVltdeADAAEPGADRRIVAFVTA---AEETADE 901
Cdd:COG0318 348 MIISGGENVYPAEVEEVLAAHPGVAEAAV----VGVPDEKWGERVVAFVVLrpgAELDAEE 404
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
400-902 |
4.29e-69 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 260.10 E-value: 4.29e-69
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 400 RLLDAWVECLESIAADRQLPLAGLPLIGAAERERYQAWQGERVEPAPVeSLVAAFDLRAALQPQAPALLDAHGSLDFATL 479
Cdd:PRK05691 1084 RLAEHFLALLEQVCEDPQRALGDVQLLDAAERAQLAQWGQAPCAPAQA-WLPELLNEQARQTPERIALVWDGGSLDYAEL 1162
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 480 RARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALADAECAGRA 559
Cdd:PRK05691 1163 HAQANRLAHYLRDKGVGPDVCVAIAAERSPQLLVGLLAILKAGGAYVPLDPDYPAERLAYMLADSGVELLLTQSHLLERL 1242
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 560 REAFAGACLDLSTLPLAGSGMSlpAPG----GRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTvYAnvVGEGLRV 635
Cdd:PRK05691 1243 PQAEGVSAIALDSLHLDSWPSQ--APGlhlhGDNLAYVIYTSGSTGQPKGVGNTHAALAERLQWMQAT-YA--LDDSDVL 1317
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 636 TVNAPFSFDSSIKQ-ILQLLSGHCLVLV-PQEVRsDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPALPgRILV 713
Cdd:PRK05691 1318 MQKAPISFDVSVWEcFWPLITGCRLVLAgPGEHR-DPQRIAELVQQYGVTTLHFVPPLLQLFIDEPLAAACTSLR-RLFS 1395
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 714 GGERFD-EASWEVAAGWRRCQVFNLYGPTEATVNAS--LARVAEHARPTIGRALANVDLHVVDGLGRRKTRGASGELWIG 790
Cdd:PRK05691 1396 GGEALPaELRNRVLQRLPQVQLHNRYGPTETAINVThwQCQAEDGERSPIGRPLGNVLCRVLDAELNLLPPGVAGELCIG 1475
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 791 GAGVARGYAGDAGEAAGRFVEEGWPGSG-RLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGE 869
Cdd:PRK05691 1476 GAGLARGYLGRPALTAERFVPDPLGEDGaRLYRTGDRARWNADGALEYLGRLDQQVKLRGFRVEPEEIQARLLAQPGVAQ 1555
|
490 500 510
....*....|....*....|....*....|...
gi 15597498 870 AAVLTDEaDAAEPgadrRIVAFVTAAEETADES 902
Cdd:PRK05691 1556 AAVLVRE-GAAGA----QLVGYYTGEAGQEAEA 1583
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
2-900 |
9.71e-67 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 252.57 E-value: 9.71e-67
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 2 SASEDLQSAVQPAASEALEGFPL--SPLQTRAWRRHAERPENTVVGVRLHAPADPVATLERLRRALDGEAQLRVAYRTMP 79
Cdd:PRK12316 2581 ASLESGQTSRAPVLQKVTRVQPLplSHAQQRQWFLWQLEPESAAYHLPSALHLRGVLDQAALEQAFDALVLRHETLRTRF 2660
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 80 GMSLPVQVLDGRAADLLVERLPGDGDWAGRFARES-ARLAASPLGGEGQPVLALGLLLDAAGEtlQGLLLAAPAFVVDAA 158
Cdd:PRK12316 2661 VEVGEQTRQVILPNMSLRIVLEDCAGVADAAIRQRvAEEIQRPFDLARGPLLRVRLLALDGQE--HVLVITQHHIVSDGW 2738
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 159 SLVALLRRGLGPAGQASADEGDE----ALLFQHFSEWANEALAGEDGESASGYWREQ---AAVAAESPLALADDLGEGEW 231
Cdd:PRK12316 2739 SMQVMVDELVQAYAGARRGEQPTlpplPLQYADYAAWQRAWMDSGEGARQLDYWRERlggEQPVLELPLDRPRPALQSHR 2818
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 232 TARRL------LPRALLERLAANGLPEAAALLAWTQV-----AGQFQGDEGLPlemarlVSGRLFNEFAELAGPFAGVAP 300
Cdd:PRK12316 2819 GARLDvaldvaLSRELLALARREGVTLFMLLLASFQVllhrySGQSDIRVGVP------IANRNRAETERLIGFFVNTQV 2892
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 301 LCLENVRAGSVGERLDALQAAILAQE--EAAALRDPFAPDWPLAELGFAWL-------------AGELDGAGVAELDCRQ 365
Cdd:PRK12316 2893 LRAQVDAQLAFRDLLGQVKEQALGAQahQDLPFEQLVEALQPERSLSHSPLfqvmynhqsgeraAAQLPGLHIESFAWDG 2972
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 366 PPLGGFLELQVLPHGEGRLASLRVRRDH-DGTLAGRLLDAWVECLESIAADRQLPLAGLPLIGAAERER-YQAWQGERVE 443
Cdd:PRK12316 2973 AATQFDLALDTWESAEGLGASLTYATDLfDARTVERLARHWQNLLRGMVENPQRSVDELAMLDAEERGQlLEAWNATAAE 3052
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 444 PAPVESLVAAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAA 523
Cdd:PRK12316 3053 YPLERGVHRLFEEQVERTPDAVALAFGEQRLSYAELNRRANRLAHRLIERGVGPDVLVGVAVERSLEMVVGLLAILKAGG 3132
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 524 VYTPVNPEFPAARVERMREAGGIVFALADAECAGRAREAFAGACLDLSTLPLAGSGMSLPAPGgRDAAYMIFTSGTSGQP 603
Cdd:PRK12316 3133 AYVPLDPEYPEERLAYMLEDSGAQLLLSQSHLRLPLAQGVQVLDLDRGDENYAEANPAIRTMP-ENLAYVIYTSGSTGKP 3211
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 604 KGVVVEHASALNLSQALARTVyanVVGEGLRVTVNAPFSFDSSIKQIL-QLLSGHCLVLVPQEVRSDPQRMLGFLEERRI 682
Cdd:PRK12316 3212 KGVGIRHSALSNHLCWMQQAY---GLGVGDRVLQFTTFSFDVFVEELFwPLMSGARVVLAGPEDWRDPALLVELINSEGV 3288
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 683 DVLDCTPSLFRLLLQAGLDDAHPALPGRILVGGERFDEASWEVAAGWrrcQVFNLYGPTEATVNASLARVAEH--ARPTI 760
Cdd:PRK12316 3289 DVLHAYPSMLQAFLEEEDAHRCTSLKRIVCGGEALPADLQQQVFAGL---PLYNLYGPTEATITVTHWQCVEEgkDAVPI 3365
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 761 GRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGR 840
Cdd:PRK12316 3366 GRPIANRACYILDGSLEPVPVGALGELYLGGEGLARGYHNRPGLTAERFVPDPFVPGERLYRTGDLARYRADGVIEYIGR 3445
|
890 900 910 920 930 940
....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 841 IDEQVKINGYRIELGEIRSALLEHPAVGEAAVLTDEAdaaepgadRRIVAFVTAAEETAD 900
Cdd:PRK12316 3446 VDHQVKIRGFRIELGEIEARLLEHPWVREAVVLAVDG--------RQLVAYVVPEDEAGD 3497
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
400-901 |
1.49e-64 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 245.08 E-value: 1.49e-64
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 400 RLLDAWVECLESIAADRQLPLAGLPLIGAAERERYQAW-QGERVEPAPVESLVAAFDLRAALQPQAPALLDAHGSLDFAT 478
Cdd:PRK05691 2139 RMAEHWQNLLEALLGDPQQRLAELPLLAAAEQQQLLDSlAGEAGEARLDQTLHGLFAAQAARTPQAPALTFAGQTLSYAE 2218
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 479 LRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALADA---EC 555
Cdd:PRK05691 2219 LDARANRLARALRERGVGPQVRVGLALERSLEMVVGLLAILKAGGAYVPLDPEYPLERLHYMIEDSGIGLLLSDRalfEA 2298
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 556 AGRAREAFAGACLDLSTLPLAG-SGMSLPA-PGGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTVyanvvgeGL 633
Cdd:PRK05691 2299 LGELPAGVARWCLEDDAAALAAySDAPLPFlSLPQHQAYLIYTSGSTGKPKGVVVSHGEIAMHCQAVIERF-------GM 2371
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 634 R--------VTVNapfsFDSSIKQIL-QLLSGHCLVLVPQEvRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAgLDDAH 704
Cdd:PRK05691 2372 RaddcelhfYSIN----FDAASERLLvPLLCGARVVLRAQG-QWGAEEICQLIREQQVSILGFTPSYGSQLAQW-LAGQG 2445
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 705 PALPGRILV-GGERFDEASWE-VAAGWRRCQVFNLYGPTEaTVNASLARVAEHARPT------IGRALANVDLHVVDGLG 776
Cdd:PRK05691 2446 EQLPVRMCItGGEALTGEHLQrIRQAFAPQLFFNAYGPTE-TVVMPLACLAPEQLEEgaasvpIGRVVGARVAYILDADL 2524
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 777 RRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGW-PGSGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELG 855
Cdd:PRK05691 2525 ALVPQGATGELYVGGAGLAQGYHDRPGLTAERFVADPFaADGGRLYRTGDLVRLRADGLVEYVGRIDHQVKIRGFRIELG 2604
|
490 500 510 520
....*....|....*....|....*....|....*....|....*.
gi 15597498 856 EIRSALLEHPAVGEAAVLtdeadAAEPGADRRIVAFVTAAEETADE 901
Cdd:PRK05691 2605 EIESRLLEHPAVREAVVL-----ALDTPSGKQLAGYLVSAVAGQDD 2645
|
|
| A_NRPS_ProA |
cd17656 |
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the ... |
462-909 |
2.04e-62 |
|
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains gramicidin S synthase 2 (also known as ATP-dependent proline adenylase or proline activase or ProA). ProA is a multifunctional enzyme involved in synthesis of the cyclic peptide antibiotic gramicidin S and able to activate and polymerize the amino acids proline, valine, ornithine and leucine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341311 [Multi-domain] Cd Length: 479 Bit Score: 222.35 E-value: 2.04e-62
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 462 PQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMR 541
Cdd:cd17656 2 PDAVAVVFENQKLTYRELNERSNQLARFLREKGVKKDSIVAIMMERSAEMIVGILGILKAGGAFVPIDPEYPEERRIYIM 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 542 EAGGIVFALADAECAGRAREAFAGACLDLSTLPlAGSGMSLPAP-GGRDAAYMIFTSGTSGQPKGVVVEHASALNLsqaL 620
Cdd:cd17656 82 LDSGVRVVLTQRHLKSKLSFNKSTILLEDPSIS-QEDTSNIDYInNSDDLLYIIYTSGTTGKPKGVQLEHKNMVNL---L 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 621 ARTVYANVVGEGLRVTVNAPFSFDSSIKQILQ-LLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLlqAG 699
Cdd:cd17656 158 HFEREKTNINFSDKVLQFATCSFDVCYQEIFStLLSGGTLYIIREETKRDVEQLFDLVKRHNIEVVFLPVAFLKFI--FS 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 700 LDDAHPALP---GRILVGGER------FDEASWEvaagwRRCQVFNLYGPTEATVnASLARVAEHAR----PTIGRALAN 766
Cdd:cd17656 236 EREFINRFPtcvKHIITAGEQlvitneFKEMLHE-----HNVHLHNHYGPSETHV-VTTYTINPEAEipelPPIGKPISN 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 767 VDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRIDEQVK 846
Cdd:cd17656 310 TWIYILDQEQQLQPQGIVGELYISGASVARGYLNRQELTAEKFFPDPFDPNERMYRTGDLARYLPDGNIEFLGRADHQVK 389
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 15597498 847 INGYRIELGEIRSALLEHPAVGEAAVLTDEADAAEpgadRRIVAFVTAAEETADE---SWLEVDLP 909
Cdd:cd17656 390 IRGYRIELGEIEAQLLNHPGVSEAVVLDKADDKGE----KYLCAYFVMEQELNISqlrEYLAKQLP 451
|
|
| DCL_NRPS |
cd19543 |
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the ... |
1361-1776 |
2.71e-62 |
|
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor; The DCL-type Condensation (C) domain catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. This domain is D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains in addition to the LCL- and DCL-types such as starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380465 [Multi-domain] Cd Length: 423 Bit Score: 220.15 E-value: 2.71e-62
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1361 YPMTSLQQGMLLQSEASGDPRLLHNVVLHEVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQVPLQWVHPAtaVAAEV 1440
Cdd:cd19543 2 YPLSPMQEGMLFHSLLDPGSGAYVEQMVITLEGPLDPDRFRAAWQAVVDRHPILRTSFVWEGLGEPLQVVLKD--RKLPW 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1441 PVHDLCGLDGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLL 1520
Cdd:cd19543 80 RELDLSHLSEAEQEAELEALAEEDRERGFDLARAPLMRLTLIRLGDDRYRLVWSFHHILLDGWSLPILLKELFAIYAALG 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1521 AGvvaREAEAPAVG-FRDYVA-LEREaEANAASAlFWLDYLAGARYR-PLP---GLAEEGPRRMAAVRVDVPADSLSRLR 1594
Cdd:cd19543 160 EG---QPPSLPPVRpYRDYIAwLQRQ-DKEAAEA-YWREYLAGFEEPtPLPkelPADADGSYEPGEVSFELSAELTARLQ 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1595 ALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPEE-PGADRLLGLFLNTLPCRLSASVDllDSARRAF-DYE 1672
Cdd:cd19543 235 ELARQHGVTLNTVVQGAWALLLSRYSGRDDVVFGTTVSGRPAElPGIETMVGLFINTLPVRVRLDPD--QTVLELLkDLQ 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1673 RASLEHRRH---PLAAIRR---RNRELrLDSLFNFVDFhQDDAAPAGVRHGGILDQVVVDVDVPLAVDFEVA---GERLE 1743
Cdd:cd19543 313 AQQLELREHeyvPLYEIQAwseGKQAL-FDHLLVFENY-PVDESLEEEQDEDGLRITDVSAEEQTNYPLTVVaipGEELT 390
|
410 420 430
....*....|....*....|....*....|...
gi 15597498 1744 VGFQYAAGRFPAERAEALAGAYREALLALLGDP 1776
Cdd:cd19543 391 IKLSYDAEVFDEATIERLLGHLRRVLEQVAANP 423
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
420-909 |
4.08e-54 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 210.79 E-value: 4.08e-54
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 420 LAGLPLIGAAERE--RYQAWQGERVEPAPvESLVAAFDLRAALQPQ--APALLDAhgSLDFATLRARSEAVAEALLAAGV 495
Cdd:PRK05691 3691 LSELPLLGEQERDflLDGCNRSERDYPLE-QSYVRLFEAQVAAHPQriAASCLDQ--QWSYAELNRAANRLGHALRAAGV 3767
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 496 RPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALADAECAGRAREAFAG-ACLDLSTL- 573
Cdd:PRK05691 3768 GVDQPVALLAERGLDLLGMIVGSFKAGAGYLPLDPGLPAQRLQRIIELSRTPVLVCSAACREQARALLDElGCANRPRLl 3847
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 574 ---PLAGSGMSLPAPG---GRDA-AYMIFTSGTSGQPKGVVVEHASALNlsQALARTVYANVvGEGLRVTVNAPFSFDSS 646
Cdd:PRK05691 3848 vweEVQAGEVASHNPGiysGPDNlAYVIYTSGSTGLPKGVMVEQRGMLN--NQLSKVPYLAL-SEADVIAQTASQSFDIS 3924
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 647 IKQILQL-LSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLfrllLQAGLDDAHPALPGR--ILVGGERFDEasw 723
Cdd:PRK05691 3925 VWQFLAApLFGARVEIVPNAIAHDPQGLLAHVQAQGITVLESVPSL----IQGMLAEDRQALDGLrwMLPTGEAMPP--- 3997
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 724 EVAAGW--RRCQV--FNLYGPTEATVNASLARV-AEHARPT---IGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVA 795
Cdd:PRK05691 3998 ELARQWlqRYPQIglVNAYGPAECSDDVAFFRVdLASTRGSylpIGSPTDNNRLYLLDEALELVPLGAVGELCVAGTGVG 4077
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 796 RGYAGDAGEAAGRFVEE--GWPGSgRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:PRK05691 4078 RGYVGDPLRTALAFVPHpfGAPGE-RLYRTGDLARRRSDGVLEYVGRIDHQVKIRGYRIELGEIEARLHEQAEVREAAVA 4156
|
490 500 510 520
....*....|....*....|....*....|....*....|....
gi 15597498 874 TDEADAAepgadRRIVAFVTAAEETADES--------WLEVDLP 909
Cdd:PRK05691 4157 VQEGVNG-----KHLVGYLVPHQTVLAQGallerikqRLRAELP 4195
|
|
| AFD_class_I |
cd04433 |
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as ... |
589-904 |
3.70e-53 |
|
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as the ANL (acyl-CoA synthetases, the NRPS adenylation domains, and the Luciferase enzymes) superfamily. It includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases.The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341228 [Multi-domain] Cd Length: 336 Bit Score: 190.57 E-value: 3.70e-53
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTVYanvVGEGLRVTVNAPFSFDSSIKQILQ-LLSGHCLVLVPqevR 667
Cdd:cd04433 1 DPALILYTSGTTGKPKGVVLSHRNLLAAAAALAASGG---LTEGDVFLSTLPLFHIGGLFGLLGaLLAGGTVVLLP---K 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 668 SDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPALPGRILV-GGERFDEASWEVAAGWRRCQVFNLYGPTEATVN 746
Cdd:cd04433 75 FDPEAALELIEREKVTILLGVPTLLARLLKAPESAGYDLSSLRALVsGGAPLPPELLERFEEAPGIKLVNGYGLTETGGT 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 747 ASLARVAEHAR--PTIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAgEAAGRFVEEGWpgsgrlYRSG 824
Cdd:cd04433 155 VATGPPDDDARkpGSVGRPVPGVEVRIVDPDGGELPPGEIGELVVRGPSVMKGYWNNP-EATAAVDEDGW------YRTG 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 825 DLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL-TDEADAAEpgadrRIVAFVTAAE-ETADES 902
Cdd:cd04433 228 DLGRLDEDGYLYIVGRLKDMIKSGGENVYPAEVEAVLLGHPGVAEAAVVgVPDPEWGE-----RVVAVVVLRPgADLDAE 302
|
..
gi 15597498 903 WL 904
Cdd:cd04433 303 EL 304
|
|
| Condensation |
pfam00668 |
Condensation domain; This domain is found in many multi-domain enzymes which synthesize ... |
1359-1779 |
2.20e-51 |
|
Condensation domain; This domain is found in many multi-domain enzymes which synthesize peptide antibiotics. This domain catalyzes a condensation reaction to form peptide bonds in non- ribosomal peptide biosynthesis. It is usually found to the carboxy side of a phosphopantetheine binding domain (pfam00550). It has been shown that mutations in the HHXXXDG motif abolish activity suggesting this is part of the active site.
Pssm-ID: 395541 [Multi-domain] Cd Length: 454 Bit Score: 189.08 E-value: 2.20e-51
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1359 DAYPMTSLQQGMLLQSEASGDPRLLHNVVLHEVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQVPLQWVHPAtaVAA 1438
Cdd:pfam00668 3 DEYPLSPAQKRMWFLEKLEPHSSAYNMPAVLKLTGELDPERLEKALQELINRHDALRTVFIRQENGEPVQVILEE--RPF 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1439 EVPVHDLCGLDGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYAD 1518
Cdd:pfam00668 81 ELEIIDISDLSESEEEEAIEAFIQRDLQSPFDLEKGPLFRAGLFRIAENRHHLLLSMHHIIVDGVSLGILLRDLADLYQQ 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1519 LLAGvvaREAEAPAV-GFRDYVALER---EAEANAASALFWLDYLAG-ARYRPLPGLAEEGP-RRMAA--VRVDVPADSL 1590
Cdd:pfam00668 161 LLKG---EPLPLPPKtPYKDYAEWLQqylQSEDYQKDAAYWLEQLEGeLPVLQLPKDYARPAdRSFKGdrLSFTLDEDTE 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1591 SRLRALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPeEPGADRLLGLFLNTLPCRL--SASVDLLDSARRA 1668
Cdd:pfam00668 238 ELLRKLAKAHGTTLNDVLLAAYGLLLSRYTGQDDIVVGTPGSGRP-SPDIERMVGMFVNTLPLRIdpKGGKTFSELIKRV 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1669 FDYERASLEHRRHPLAAIRRR-------NRELRLDSLFNF---------VDFHQDDAAPAGVRhggildqvvvdVDVPLA 1732
Cdd:pfam00668 317 QEDLLSAEPHQGYPFGDLVNDlrlprdlSRHPLFDPMFSFqnylgqdsqEEEFQLSELDLSVS-----------SVIEEE 385
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|...
gi 15597498 1733 VDFEVA------GERLEVGFQYAAGRFPAERAEALAGAYREALLALLGDPVQP 1779
Cdd:pfam00668 386 AKYDLSltaserGGGLTIKIDYNTSLFDEETIERFAEHFKELLEQAIAHPSQP 438
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1199-1825 |
6.34e-51 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 200.39 E-value: 6.34e-51
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1199 ALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRRALLAALAAEAAAQTLEaPANATEAALLEIWKSVLKRPAIGVSDN 1278
Cdd:PRK12467 975 ELKAQLRQVLPDYMVPAHLLLLDSLPLTPNGKLDRKALPKPDASAVQATFVA-PQTELEKRLAAIWADVLKVERVGLTDN 1053
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1279 FFQVGGDSirLIQMQVMAR---EAGLAFTLRDVFNHQSIRELARLLAaPASPADALGTSAPQSLEPFALLSAAERKRLPE 1355
Cdd:PRK12467 1054 FFELGGHS--LLATQVISRvrqRLGIQVPLRTLFEHQTLAGFAQAVA-AQQQGAQPALPDVDRDQPLPLSYAQERQWFLW 1130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1356 GLDDaypmtslqqgmllQSEASGDPRLLhnvvlhEVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQvPLQWVHPATA 1435
Cdd:PRK12467 1131 QLEP-------------GSAAYHIPQAL------RLKGPLDIEALERSFDALVARHESLRTTFVQEDGR-TRQVIHPVGS 1190
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1436 VAAEVPVHDLCGLDGEtrrlRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAV 1515
Cdd:PRK12467 1191 LTLEEPLLLAADKDEA----QLKVYVEAEARQPFDLEQGPLLRVGLLRLAADEHVLVLTLHHIVSDGWSMQVLVDELVAL 1266
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1516 YADLLAGVVAREAEAPaVGFRDYVALEREAEANAASA---LFWLDYLAGAryRPLPGLAEEGPR------RMAAVRVDVP 1586
Cdd:PRK12467 1267 YAAYSQGQSLQLPALP-IQYADYAVWQRQWMDAGERArqlAYWKAQLGGE--QPVLELPTDRPRpavqshRGARLAFELP 1343
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1587 ADSLSRLRALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPEEPgADRLLGLFLNTLPcrLSASVDLLDSAR 1666
Cdd:PRK12467 1344 PALAEGLRALARREGVTLFMLLLASFQTLLHRYSGQDDIRVGVPIANRNRAE-TEGLIGFFVNTQV--LRAEVDGQASFQ 1420
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1667 RAF-DYERASLEHRRH------PLAAIRRRNRELRLDSLFNFV-----DFHQDDAAPAGVRHGGILDQVVVDVDVPLAVD 1734
Cdd:PRK12467 1421 QLLqQVKQAALEAQAHqdlpfeQLVEALQPERSLSHSPLFQVMfnhqrDDHQAQAQLPGLSVESLSWESQTAQFDLTLDT 1500
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1735 FEvAGERLEVGFQYAAGRFPAERAEALAGAYREALLALLGDPVQPPAAAQAEDSVELRRVLKVLSrvlgrplAADQGFAS 1814
Cdd:PRK12467 1501 YE-SSEGLQASLTYATDLFEASTIERLAGHWLNLLQGLVADPERRLGELDLLDEAERRQILEGWN-------ATHTGYPL 1572
|
650
....*....|..
gi 15597498 1815 AGG-HSLLGVQA 1825
Cdd:PRK12467 1573 ARLvHQLIEDQA 1584
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1192-1804 |
2.79e-50 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 198.26 E-value: 2.79e-50
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRRALLAALAAEAAAQTLEaPANATEAALLEIWKSVLKRP 1271
Cdd:PRK12316 2454 AAEDLLAELRAWLAARLPAYMVPAHWVVLERLPLNPNGKLDRKALPKPDVSQLRQAYVA-PQEGLEQRLAAIWQAVLKVE 2532
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1272 AIGVSDNFFQVGGDSIRLIQMQVMAREA-GLAFTLRDVFNHQSIRELARLLAAPASpADALGTSAPQSLEPFALLSAAER 1350
Cdd:PRK12316 2533 QVGLDDHFFELGGHSLLATQVVSRVRQDlGLEVPLRILFERPTLAAFAASLESGQT-SRAPVLQKVTRVQPLPLSHAQQR 2611
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1351 KRLPEGLDDaypmtslqqgmllQSEASGDPRLLHnvvlheVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQVpLQWV 1430
Cdd:PRK12316 2612 QWFLWQLEP-------------ESAAYHLPSALH------LRGVLDQAALEQAFDALVLRHETLRTRFVEVGEQT-RQVI 2671
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1431 HPATAVAaEVPVHDLCGLDGetrrlRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVD 1510
Cdd:PRK12316 2672 LPNMSLR-IVLEDCAGVADA-----AIRQRVAEEIQRPFDLARGPLLRVRLLALDGQEHVLVITQHHIVSDGWSMQVMVD 2745
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1511 ELLAVYADLLAGVVAREAEAPaVGFRDYVALER---EAEANAASALFWLDYLAGARY-------RPLPGLAEegpRRMAA 1580
Cdd:PRK12316 2746 ELVQAYAGARRGEQPTLPPLP-LQYADYAAWQRawmDSGEGARQLDYWRERLGGEQPvlelpldRPRPALQS---HRGAR 2821
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1581 VRVDVPADSLSRLRALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRpEEPGADRLLGLFLNTLPCRLS---- 1656
Cdd:PRK12316 2822 LDVALDVALSRELLALARREGVTLFMLLLASFQVLLHRYSGQSDIRVGVPIANR-NRAETERLIGFFVNTQVLRAQvdaq 2900
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1657 -ASVDLLDSARRAFDYERASLEHRRHPLAAIRRRNRELRLDSLFNFVDFHQD---DAAPAGVRHGGILDQVVVDVDVPLA 1732
Cdd:PRK12316 2901 lAFRDLLGQVKEQALGAQAHQDLPFEQLVEALQPERSLSHSPLFQVMYNHQSgerAAAQLPGLHIESFAWDGAATQFDLA 2980
|
570 580 590 600 610 620 630
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 15597498 1733 VDFEVAGERLEVGFQYAAGRFPAERAEALAGAYREALLALLGDPVQPPAAAQAEDSVELRRVLKVLSRVLGR 1804
Cdd:PRK12316 2981 LDTWESAEGLGASLTYATDLFDARTVERLARHWQNLLRGMVENPQRSVDELAMLDAEERGQLLEAWNATAAE 3052
|
|
| CT_NRPS-like |
cd19542 |
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike ... |
1361-1776 |
3.71e-48 |
|
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike bacterial NRPS, which typically have specialized terminal thioesterase (TE) domains to cyclize peptide products, many fungal NRPSs employ a terminal condensation-like (CT) domain to produce macrocyclic peptidyl products (e.g. cyclosporine and echinocandin). Domains in this subfamily (which includes both terminal and non-terminal domains) typically have a non-canonical conserved [SN]HxxxDx(14)Y motif at their active site compared to the standard Condensation (C) domain active site motif (HHxxxD). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380464 [Multi-domain] Cd Length: 401 Bit Score: 178.27 E-value: 3.71e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1361 YPMTSLQQGMLLQSEASGdPRLLHNVVLHeVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQVPLQWVhpaTAVAAEV 1440
Cdd:cd19542 2 YPCTPMQEGMLLSQLRSP-GLYFNHFVFD-LDSSVDVERLRNAWRQLVQRHDILRTVFVESSAEGTFLQV---VLKSLDP 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1441 PVHDLcgldgETRRLRLRAWIEEEQATPFDWSRPPL-VRLAALALDERRFALGVaeHHSVLDGWSLQSLVDELLAVYADL 1519
Cdd:cd19542 77 PIEEV-----ETDEDSLDALTRDLLDDPTLFGQPPHrLTLLETSSGEVYLVLRI--SHALYDGVSLPIILRDLAAAYNGQ 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1520 LagvvareaEAPAVGFRDYVALEREAEANAASAlFWLDYLAGARYRPLPGLAeegPRRMAAVRVDVPADSLSRLRALAER 1599
Cdd:cd19542 150 L--------LPPAPPFSDYISYLQSQSQEESLQ-YWRKYLQGASPCAFPSLS---PKRPAERSLSSTRRSLAKLEAFCAS 217
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1600 SGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGR--PeEPGADRLLGLFLNTLPCRL----SASV-DLLDSARRAFDye 1672
Cdd:cd19542 218 LGVTLASLFQAAWALVLARYTGSRDVVFGYVVSGRdlP-VPGIDDIVGPCINTLPVRVkldpDWTVlDLLRQLQQQYL-- 294
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1673 rASLEHRRHPLAAIRRRNRELRLDSLFN-FVDFHQDDAAPAGVRHGGILDQVVVDVDVPL---AVDFEVAGERLEVGFQY 1748
Cdd:cd19542 295 -RSLPHQHLSLREIQRALGLWPSGTLFNtLVSYQNFEASPESELSGSSVFELSAAEDPTEypvAVEVEPSGDSLKVSLAY 373
|
410 420
....*....|....*....|....*...
gi 15597498 1749 AAGRFPAERAEALAGAYREALLALLGDP 1776
Cdd:cd19542 374 STSVLSEEQAEELLEQFDDILEALLANP 401
|
|
| PRK04813 |
PRK04813 |
D-alanine--poly(phosphoribitol) ligase subunit DltA; |
449-873 |
2.25e-43 |
|
D-alanine--poly(phosphoribitol) ligase subunit DltA;
Pssm-ID: 235313 [Multi-domain] Cd Length: 503 Bit Score: 166.99 E-value: 2.25e-43
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 449 SLVAAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPV 528
Cdd:PRK04813 3 DIIETIEEFAQTQPDFPAYDYLGEKLTYGQLKEDSDALAAFIDSLKLPDKSPIIVFGHMSPEMLATFLGAVKAGHAYIPV 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 529 NPEFPAARVERMREAGG--IVFALADAEcagrareafagacLDLSTLP------LAGSGMSLPAP------GGRDAAYMI 594
Cdd:PRK04813 83 DVSSPAERIEMIIEVAKpsLIIATEELP-------------LEILGIPvitldeLKDIFATGNPYdfdhavKGDDNYYII 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 595 FTSGTSGQPKGVVVEHASALNLSQALartVYANVVGEGLRVTVNAPFSFDSSIKQI-LQLLSGHCLVLVPQEVRSDPQRM 673
Cdd:PRK04813 150 FTSGTTGKPKGVQISHDNLVSFTNWM---LEDFALPEGPQFLNQAPYSFDLSVMDLyPTLASGGTLVALPKDMTANFKQL 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 674 LGFLEERRIDVLDCTPSLFRL-LLQAGLDDAH-PALPgRILVGGE------------RFDEAswevaagwrrcQVFNLYG 739
Cdd:PRK04813 227 FETLPQLPINVWVSTPSFADMcLLDPSFNEEHlPNLT-HFLFCGEelphktakklleRFPSA-----------TIYNTYG 294
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 740 PTEATVNASLARV-----AEHARPTIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGD-AGEAAGRFVEEG 813
Cdd:PRK04813 295 PTEATVAVTSIEItdemlDQYKRLPIGYAKPDSPLLIIDEEGTKLPDGEQGEIVISGPSVSKGYLNNpEKTAEAFFTFDG 374
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 814 WPGsgrlYRSGDLVRWrADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:PRK04813 375 QPA----YHTGDAGYL-EDGLLFYQGRIDFQIKLNGYRIELEEIEQNLRQSSYVESAVVV 429
|
|
| A_NRPS_acs4 |
cd17654 |
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal ... |
499-893 |
7.24e-43 |
|
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains acyl-CoA synthethase family member 4, also known as 2-aminoadipic 6-semialdehyde dehydrogenase or aminoadipate-semialdehyde dehydrogenase, most of which are uncharacterized. Acyl-CoA synthetase catalyzes the initial reaction in fatty acid metabolism, by forming a thioester with CoA. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341309 [Multi-domain] Cd Length: 449 Bit Score: 164.18 E-value: 7.24e-43
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 499 QAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALADaecaGRAREAFagacldlSTLPLAGS 578
Cdd:cd17654 42 RAIGLRCDRGTESPVAILAILFLGAAYAPIDPASPEQRSLTVMKKCHVSYLLQN----KELDNAP-------LSFTPEHR 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 579 GMSLPAPGGrdAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTVyaNVVGEGLRVTVNaPFSFDSSIKQI-LQLLSGH 657
Cdd:cd17654 111 HFNIRTDEC--LAYVIHTSGTTGTPKIVAVPHKCILPNIQHFRSLF--NITSEDILFLTS-PLTFDPSVVEIfLSLSSGA 185
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 658 CLVLVPQEVRSDPQRMLGFLEER-RIDVLDCTPSLFRLLLQAGLDD----AHPALpgRIL-VGGERFdeASWEVAAGWR- 730
Cdd:cd17654 186 TLLIVPTSVKVLPSKLADILFKRhRITVLQATPTLFRRFGSQSIKStvlsATSSL--RVLaLGGEPF--PSLVILSSWRg 261
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 731 ---RCQVFNLYGPTEATVNASLARVAEHARPT-IGRALANVDLHVVDGLGRRKTrgasGELWIGGagVARGYAGDAgeaa 806
Cdd:cd17654 262 kgnRTRIFNIYGITEVSCWALAYKVPEEDSPVqLGSPLLGTVIEVRDQNGSEGT----GQVFLGG--LNRVCILDD---- 331
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 807 grfvEEGWPgSGRLYRSGDLVRwRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLTDEadaaepgaDR 886
Cdd:cd17654 332 ----EVTVP-KGTMRATGDFVT-VKDGELFFLGRKDSQIKRRGKRINLDLIQQVIESCLGVESCAVTLSD--------QQ 397
|
....*..
gi 15597498 887 RIVAFVT 893
Cdd:cd17654 398 RLIAFIV 404
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1132-1773 |
2.19e-42 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 172.45 E-value: 2.19e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1132 RADALSDLLRRHGFEVSIRqDALLEGTDRYNCYAVRPGYAESLAERIDWRALAPRPAAALGGELSEQALRGFLEARLPAY 1211
Cdd:PRK12316 3435 RADGVIEYIGRVDHQVKIR-GFRIELGEIEARLLEHPWVREAVVLAVDGRQLVAYVVPEDEAGDLREALKAHLKASLPEY 3513
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1212 MLPSRIARVERLPLTAEGKLDRRALLAALAAEAAAQTLEaPANATEAALLEIWKSVLKRPAIGVSDNFFQVGGDSIRLIQ 1291
Cdd:PRK12316 3514 MVPAHLLFLERMPLTPNGKLDRKALPRPDAALLQQDYVA-PVNELERRLAAIWADVLKLEQVGLTDNFFELGGDSIISLQ 3592
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1292 MQVMAREAGLAFTLRDVFNHQSIRELARLLAAPASPA-DALGTSAPQSLEPFallsaaerkrlpeglddaypmtslQQGM 1370
Cdd:PRK12316 3593 VVSRARQAGIRFTPKDLFQHQTIQGLARVARVGGGVAvDQGPVSGETLLLPI------------------------QQQF 3648
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1371 LlqSEASGDPRLLHNVVLHEVHGRLDGELLARAWAILIGRHAILRTGFDlhggQVPLQWvhpaTAVAAEVPVHDLCGLDG 1450
Cdd:PRK12316 3649 F--EEPVPERHHWNQSLLLKPREALDAAALEAALQALVEHHDALRLRFV----EDAGGW----TAEHLPVELGGALLWRA 3718
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1451 ETRRLRLRAWIEEEQATPFDWSRPPLVR--LAALALDERRFALgvAEHHSVLDGWSLQSLVDELLAVYADLLAGvvaREA 1528
Cdd:PRK12316 3719 ELDDAEELERLGEEAQRSLDLADGPLLRalLATLADGSQRLLL--VIHHLVVDGVSWRILLEDLQQAYQQLLQG---EAP 3793
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1529 EAPA--VGFRDYVALERE---AEANAASALFWLDYLAGARYRpLPGLAEEGPRRMAAVRVDVPADSLSRLRALAERSGLP 1603
Cdd:PRK12316 3794 RLPAktSSFKAWAERLQEharGEALKAELAYWQEQLQGVSSE-LPCDHPQGALQNRHAASVQTRLDRELTRRLLQQAPAA 3872
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1604 LRS----LLLAAHGRALCRFSDADEVVTGFVSHGRpEEPGAD----RLLGLFLNTLPCRLSASVDLLDSARRAFDYERAS 1675
Cdd:PRK12316 3873 YRTqvndLLLTALARVVCRWTGEASALVQLEGHGR-EDLFADidlsRTVGWFTSLFPVRLSPVEDLGASIKAIKEQLRAI 3951
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1676 LEH-------RRHPLAAIRRRNRELRLDSL-FNFV-------DFHQDDAAPAGVRHGGILDQVVVDVDVPLAVDfEVAGE 1740
Cdd:PRK12316 3952 PNKgigfgllRYLGDEESRRTLAGLPVPRItFNYLgqfdgsfDEEMALFVPAGESAGAEQSPDAPLDNWLSLNG-RVYGG 4030
|
650 660 670
....*....|....*....|....*....|...
gi 15597498 1741 RLEVGFQYAAGRFPAERAEALAGAYREALLALL 1773
Cdd:PRK12316 4031 ELSLDWTFSREMFEEATIQRLADDYAAELTALV 4063
|
|
| SgcC5_NRPS-like |
cd19539 |
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- ... |
1365-1776 |
8.28e-42 |
|
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- bond forming activity and similar C-domains of modular NRPSs; SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. This subfamily also includes similar C-domains of modular NRPSs such as Penicillium chrysogenum N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase PCBAB. Condensation (C) domains of NRPSs normally catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380462 [Multi-domain] Cd Length: 427 Bit Score: 160.24 E-value: 8.28e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1365 SLQQGMLLQSEASGDPRLLHNVVL-HEVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQVPLQWVHPATAvaAEVPVH 1443
Cdd:cd19539 5 SFAQERLWFIDQGEDGGPAYNIPGaWRLTGPLDVEALREALRDVVARHEALRTLLVRDDGGVPRQEILPPGP--APLEVR 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1444 DLCGLDGETRRlRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLLAGV 1523
Cdd:cd19539 83 DLSDPDSDRER-RLEELLRERESRGFDLDEEPPIRAVLGRFDPDDHVLVLVAHHTAFDAWSLDVFARDLAALYAARRKGP 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1524 VAREAEaPAVGFRDYVALERE---AEANAASALFWLDYLAGARYRPLPG---LAEEGPRRMAAVRVDVPADSLSRLRALA 1597
Cdd:cd19539 162 AAPLPE-LRQQYKEYAAWQREalaAPRAAELLDFWRRRLRGAEPTALPTdrpRPAGFPYPGADLRFELDAELVAALRELA 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1598 ERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPeEPGADRLLGLFLNTLPCRL-----SASVDLLDSARR----A 1668
Cdd:cd19539 241 KRARSSLFMVLLAAYCVLLRRYTGQTDIVVGTPVAGRN-HPRFESTVGFFVNLLPLRVdvsdcATFRDLIARVRKalvdA 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1669 FDYERASLEHRRHPLAAIRRRNRELRLDSLFNFVDF---HQDDAAPAGVRHGgilDQVVVDVDVPLAVDFEVAGERLEVG 1745
Cdd:cd19539 320 QRHQELPFQQLVAELPVDRDAGRHPLVQIVFQVTNApagELELAGGLSYTEG---SDIPDGAKFDLNLTVTEEGTGLRGS 396
|
410 420 430
....*....|....*....|....*....|.
gi 15597498 1746 FQYAAGRFPAERAEALAGAYREALLALLGDP 1776
Cdd:cd19539 397 LGYATSLFDEETIQGFLADYLQVLRQLLANP 427
|
|
| LCL_NRPS-like |
cd19531 |
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar ... |
1391-1776 |
2.96e-41 |
|
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar domains including the C-domain of SgcC5, a free-standing NRPS with both ester- and amide- bond forming activity; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. Streptomyces globisporus SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380454 [Multi-domain] Cd Length: 427 Bit Score: 158.67 E-value: 2.96e-41
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1391 VHGRLDGELLARAWAILIGRHAILRTGFDLHGGQvPLQWVHPATAVaaEVPVHDLCGLDGETRRLRLRAWIEEEQATPFD 1470
Cdd:cd19531 32 LRGPLDVAALERALNELVARHEALRTTFVEVDGE-PVQVILPPLPL--PLPVVDLSGLPEAEREAEAQRLAREEARRPFD 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1471 WSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLLAGVVAREAEaPAVGFRDYVALERE---AEA 1547
Cdd:cd19531 109 LARGPLLRATLLRLGEDEHVLLLTMHHIVSDGWSMGVLLRELAALYAAFLAGRPSPLPP-LPIQYADYAVWQREwlqGEV 187
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1548 NAASALFWLDYLAGAryRPLPGLAEEGPR------RMAAVRVDVPADSLSRLRALAERSGLPLRSLLLAAHGRALCRFSD 1621
Cdd:cd19531 188 LERQLAYWREQLAGA--PPVLELPTDRPRpavqsfRGARVRFTLPAELTAALRALARREGATLFMTLLAAFQVLLHRYSG 265
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1622 ADEVVTGFVSHGRPeEPGADRLLGLFLNTLP--CRLSAS---VDLLDSARR----AFDYERASLEH-----------RRH 1681
Cdd:cd19531 266 QDDIVVGTPVAGRN-RAELEGLIGFFVNTLVlrTDLSGDptfRELLARVREtaleAYAHQDLPFEKlvealqperdlSRS 344
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1682 PLAairrrnrelrlDSLFNFVDFHQDDAAPAGVRhggildqVVVDVDVPLAVDFEVA------GERLEVGFQYAAGRFPA 1755
Cdd:cd19531 345 PLF-----------QVMFVLQNAPAAALELPGLT-------VEPLEVDSGTAKFDLTlsltetDGGLRGSLEYNTDLFDA 406
|
410 420
....*....|....*....|.
gi 15597498 1756 ERAEALAGAYREALLALLGDP 1776
Cdd:cd19531 407 ATIERMAGHFQTLLEAIVADP 427
|
|
| COG4908 |
COG4908 |
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General ... |
1363-1601 |
6.60e-41 |
|
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General function prediction only];
Pssm-ID: 443936 [Multi-domain] Cd Length: 243 Bit Score: 152.11 E-value: 6.60e-41
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1363 MTSLQQGMLlqsEASGDPRLLHNVVLHEVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQvPLQWVHPAtaVAAEVPV 1442
Cdd:COG4908 1 LSPAQKRFL---FLEPGSNAYNIPAVLRLEGPLDVEALERALRELVRRHPALRTRFVEEDGE-PVQRIDPD--ADLPLEV 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1443 HDLCGLDGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLLAG 1522
Cdd:COG4908 75 VDLSALPEPEREAELEELVAEEASRPFDLARGPLLRAALIRLGEDEHVLLLTIHHIISDGWSLGILLRELAALYAALLEG 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1523 VVAREAEAPaVGFRDYVALEREA---EANAASALFWLDYLAGA-RYRPLPGLAEEGPRRM---AAVRVDVPADSLSRLRA 1595
Cdd:COG4908 155 EPPPLPELP-IQYADYAAWQRAWlqsEALEKQLEYWRQQLAGApPVLELPTDRPRPAVQTfrgATLSFTLPAELTEALKA 233
|
....*.
gi 15597498 1596 LAERSG 1601
Cdd:COG4908 234 LAKAHG 239
|
|
| C_NRPS-like |
cd19066 |
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ... |
1361-1776 |
2.90e-40 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380453 [Multi-domain] Cd Length: 427 Bit Score: 156.03 E-value: 2.90e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1361 YPMTSLQQGMLLQSEASGDPRLLHNVVLHEVHGRLDGELLARAWAILIGRHAILRTGFdLHGGQVPLQWVHPATaVAAEV 1440
Cdd:cd19066 2 IPLSPMQRGMWFLKKLATDPSAFNVAIEMFLTGSLDLARLKQALDAVMERHDVLRTRF-CEEAGRYEQVVLDKT-VRFRI 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1441 PVHDLCGLDgeTRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLL 1520
Cdd:cd19066 80 EIIDLRNLA--DPEARLLELIDQIQQTIYDLERGPLVRVALFRLADERDVLVVAIHHIIVDGGSFQILFEDISSVYDAAE 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1521 AGvvAREAEAPAVGFRDYVA-LE--REAEANAASALFWLDYLAG-ARYRPLPGLAEEGPRRMAAVRV---DVPADSLSRL 1593
Cdd:cd19066 158 RQ--KPTLPPPVGSYADYAAwLEkqLESEAAQADLAYWTSYLHGlPPPLPLPKAKRPSQVASYEVLTlefFLRSEETKRL 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1594 RALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPeEPGADRLLGLFLNTLPCRLSASVD---------LLDS 1664
Cdd:cd19066 236 REVARESGTTPTQLLLAAFALALKRLTASIDVVIGLTFLNRP-DEAVEDTIGLFLNLLPLRIDTSPDatfpellkrTKEQ 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1665 ARRAFDYERASLEHRRHPLAAIRRRNRELRLDSLFNFVDFHQDDAAPAGVRHGGILDQVVVDVDVPLAVDF--EVAGErL 1742
Cdd:cd19066 315 SREAIEHQRVPFIELVRHLGVVPEAPKHPLFEPVFTFKNNQQQLGKTGGFIFTTPVYTSSEGTVFDLDLEAseDPDGD-L 393
|
410 420 430
....*....|....*....|....*....|....
gi 15597498 1743 EVGFQYAAGRFPAERAEALAGAYREALLALLGDP 1776
Cdd:cd19066 394 LLRLEYSRGVYDERTIDRFAERYMTALRQLIENP 427
|
|
| Acs |
COG0365 |
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism]; |
453-908 |
4.64e-40 |
|
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism];
Pssm-ID: 440134 [Multi-domain] Cd Length: 565 Bit Score: 158.35 E-value: 4.64e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 453 AFDLRAALQPQAPALL-----DAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTP 527
Cdd:COG0365 14 CLDRHAEGRGDKVALIwegedGEERTLTYAELRREVNRFANALRALGVKKGDRVAIYLPNIPEAVIAMLACARIGAVHSP 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 528 VNPEF-PAARVERMREAGgIVFALADAECAGRAR-----EAFAGACLDLSTLP----LAGSGMSLPAPGGR--------- 588
Cdd:COG0365 94 VFPGFgAEALADRIEDAE-AKVLITADGGLRGGKvidlkEKVDEALEELPSLEhvivVGRTGADVPMEGDLdwdellaaa 172
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 ------------DAAYMIFTSGTSGQPKGVVveHASALNLSQALARTVYANVVGEGLRVTVNAPFSF---DSSIkQILQL 653
Cdd:COG0365 173 saefepeptdadDPLFILYTSGTTGKPKGVV--HTHGGYLVHAATTAKYVLDLKPGDVFWCTADIGWatgHSYI-VYGPL 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 654 LSGHCLVLVP-QEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAH----PALpgRILV-GGERFDEASWEVaa 727
Cdd:COG0365 250 LNGATVVLYEgRPDFPDPGRLWELIEKYGVTVFFTAPTAIRALMKAGDEPLKkydlSSL--RLLGsAGEPLNPEVWEW-- 325
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 728 gWRR---CQVFNLYGPTEATVNASLARVAEHARP-TIGRALANVDLHVVDGLGRRKTRGASGELWIGGA--GVARGYAGD 801
Cdd:COG0365 326 -WYEavgVPIVDGWGQTETGGIFISNLPGLPVKPgSMGKPVPGYDVAVVDEDGNPVPPGEEGELVIKGPwpGMFRGYWND 404
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 802 AGeaagRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLtdeadaAE 881
Cdd:COG0365 405 PE----RYRETYFGRFPGWYRTGDGARRDEDGYFWILGRSDDVINVSGHRIGTAEIESALVSHPAVAEAAVV------GV 474
|
490 500
....*....|....*....|....*....
gi 15597498 882 PGADR--RIVAFVTAAEETADESWLEVDL 908
Cdd:COG0365 475 PDEIRgqVVKAFVVLKPGVEPSDELAKEL 503
|
|
| Firefly_Luc_like |
cd05911 |
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family ... |
466-884 |
9.39e-40 |
|
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341237 [Multi-domain] Cd Length: 486 Bit Score: 155.83 E-value: 9.39e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 466 ALLDAHG--SLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREA 543
Cdd:cd05911 1 AQIDADTgkELTYAQLRTLSRRLAAGLRKLGLKKGDVVGIISPNSTYYPPVFLGCLFAGGIFSAANPIYTADELAHQLKI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 544 GG--IVF--------ALADAECAG--------RAREAFAGACLDLSTLPLAGSGMSLPAP---GGRDAAYMIFTSGTSGQ 602
Cdd:cd05911 81 SKpkVIFtdpdglekVKEAAKELGpkdkiivlDDKPDGVLSIEDLLSPTLGEEDEDLPPPlkdGKDDTAAILYSSGTTGL 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 603 PKGVVVEHASAL-NLSQALARTVYANVVGEglrvTVNAPFSFDSS---IKQILQLLSGHCLVLVPqevRSDPQRMLGFLE 678
Cdd:cd05911 161 PKGVCLSHRNLIaNLSQVQTFLYGNDGSND----VILGFLPLYHIyglFTTLASLLNGATVIIMP---KFDSELFLDLIE 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 679 ERRIDVLDCTPSLFRLLLQAGLDDAHpALPG--RILVGG----ERFDEaswEVAAGWRRCQVFNLYGPTEATVNASLARV 752
Cdd:cd05911 234 KYKITFLYLVPPIAAALAKSPLLDKY-DLSSlrVILSGGaplsKELQE---LLAKRFPNATIKQGYGMTETGGILTVNPD 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 753 AEHARPTIGRALANVDLHVVDGLGRRKT-RGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRA 831
Cdd:cd05911 310 GDDKPGSVGRLLPNVEAKIVDDDGKDSLgPNEPGEICVRGPQVMKGYYNNPEATKETFDEDGW------LHTGDIGYFDE 383
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*
gi 15597498 832 DGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV--LTDEADAAEPGA 884
Cdd:cd05911 384 DGYLYIVDRKKELIKYKGFQVAPAELEAVLLEHPGVADAAVigIPDEVSGELPRA 438
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1199-1774 |
1.69e-38 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 159.56 E-value: 1.69e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1199 ALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRRALLAALAAEAAAQTLEaPANATEAALLEIWKSVLKRPAIGVSDN 1278
Cdd:PRK12467 2042 ILKNHLKASLPEYMVPAHLVFLARMPLTPNGKLDRKALPAPDASELQQAYVA-PQSELEQRLAAIWQDVLGLEQVGLHDN 2120
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1279 FFQVGGDSIRLIQMQVMAREAGLAFTLRDVFNHQSIRELArllaAPASPADAlGTSAPQSlepfallsaaerkrlpeGLD 1358
Cdd:PRK12467 2121 FFELGGDSIISIQVVSRARQAGIRFTPKDLFQHQTVQSLA----AVAQEGDG-TVSIDQG-----------------PVT 2178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1359 DAYPMTSLQQgmLLQSEASGDPRLLHNVVLHEVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQVPLQWVHPATAVAA 1438
Cdd:PRK12467 2179 GDLPLLPIQQ--MFFADDIPERHHWNQSVLLEPREALDAELLEAALQALLVHHDALRLGFVQEDGGWSAMHRAPEQERRP 2256
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1439 ---EVPVHDlcglDGEtrrlrLRAWIEEEQATpFDWSRPPLVR--LAALALDERRFALGVaeHHSVLDGWSLQSLVDELL 1513
Cdd:PRK12467 2257 llwQVVVAD----KEE-----LEALCEQAQRS-LDLEEGPLLRavLATLPDGSQRLLLVI--HHLVVDGVSWRILLEDLQ 2324
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1514 AVYADLLAG-VVAREAEAPAvgFRDYVA-LEREAE--ANAASALFWLDYLAGARyRPLPGLAEEGP---RRMAAVRVDVP 1586
Cdd:PRK12467 2325 TAYRQLQGGqPVKLPAKTSA--FKAWAErLQTYAAsaALADELGYWQAQLQGAS-TELPCDHPQGGlqrRHAASVTTHLD 2401
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1587 ADSLSRLRALAERS-GLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPE-EPGAD--RLLGLFLNTLPCRLSASVDLL 1662
Cdd:PRK12467 2402 SEWTRRLLQEAPAAyRTQVNDLLLTALARVIARWTGQASTLIQLEGHGREDlFDEIDltRTVGWFTSLYPVKLSPTASLA 2481
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1663 DSARRAFDYERASLEH-------RRHPLAAIRRRNREL-RLDSLFNFV-----DFHQDDAA---PAGVRHGGiLDQVVVD 1726
Cdd:PRK12467 2482 TSIKTIKEQLRAVPNKglgfgvlRYLGSEAARQTLQALpVPRITFNYLgqfdgSFDAEKQAlfvPSGEFSGA-EQSEEAP 2560
|
570 580 590 600
....*....|....*....|....*....|....*....|....*...
gi 15597498 1727 VDVPLAVDFEVAGERLEVGFQYAAGRFPAERAEALAGAYREALLALLG 1774
Cdd:PRK12467 2561 LGNWLSINGQVYGGELNLGWTFSQEMFDEATIQRLADAYAEELRALIE 2608
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1198-1774 |
2.03e-37 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 155.71 E-value: 2.03e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1198 QALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRRALLAALAAEAAAQTLEaPANATEAALLEIWKSVLKRPAIGVSD 1277
Cdd:PRK05691 2653 EALKAHLKQQLPDYMVPAHLILLDSLPLTANGKLDRRALPAPDPELNRQAYQA-PRSELEQQLAQIWREVLNVERVGLGD 2731
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1278 NFFQVGGDSIRLIQMQVMAREAGLAFTLRDVFNHQSIRELARLLAAPASPADALGTsapqslepfallsaaerkrlpegL 1357
Cdd:PRK05691 2732 NFFELGGDSILSIQVVSRARQLGIHFSPRDLFQHQTVQTLAAVATHSEAAQAEQGP-----------------------L 2788
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1358 DDAYPMTSLQQGMLLQSEAsgDPRLLHNVVLHEVHGRLDGELLARAWAILIGRHAILRTGFDLHGGqvplQWVHPATAVA 1437
Cdd:PRK05691 2789 QGASGLTPIQHWFFDSPVP--QPQHWNQALLLEPRQALDPALLEQALQALVEHHDALRLRFSQADG----RWQAEYRAVT 2862
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1438 AE-----VPVHDLCgldgetrrlRLRAWIEEEQATpFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDEL 1512
Cdd:PRK05691 2863 AQellwqVTVADFA---------ECAALFADAQRS-LDLQQGPLLRALLVDGPQGQQRLLLAIHHLVVDGVSWRVLLEDL 2932
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1513 LAVYADLLAGVVAREAeAPAVGFRDYVAlEREAEANAASA----LFWLDYLAGARyRPLPGLAEEGPRRMA-----AVRV 1583
Cdd:PRK05691 2933 QALYRQLSAGAEPALP-AKTSAFRDWAA-RLQAYAGSESLreelGWWQAQLGGPR-AELPCDRPQGGNLNRhaqtvSVRL 3009
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1584 DVpadslSRLRALAERSGLPLRS----LLLAAHGRALCRFSDADEVVTGFVSHGRP---EEPGADRLLGLFLNTLPCRLS 1656
Cdd:PRK05691 3010 DA-----ERTRQLLQQAPAAYRTqvndLLLTALARVLCRWSGQPSVLVQLEGHGREalfDDIDLTRSVGWFTSAYPLRLT 3084
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1657 ASVdLLDSAR----RAFDYERASLEHR-------RHpLA--AIRRRNRELRLDSL-FNFV-DFHQ---DDA------APA 1712
Cdd:PRK05691 3085 PAP-GDDAARgesiKAIKEQLRAVPHKglgygvlRY-LAdaAVREAMAALPQAPItFNYLgQFDQsfaSDAlfrpldEPA 3162
|
570 580 590 600 610 620
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 15597498 1713 GVRHggildQVVVDVDVPLAVDFEVAGERLEVGFQYAAGRFPAERAEALAGAYREALLALLG 1774
Cdd:PRK05691 3163 GPAH-----DPDAPLPNELSVDGQVYGGELVLRWTYSAERYDEQTIAELAEAYLAELQALIA 3219
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1293-1804 |
2.24e-37 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 155.89 E-value: 2.24e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1293 QVMAREAGLAFTL-RDVFNHQSIRELA-----RLLAAPASPADALGTSAPQSLEPFALLSAAERKRLP---EGLDDAYPM 1363
Cdd:PRK12316 4026 RVYGGELSLDWTFsREMFEEATIQRLAddyaaELTALVEHCCDAERHGVTPSDFPLAGLDQARLDALPlplGEIEDIYPL 4105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1364 TSLQQGMLLQS---EASGDprlLHNVVLHEVHGrLDGELLARAWAILIGRHAILRTGFDLHGG-QVPLQWVHpaTAVAAE 1439
Cdd:PRK12316 4106 SPMQQGMLFHSlyeQEAGD---YINQMRVDVQG-LDVERFRAAWQAALDRHDVLRSGFVWQGElGRPLQVVH--KQVSLP 4179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1440 VPVHDLCGldGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYAdl 1519
Cdd:PRK12316 4180 FAELDWRG--RADLQAALDALAAAERERGFDLQRAPLLRLVLVRTAEGRHHLIYTNHHILMDGWSNSQLLGEVLERYS-- 4255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1520 lagvvAREAEAPAVGFRDYVALEREAEANAASAlFWLDYLAG--ARYRPLPGLAEEGPRRMAAV---RVDVPADSLSRLR 1594
Cdd:PRK12316 4256 -----GRPPAQPGGRYRDYIAWLQRQDAAASEA-FWREQLAAldEPTRLAQAIARADLRSANGYgehVRELDATATARLR 4329
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1595 ALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPEE-PGADRLLGLFLNTLPCRLSASVDL-LDSARRAFDYE 1672
Cdd:PRK12316 4330 EFARTQRVTLNTLVQAAWLLLLQRYTGQDTVAFGATVAGRPAElPGIEGQIGLFINTLPVIATPRAQQsVVEWLQQVQRQ 4409
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1673 RASL-EHRRHPLAAIRR---RNRELRLDSLFNF----VDFHQDDAAPAGVRHGGILDQVVVDVDVPLAVDFevaGERLEV 1744
Cdd:PRK12316 4410 NLALrEHEHTPLYEIQRwagQGGEALFDSLLVFenypVSEALQQGAPGGLRFGEVTNHEQTNYPLTLAVGL---GETLSL 4486
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1745 GFQYAAGRFPAERAEALAGAYREALLALLGDPVQPPAAAQAEDSVELRRVLKVLSRVLGR 1804
Cdd:PRK12316 4487 QFSYDRGHFDAATIERLARHLTNLLEAMAEDPQRRLGELQLLEKAEQQRIVALWNRTDAG 4546
|
|
| FACL_FadD13-like |
cd17631 |
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, ... |
454-873 |
4.10e-37 |
|
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, including Mycobacterium tuberculosis acid-induced operon MymA encoding the fatty acyl-CoA synthetase FadD13 which is essential for virulence and intracellular growth of the pathogen. The fatty acyl-CoA synthetase activates lipids before entering into the metabolic pathways and is also involved in transmembrane lipid transport. However, unlike soluble fatty acyl-CoA synthetases, but like the mammalian integral-membrane very-long-chain acyl-CoA synthetases, FadD13 accepts lipid substrates up to the maximum length of C26, and this is facilitated by an extensive hydrophobic tunnel from the active site to a positively charged patch. Also included is feruloyl-CoA synthetase (Fcs) in Rhodococcus strains where it is involved in biotechnological vanillin production from eugenol and ferulic acid via a non-beta-oxidative pathway.
Pssm-ID: 341286 [Multi-domain] Cd Length: 435 Bit Score: 146.60 E-value: 4.10e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 454 FDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPefp 533
Cdd:cd17631 1 LRRRARRHPDRTALVFGGRSLTYAELDERVNRLAHALRALGVAKGDRVAVLSKNSPEFLELLFAAARLGAVFVPLNF--- 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 534 aarverMREAGGIVFALADAEcagrareafAGACLDlstlplagsgmslpapggrDAAYMIFTSGTSGQPKGVVVEHAsa 613
Cdd:cd17631 78 ------RLTPPEVAYILADSG---------AKVLFD-------------------DLALLMYTSGTTGRPKGAMLTHR-- 121
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 614 lNLSQALARTVYANVVGEGLRVTVNAPFS--FDSSIKQILQLLSGHCLVLVPqevRSDPQRMLGFLEERRIDVLDCTPSL 691
Cdd:cd17631 122 -NLLWNAVNALAALDLGPDDVLLVVAPLFhiGGLGVFTLPTLLRGGTVVILR---KFDPETVLDLIERHRVTSFFLVPTM 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 692 FRLLLQaglddaHPALPGR-------ILVGGERFDEASweVAAGWRRCQVF-NLYGPTEATVNASLARVAEHARP--TIG 761
Cdd:cd17631 198 IQALLQ------HPRFATTdlsslraVIYGGAPMPERL--LRALQARGVKFvQGYGMTETSPGVTFLSPEDHRRKlgSAG 269
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 762 RALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAgEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRI 841
Cdd:cd17631 270 RPVFFVEVRIVDPDGREVPPGEVGEIVVRGPHVMAGYWNRP-EATAAAFRDGW------FHTGDLGRLDEDGYLYIVDRK 342
|
410 420 430
....*....|....*....|....*....|..
gi 15597498 842 DEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:cd17631 343 KDMIISGGENVYPAEVEDVLYEHPAVAEVAVI 374
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
1344-1795 |
4.10e-37 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 153.86 E-value: 4.10e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1344 LLSAAERKRLPEGLDDAYPMTSLQQGMLLQSEASGDPRLLHNVVLHEVHGRLDGELLARAWAILIGRHAILRTGFDLHGG 1423
Cdd:COG1020 1 AAAAAAAALPPAAAAAPLPLSAAQQRLWLLLLLLLGSAAYNLALALLLLGLLLVAALLLLAALLARRRRALRTRLRTRAG 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1424 QVPLQWVHPataVAAEVPVHDLCGLDGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGW 1503
Cdd:COG1020 81 RPVQVIQPV---VAAPLPVVVLLVDLEALAEAAAEAAAAAEALAPFDLLRGPLLRLLLLLLLLLLLLLLLALHHIISDGL 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1504 SLQSLVDELLAVYADLLAGVVAREAEAPAVGFRDYVALER--EAEANAASALFWLDYLAGAryRPLPGLAEEGPR----- 1576
Cdd:COG1020 158 SDGLLLAELLRLYLAAYAGAPLPLPPLPIQYADYALWQREwlQGEELARQLAYWRQQLAGL--PPLLELPTDRPRpavqs 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1577 -RMAAVRVDVPADSLSRLRALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPeEPGADRLLGLFLNTLP--C 1653
Cdd:COG1020 236 yRGARVSFRLPAELTAALRALARRHGVTLFMVLLAAFALLLARYSGQDDVVVGTPVAGRP-RPELEGLVGFFVNTLPlrV 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1654 RLSASVDLLDSARRAFDYERASLEHRRHPLAAIRRRNRELRL-------DSLFNFVDFHQDDAAPAGVRhGGILDQVVVD 1726
Cdd:COG1020 315 DLSGDPSFAELLARVRETLLAAYAHQDLPFERLVEELQPERDlsrnplfQVMFVLQNAPADELELPGLT-LEPLELDSGT 393
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 15597498 1727 VDVPLAVDFEVAGERLEVGFQYAAGRFPAERAEALAGAYREALLALLGDPVQPPAAAQAEDSVELRRVL 1795
Cdd:COG1020 394 AKFDLTLTVVETGDGLRLTLEYNTDLFDAATIERMAGHLVTLLEALAADPDQPLGDLPLLTAAERQQLL 462
|
|
| MACS_like |
cd05972 |
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of ... |
476-872 |
2.97e-36 |
|
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes.
Pssm-ID: 341276 [Multi-domain] Cd Length: 428 Bit Score: 144.02 E-value: 2.97e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 476 FATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALADAEc 555
Cdd:cd05972 3 FRELKRESAKAANVLAKLGLRKGDRVAVLLPRVPELWAVILAVIKLGAVYVPLTTLLGPKDIEYRLEAAGAKAIVTDAE- 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 556 agrareafagacldlstlplagsgmslpapggrDAAYMIFTSGTSGQPKGVVVEHASALNlsqALARTVYANVVGEG-LR 634
Cdd:cd05972 82 ---------------------------------DPALIYFTSGTTGLPKGVLHTHSYPLG---HIPTAAYWLGLRPDdIH 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 635 VTVNAP-------FSFdssikqILQLLSGhCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPAL 707
Cdd:cd05972 126 WNIADPgwakgawSSF------FGPWLLG-ATVFVYEGPRFDAERILELLERYGVTSFCGPPTAYRMLIKQDLSSYKFSH 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 708 PGRILVGGERFDEaswEVAAGWRRC---QVFNLYGPTEATVNASLARVAEHARPTIGRALANVDLHVVDGLGRRKTRGAS 784
Cdd:cd05972 199 LRLVVSAGEPLNP---EVIEWWRAAtglPIRDGYGQTETGLTVGNFPDMPVKPGSMGRPTPGYDVAIIDDDGRELPPGEE 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 785 GELWI--GGAGVARGYAGDAGEAAGRFVEeGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALL 862
Cdd:cd05972 276 GDIAIklPPPGLFLGYVGDPEKTEASIRG-DY------YLTGDRAYRDEDGYFWFVGRADDIIKSSGYRIGPFEVESALL 348
|
410
....*....|
gi 15597498 863 EHPAVGEAAV 872
Cdd:cd05972 349 EHPAVAEAAV 358
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1290-1776 |
5.49e-36 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 151.08 E-value: 5.49e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1290 IQMQVMAREAGLAFTL-RDVFNHQSIRELA-----RLLAAPASPADALGTSAPQSLEPFALLSAAERKRLP---EGLDDA 1360
Cdd:PRK12467 2567 INGQVYGGELNLGWTFsQEMFDEATIQRLAdayaeELRALIEHCCSNDQRGVTPSDFPLAGLSQEQLDRLPvavGDIEDI 2646
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1361 YPMTSLQQGMLLQSEASGDPRLLHNVVLHEVHGrLDGELLARAWAILIGRHAILRTGFDLHGG-QVPLQWVHPAtavaAE 1439
Cdd:PRK12467 2647 YPLSPMQQGMLFHTLYEGGAGDYINQMRVDVEG-LDVERFRTAWQAVIDRHEILRSGFLWDGElEEPLQVVYKQ----AR 2721
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1440 VPVHDLCGLDGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYAdl 1519
Cdd:PRK12467 2722 LPFSRLDWRDRADLEQALDALAAADRQQGFDLLSAPLLRLTLVRTGEDRHHLIYTNHHILMDGWSGSQLLGEVLQRYF-- 2799
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1520 lagvvAREAEAPAVGFRDYVALeREAEANAASALFWLDYLAGAR-----YRPLPGLAEEGPRRMAAVRVDVPADSLSRLR 1594
Cdd:PRK12467 2800 -----GQPPPAREGRYRDYIAW-LQAQDAEASEAFWKEQLAALEeptrlARALYPAPAEAVAGHGAHYLHLDATQTRQLI 2873
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1595 ALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPEE-PGADRLLGLFLNTLPCRLS--ASVDLLDSARRAFDY 1671
Cdd:PRK12467 2874 EFARRHRVTLNTLVQGAWLLLLQRFTGQDTVCFGATVAGRPAQlRGAEQQLGLFINTLPVIASprAEQTVSDWLQQVQAQ 2953
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1672 ERASLEHRRHPLAAIRR---RNRELRLDSLFNF----VDFHQDDAAPAGVRHGGILDQVVVDVDVPLAVDfevAGERLEV 1744
Cdd:PRK12467 2954 NLALREFEHTPLADIQRwagQGGEALFDSILVFenypISEALKQGAPSGLRFGAVSSREQTNYPLTLAVG---LGDTLEL 3030
|
490 500 510
....*....|....*....|....*....|..
gi 15597498 1745 GFQYAAGRFPAERAEALAGAYREALLALLGDP 1776
Cdd:PRK12467 3031 EFSYDRQHFDAAAIERLAESFDRLLQAMLNNP 3062
|
|
| PRK07656 |
PRK07656 |
long-chain-fatty-acid--CoA ligase; Validated |
445-872 |
2.24e-35 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236072 [Multi-domain] Cd Length: 513 Bit Score: 143.12 E-value: 2.24e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 445 APVESLVAAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAV 524
Cdd:PRK07656 2 NEWMTLPELLARAARRFGDKEAYVFGDQRLTYAELNARVRRAAAALAALGIGKGDRVAIWAPNSPHWVIAALGALKAGAV 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 525 YTPVNPEFPAARVERMREAGG--IVFALAD------------------AECAGRAREAFAGACLDLSTLPLAGSGMSLPA 584
Cdd:PRK07656 82 VVPLNTRYTADEAAYILARGDakALFVLGLflgvdysattrlpalehvVICETEEDDPHTEKMKTFTDFLAAGDPAERAP 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 585 P-GGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARtvYANVVGE-------------GLRVTVNAPfsfdssikqi 650
Cdd:PRK07656 162 EvDPDDVADILFTSGTTGRPKGAMLTHRQLLSNAADWAE--YLGLTEGdrylaanpffhvfGYKAGVNAP---------- 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 651 lqLLSGHCLVLVPQevrSDPQRMLGFLEERRIDVLDCTPSLFRLLLQaglddaHPALPG------RILVGG--------- 715
Cdd:PRK07656 230 --LMRGATILPLPV---FDPDEVFRLIETERITVLPGPPTMYNSLLQ------HPDRSAedlsslRLAVTGaasmpvall 298
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 716 ERFDE--ASWEVAAGwrrcqvfnlYGPTEATVNASLAR---VAEHARPTIGRALANVDLHVVDGLGRRKTRGASGELWIG 790
Cdd:PRK07656 299 ERFESelGVDIVLTG---------YGLSEASGVTTFNRlddDRKTVAGTIGTAIAGVENKIVNELGEEVPVGEVGELLVR 369
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 791 GAGVARGYAGDAGEAAGRFVEEGWpgsgrLYrSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEA 870
Cdd:PRK07656 370 GPNVMKGYYDDPEATAAAIDADGW-----LH-TGDLGRLDEEGYLYIVDRKKDMFIVGGFNVYPAEVEEVLYEHPAVAEA 443
|
..
gi 15597498 871 AV 872
Cdd:PRK07656 444 AV 445
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1393-1825 |
2.49e-33 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 142.22 E-value: 2.49e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1393 GRLDGELLARAWAILIGRHAILRTGFDLHGGQVpLQWVHPATAVaaEVPVHDLCGLDGETRRLRLRAWIEEEQATPFDWS 1472
Cdd:PRK12467 82 GELDVSALRRAFDALVARHESLRTRFVQDEEGF-RQVIDASLSL--TIPLDDLANEQGRARESQIEAYINEEVARPFDLA 158
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1473 RPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLLAGvvaREAEAPA--VGFRDYVALER---EAEA 1547
Cdd:PRK12467 159 NGPLLRVRLLRLADDEHVLVVTLHHIISDGWSMRVLVEELVQLYSAYSQG---REPSLPAlpIQYADYAIWQRswlEAGE 235
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1548 NAASALFWLDYLAGAryRPLPGLAEEGPR------RMAAVRVDVPADSLSRLRALAERSGLPLRSLLLAAHGRALCRFSD 1621
Cdd:PRK12467 236 RERQLAYWQEQLGGE--HTVLELPTDRPRpavpsyRGARLRVDLPQALSAGLKALAQREGVTLFMVLLASFQTLLHRYSG 313
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1622 ADEVVTGFVSHGRPEEPgADRLLGLFLNT--LPCRLSASVDLLDSARRAfdyERASLEHRRH------PLAAIRRRNREL 1693
Cdd:PRK12467 314 QSDIRIGVPNANRNRVE-TERLIGFFVNTqvLKAEVDPQASFLELLQQV---KRTALGAQAHqdlpfeQLVEALQPERSL 389
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1694 RLDSLFNFVDFHQDDAAPAGVRHGGILDQVVVDVDVPLAVD---------FEVAgERLEVGFQYAAGRFPAERAEALAGA 1764
Cdd:PRK12467 390 SHSPLFQVMFNHQNTATGGRDREGAQLPGLTVEELSWARHTaqfdlaldtYESA-QGLWAAFTYATDLFEATTIERLATH 468
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 15597498 1765 YREALLALLGDPVQPPAAAQAEDSVELRRVLKVLSrvlgrplAADQGFASAGGHSLLGVQA 1825
Cdd:PRK12467 469 WRNLLEAIVAEPRRRLGELPLLDAEERARELVRWN-------APATEYAPDCVHQLIEAQA 522
|
|
| FC-FACS_FadD_like |
cd05936 |
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This ... |
450-901 |
2.59e-33 |
|
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This subfamily of the AMP-forming adenylation family contains Escherichia coli FadD and similar prokaryotic fatty acid CoA synthetases. FadD was characterized as a long-chain fatty acid CoA synthetase. The gene fadD is regulated by the fatty acid regulatory protein FadR. Fatty acid CoA synthetase catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341259 [Multi-domain] Cd Length: 468 Bit Score: 136.15 E-value: 2.59e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 450 LVAAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVN 529
Cdd:cd05936 1 LADLLEEAARRFPDKTALIFMGRKLTYRELDALAEAFAAGLQNLGVQPGDRVALMLPNCPQFPIAYFGALKAGAVVVPLN 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 530 PEFPAARVERMREAGGIVFALADaecagrarEAFAGAcldLSTLPLAGSGMSLPAPggrDAAYMIFTSGTSGQPKGVVVE 609
Cdd:cd05936 81 PLYTPRELEHILNDSGAKALIVA--------VSFTDL---LAAGAPLGERVALTPE---DVAVLQYTSGTTGVPKGAMLT 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 610 HASAL-NLSQALArtvYANVVGEGLRVTVNA-PF--SFDSSIKQILQLLSGHCLVLVPqevRSDPQRMLGFLEERRIDVL 685
Cdd:cd05936 147 HRNLVaNALQIKA---WLEDLLEGDDVVLAAlPLfhVFGLTVALLLPLALGATIVLIP---RFRPIGVLKEIRKHRVTIF 220
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 686 DCTPSLFRLLLQAGlDDAHPALPG--RILVGGERFDEaswEVAAGWRR---CQVFNLYGPTEATVNASLARVAEHARP-T 759
Cdd:cd05936 221 PGVPTMYIALLNAP-EFKKRDFSSlrLCISGGAPLPV---EVAERFEEltgVPIVEGYGLTETSPVVAVNPLDGPRKPgS 296
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 760 IGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVeEGWpgsgrlYRSGDLVRWRADGCLEFLG 839
Cdd:cd05936 297 IGIPLPGTEVKIVDDDGEELPPGEVGELWVRGPQVMKGYWNRPEETAEAFV-DGW------LRTGDIGYMDEDGYFFIVD 369
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 15597498 840 RIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLtdeadaAEPGADR--RIVAFVTAAEE---TADE 901
Cdd:cd05936 370 RKKDMIIVGGFNVYPREVEEVLYEHPAVAEAAVV------GVPDPYSgeAVKAFVVLKEGaslTEEE 430
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1223-1795 |
3.44e-32 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 138.76 E-value: 3.44e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1223 LPLTAEGKLDRRALLAALAAEAAAQTLEAPANAT-------------EAALLEIWKSVLKRPAIGVSDNFFQVGGDSIRL 1289
Cdd:PRK05691 541 LPKTSSGKLQRSACRLRLADGSLDSYALFPALQAveaaqtaasgdelQARIAAIWCEQLKVEQVAADDHFFLLGGNSIAA 620
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1290 IQMQVMAREA-GLAFTLRDVFNhqsirelARLLAAPASPADALGTSAPQSLEPFALLSAAErkrlpeglddAYPMTSLQQ 1368
Cdd:PRK05691 621 TQVVARLRDElGIDLNLRQLFE-------APTLAAFSAAVARQLAGGGAAQAAIARLPRGQ----------ALPQSLAQN 683
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1369 GMLL------QSEASGDPRLLHnvvlheVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQvPLQWVHPAtavaAEVPV 1442
Cdd:PRK05691 684 RLWLlwqldpQSAAYNIPGGLH------LRGELDEAALRASFQRLVERHESLRTRFYERDGV-ALQRIDAQ----GEFAL 752
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1443 H--DLCGLDGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLL 1520
Cdd:PRK05691 753 QriDLSDLPEAEREARAAQIREEEARQPFDLEKGPLLRVTLVRLDDEEHQLLVTLHHIVADGWSLNILLDEFSRLYAAAC 832
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1521 AGVVAREAEaPAVGFRDYVALERE--AEANAASAL-FWLDYLAGAryRPLPGLAEEGPR----RMAAVR--VDVPADSLS 1591
Cdd:PRK05691 833 QGQTAELAP-LPLGYADYGAWQRQwlAQGEAARQLaYWKAQLGDE--QPVLELATDHPRsarqAHSAARysLRVDASLSE 909
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1592 RLRALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPeEPGADRLLGLFLNT------LPCRLSASvDLLDSA 1665
Cdd:PRK05691 910 ALRGLAQAHQATLFMVLLAAFQALLHRYSGQGDIRIGVPNANRP-RLETQGLVGFFINTqvlraqLDGRLPFT-ALLAQV 987
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1666 RRAFDYERAsleHRRHPLAAIRRRNRELRLDSLFNFVDFHQDDAAPAGVRHGGILDQVVVDVDVPLAVDFEVAGE----- 1740
Cdd:PRK05691 988 RQATLGAQA---HQDLPFEQLVEALPQAREQGLFQVMFNHQQRDLSALRRLPGLLAEELPWHSREAKFDLQLHSEedrng 1064
|
570 580 590 600 610
....*....|....*....|....*....|....*....|....*....|....*
gi 15597498 1741 RLEVGFQYAAGRFPAERAEALAGAYREALLALLGDPVQPPAAAQAEDSVELRRVL 1795
Cdd:PRK05691 1065 RLTLSFDYAAELFDAATIERLAEHFLALLEQVCEDPQRALGDVQLLDAAERAQLA 1119
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1192-1668 |
5.41e-32 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 137.99 E-value: 5.41e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRRALLAALAAEAAAQTleaPANATEAALLEIWKSVLKRP 1271
Cdd:PRK05691 1578 GQEAEAERLKAALAAELPEYMVPAQLIRLDQMPLGPSGKLDRRALPEPVWQQREHVE---PRTELQQQIAAIWREVLGLP 1654
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1272 AIGVSDNFFQVGGDSIRLIQMQVMAREA-GLAFTLRDVFNHQSIRELARLLAApaspadalgtsapqslepfaLLSAAER 1350
Cdd:PRK05691 1655 RVGLRDDFFALGGHSLLATQIVSRTRQAcDVELPLRALFEASELGAFAEQVAR--------------------IQAAGER 1714
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1351 KRLP--EGLD--DAYPMTSLQQGM--LLQSEASGDPrllHNVV-LHEVHGRLDGELLARAWAILIGRHAILRTGFDLHGG 1423
Cdd:PRK05691 1715 NSQGaiARVDrsQPVPLSYSQQRMwfLWQMEPDSPA---YNVGgMARLSGVLDVDRFEAALQALILRHETLRTTFPSVDG 1791
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1424 qVPLQWVHPATAVaaEVPVHDLCGLDGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGW 1503
Cdd:PRK05691 1792 -VPVQQVAEDSGL--RMDWQDFSALPADARQQRLQQLADSEAHQPFDLERGPLLRACLVKAAEREHYFVLTLHHIVTEGW 1868
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1504 SLQSLVDELLAVYADLLAGvvaREA--EAPAVGFRDYVALER---EAEANAASALFWLDYLagARYRPLPGLAEEGPR-- 1576
Cdd:PRK05691 1869 AMDIFARELGALYEAFLDD---RESplEPLPVQYLDYSVWQRqwlESGERQRQLDYWKAQL--GNEHPLLELPADRPRpp 1943
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1577 ----RMAAVRVDVPADSLSRLRALAERSGLPLRSLLLAAHGRALCRFSDADEVVTG--FVSHGRPEEPGadrLLGLFLNT 1650
Cdd:PRK05691 1944 vqshRGELYRFDLSPELAARVRAFNAQRGLTLFMTMTATLAALLYRYSGQRDLRIGapVANRIRPESEG---LIGAFLNT 2020
|
490 500
....*....|....*....|...
gi 15597498 1651 --LPCRLSASV---DLLDSARRA 1668
Cdd:PRK05691 2021 qvLRCQLDGQMsvsELLEQVRQT 2043
|
|
| BCL_4HBCL |
cd05959 |
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate ... |
452-908 |
6.61e-32 |
|
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate CoA ligase and 4-hydroxybenzoate-coenzyme A ligase catalyze the first activating step for benzoate and 4-hydroxybenzoate catabolic pathways, respectively. Although these two enzymes share very high sequence homology, they have their own substrate preference. The reaction proceeds via a two-step process; the first ATP-dependent step forms the substrate-AMP intermediate, while the second step forms the acyl-CoA ester, releasing the AMP. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Some bacteria can use benzoic acid or benzenoid compounds as the sole source of carbon and energy through degradation. Benzoate CoA ligase and 4-hydroxybenzoate-Coenzyme A ligase are key enzymes of this process.
Pssm-ID: 341269 [Multi-domain] Cd Length: 508 Bit Score: 132.88 E-value: 6.61e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 452 AAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPE 531
Cdd:cd05959 8 LVDLNLNEGRGDKTAFIDDAGSLTYAELEAEARRVAGALRALGVKREERVLLIMLDTVDFPTAFLGAIRAGIVPVPVNTL 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 532 FPAARVERMREAGGIVFALADAECAGRAREAFAGACLDLSTLPLAGSGMSL------------------PAPGGRDA-AY 592
Cdd:cd05959 88 LTPDDYAYYLEDSRARVVVVSGELAPVLAAALTKSEHTLVVLIVSGGAGPEagalllaelvaaeaeqlkPAATHADDpAF 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 593 MIFTSGTSGQPKGVVVEHASALNLSQALARTVYA----NVV--------GEGLRVTVNAPFSFdssikqilqllsGHCLV 660
Cdd:cd05959 168 WLYSSGSTGRPKGVVHLHADIYWTAELYARNVLGiredDVCfsaaklffAYGLGNSLTFPLSV------------GATTV 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 661 LVPQevRSDPQRMLGFLEERRIDVLDCTPSLFRLLLqaglddAHPALPGRILV-------GGERFDEASWEvaaGWRR-- 731
Cdd:cd05959 236 LMPE--RPTPAAVFKRIRRYRPTVFFGVPTLYAAML------AAPNLPSRDLSslrlcvsAGEALPAEVGE---RWKArf 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 732 -CQVFNLYGPTEAtVNASLARVAEHARP-TIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRF 809
Cdd:cd05959 305 gLDILDGIGSTEM-LHIFLSNRPGRVRYgTTGKPVPGYEVELRDEDGGDVADGEPGELYVRGPSSATMYWNNRDKTRDTF 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 810 vEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLtdeadaAEPGADRRI- 888
Cdd:cd05959 384 -QGEW------TRTGDKYVRDDDGFYTYAGRADDMLKVSGIWVSPFEVESALVQHPAVLEAAVV------GVEDEDGLTk 450
|
490 500
....*....|....*....|.
gi 15597498 889 -VAFVTAAEETADESWLEVDL 908
Cdd:cd05959 451 pKAFVVLRPGYEDSEALEEEL 471
|
|
| Thioesterase |
pfam00975 |
Thioesterase domain; Peptide synthetases are involved in the non-ribosomal synthesis of ... |
1886-2110 |
4.32e-31 |
|
Thioesterase domain; Peptide synthetases are involved in the non-ribosomal synthesis of peptide antibiotics. Next to the operons encoding these enzymes, in almost all cases, are genes that encode proteins that have similarity to the type II fatty acid thioesterases of vertebrates. There are also modules within the peptide synthetases that also share this similarity. With respect to antibiotic production, thioesterases are required for the addition of the last amino acid to the peptide antibiotic, thereby forming a cyclic antibiotic. Thioesterases (non-integrated) have molecular masses of 25-29 kDa.
Pssm-ID: 395776 [Multi-domain] Cd Length: 223 Bit Score: 122.88 E-value: 4.32e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1886 RLIALPPAGGNAGTFRGWDARLPADVELLAIQYPGRQErqDEPFVTDVEAMLCAIDDALLPLLDR-PFALIGASLGGMLA 1964
Cdd:pfam00975 2 PLFCFPPAGGSASSFRSLARRLPPPAEVLAVQYPGRGR--GEPPLNSIEALADEYAEALRQIQPEgPYALFGHSMGGMLA 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1965 YELAARLESLhGLRARQLFVISSRAPGPDlEYPRFHAMGDAELLRTLREYDVLPLEVLDDPELREISLATLRADSRLAAD 2044
Cdd:pfam00975 80 FEVARRLERQ-GEAVRSLFLSDASAPHTV-RYEASRAPDDDEVVAEFTDEGGTPEELLEDEELLSMLLPALRADYRALES 157
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 15597498 2045 YRYRPREplAIPITAILGEQDPGVSRVAIDGWRRHASRYE--LETLAGGHGLVVTAAEEVCAILRQRL 2110
Cdd:pfam00975 158 YSCPPLD--AQSATLFYGSDDPLHDADDLAEWVRDHTPGEfdVHVFDGDHFYLIEHLEAVLEIIEAKL 223
|
|
| FACL_like_6 |
cd05922 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
494-897 |
6.38e-31 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341246 [Multi-domain] Cd Length: 457 Bit Score: 128.71 E-value: 6.38e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 494 GVRPGQAVAVMTGRNREAIVALLGVMRAAA----VYTPVNPEFPAARVERMREAGGIVFALADAECAGRAREAfAGACLD 569
Cdd:cd05922 14 GGVRGERVVLILPNRFTYIELSFAVAYAGGrlglVFVPLNPTLKESVLRYLVADAGGRIVLADAGAADRLRDA-LPASPD 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 570 LSTL----PLAGSGMSLPA--PGGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARtvYANVVGEGlRVTVNAPFSF 643
Cdd:cd05922 93 PGTVldadGIRAARASAPAheVSHEDLALLLYTSGSTGSPKLVRLSHQNLLANARSIAE--YLGITADD-RALTVLPLSY 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 644 DSSIKQIL-QLLSGHCLVLVPQEVRsdPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAH-PALPGRILVGGERFDEA 721
Cdd:cd05922 170 DYGLSVLNtHLLRGATLVLTNDGVL--DDAFWEDLREHGATGLAGVPSTYAMLTRLGFDPAKlPSLRYLTQAGGRLPQET 247
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 722 SWEVAAGWRRCQVFNLYGPTEATVNAS-LARVAEHARPT-IGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYA 799
Cdd:cd05922 248 IARLRELLPGAQVYVMYGQTEATRRMTyLPPERILEKPGsIGLAIPGGEFEILDDDGTPTPPGEPGEIVHRGPNVMKGYW 327
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 800 GD-AGEAAGRfveegwPGSGRLYrSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLtdead 878
Cdd:cd05922 328 NDpPYRRKEG------RGGGVLH-TGDLARRDEDGFLFIVGRRDRMIKLFGNRISPTEIEAAARSIGLIIEAAAV----- 395
|
410
....*....|....*....
gi 15597498 879 AAEPGADRRIVAFVTAAEE 897
Cdd:cd05922 396 GLPDPLGEKLALFVTAPDK 414
|
|
| FACL_fum10p_like |
cd05926 |
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL ... |
462-872 |
4.48e-30 |
|
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Fum10p is a fatty acid CoA ligase involved in the synthesis of fumonisin, a polyketide mycotoxin, in Gibberella moniliformis.
Pssm-ID: 341249 [Multi-domain] Cd Length: 493 Bit Score: 127.04 E-value: 4.48e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 462 PQAPALL--DAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVER 539
Cdd:cd05926 1 PDAPALVvpGSTPALTYADLAELVDDLARQLAALGIKKGDRVAIALPNGLEFVVAFLAAARAGAVVAPLNPAYKKAEFEF 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 540 MREAGGIVFALADAEC---AGRAREAFAGACLDL----STLPLAGSGMSLPA-------------PGGRDAAYMIFTSGT 599
Cdd:cd05926 81 YLADLGSKLVLTPKGElgpASRAASKLGLAILELaldvGVLIRAPSAESLSNlladkknaksegvPLPDDLALILHTSGT 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 600 SGQPKGVVVEH----ASALNLSQALARTVYANVV-------GEGLRVTVNAPfsfdssikqilqLLSGHCLVLVPqevRS 668
Cdd:cd05926 161 TGRPKGVPLTHrnlaASATNITNTYKLTPDDRTLvvmplfhVHGLVASLLST------------LAAGGSVVLPP---RF 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 669 DPQRMLGFLEERRIDVLDCTPSLFRLLLqagldDAHPALPGRILvGGERF--------DEASWEVAAGWRRCQVFNLYGP 740
Cdd:cd05926 226 SASTFWPDVRDYNATWYTAVPTIHQILL-----NRPEPNPESPP-PKLRFirscsaslPPAVLEALEATFGAPVLEAYGM 299
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 741 TEATVNASLARVAEHARP--TIGRAlANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgsg 818
Cdd:cd05926 300 TEAAHQMTSNPLPPGPRKpgSVGKP-VGVEVRILDEDGEILPPGVVGEICLRGPNVTRGYLNNPEANAEAAFKDGW---- 374
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....
gi 15597498 819 rlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV 872
Cdd:cd05926 375 --FRTGDLGYLDADGYLFLTGRIKELINRGGEKISPLEVDGVLLSHPAVLEAVA 426
|
|
| MACS_like_4 |
cd05969 |
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most ... |
476-892 |
8.92e-30 |
|
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most similar to acetyl-CoA synthetase. Acetyl-CoA synthetase (ACS) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is only present in bacteria.
Pssm-ID: 341273 [Multi-domain] Cd Length: 442 Bit Score: 124.92 E-value: 8.92e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 476 FATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEF-PAARVERMREAGGIVfALADAE 554
Cdd:cd05969 3 FAQLKVLSARFANVLKSLGVGKGDRVFVLSPRSPELYFSMLGIGKIGAVICPLFSAFgPEAIRDRLENSEAKV-LITTEE 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 555 CAGRareafagacldlstlplagsgMSLpapggRDAAYMIFTSGTSGQPKGVVveHASALNLSQAL-ARTVYANVVGEGL 633
Cdd:cd05969 82 LYER---------------------TDP-----EDPTLLHYTSGTTGTPKGVL--HVHDAMIFYYFtGKYVLDLHPDDIY 133
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 634 RVTVNAPFSFDSSIKQILQLLSGHCLVLVpqEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAhpalpgrilv 713
Cdd:cd05969 134 WCTADPGWVTGTVYGIWAPWLNGVTNVVY--EGRFDAESWYGIIERVKVTVWYTAPTAIRMLMKEGDELA---------- 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 714 ggERFDEASWEVAAG-----------WRRcQVFNL-----YGPTEATVNASLARVAEHARP-TIGRALANVDLHVVDGLG 776
Cdd:cd05969 202 --RKYDLSSLRFIHSvgeplnpeairWGM-EVFGVpihdtWWQTETGSIMIANYPCMPIKPgSMGKPLPGVKAAVVDENG 278
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 777 RRKTRGASGELWI--GGAGVARGYAGDAGEAAGRFVEeGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIEL 854
Cdd:cd05969 279 NELPPGTKGILALkpGWPSMFRGIWNDEERYKNSFID-GW------YLTGDLAYRDEDGYFWFVGRADDIIKTSGHRVGP 351
|
410 420 430
....*....|....*....|....*....|....*...
gi 15597498 855 GEIRSALLEHPAVGEAAVLTDEadaaEPGADRRIVAFV 892
Cdd:cd05969 352 FEVESALMEHPAVAEAGVIGKP----DPLRGEIIKAFI 385
|
|
| BCL_like |
cd05919 |
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate ... |
465-899 |
9.69e-30 |
|
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate CoA ligase (BCL) and related ligases that catalyze the acylation of benzoate derivatives, 2-aminobenzoate and 4-hydroxybenzoate. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Xenobiotic aromatic compounds are also a major class of man-made pollutants. Some bacteria use benzoate as the sole source of carbon and energy through benzoate degradation. Benzoate degradation starts with its activation to benzoyl-CoA by benzoate CoA ligase. The reaction catalyzed by benzoate CoA ligase proceeds via a two-step process; the first ATP-dependent step forms an acyl-AMP intermediate, and the second step forms the acyl-CoA ester with release of the AMP.
Pssm-ID: 341243 [Multi-domain] Cd Length: 436 Bit Score: 124.88 E-value: 9.69e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 465 PALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVErmreag 544
Cdd:cd05919 2 TAFYAADRSVTYGQLHDGANRLGSALRNLGVSSGDRVLLLMLDSPELVQLFLGCLARGAIAVVINPLLHPDDYA------ 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 545 givFALADAECAGRAREAfagacldlstlplagsgmslpapggRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTV 624
Cdd:cd05919 76 ---YIARDCEARLVVTSA-------------------------DDIAYLLYSSGTTGPPKGVMHAHRDPLLFADAMAREA 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 625 YANVVGEGLRVTVNAPFSFDSSIKQILQLLSGHCLVLVPQevRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAH 704
Cdd:cd05919 128 LGLTPGDRVFSSAKMFFGYGLGNSLWFPLAVGASAVLNPG--WPTAERVLATLARFRPTVLYGVPTFYANLLDSCAGSPD 205
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 705 PALPGRILV-GGERFDEASWEVAAGWRRCQVFNLYGPTEaTVNASLARVAEHARP-TIGRALANVDLHVVDGLGRRKTRG 782
Cdd:cd05919 206 ALRSLRLCVsAGEALPRGLGERWMEHFGGPILDGIGATE-VGHIFLSNRPGAWRLgSTGRPVPGYEIRLVDEEGHTIPPG 284
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 783 ASGELWIGGAGVARGYAGDAGEAAGRFvEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALL 862
Cdd:cd05919 285 EEGDLLVRGPSAAVGYWNNPEKSRATF-NGGW------YRTGDKFCRDADGWYTHAGRADDMLKVGGQWVSPVEVESLII 357
|
410 420 430
....*....|....*....|....*....|....*...
gi 15597498 863 EHPAVGEAAVL-TDEADAAEpgadrRIVAFVTAAEETA 899
Cdd:cd05919 358 QHPAVAEAAVVaVPESTGLS-----RLTAFVVLKSPAA 390
|
|
| MCS |
cd05941 |
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step ... |
463-899 |
1.01e-29 |
|
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step reaction consisting of the adenylation of malonate with ATP, followed by malonyl transfer from malonyl-AMP to CoA. Malonic acid and its derivatives are the building blocks of polyketides and malonyl-CoA serves as the substrate of polyketide synthases. Malonyl-CoA synthetase has broad substrate tolerance and can activate a variety of malonyl acid derivatives. MCS may play an important role in biosynthesis of polyketides, the important secondary metabolites with therapeutic and agrochemical utility.
Pssm-ID: 341264 [Multi-domain] Cd Length: 442 Bit Score: 124.71 E-value: 1.01e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 463 QAPALLDAHGSLDFATLRARSEAVAEA-LLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMr 541
Cdd:cd05941 1 DRIAIVDDGDSITYADLVARAARLANRlLALGKDLRGDRVAFLAPPSAEYVVAQLAIWRAGGVAVPLNPSYPLAELEYV- 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 542 eaggivfaLADAEcagrareafagacldlSTLPLagsgmslpapggrDAAYMIFTSGTSGQPKGVVVEHASALNLSQALa 621
Cdd:cd05941 80 --------ITDSE----------------PSLVL-------------DPALILYTSGTTGRPKGVVLTHANLAANVRAL- 121
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 622 rtvyanvvgeglrvtVNA-PFSFDSSIKQILQLLSGHCLV---LVPQEVRS--------DPQRMLGFLEERRIDVLDCTP 689
Cdd:cd05941 122 ---------------VDAwRWTEDDVLLHVLPLHHVHGLVnalLCPLFAGAsveflpkfDPKEVAISRLMPSITVFMGVP 186
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 690 SLF-RLLLQAGLDDAHPALPG-------RILVGG------ERFDEasWEVAAGWRrcqVFNLYGPTEATVNASlARVAEH 755
Cdd:cd05941 187 TIYtRLLQYYEAHFTDPQFARaaaaerlRLMVSGsaalpvPTLEE--WEAITGHT---LLERYGMTEIGMALS-NPLDGE 260
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 756 ARP-TIGRALANVDLHVVDGLGRRKT-RGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADG 833
Cdd:cd05941 261 RRPgTVGMPLPGVQARIVDEETGEPLpRGEVGEIQVRGPSVFKEYWNKPEATKEEFTDDGW------FKTGDLGVVDEDG 334
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 15597498 834 CLEFLGRI-DEQVKINGYRIELGEIRSALLEHPAVGEAAVLtdeadaAEPGAD--RRIVAFVTAAEETA 899
Cdd:cd05941 335 YYWILGRSsVDIIKSGGYKVSALEIERVLLAHPGVSECAVI------GVPDPDwgERVVAVVVLRAGAA 397
|
|
| fkbM_fam |
TIGR01444 |
methyltransferase, FkbM family; Members of this family are characterized by two well-conserved ... |
947-1122 |
1.42e-29 |
|
methyltransferase, FkbM family; Members of this family are characterized by two well-conserved short regions separated by a variable in both sequence and length. The first of the two regions is found in a large number of proteins outside this subfamily, a number of which have been characterized as methyltransferases. One member of the present family, FkbM, was shown to be required for a specific methylation in the biosynthesis of the immunosuppressant FK506 in Streptomyces strain MA6548.
Pssm-ID: 273628 Cd Length: 143 Bit Score: 115.87 E-value: 1.42e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 947 VVLDVGANIGLFSLYIASRAPRARVVAFEPLAPIRRRLEANLGRYA-PQVEVFGIGLSDAEREETFTYYPGYSTFSGIAE 1025
Cdd:TIGR01444 1 VVIDVGANIGDTSLYFARKGAEGRVIAFEPLPDAYEILEENVKLNNlPNVVLLNAAVGDRDGELEFNVSDDDTGNSSLLP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1026 YADASGERDVirrylsnqgeegganllldnideilddrlraeahRCRLRRLDQVIGELGLERIDLLKIDVQRAEMDVLLG 1105
Cdd:TIGR01444 81 TPDADRESEI----------------------------------EVEVVTLDDLVEEFGLDKVDLLKIDVEGAELEVLRG 126
|
170
....*....|....*..
gi 15597498 1106 LDDAALAKVRQIVLEVH 1122
Cdd:TIGR01444 127 AAETLLEKRPVIVLEVH 143
|
|
| PRK06187 |
PRK06187 |
long-chain-fatty-acid--CoA ligase; Validated |
458-901 |
7.64e-29 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235730 [Multi-domain] Cd Length: 521 Bit Score: 123.76 E-value: 7.64e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 458 AALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARV 537
Cdd:PRK06187 16 ARKHPDKEAVYFDGRRTTYAELDERVNRLANALRALGVKKGDRVAVFDWNSHEYLEAYFAVPKIGAVLHPINIRLKPEEI 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 538 ER-MREAGGIVFaLADAECAG---RAREAF--------AGACLDLSTLPLAGSGMSL----------PAPGGRDAAYMIF 595
Cdd:PRK06187 96 AYiLNDAEDRVV-LVDSEFVPllaAILPQLptvrtvivEGDGPAAPLAPEVGEYEELlaaasdtfdfPDIDENDAAAMLY 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 596 TSGTSGQPKGVVVEHASALNLSQALARtvyANVVGEGLRVTVNAP-F-SFDSSIKqILQLLSGHCLVLVPqevRSDPQRM 673
Cdd:PRK06187 175 TSGTTGHPKGVVLSHRNLFLHSLAVCA---WLKLSRDDVYLVIVPmFhVHAWGLP-YLALMAGAKQVIPR---RFDPENL 247
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 674 LGFLEERRIDVLDCTPSLFRLLLQAglDDAHPA-LPGR--ILVGG--------ERFDEASwevaagwrRCQVFNLYGPTE 742
Cdd:PRK06187 248 LDLIETERVTFFFAVPTIWQMLLKA--PRAYFVdFSSLrlVIYGGaalppallREFKEKF--------GIDLVQGYGMTE 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 743 ATVNASLARVAEHA------RPTIGRALANVDLHVVDGLGRR--KTRGASGELWIGGAGVARGYAGDAgEAAGRFVEEGW 814
Cdd:PRK06187 318 TSPVVSVLPPEDQLpgqwtkRRSAGRPLPGVEARIVDDDGDElpPDGGEVGEIIVRGPWLMQGYWNRP-EATAETIDGGW 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 815 pgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL--TDEAdaaepgADRRIVAFV 892
Cdd:PRK06187 397 ------LHTGDVGYIDEDGYLYITDRIKDVIISGGENIYPRELEDALYGHPAVAEVAVIgvPDEK------WGERPVAVV 464
|
490
....*....|
gi 15597498 893 TAAE-ETADE 901
Cdd:PRK06187 465 VLKPgATLDA 474
|
|
| 4CL |
cd05904 |
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the ... |
446-901 |
1.21e-28 |
|
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the phenylpropanoid metabolic pathway for monolignol and flavonoid biosynthesis. It catalyzes the synthesis of hydroxycinnamate-CoA thioesters in a two-step reaction, involving the formation of hydroxycinnamate-AMP anhydride and the nucleophilic substitution of AMP by CoA. The phenylpropanoid pathway is one of the most important secondary metabolism pathways in plants and hydroxycinnamate-CoA thioesters are the precursors of lignin and other important phenylpropanoids.
Pssm-ID: 341230 [Multi-domain] Cd Length: 505 Bit Score: 122.73 E-value: 1.21e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 446 PVESLVAAFDLRAALQ-PQAPALLDAHG--SLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAA 522
Cdd:cd05904 2 PTDLPLDSVSFLFASAhPSRPALIDAATgrALTYAELERRVRRLAAGLAKRGGRKGDVVLLLSPNSIEFPVAFLAVLSLG 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 523 AVYTPVNPEFPAARVERMREAGGIVFALADAECAGRAR----------EAFAGACLDLSTLPLAGSGMSLPAPGGR-DAA 591
Cdd:cd05904 82 AVVTTANPLSTPAEIAKQVKDSGAKLAFTTAELAEKLAslalpvvlldSAEFDSLSFSDLLFEADEAEPPVVVIKQdDVA 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 592 YMIFTSGTSGQPKGVVVEHAsalNLSQALARTV-YANVVGEGLRVTVNA-P----FSFDSSIKQILQLlsGHCLVLVPqe 665
Cdd:cd05904 162 ALLYSSGTTGRSKGVMLTHR---NLIAMVAQFVaGEGSNSDSEDVFLCVlPmfhiYGLSSFALGLLRL--GATVVVMP-- 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 666 vRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPALPGR-ILVGGERFDEaswEVAAGWRR----CQVFNLYGP 740
Cdd:cd05904 235 -RFDLEELLAAIERYKVTHLPVVPPIVLALVKSPIVDKYDLSSLRqIMSGAAPLGK---ELIEAFRAkfpnVDLGQGYGM 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 741 TEAT-VNASLARVAEHARP--TIGRALANVDLHVVD-GLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpg 816
Cdd:cd05904 311 TESTgVVAMCFAPEKDRAKygSVGRLVPNVEAKIVDpETGESLPPNQTGELWIRGPSIMKGYLNNPEATAATIDKEGW-- 388
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 817 sgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV--LTDEaDAAE-PgadrriVAFV- 892
Cdd:cd05904 389 ----LHTGDLCYIDEDGYLFIVDRLKELIKYKGFQVAPAELEALLLSHPEILDAAVipYPDE-EAGEvP------MAFVv 457
|
490
....*....|.
gi 15597498 893 --TAAEETADE 901
Cdd:cd05904 458 rkPGSSLTEDE 468
|
|
| A_NRPS_alphaAR |
cd17647 |
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as ... |
494-909 |
1.58e-28 |
|
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as alpha-aminoadipate reductase (EC 1.2.1.95) or alpha-AR or L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), which catalyzes the activation of alpha-aminoadipate by ATP-dependent adenylation and the reduction of activated alpha-aminoadipate by NADPH. The activated alpha-aminoadipate is bound to the phosphopantheinyl group of the enzyme itself before it is reduced to (S)-2-amino-6-oxohexanoate.
Pssm-ID: 341302 [Multi-domain] Cd Length: 520 Bit Score: 122.63 E-value: 1.58e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 494 GVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARvermreagGIVFaLADAECAGRAREAFAGACLDLSTL 573
Cdd:cd17647 41 GIKRGDVVMIYSYRGVDLMVAVMGVLKAGATFSVIDPAYPPAR--------QNIY-LGVAKPRGLIVIRAAGVVVGPDSN 111
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 574 PLagsgmslpapggrdaayMIFTSGTSGQPKGVVVEHASAlnlsqalarTVYANVVGEGLRVTVNAPFSFDSSIKQ---- 649
Cdd:cd17647 112 PT-----------------LSFTSGSEGIPKGVLGRHFSL---------AYYFPWMAKRFNLSENDKFTMLSGIAHdpiq 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 650 ---ILQLLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLlQAGLDDAHPALPGRILVGG--ERFDEASWE 724
Cdd:cd17647 166 rdmFTPLFLGAQLLVPTQDDIGTPGRLAEWMAKYGATVTHLTPAMGQLL-TAQATTPFPKLHHAFFVGDilTKRDCLRLQ 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 725 VAAgwRRCQVFNLYGPTEATVNASLARV-AEHARPTI----------GRALANVDLHVVDGLGRRKTRGAS--GELWIGG 791
Cdd:cd17647 245 TLA--ENVRIVNMYGTTETQRAVSYFEVpSRSSDPTFlknlkdvmpaGRGMLNVQLLVVNRNDRTQICGIGevGEIYVRA 322
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 792 AGVARGYAGDAGEAAGRF-----VEEG----------------WPG-SGRLYRSGDLVRWRADGCLEFLGRIDEQVKING 849
Cdd:cd17647 323 GGLAEGYRGLPELNKEKFvnnwfVEPDhwnyldkdnnepwrqfWLGpRDRLYRTGDLGRYLPNGDCECCGRADDQVKIRG 402
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 850 YRIELGEIRSALLEHPAVGEAAVLTDEADAAEPGAdrrIVAFVTAAEETADESWLEVDLP 909
Cdd:cd17647 403 FRIELGEIDTHISQHPLVRENITLVRRDKDEEPTL---VSYIVPRFDKPDDESFAQEDVP 459
|
|
| MACS_AAE_MA_like |
cd05970 |
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation ... |
455-872 |
1.70e-27 |
|
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This family of MACS enzymes is found in archaea and bacteria. It is represented by the acyl-adenylating enzyme from Methanosarcina acetivorans (AAE_MA). AAE_MA is most active with propionate, butyrate, and the branched analogs: 2-methyl-propionate, butyrate, and pentanoate. The specific activity is weaker for smaller or larger acids.
Pssm-ID: 341274 [Multi-domain] Cd Length: 537 Bit Score: 119.52 E-value: 1.70e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 455 DLRAALQPQAPALL--DAHGS---LDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVN 529
Cdd:cd05970 24 DAMAKEYPDKLALVwcDDAGEeriFTFAELADYSDKTANFFKAMGIGKGDTVMLTLKRRYEFWYSLLALHKLGAIAIPAT 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 530 PEFPAARVERMREAGGIVFALADAEcaGRAREAFAGACLDLSTLP-LAGSGMSLP------------------------A 584
Cdd:cd05970 104 HQLTAKDIVYRIESADIKMIVAIAE--DNIPEEIEKAAPECPSKPkLVWVGDPVPegwidfrkliknaspdferptansY 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 585 PGGRDAAYMIFTSGTSGQPKgvVVEHASALNLSQALARTVYANVVGEGLRVTVnAPFSFDSSI--KQILQLLSGhCLVLV 662
Cdd:cd05970 182 PCGEDILLVYFSSGTTGMPK--MVEHDFTYPLGHIVTAKYWQNVREGGLHLTV-ADTGWGKAVwgKIYGQWIAG-AAVFV 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 663 PQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPALPGRILVGGERFDEaswEVAAGWRR---CQVFNLYG 739
Cdd:cd05970 258 YDYDKFDPKALLEKLSKYGVTTFCAPPTIYRFLIREDLSRYDLSSLRYCTTAGEALNP---EVFNTFKEktgIKLMEGFG 334
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 740 PTEATVNASLARVAEHARPTIGRALANVDLHVVDGLGRRKTRGASGELWIGGA-----GVARGYAGDAGEAAgrfveEGW 814
Cdd:cd05970 335 QTETTLTIATFPWMEPKPGSMGKPAPGYEIDLIDREGRSCEAGEEGEIVIRTSkgkpvGLFGGYYKDAEKTA-----EVW 409
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*....
gi 15597498 815 PGSgrLYRSGDlVRWR-ADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV 872
Cdd:cd05970 410 HDG--YYHTGD-AAWMdEDGYLWFVGRTDDLIKSSGYRIGPFEVESALIQHPAVLECAV 465
|
|
| E-C_NRPS |
cd19544 |
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); ... |
1361-1688 |
4.04e-27 |
|
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); Dual function Epimerization/Condensation (E/C) domains have both an epimerization and a DCL condensation activity. Dual E/C domains first epimerize the substrate amino acid to produce a D-configuration, then catalyze the condensation between the D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. They are D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. These Dual E/C domains contain an extended His-motif (HHx(N)GD) near the N-terminus of the domain in addition to the standard Condensation (C) domain active site motif (HHxxxD). C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains, these include the DCL-type, LCL-type, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C domains, and the X-domain.
Pssm-ID: 380466 [Multi-domain] Cd Length: 413 Bit Score: 116.38 E-value: 4.04e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1361 YPMTSLQQGML----LQSEasGDPRLLHNVVLHEVHGRLDGelLARAWAILIGRHAILRTGFDLHGGQVPLQWVHPAtav 1436
Cdd:cd19544 2 YPLAPLQEGILfhhlLAEE--GDPYLLRSLLAFDSRARLDA--FLAALQQVIDRHDILRTAILWEGLSEPVQVVWRQ--- 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1437 aAEVPVHDLCGLDGETRRLRLRAWIEEEQaTPFDWSRPPLVRLAAlALDER--RFALGVAEHHSVLDGWSLQSLVDELLA 1514
Cdd:cd19544 75 -AELPVEELTLDPGDDALAQLRARFDPRR-YRLDLRQAPLLRAHV-AEDPAngRWLLLLLFHHLISDHTSLELLLEEIQA 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1515 vyadLLAGvvaREAE-APAVGFRDYVALEREAEANAASALFWLDYLAGARYRPLP-GLAE--EGPRRMAAVRVDVPADSL 1590
Cdd:cd19544 152 ----ILAG---RAAAlPPPVPYRNFVAQARLGASQAEHEAFFREMLGDVDEPTAPfGLLDvqGDGSDITEARLALDAELA 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1591 SRLRALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGR-PEEPGADRLLGLFLNTLPCRLS-ASVDLLDSARRA 1668
Cdd:cd19544 225 QRLRAQARRLGVSPASLFHLAWALVLARCSGRDDVVFGTVLSGRmQGGAGADRALGMFINTLPLRVRlGGRSVREAVRQT 304
|
330 340
....*....|....*....|
gi 15597498 1669 FDYERASLEHRRHPLAAIRR 1688
Cdd:cd19544 305 HARLAELLRHEHASLALAQR 324
|
|
| CHC_CoA_lg |
cd05903 |
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); ... |
473-876 |
4.31e-27 |
|
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); Cyclohexanecarboxylate-CoA ligase activates the aliphatic ring compound, cyclohexanecarboxylate, for degradation. It catalyzes the synthesis of cyclohexanecarboxylate-CoA thioesters in a two-step reaction involving the formation of cyclohexanecarboxylate-AMP anhydride, followed by the nucleophilic substitution of AMP by CoA.
Pssm-ID: 341229 [Multi-domain] Cd Length: 437 Bit Score: 116.71 E-value: 4.31e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 473 SLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFpaarveRMREAGgivFALAD 552
Cdd:cd05903 1 RLTYSELDTRADRLAAGLAALGVGPGDVVAFQLPNWWEFAVLYLACLRIGAVTNPILPFF------REHELA---FILRR 71
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 553 AecagRAREAFAgacldlstlPLAGSGMSlPAPGGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTVyanVVGEG 632
Cdd:cd05903 72 A----KAKVFVV---------PERFRQFD-PAAMPDAVALLLFTSGTTGEPKGVMHSHNTLSASIRQYAERL---GLGPG 134
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 633 LRVTVNAPfsfdssIKQILQLLSGHCLVLV---PQEVRS--DPQRMLGFLEERRID-VLDCTPSLFRLLLQAGLDDAHPA 706
Cdd:cd05903 135 DVFLVASP------MAHQTGFVYGFTLPLLlgaPVVLQDiwDPDKALALMREHGVTfMMGATPFLTDLLNAVEEAGEPLS 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 707 LPGRILVGGERFDEASWEVAAGWRRCQVFNLYGPTE---ATVNASLARVaEHARPTIGRALANVDLHVVDGLGRRKTRGA 783
Cdd:cd05903 209 RLRTFVCGGATVPRSLARRAAELLGAKVCSAYGSTEcpgAVTSITPAPE-DRRLYTDGRPLPGVEIKVVDDTGATLAPGV 287
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 784 SGELWIGGAGVARGYAgDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLE 863
Cdd:cd05903 288 EGELLSRGPSVFLGYL-DRPDLTADAAPEGW------FRTGDLARLDEDGYLRITGRSKDIIIRGGENIPVLEVEDLLLG 360
|
410
....*....|....*
gi 15597498 864 HPAVGEAAV--LTDE 876
Cdd:cd05903 361 HPGVIEAAVvaLPDE 375
|
|
| beta-lac_NRPS |
cd19547 |
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis ... |
1361-1708 |
6.87e-27 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis NocB which exhibits an unusual cyclization to form beta-lactam rings in pro-nocardicin G synthesis; Nocardia uniformis NRPS NocB acts centrally in the biosynthesis of the nocardicin monocyclic beta-lactam antibiotics. Along with another NRPS NocA, it mediates an unusual cyclization to form beta-lactam rings in the synthesis of the beta-lactam-containing pentapeptide pro-nocardicin G. This small subfamily is related to DCL-type Condensation (C) domains, which catalyze condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; domains belonging to this subfamily have an HHHxxxD motif at the active site.
Pssm-ID: 380469 [Multi-domain] Cd Length: 422 Bit Score: 115.87 E-value: 6.87e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1361 YPMTSLQQGMLLQSEASGDPRLLHNVVLHEVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQVPLQWVHpaTAVAAEV 1440
Cdd:cd19547 2 YPLAPMQEGMLFRGLFWPDSDAYFNQNVLELVGGTDEDVLREAWRRVADRYEILRTGFTWRDRAEPLQYVR--DDLAPPW 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1441 PVHDLCGLDGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLL 1520
Cdd:cd19547 80 ALLDWSGEDPDRRAELLERLLADDRAAGLSLADCPLYRLTLVRLGGGRHYLLWSHHHILLDGWCLSLIWGDVFRVYEELA 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1521 AGvvaREAE-APAVGFRDYVALEREAEANA-ASALFWLDYLAGARYRPLPGLAEEGPRRMAAVRVDVPaDSLSRLRALAE 1598
Cdd:cd19547 160 HG---REPQlSPCRPYRDYVRWIRARTAQSeESERFWREYLRDLTPSPFSTAPADREGEFDTVVHEFP-EQLTRLVNEAA 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1599 RS-GLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPEE-PGADRLLGLFLNTLPCRLSASVD-----LLDSARRAFDY 1671
Cdd:cd19547 236 RGyGVTTNAISQAAWSMLLALQTGARDVVHGLTIAGRPPElEGSEHMVGIFINTIPLRIRLDPDqtvtgLLETIHRDLAT 315
|
330 340 350 360
....*....|....*....|....*....|....*....|...
gi 15597498 1672 ERAsleHRRHPLAAIRRRNRELRL------DSLFNFVDFHQDD 1708
Cdd:cd19547 316 TAA---HGHVPLAQIKSWASGERLsggrvfDNLVAFENYPEDN 355
|
|
| FUM14_C_NRPS-like |
cd19545 |
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond ... |
1360-1776 |
1.92e-26 |
|
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond forming Fusarium verticillioides FUM14 protein; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) typically catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. However, some C-domains have ester-bond forming activity. This subfamily includes Fusarium verticillioides FUM14 (also known as NRPS8), a bi-domain protein with an ester-bond forming NRPS C-domain, which catalyzes linkages between an aminoacyl/peptidyl-PCP donor and a hydroxyl-containing acceptor. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. FUM14 has an altered active site motif DHTHCD instead of the typical HHxxxD motif seen in other subfamily members. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380467 [Multi-domain] Cd Length: 395 Bit Score: 113.93 E-value: 1.92e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1360 AYPMTSLQQGMLLQSEASGDPRLLHNVVlhEVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQVPLQwvhpatAVAAE 1439
Cdd:cd19545 1 IYPCTPLQEGLMALTARQPGAYVGQRVF--ELPPDIDLARLQAAWEQVVQANPILRTRIVQSDSGGLLQ------VVVKE 72
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1440 VPVHDLCGLDgetrrlrLRAWIEEEQATPFDWSrPPLVRLAAL--ALDERRFALGVaeHHSVLDGWSLQSLVDELLAVYA 1517
Cdd:cd19545 73 SPISWTESTS-------LDEYLEEDRAAPMGLG-GPLVRLALVedPDTERYFVWTI--HHALYDGWSLPLILRQVLAAYQ 142
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1518 DllagvvarEAEAPAVGFRDYVALEREAEAnAASALFWLDYLAGAR---YRPLPGLAEEgPRRMAAVRVDVPADSLSrlr 1594
Cdd:cd19545 143 G--------EPVPQPPPFSRFVKYLRQLDD-EAAAEFWRSYLAGLDpavFPPLPSSRYQ-PRPDATLEHSISLPSSA--- 209
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1595 alaeRSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGR--PeEPGADRLLGLFLNTLPCRLS----ASV-DLLDSARR 1667
Cdd:cd19545 210 ----SSGVTLATVLRAAWALVLSRYTGSDDVVFGVTLSGRnaP-VPGIEQIVGPTIATVPLRVRidpeQSVeDFLQTVQK 284
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1668 AfDYERASLEHRrhPLAAIRRRNRELR----LDSLFNFVdfHQDDAAPAGVRHGGILDQVVVDVDVPLAV---DFEVAGE 1740
Cdd:cd19545 285 D-LLDMIPFEHT--GLQNIRRLGPDARaacnFQTLLVVQ--PALPSSTSESLELGIEEESEDLEDFSSYGltlECQLSGS 359
|
410 420 430
....*....|....*....|....*....|....*.
gi 15597498 1741 RLEVGFQYAAGRFPAERAEALAGAYREALLALLGDP 1776
Cdd:cd19545 360 GLRVRARYDSSVISEEQVERLLDQFEHVLQQLASAP 395
|
|
| EntE |
COG1021 |
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase ... |
432-898 |
2.50e-26 |
|
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440644 [Multi-domain] Cd Length: 533 Bit Score: 116.01 E-value: 2.50e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 432 ERYQA---WQGErvepapveSLVAAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRN 508
Cdd:COG1021 14 ARYREagyWRGE--------TLGDLLRRRAERHPDRIAVVDGERRLSYAELDRRADRLAAGLLALGLRPGDRVVVQLPNV 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 509 REAIVALLGVMRAAAVytPVNPEFPAARVE-----RMREAGGIVFA-----LADAECAGRAREAF-----------AGAC 567
Cdd:COG1021 86 AEFVIVFFALFRAGAI--PVFALPAHRRAEishfaEQSEAVAYIIPdrhrgFDYRALARELQAEVpslrhvlvvgdAGEF 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 568 LDLSTLPLAGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALAR-------TVYAnvvgeglrVTVNAP 640
Cdd:COG1021 164 TSLDALLAAPADLSEPRPDPDDVAFFQLSGGTTGLPKLIPRTHDDYLYSVRASAEicgldadTVYL--------AALPAA 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 641 FSFDSSIKQIL-QLLSGHCLVLVPqevRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAgLDDAHPALPG--RILVGGER 717
Cdd:COG1021 236 HNFPLSSPGVLgVLYAGGTVVLAP---DPSPDTAFPLIERERVTVTALVPPLALLWLDA-AERSRYDLSSlrVLQVGGAK 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 718 FDEaswEVAA------GWRRCQVFnlyGPTEATVN-----ASLARVAEharpTIGRALANVD-LHVVDGLGRRKTRGASG 785
Cdd:COG1021 312 LSP---ELARrvrpalGCTLQQVF---GMAEGLVNytrldDPEEVILT----TQGRPISPDDeVRIVDEDGNPVPPGEVG 381
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 786 ELWIGGAGVARGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQvkIN--GYRIELGEIRSALLE 863
Cdd:COG1021 382 ELLTRGPYTIRGYYRAPEHNARAFTPDGF------YRTGDLVRRTPDGYLVVEGRAKDQ--INrgGEKIAAEEVENLLLA 453
|
490 500 510
....*....|....*....|....*....|....*....
gi 15597498 864 HPAVGEAAVLtdeadaAEPgaDR----RIVAFVTAAEET 898
Cdd:COG1021 454 HPAVHDAAVV------AMP--DEylgeRSCAFVVPRGEP 484
|
|
| starter-C_NRPS |
cd19533 |
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases ... |
1361-1716 |
3.03e-26 |
|
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. While standard C-domains catalyze peptide bond formation between two amino acids, an initial, ('starter') C-domain may instead acylate an amino acid with a fatty acid. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380456 [Multi-domain] Cd Length: 419 Bit Score: 114.00 E-value: 3.03e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1361 YPMTSLQQGMLLQSEASGDPRLLHNVVLHEVHGRLDGELLARAWAILIGRHAILRTGFDLHGGqVPLQWVHPATAVAAEV 1440
Cdd:cd19533 2 LPLTSAQRGVWFAEQLDPEGSIYNLAEYLEITGPVDLAVLERALRQVIAEAETLRLRFTEEEG-EPYQWIDPYTPVPIRH 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1441 PvhDLCGldGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLL 1520
Cdd:cd19533 81 I--DLSG--DPDPEGAAQQWMQEDLRKPLPLDNDPLFRHALFTLGDNRHFWYQRVHHIVMDGFSFALFGQRVAEIYTALL 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1521 AGVVAREAEAPAvgFRDYVALE---REAEANAASALFWLDYLAGAryRPLPGLAEEGPRRMAAVRV---DVPADSLSRLR 1594
Cdd:cd19533 157 KGRPAPPAPFGS--FLDLVEEEqayRQSERFERDRAFWTEQFEDL--PEPVSLARRAPGRSLAFLRrtaELPPELTRTLL 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1595 ALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPEEpGADRLLGLFLNTLPCRL--SASVDLLDSARRAFDYE 1672
Cdd:cd19533 233 EAAEAHGASWPSFFIALVAAYLHRLTGANDVVLGVPVMGRLGA-AARQTPGMVANTLPLRLtvDPQQTFAELVAQVSREL 311
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|.
gi 15597498 1673 RASLEHRRHPLAAIRRRNRELR-LDSLFNFV------DFHQDDAAPAGVRH 1716
Cdd:cd19533 312 RSLLRHQRYRYEDLRRDLGLTGeLHPLFGPTvnympfDYGLDFGGVVGLTH 362
|
|
| CBAL |
cd05923 |
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) ... |
458-905 |
6.55e-26 |
|
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) to 4-chlorobenzoyl-coenzyme A (4-CB-CoA) by the two-step adenylation and thioester-forming reactions. 4-Chlorobenzoate (4-CBA) is an environmental pollutant derived from microbial breakdown of aromatic pollutants, such as polychlorinated biphenyls (PCBs), DDT, and certain herbicides. The 4-CBA degrading pathway converts 4-CBA to the metabolite 4-hydroxybezoate (4-HBA), allowing some soil-dwelling microbes to utilize 4-CBA as an alternate carbon source. This pathway consists of three chemical steps catalyzed by 4-CBA-CoA ligase, 4-CBA-CoA dehalogenase, and 4HBA-CoA thioesterase in sequential reactions.
Pssm-ID: 341247 [Multi-domain] Cd Length: 493 Bit Score: 114.14 E-value: 6.55e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 458 AALQPQAPALLDAHGSLD--FATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAA 535
Cdd:cd05923 11 ASRAPDACAIADPARGLRltYSELRARIEAVAARLHARGLRPGQRVAVVLPNSVEAVIALLALHRLGAVPALINPRLKAA 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 536 RVERMREAGGIVFAL-------ADAECAGRAREAFAGACLDLSTLPLAGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVV 608
Cdd:cd05923 91 ELAELIERGEMTAAViavdaqvMDAIFQSGVRVLALSDLVGLGEPESAGPLIEDPPREPEQPAFVFYTSGTTGLPKGAVI 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 609 EHASALNLSQALArTVYANVVGEGLRVTVNAPFSFDSSIKQILQL-LSGHCLVLVPQEVrsDPQRMLGFLEERRIDVLDC 687
Cdd:cd05923 171 PQRAAESRVLFMS-TQAGLRHGRHNVVLGLMPLYHVIGFFAVLVAaLALDGTYVVVEEF--DPADALKLIEQERVTSLFA 247
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 688 TPSLFRLLL----QAGLDD--------AHPALPGRILvggERFDEAswevaagwRRCQVFNLYGPTEAtVNASLARVAeh 755
Cdd:cd05923 248 TPTHLDALAaaaeFAGLKLsslrhvtfAGATMPDAVL---ERVNQH--------LPGEKVNIYGTTEA-MNSLYMRDA-- 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 756 ARPTIGRALANVDLHVVDGLGRRKTR---GASGELWIGGAGVA--RGYAGDAgEAAGRFVEEGWpgsgrlYRSGDLVRWR 830
Cdd:cd05923 314 RTGTEMRPGFFSEVRIVRIGGSPDEAlanGEEGELIVAAAADAafTGYLNQP-EATAKKLQDGW------YRTGDVGYVD 386
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 15597498 831 ADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLtdeaDAAEPGADRRIVAFVTAAEETADESWLE 905
Cdd:cd05923 387 PSGDVRILGRVDDMIISGGENIHPSEIERVLSRHPGVTEVVVI----GVADERWGQSVTACVVPREGTLSADELD 457
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1290-1713 |
8.29e-26 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 117.58 E-value: 8.29e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1290 IQMQVMAREAGLAFTL-RDVFNHQSIRELA-----RLLAAPASP-ADALGTSAPQSLePFALLSAAERKRLP---EGLDD 1359
Cdd:PRK05691 3178 VDGQVYGGELVLRWTYsAERYDEQTIAELAeaylaELQALIAHClADGAGGLTPSDF-PLAQLTQAQLDALPvpaAEIED 3256
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1360 AYPMTSLQQGMLLQSEASGDPRLLHNVVLHEVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQVPLQWVHPATAVAAE 1439
Cdd:PRK05691 3257 VYPLTPMQEGLLLHTLLEPGTGLYYMQDRYRINSALDPERFAQAWQAVVARHEALRASFSWNAGETMLQVIHKPGRTPID 3336
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1440 VpvHDLCGLDGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADL 1519
Cdd:PRK05691 3337 Y--LDWRGLPEDGQEQRLQALHKQEREAGFDLLNQPPFHLRLIRVDEARYWFMMSNHHILIDAWCRSLLMNDFFEIYTAL 3414
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1520 LAGVVAREAEAPAvgFRDYVA-LEREAEANAASalFWLDYLAG-ARYRPLPG----LAEEGPRRMAAV------RVDVpA 1587
Cdd:PRK05691 3415 GEGREAQLPVPPR--YRDYIGwLQRQDLAQARQ--WWQDNLRGfERPTPIPSdrpfLREHAGDSGGMVvgdcytRLDA-A 3489
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1588 DSlSRLRALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRP-EEPGADRLLGLFLNTLPCRLSASVdlldsar 1666
Cdd:PRK05691 3490 DG-ARLRELAQAHQLTVNTFAQAAWALVLRRYSGDRDVLFGVTVAGRPvSMPQMQRTVGLFINSIALRVQLPA------- 3561
|
410 420 430 440
....*....|....*....|....*....|....*....|....*..
gi 15597498 1667 rafDYERASLehrRHPLAAIRRRNRELRLDSLFNFVDFHQDDAAPAG 1713
Cdd:PRK05691 3562 ---AGQRCSV---RQWLQGLLDSNMELREYEYLPLVAIQECSELPKG 3602
|
|
| VL_LC_FACS_like |
cd05907 |
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA ... |
494-917 |
1.31e-25 |
|
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA synthetases; This family includes long-chain fatty acid (C12-C20) CoA synthetases and Bubblegum-like very long-chain (>C20) fatty acid CoA synthetases. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Drosophila melanogaster mutant bubblegum (BGM) have elevated levels of very-long-chain fatty acids (VLCFA) caused by a defective gene later named bubblegum. The human homolog (hsBG) of bubblegum has been characterized as a very long chain fatty acid CoA synthetase that functions specifically in the brain; hsBG may play a central role in brain VLCFA metabolism and myelinogenesis. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341233 [Multi-domain] Cd Length: 452 Bit Score: 112.69 E-value: 1.31e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 494 GVRPGQAVAVMtGRNR-EAIVALLGVMRAAAVYTPVNPEFPAARVERMreaggivfaLADAEcagrAREAFAGACLDLST 572
Cdd:cd05907 26 GVEPGDRVAIL-SRNRpEWTIADLAILAIGAVPVPIYPTSSAEQIAYI---------LNDSE----AKALFVEDPDDLAT 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 573 LplagsgmslpapggrdaaymIFTSGTSGQPKGVVVEHASALNLSQALARTVYAnvvGEGLRVTVNAPFS--FDSSIKQI 650
Cdd:cd05907 92 I--------------------IYTSGTTGRPKGVMLSHRNILSNALALAERLPA---TEGDRHLSFLPLAhvFERRAGLY 148
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 651 LQLLSGHCLVLVPqevrsDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPALPGRIL------------VGGERF 718
Cdd:cd05907 149 VPLLAGARIYFAS-----SAETLLDDLSEVRPTVFLAVPRVWEKVYAAIKVKAVPGLKRKLFdlavggrlrfaaSGGAPL 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 719 DE--ASWEVAAGwrrCQVFNLYGPTEATVNASLARVAEHARPTIGRALANVDLHVVDglgrrktrgaSGELWIGGAGVAR 796
Cdd:cd05907 224 PAelLHFFRALG---IPVYEGYGLTETSAVVTLNPPGDNRIGTVGKPLPGVEVRIAD----------DGEILVRGPNVML 290
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 797 GYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRI-DEQVKINGYRIELGEIRSALLEHPAVGEAAVLTD 875
Cdd:cd05907 291 GYYKNPEATAEALDADGW------LHTGDLGEIDEDGFLHITGRKkDLIITSGGKNISPEPIENALKASPLISQAVVIGD 364
|
410 420 430 440
....*....|....*....|....*....|....*....|..
gi 15597498 876 eadaaepgADRRIVAFVTAAEETAdESWLEVDLPSGHRVAGL 917
Cdd:cd05907 365 --------GRPFLVALIVPDPEAL-EAWAEEHGIAYTDVAEL 397
|
|
| ttLC_FACS_AlkK_like |
cd12119 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes ... |
475-901 |
3.03e-25 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes fatty acyl-CoA synthetases that can activate medium-chain to long-chain fatty acids. They catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family catalyzes the long-chain fatty acid, myristoyl acid, while another member in this family, the AlkK protein identified from Pseudomonas oleovorans, targets medium chain fatty acids. This family also includes uncharacterized FACS proteins.
Pssm-ID: 341284 [Multi-domain] Cd Length: 518 Bit Score: 112.34 E-value: 3.03e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 475 DFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVER-MREAG-GIVFAlaD 552
Cdd:cd12119 27 TYAEVAERARRLANALRRLGVKPGDRVATLAWNTHRHLELYYAVPGMGAVLHTINPRLFPEQIAYiINHAEdRVVFV--D 104
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 553 AECAGRArEAFAGACLDLSTLPLAGSGMSLPAPGG------------------------RDAAYMIFTSGTSGQPKGVV- 607
Cdd:cd12119 105 RDFLPLL-EAIAPRLPTVEHVVVMTDDAAMPEPAGvgvlayeellaaespeydwpdfdeNTAAAICYTSGTTGNPKGVVy 183
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 608 -----VEHASALNLSQALA---RTVYanvvgegLRVT----VNA---PFSfdssikqilQLLSGHCLVLvPQeVRSDPQR 672
Cdd:cd12119 184 shrslVLHAMAALLTDGLGlseSDVV-------LPVVpmfhVNAwglPYA---------AAMVGAKLVL-PG-PYLDPAS 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 673 MLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPALPGR-ILVGG--------ERFDEASWEVAAGWrrcqvfnlyGPTE- 742
Cdd:cd12119 246 LAELIEREGVTFAAGVPTVWQGLLDHLEANGRDLSSLRrVVIGGsavprsliEAFEERGVRVIHAW---------GMTEt 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 743 ---ATVNASLARVAE-------HARPTIGRALANVDLHVVDGLGRRKTR--GASGELWIGGAGVARGYAGDAGEAAGRFv 810
Cdd:cd12119 317 splGTVARPPSEHSNlsedeqlALRAKQGRPVPGVELRIVDDDGRELPWdgKAVGELQVRGPWVTKSYYKNDEESEALT- 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 811 EEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLTdeadAAEPGADRRIVA 890
Cdd:cd12119 396 EDGW------LRTGDVATIDEDGYLTITDRSKDVIKSGGEWISSVELENAIMAHPAVAEAAVIG----VPHPKWGERPLA 465
|
490
....*....|....
gi 15597498 891 FVTAAEE---TADE 901
Cdd:cd12119 466 VVVLKEGatvTAEE 479
|
|
| C_PKS-NRPS |
cd20483 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1362-1686 |
4.16e-25 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHXXXD motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380471 [Multi-domain] Cd Length: 430 Bit Score: 110.81 E-value: 4.16e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1362 PMTSLQQGMLLQSEASGDPRLLHNVVLHEVHGRLDGELLARAWAILIGRHAILRTGFdLHGGQVPLQwvHPATAVAAEVP 1441
Cdd:cd20483 3 PMSTFQRRLWFLHNFLEDKTFLNLLLVCHIKGKPDVNLLQKALSELVRRHEVLRTAY-FEGDDFGEQ--QVLDDPSFHLI 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1442 VHDLCglDGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLLA 1521
Cdd:cd20483 80 VIDLS--EAADPEAALDQLVRNLRRQELDIEEGEVIRGWLVKLPDEEFALVLASHHIAWDRGSSKSIFEQFTALYDALRA 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1522 GVVAREAEAPAVGFRDYVALERE---AEANAASALFWLDYLAGAryrP-----LPGLAEEGPRRM----AAVRVDVPADS 1589
Cdd:cd20483 158 GRDLATVPPPPVQYIDFTLWHNAllqSPLVQPLLDFWKEKLEGI---PdasklLPFAKAERPPVKdyerSTVEATLDKEL 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1590 LSRLRALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPeEPGADRLLGLFLNTLPCRLSAS-----VDLLDS 1664
Cdd:cd20483 235 LARMKRICAQHAVTPFMFLLAAFRAFLYRYTEDEDLTIGMVDGDRP-HPDFDDLVGFFVNMLPIRCRMDcdmsfDDLLES 313
|
330 340
....*....|....*....|...
gi 15597498 1665 AR-RAFDyeraSLEHRRHPLAAI 1686
Cdd:cd20483 314 TKtTCLE----AYEHSAVPFDYI 332
|
|
| MACS_like_2 |
cd05973 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
474-873 |
1.67e-24 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341277 [Multi-domain] Cd Length: 437 Bit Score: 109.14 E-value: 1.67e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 474 LDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEF-PAARVERMREAGGIVFaLAD 552
Cdd:cd05973 1 LTFGELRALSARFANALQELGVGPGDVVAGLLPRTPELVVTILGIWRLGAVYQPLFTAFgPKAIEHRLRTSGARLV-VTD 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 553 AecAGRAReafagacldLSTLPLAgsgmslpapggrdaayMIFTSGTSGQPKGVVVEhASALNLSQALAR--------TV 624
Cdd:cd05973 80 A--ANRHK---------LDSDPFV----------------MMFTSGTTGLPKGVPVP-LRALAAFGAYLRdavdlrpeDS 131
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 625 YANVV----GEGLRVTVNAPfsfdssikqilqLLSGHCLVLVpqEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGL 700
Cdd:cd05973 132 FWNAAdpgwAYGLYYAITGP------------LALGHPTILL--EGGFSVESTWRVIERLGVTNLAGSPTAYRLLMAAGA 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 701 DdAHPALPGRILVGGERFDEASWEVAAGWRRC---QVFNLYGPTEatVNASLARVAEHARP----TIGRALANVDLHVVD 773
Cdd:cd05973 198 E-VPARPKGRLRRVSSAGEPLTPEVIRWFDAAlgvPIHDHYGQTE--LGMVLANHHALEHPvhagSAGRAMPGWRVAVLD 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 774 GLGRRKTRGASGELWIGGAGVA----RGYAGDAGEAAgrfveegwpgSGRLYRSGDLVRWRADGCLEFLGRIDEQVKING 849
Cdd:cd05973 275 DDGDELGPGEPGRLAIDIANSPlmwfRGYQLPDTPAI----------DGGYYLTGDTVEFDPDGSFSFIGRADDVITMSG 344
|
410 420
....*....|....*....|....
gi 15597498 850 YRIELGEIRSALLEHPAVGEAAVL 873
Cdd:cd05973 345 YRIGPFDVESALIEHPAVAEAAVI 368
|
|
| FACL_DitJ_like |
cd05934 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
476-872 |
8.67e-24 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Members of this family include DitJ from Pseudomonas and similar proteins.
Pssm-ID: 341257 [Multi-domain] Cd Length: 422 Bit Score: 106.61 E-value: 8.67e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 476 FATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPefpaarvermreaggivfALADAEC 555
Cdd:cd05934 6 YAELLRESARIAAALAALGIRPGDRVALMLDNCPEFLFAWFALAKLGAVLVPINT------------------ALRGDEL 67
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 556 AGRAREAfaGACLDLStlplagsgmslpapggrDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARtvyANVVGEGLRV 635
Cdd:cd05934 68 AYIIDHS--GAQLVVV-----------------DPASILYTSGTTGPPKGVVITHANLTFAGYYSAR---RFGLGEDDVY 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 636 TVNAP-FSFDSSIKQILQ-LLSGHCLVLVPqevRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQA--GLDDAH------- 704
Cdd:cd05934 126 LTVLPlFHINAQAVSVLAaLSVGATLVLLP---RFSASRFWSDVRRYGATVTNYLGAMLSYLLAQppSPDDRAhrlraay 202
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 705 --PALPGRILVGGERFDeaswevaagwrrCQVFNLYGPTEATVNASLARVAEHARPTIGRALANVDLHVVDGLGRRKTRG 782
Cdd:cd05934 203 gaPNPPELHEEFEERFG------------VRLLEGYGMTETIVGVIGPRDEPRRPGSIGRPAPGYEVRIVDDDGQELPAG 270
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 783 ASGELWI---GGAGVARGYAGDAGEAAGRFvEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRS 859
Cdd:cd05934 271 EPGELVIrglRGWGFFKGYYNMPEATAEAM-RNGW------FHTGDLGYRDADGFFYFVDRKKDMIRRRGENISSAEVER 343
|
410
....*....|...
gi 15597498 860 ALLEHPAVGEAAV 872
Cdd:cd05934 344 AILRHPAVREAAV 356
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1391-1778 |
9.61e-24 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 110.82 E-value: 9.61e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1391 VHGRLDGELLARAWAILIGRHAILRTGFDLHGGQVpLQWVHPATAVaaEVPVHDLCGLDGETRRLRLRAWIEEEQATPFD 1470
Cdd:PRK12316 80 LNGPLDRQALERAFASLVQRHETLRTVFPRGADDS-LAQVPLDRPL--EVEFEDCSGLPEAEQEARLRDEAQRESLQPFD 156
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1471 WSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLLAGvvaREAEAPA--VGFRDYVALER---EA 1545
Cdd:PRK12316 157 LCEGPLLRVRLLRLGEEEHVLLLTLHHIVSDGWSMNVLIEEFSRFYSAYATG---AEPGLPAlpIQYADYALWQRswlEA 233
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1546 EANAASALFWLDYLAGAryRPLPGLAEEGPR------RMAAVRVDVPADSLSRLRALAERSGLPLRSLLLAAHGRALCRF 1619
Cdd:PRK12316 234 GEQERQLEYWRAQLGEE--HPVLELPTDHPRpavpsyRGSRYEFSIDPALAEALRGTARRQGLTLFMLLLGAFNVLLHRY 311
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1620 SDADEVVTGFVSHGRpEEPGADRLLGLFLNTLPCR----LSASV-DLLDSARRAFDYERASLEHRRHPLAAIRRRNRELR 1694
Cdd:PRK12316 312 SGQTDIRVGVPIANR-NRAEVEGLIGFFVNTQVLRsvfdGRTRVaTLLAGVKDTVLGAQAHQDLPFERLVEALKVERSLS 390
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1695 LDSLFNFVDFHQDDAAPAGVRHGGILDQVVVDVDVPLAVDFEVA------GERLEVGFQYAAGRFPAERAEALAGAYREA 1768
Cdd:PRK12316 391 HSPLFQVMYNHQPLVADIEALDTVAGLEFGQLEWKSRTTQFDLTldtyekGGRLHAALTYATDLFEARTVERMARHWQNL 470
|
410
....*....|
gi 15597498 1769 LLALLGDPVQ 1778
Cdd:PRK12316 471 LRGMVENPQA 480
|
|
| MACS_like_1 |
cd05974 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
474-873 |
1.17e-23 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341278 [Multi-domain] Cd Length: 432 Bit Score: 106.50 E-value: 1.17e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 474 LDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALADA 553
Cdd:cd05974 1 VSFAEMSARSSRVANFLRSIGVGRGDRILLMLGNVVELWEAMLAAMKLGAVVIPATTLLTPDDLRDRVDRGGAVYAAVDE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 554 ECAGRareafagacldlstlplagsgmslpapggrDAAYMIFTSGTSGQPKgvVVEHASALNLSQALARTVYANVVGEGL 633
Cdd:cd05974 81 NTHAD------------------------------DPMLLYFTSGTTSKPK--LVEHTHRSYPVGHLSTMYWIGLKPGDV 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 634 RVTVNAPFSFDSSIKQILQLLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLddAHPALPGRILV 713
Cdd:cd05974 129 HWNISSPGWAKHAWSCFFAPWNAGATVFLFNYARFDAKRVLAALVRYGVTTLCAPPTVWRMLIQQDL--ASFDVKLREVV 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 714 G-GERFD-EASWEVAAGWRRcQVFNLYGPTEATVNASLARVAEHARPTIGRALANVDLHVVDGLGRRKTRGASGeLWIGG 791
Cdd:cd05974 207 GaGEPLNpEVIEQVRRAWGL-TIRDGYGQTETTALVGNSPGQPVKAGSMGRPLPGYRVALLDPDGAPATEGEVA-LDLGD 284
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 792 ---AGVARGYAGDAGEAAGRFveegwpgSGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVG 868
Cdd:cd05974 285 trpVGLMKGYAGDPDKTAHAM-------RGGYYRTGDIAMRDEDGYLTYVGRADDVFKSSDYRISPFELESVLIEHPAVA 357
|
....*
gi 15597498 869 EAAVL 873
Cdd:cd05974 358 EAAVV 362
|
|
| LCL_NRPS-like |
cd19540 |
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; ... |
1392-1668 |
3.24e-23 |
|
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380463 [Multi-domain] Cd Length: 433 Bit Score: 105.20 E-value: 3.24e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1392 HGRLDGELLARAWAILIGRHAILRTGFDLHGGqVPLQWVHPATAVAAEVPVHDLcgldGETRrlrLRAWIEEEQATPFDW 1471
Cdd:cd19540 33 TGALDVDALRAALADVVARHESLRTVFPEDDG-GPYQVVLPAAEARPDLTVVDV----TEDE---LAARLAEAARRGFDL 104
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1472 SRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLLAGvVAREAEAPAVGFRDYVALERE---AEAN 1548
Cdd:cd19540 105 TAELPLRARLFRLGPDEHVLVLVVHHIAADGWSMAPLARDLATAYAARRAG-RAPDWAPLPVQYADYALWQREllgDEDD 183
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1549 AASAL-----FWLDYLAGARY-------RPLPGLAEegpRRMAAVRVDVPADSLSRLRALAERSGLPLRSLLLAAHGRAL 1616
Cdd:cd19540 184 PDSLAarqlaYWRETLAGLPEelelptdRPRPAVAS---YRGGTVEFTIDAELHARLAALAREHGATLFMVLHAALAVLL 260
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*..
gi 15597498 1617 CRFSDADEVVTGFVSHGRPEEpGADRLLGLFLNTLPCRLSAS-----VDLLDSARRA 1668
Cdd:cd19540 261 SRLGAGDDIPIGTPVAGRGDE-ALDDLVGMFVNTLVLRTDVSgdptfAELLARVRET 316
|
|
| alpha_am_amid |
TIGR03443 |
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ... |
494-869 |
3.93e-23 |
|
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.
Pssm-ID: 274582 [Multi-domain] Cd Length: 1389 Bit Score: 108.23 E-value: 3.93e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 494 GVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAAR------VERMReaggivfALADAECAGRAR---EAFA 564
Cdd:TIGR03443 291 GIKRGDVVMIYAYRGVDLVVAVMGVLKAGATFSVIDPAYPPARqtiylsVAKPR-------ALIVIEKAGTLDqlvRDYI 363
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 565 GACLDLST----LPLAGSGM---SLPAPGGRD--AAY-------------------MIFTSGTSGQPKGVVVEHASAlnl 616
Cdd:TIGR03443 364 DKELELRTeipaLALQDDGSlvgGSLEGGETDvlAPYqalkdtptgvvvgpdsnptLSFTSGSEGIPKGVLGRHFSL--- 440
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 617 sqalarTVYANVVGEGLRVTVNAPFSFDSSI------KQILQLLSGHCLVLVP-QEVRSDPQRMLGFLEERRIDVLDCTP 689
Cdd:TIGR03443 441 ------AYYFPWMAKRFGLSENDKFTMLSGIahdpiqRDMFTPLFLGAQLLVPtADDIGTPGRLAEWMAKYGATVTHLTP 514
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 690 SLFRLLlQAGLDDAHPALPGRILVGG--ERFDEASWEVAAgwRRCQVFNLYGPTEATVNASLARVAEHAR-PTI------ 760
Cdd:TIGR03443 515 AMGQLL-SAQATTPIPSLHHAFFVGDilTKRDCLRLQTLA--ENVCIVNMYGTTETQRAVSYFEIPSRSSdSTFlknlkd 591
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 761 ----GRALANVDLHVVDGLGRRKT--RGASGELWIGGAGVARGYAGDAGEAAGRFV---------------------EEG 813
Cdd:TIGR03443 592 vmpaGKGMKNVQLLVVNRNDRTQTcgVGEVGEIYVRAGGLAEGYLGLPELNAEKFVnnwfvdpshwidldkennkpeREF 671
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*..
gi 15597498 814 WPG-SGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGE 869
Cdd:TIGR03443 672 WLGpRDRLYRTGDLGRYLPDGNVECCGRADDQVKIRGFRIELGEIDTHLSQHPLVRE 728
|
|
| ACS-like |
cd17634 |
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the ... |
494-906 |
9.58e-23 |
|
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases. The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341289 [Multi-domain] Cd Length: 587 Bit Score: 105.35 E-value: 9.58e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 494 GVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEF-PAARVERMREAGGIVFALADAEC-AGRA------------ 559
Cdd:cd17634 105 GVKKGDRVAIYMPMIPEAAVAMLACARIGAVHSVIFGGFaPEAVAGRIIDSSSRLLITADGGVrAGRSvplkknvddaln 184
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 560 -------------REAFA-----GACLDLSTLPLAGSGMSLPAP-GGRDAAYMIFTSGTSGQPKGVVVEHAS-ALNLSQA 619
Cdd:cd17634 185 pnvtsvehvivlkRTGSDidwqeGRDLWWRDLIAKASPEHQPEAmNAEDPLFILYTSGTTGKPKGVLHTTGGyLVYAATT 264
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 620 LaRTVYANVVGEGLRVTVNAPFSFDSSIKQILQLLSGHCLVL---VPqeVRSDPQRMLGFLEERRIDVLDCTPSLFRLLL 696
Cdd:cd17634 265 M-KYVFDYGPGDIYWCTADVGWVTGHSYLLYGPLACGATTLLyegVP--NWPTPARMWQVVDKHGVNILYTAPTAIRALM 341
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 697 QAGLD--DAHPALPGRILVG-GERFDEASWEVAA---GWRRCQVFNLYGPTEAT----VNASLARVAEHARPTigRALAN 766
Cdd:cd17634 342 AAGDDaiEGTDRSSLRILGSvGEPINPEAYEWYWkkiGKEKCPVVDTWWQTETGgfmiTPLPGAIELKAGSAT--RPVFG 419
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 767 VDLHVVDGLGRRKTRGASGELWIGGA--GVARGYAGDAGeaagRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRIDEQ 844
Cdd:cd17634 420 VQPAVVDNEGHPQPGGTEGNLVITDPwpGQTRTLFGDHE----RFEQTYFSTFKGMYFSGDGARRDEDGYYWITGRSDDV 495
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 15597498 845 VKINGYRIELGEIRSALLEHPAVGEAAVLtdeaDAAEPGADRRIVAFVT--AAEETADESWLEV 906
Cdd:cd17634 496 INVAGHRLGTAEIESVLVAHPKVAEAAVV----GIPHAIKGQAPYAYVVlnHGVEPSPELYAEL 555
|
|
| FAA1 |
COG1022 |
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; |
440-905 |
9.08e-22 |
|
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism];
Pssm-ID: 440645 [Multi-domain] Cd Length: 603 Bit Score: 102.49 E-value: 9.08e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 440 ERVEPAPVESLVAAFDLRAALQPQAPALLDAHG----SLDFATLRARSEAVAEALLAAGVRPGQAVAVMtGRNR-EAIVA 514
Cdd:COG1022 3 EFSDVPPADTLPDLLRRRAARFPDRVALREKEDgiwqSLTWAEFAERVRALAAGLLALGVKPGDRVAIL-SDNRpEWVIA 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 515 LLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALA-DAECAGRAREAFAGA-------------------CLDLSTLP 574
Cdd:COG1022 82 DLAILAAGAVTVPIYPTSSAEEVAYILNDSGAKVLFVeDQEQLDKLLEVRDELpslrhivvldprglrddprLLSLDELL 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 575 LAGSGMSLP--------APGGRDAAYMIFTSGTSGQPKGVVVEHAS----ALNLSQALART-------------VYANVV 629
Cdd:COG1022 162 ALGREVADPaelearraAVKPDDLATIIYTSGTTGRPKGVMLTHRNllsnARALLERLPLGpgdrtlsflplahVFERTV 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 630 GEGL---RVTVNapfsFDSSIKQILQLLsghclvlvpQEVRsdPQRMLG---FLE------ERRIDvlDCTP---SLFRL 694
Cdd:COG1022 242 SYYAlaaGATVA----FAESPDTLAEDL---------REVK--PTFMLAvprVWEkvyagiQAKAE--EAGGlkrKLFRW 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 695 LLQAGLDDAHPALPGRILVGGER--FDEASWEVAAGWR-----RCQ-----------------------VFNLYGPTEAT 744
Cdd:COG1022 305 ALAVGRRYARARLAGKSPSLLLRlkHALADKLVFSKLRealggRLRfavsggaalgpelarffralgipVLEGYGLTETS 384
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 745 VNASlARVAEHARP-TIGRALANVDLHVvdglgrrktrGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgsgrlYRS 823
Cdd:COG1022 385 PVIT-VNRPGDNRIgTVGPPLPGVEVKI----------AEDGEILVRGPNVMKGYYKNPEATAEAFDADGW------LHT 447
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 824 GDLVRWRADGCLEFLGRIDEQVKI-NGYRIELGEIRSALLEHPAVGEAAVLtdeadaaepGADRR-IVAFVTAAEETAdE 901
Cdd:COG1022 448 GDIGELDEDGFLRITGRKKDLIVTsGGKNVAPQPIENALKASPLIEQAVVV---------GDGRPfLAALIVPDFEAL-G 517
|
....
gi 15597498 902 SWLE 905
Cdd:COG1022 518 EWAE 521
|
|
| PRK07788 |
PRK07788 |
acyl-CoA synthetase; Validated |
458-899 |
9.40e-22 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236097 [Multi-domain] Cd Length: 549 Bit Score: 101.93 E-value: 9.40e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 458 AALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARV 537
Cdd:PRK07788 59 ARRAPDRAALIDERGTLTYAELDEQSNALARGLLALGVRAGDGVAVLARNHRGFVLALYAAGKVGARIILLNTGFSGPQL 138
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 538 ERMREAGGIVFALADAECAGRAR-------------------EAFAGACLDLSTLPLAGSGMSLPAPgGRDAAYMIFTSG 598
Cdd:PRK07788 139 AEVAAREGVKALVYDDEFTDLLSalppdlgrlrawggnpdddEPSGSTDETLDDLIAGSSTAPLPKP-PKPGGIVILTSG 217
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 599 TSGQPKGVVVEHASALN-LSQALAR------------------TVYAN-VVGEGLRVTVNAPFSFDSsiKQILQLLSGH- 657
Cdd:PRK07788 218 TTGTPKGAPRPEPSPLApLAGLLSRvpfragettllpapmfhaTGWAHlTLAMALGSTVVLRRRFDP--EATLEDIAKHk 295
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 658 --CLVLVPQEVrsdpQRMLGFLEERRIDVlDCtpSLFRLLLQAGlddahPALPGRIlvgGERFDEASWEVaagwrrcqVF 735
Cdd:PRK07788 296 atALVVVPVML----SRILDLGPEVLAKY-DT--SSLKIIFVSG-----SALSPEL---ATRALEAFGPV--------LY 352
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 736 NLYGPTEATVnASLARVAEHARP--TIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAagrfVEEG 813
Cdd:PRK07788 353 NLYGSTEVAF-ATIATPEDLAEApgTVGRPPKGVTVKILDENGNEVPRGVVGRIFVGNGFPFEGYTDGRDKQ----IIDG 427
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 814 wpgsgrLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLTDEADaaEPGAdrRIVAFVT 893
Cdd:PRK07788 428 ------LLSSGDVGYFDEDGLLFVDGRDDDMIVSGGENVFPAEVEDLLAGHPDVVEAAVIGVDDE--EFGQ--RLRAFVV 497
|
....*.
gi 15597498 894 AAEETA 899
Cdd:PRK07788 498 KAPGAA 503
|
|
| MACS_like_3 |
cd05971 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
476-873 |
1.40e-21 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341275 [Multi-domain] Cd Length: 439 Bit Score: 100.20 E-value: 1.40e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 476 FATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVErmreaggivFALADAEc 555
Cdd:cd05971 9 FKELKTASNRFANVLKEIGLEKGDRVGVFLSQGPECAIAHIAILRSGAIAVPLFALFGPEALE---------YRLSNSG- 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 556 agrareafaGACL--DLSTlplagsgmslpapggrDAAYMIFTSGTSGQPKG------VVVEHASALNLSQALARTvyan 627
Cdd:cd05971 79 ---------ASALvtDGSD----------------DPALIIYTSGTTGPPKGalhahrVLLGHLPGVQFPFNLFPR---- 129
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 628 vvgEGLRVTVNAPFSFDSSIKQILQLLSGHCLVLVPQEVRS-DPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPA 706
Cdd:cd05971 130 ---DGDLYWTPADWAWIGGLLDVLLPSLYFGVPVLAHRMTKfDPKAALDLMSRYGVTTAFLPPTALKMMRQQGEQLKHAQ 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 707 LPGRILVGGerfDEASWEVAAGWRRCQ----VFNLYGPTEATVNASLARVAEHARP-TIGRALANVDLHVVDGLGRRKTR 781
Cdd:cd05971 207 VKLRAIATG---GESLGEELLGWAREQfgveVNEFYGQTECNLVIGNCSALFPIKPgSMGKPIPGHRVAIVDDNGTPLPP 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 782 GASGELwiggaGVAR-------GYAGDAGEAAGRFVeegwpgsGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIEL 854
Cdd:cd05971 284 GEVGEI-----AVELpdpvaflGYWNNPSATEKKMA-------GDWLLTGDLGRKDSDGYFWYVGRDDDVITSSGYRIGP 351
|
410
....*....|....*....
gi 15597498 855 GEIRSALLEHPAVGEAAVL 873
Cdd:cd05971 352 AEIEECLLKHPAVLMAAVV 370
|
|
| PRK07470 |
PRK07470 |
acyl-CoA synthetase; Validated |
458-873 |
2.06e-21 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 180988 [Multi-domain] Cd Length: 528 Bit Score: 100.50 E-value: 2.06e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 458 AALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARV 537
Cdd:PRK07470 17 ARRFPDRIALVWGDRSWTWREIDARVDALAAALAARGVRKGDRILVHSRNCNQMFESMFAAFRLGAVWVPTNFRQTPDEV 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 538 ERMREAGGIVFALADAECAGRAREAFAGACLDLSTLPLAGSGMSLP-------APGGR---------DAAYMIFTSGTSG 601
Cdd:PRK07470 97 AYLAEASGARAMICHADFPEHAAAVRAASPDLTHVVAIGGARAGLDyealvarHLGARvanaavdhdDPCWFFFTSGTTG 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 602 QPKGVVVEHAS-ALNLSQALARTVYAnvVGEGLRVTVNAPFSFDSSIKQILQLLSGHCLVLVPQEvRSDPQRMLGFLEER 680
Cdd:PRK07470 177 RPKAAVLTHGQmAFVITNHLADLMPG--TTEQDASLVVAPLSHGAGIHQLCQVARGAATVLLPSE-RFDPAEVWALVERH 253
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 681 RIDVLDCTPSLFRLLLQaglddaHPALpgrilvggERFDEAS--WEVAAG---WRRCQVFNL----------YGPTEATV 745
Cdd:PRK07470 254 RVTNLFTVPTILKMLVE------HPAV--------DRYDHSSlrYVIYAGapmYRADQKRALaklgkvlvqyFGLGEVTG 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 746 NASLARVAEHARP--------TIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAgEAAGRFVEEGWpgs 817
Cdd:PRK07470 320 NITVLPPALHDAEdgpdarigTCGFERTGMEVQIQDDEGRELPPGETGEICVIGPAVFAGYYNNP-EANAKAFRDGW--- 395
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*.
gi 15597498 818 grlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:PRK07470 396 ---FRTGDLGHLDARGFLYITGRASDMYISGGSNVYPREIEEKLLTHPAVSEVAVL 448
|
|
| 23DHB-AMP_lg |
cd05920 |
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2, ... |
428-897 |
2.12e-21 |
|
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2,3-dihydroxybenzoate (DHB) by ligation of AMP from ATP with the release of pyrophosphate. However, it can also catalyze the ATP-PPi exchange for 2,3-DHB analogs, such as salicyclic acid (o-hydrobenzoate), as well as 2,4-DHB and 2,5-DHB, but with less efficiency. Proteins in this family are the stand-alone adenylation components of non-ribosomal peptide synthases (NRPSs) involved in the biosynthesis of siderophores, which are low molecular weight iron-chelating compounds synthesized by many bacteria to aid in the acquisition of this vital trace elements. In Escherichia coli, the 2,3-dihydroxybenzoate-AMP ligase is called EntE, the adenylation component of the enterobactin NRPS system.
Pssm-ID: 341244 [Multi-domain] Cd Length: 482 Bit Score: 100.09 E-value: 2.12e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 428 AAERERYQAWQGErvepaPVESLVAAfdlRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGR 507
Cdd:cd05920 3 ARRYRAAGYWQDE-----PLGDLLAR---SAARHPDRIAVVDGDRRLTYRELDRRADRLAAGLRGLGIRPGDRVVVQLPN 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 508 NREAIVALLGVMRAAAVytPVNpefpAARVERMREAGGIV-FALADAECAGRAREAFAGACLdlstlplagsgMSLPAPG 586
Cdd:cd05920 75 VAEFVVLFFALLRLGAV--PVL----ALPSHRRSELSAFCaHAEAVAYIVPDRHAGFDHRAL-----------ARELAES 137
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 587 GRDAAYMIFTSGTSGQPKGVVVEH--------ASAlNLSQALARTVYANVVGEGLRVTVNAPFSFDSsikqilqLLSGHC 658
Cdd:cd05920 138 IPEVALFLLSGGTTGTPKLIPRTHndyaynvrASA-EVCGLDQDTVYLAVLPAAHNFPLACPGVLGT-------LLAGGR 209
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 659 LVLVPqevRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPALPGRIL-VGGERFDEASWEVAAGWRRCQVFNL 737
Cdd:cd05920 210 VVLAP---DPSPDAAFPLIEREGVTVTALVPALVSLWLDAAASRRADLSSLRLLqVGGARLSPALARRVPPVLGCTLQQV 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 738 YGPTEATVNAS-LARVAEHARPTIGRALANVD-LHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWp 815
Cdd:cd05920 287 FGMAEGLLNYTrLDDPDEVIIHTQGRPMSPDDeIRVVDEEGNPVPPGEEGELLTRGPYTIRGYYRAPEHNARAFTPDGF- 365
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 816 gsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLTdeadAAEPGADRRIVAFVTAA 895
Cdd:cd05920 366 -----YRTGDLVRRTPDGYLVVEGRIKDQINRGGEKIAAEEVENLLLRHPAVHDAAVVA----MPDELLGERSCAFVVLR 436
|
..
gi 15597498 896 EE 897
Cdd:cd05920 437 DP 438
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1198-1372 |
5.54e-21 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 101.39 E-value: 5.54e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1198 QALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRRALLAALAAEAAAQTLeaPANATEAALLEIWKSVLKRPAIGVSD 1277
Cdd:PRK12467 3550 ETLRDHLAASLPDYMVPAQLLVLAAMPLGPNGKVDRKALPDPDAKGSREYVA--PRSEVEQQLAAIWADVLGVEQVGVTD 3627
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1278 NFFQVGGDSIRLIQMQVMAREA-GLAFTLRDVFNHQSIRELA------RLLAAPASPADALGTSAPQSLEPFALL-SAAE 1349
Cdd:PRK12467 3628 NFFELGGDSLLALQVLSRIRQSlGLKLSLRDLMSAPTIAELAgysplgDVPVNLLLDLNRLETGFPALFCRHEGLgTVFD 3707
|
170 180
....*....|....*....|...
gi 15597498 1350 RKRLPEGLDDAYPMTSLQQGMLL 1372
Cdd:PRK12467 3708 YEPLAVILEGDRHVLGLTCRHLL 3730
|
|
| OSB_MenE-like |
cd17630 |
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) ... |
591-905 |
8.47e-21 |
|
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) synthetase (also known as O-succinylbenzoic acid CoA ligase) that belongs to the ANL superfamily and catalyzes the ligation of CoA to o-succinylbenzoate (OSB). It includes MenE in the bacterial menaquinone biosynthesis pathway which is a promising target for the development of novel antibacterial agents. MenE catalyzes CoA ligation via an acyl-adenylate intermediate; tight-binding inhibitors of MenE based on stable acyl-sulfonyladenosine analogs of this intermediate provide a pathway toward the development of optimized MenE inhibitors.
Pssm-ID: 341285 [Multi-domain] Cd Length: 325 Bit Score: 95.86 E-value: 8.47e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 591 AYMIFTSGTSGQPKGVVVEHAsalnlsqalarTVYANVVGeglrvtVNAPFSFDSSIKQILQLLSGH---------CL-- 659
Cdd:cd17630 3 ATVILTSGSTGTPKAVVHTAA-----------NLLASAAG------LHSRLGFGGGDSWLLSLPLYHvgglailvrSLla 65
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 660 --VLVPQEVRSDPQRMLgflEERRIDVLDCTPSLFRLLLQAGLDDAHPALPGRILVGG--------ERFDEASWEVAAGw 729
Cdd:cd17630 66 gaELVLLERNQALAEDL---APPGVTHVSLVPTQLQRLLDSGQGPAALKSLRAVLLGGapippellERAADRGIPLYTT- 141
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 730 rrcqvfnlYGPTEATVNASLARVAEHARPTIGRALANVDLHVVDGlgrrktrgasGELWIGGAGVARGYAgdAGEAAGRF 809
Cdd:cd17630 142 --------YGMTETASQVATKRPDGFGRGGVGVLLPGRELRIVED----------GEIWVGGASLAMGYL--RGQLVPEF 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 810 VEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLtDEADaAEPGAdrRIV 889
Cdd:cd17630 202 NEDGW------FTTKDLGELHADGRLTVLGRADNMIISGGENIQPEEIEAALAAHPAVRDAFVV-GVPD-EELGQ--RPV 271
|
330
....*....|....*.
gi 15597498 890 AFVTAAEETADESWLE 905
Cdd:cd17630 272 AVIVGRGPADPAELRA 287
|
|
| PRK05852 |
PRK05852 |
fatty acid--CoA ligase family protein; |
449-875 |
1.27e-20 |
|
fatty acid--CoA ligase family protein;
Pssm-ID: 235625 [Multi-domain] Cd Length: 534 Bit Score: 98.42 E-value: 1.27e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 449 SLVAAFDLRAALQPQAPALL--DAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYT 526
Cdd:PRK05852 17 RIADLVEVAATRLPEAPALVvtADRIAISYRDLARLVDDLAGQLTRSGLLPGDRVALRMGSNAEFVVALLAASRADLVVV 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 527 PVNPEFPAA-RVERMREAGG-IVFALADAEC---------------AGRAREAFAGAC---LDLSTLPLAGSgmSLPAPG 586
Cdd:PRK05852 97 PLDPALPIAeQRVRSQAAGArVVLIDADGPHdraepttrwwpltvnVGGDSGPSGGTLsvhLDAATEPTPAT--STPEGL 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 587 GRDAAYMIFTSGTSGQPKGVVVEHASalnlsqaLARTVYANVVGEGL-----RVTVNAPFSFDSSIKQILQLLSGHCLVL 661
Cdd:PRK05852 175 RPDDAMIMFTGGTTGLPKMVPWTHAN-------IASSVRAIITGYRLsprdaTVAVMPLYHGHGLIAALLATLASGGAVL 247
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 662 VPQEVRSDPQRmlgFLEErrIDVLDCT-----PSLFRLLLQAGLDDAHPALPGRIlvggeRF--------DEASWEVAAG 728
Cdd:PRK05852 248 LPARGRFSAHT---FWDD--IKAVGATwytavPTIHQILLERAATEPSGRKPAAL-----RFirscsaplTAETAQALQT 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 729 WRRCQVFNLYGPTEATVNASLARVAEHAR---PTIGRALAN----VDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGD 801
Cdd:PRK05852 318 EFAAPVVCAFGMTEATHQVTTTQIEGIGQtenPVVSTGLVGrstgAQIRIVGSDGLPLPAGAVGEVWLRGTTVVRGYLGD 397
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 15597498 802 AGEAAGRFVeEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLTD 875
Cdd:PRK05852 398 PTITAANFT-DGW------LRTGDLGSLSAAGDLSIRGRIKELINRGGEKISPERVEGVLASHPNVMEAAVFGV 464
|
|
| ABCL |
cd05958 |
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate ... |
464-899 |
1.94e-20 |
|
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate aerobic degradation pathway by activating 2-aminobenzoate to 2-aminobenzoyl-CoA. The reaction is carried out via a two-step process; the first step is ATP-dependent and forms a 2-aminobenzoyl-AMP intermediate, and the second step forms the 2-aminobenzoyl-CoA ester and releases the AMP. 2-Aminobenzoyl-CoA is further converted to 2-amino-5-oxo-cyclohex-1-ene-1-carbonyl-CoA catalyzed by 2-aminobenzoyl-CoA monooxygenase/reductase. ABCL has been purified from cells aerobically grown with 2-aminobenzoate as sole carbon, energy, and nitrogen source, and has been characterized as a monomer.
Pssm-ID: 341268 [Multi-domain] Cd Length: 439 Bit Score: 96.78 E-value: 1.94e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 464 APALLDAHGSLDFATLRARS-EAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMRE 542
Cdd:cd05958 1 RTCLRSPEREWTYRDLLALAnRIANVLVGELGIVPGNRVLLRGSNSPELVACWFGIQKAGAIAVATMPLLRPKELAYILD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 543 AGGIVFALadaeCAGRAREAfagacldlstlplagsgmslpapggRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALAR 622
Cdd:cd05958 81 KARITVAL----CAHALTAS-------------------------DDICILAFTSGTTGAPKATMHFHRDPLASADRYAV 131
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 623 tvyaNVVG--EGLRVTVNAP--FSFDSSIKQILQLLSGHCLVLVPQEVrsdPQRMLGFLEERRIDVLDCTPSLFRLLLqA 698
Cdd:cd05958 132 ----NVLRlrEDDRFVGSPPlaFTFGLGGVLLFPFGVGASGVLLEEAT---PDLLLSAIARYKPTVLFTAPTAYRAML-A 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 699 GLDDAHPALPG--RILVGGERFDEASWEVaagWRRC---QVFNLYGPTEAtVNASLARVAEHARP-TIGRALANVDLHVV 772
Cdd:cd05958 204 HPDAAGPDLSSlrKCVSAGEALPAALHRA---WKEAtgiPIIDGIGSTEM-FHIFISARPGDARPgATGKPVPGYEAKVV 279
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 773 DGLGRRKTRGASGELWIGGAgvaRGYAGDAGEAAGRFVEEGWPGSGRLYRSGdlvrwrADGCLEFLGRIDEQVKINGYRI 852
Cdd:cd05958 280 DDEGNPVPDGTIGRLAVRGP---TGCRYLADKRQRTYVQGGWNITGDTYSRD------PDGYFRHQGRSDDMIVSGGYNI 350
|
410 420 430 440
....*....|....*....|....*....|....*....|....*....
gi 15597498 853 ELGEIRSALLEHPAVGEAAVLtdeadaAEPGADRRIV--AFVTAAEETA 899
Cdd:cd05958 351 APPEVEDVLLQHPAVAECAVV------GHPDESRGVVvkAFVVLRPGVI 393
|
|
| PRK08316 |
PRK08316 |
acyl-CoA synthetase; Validated |
458-872 |
2.08e-20 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181381 [Multi-domain] Cd Length: 523 Bit Score: 97.31 E-value: 2.08e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 458 AALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMtGRNREAIVAL-LGVMRAAAVYTPVNPEFPAAR 536
Cdd:PRK08316 21 ARRYPDKTALVFGDRSWTYAELDAAVNRVAAALLDLGLKKGDRVAAL-GHNSDAYALLwLACARAGAVHVPVNFMLTGEE 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 537 VERMREAGGIVFALADAECAGRAREAFAGACLDLSTLPLAGSG--------------------MSLPAPGGRDAAYMIFT 596
Cdd:PRK08316 100 LAYILDHSGARAFLVDPALAPTAEAALALLPVDTLILSLVLGGreapggwldfadwaeagsvaEPDVELADDDLAQILYT 179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 597 SGTSGQPKGVVVEHasalnlsQALARTVYANVVGEGLR---VTVNAPFSFDSSIKQIL---QLLSGHCLVLVPqevRSDP 670
Cdd:PRK08316 180 SGTESLPKGAMLTH-------RALIAEYVSCIVAGDMSaddIPLHALPLYHCAQLDVFlgpYLYVGATNVILD---APDP 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 671 QRMLGFLEERRIDVLDCTPSLFRLLLQaglddaHPALPGRILVGGER-FDEASW---EVAAGWRRC----QVFNLYGPTE 742
Cdd:PRK08316 250 ELILRTIEAERITSFFAPPTVWISLLR------HPDFDTRDLSSLRKgYYGASImpvEVLKELRERlpglRFYNCYGQTE 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 743 ATVNASLARVAEHAR--PTIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFvEEGWpgsgrl 820
Cdd:PRK08316 324 IAPLATVLGPEEHLRrpGSAGRPVLNVETRVVDDDGNDVAPGEVGEIVHRSPQLMLGYWDDPEKTAEAF-RGGW------ 396
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|..
gi 15597498 821 YRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV 872
Cdd:PRK08316 397 FHSGDLGVMDEEGYITVVDRKKDMIKTGGENVASREVEEALYTHPAVAEVAV 448
|
|
| LC_FACS_like |
cd05935 |
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain ... |
473-884 |
3.37e-20 |
|
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain fatty acyl-CoA synthetases, which catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters.
Pssm-ID: 341258 [Multi-domain] Cd Length: 430 Bit Score: 96.01 E-value: 3.37e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 473 SLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVErmreaggivFALAD 552
Cdd:cd05935 1 SLTYLELLEVVKKLASFLSNKGVRKGDRVGICLQNSPQYVIAYFAIWRANAVVVPINPMLKERELE---------YILND 71
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 553 AEcagrAREAFAGACLDlstlplagsgmslpapggrDAAYMIFTSGTSGQPKGVVVEHASAlnLSQALARTVYANVVGEG 632
Cdd:cd05935 72 SG----AKVAVVGSELD-------------------DLALIPYTSGTTGLPKGCMHTHFSA--AANALQSAVWTGLTPSD 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 633 LRVTVNAPF---SFDSSIKqiLQLLSGHCLVLVpqeVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPALPG 709
Cdd:cd05935 127 VILACLPLFhvtGFVGSLN--TAVYVGGTYVLM---ARWDRETALELIEKYKVTFWTNIPTMLVDLLATPEFKTRDLSSL 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 710 RILVGGerfdEASWEVAAGWRRCQVFNL-----YGPTEATvnaSLARVAEHARP---TIGRALANVDLHVVD-GLGRRKT 780
Cdd:cd05935 202 KVLTGG----GAPMPPAVAEKLLKLTGLrfvegYGLTETM---SQTHTNPPLRPklqCLGIP*FGVDARVIDiETGRELP 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 781 RGASGELWIGGAGVARGYAGDAGEAAGRFVEEgwpGSGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSA 860
Cdd:cd05935 275 PNEVGEIVVRGPQIFKGYWNRPEETEESFIEI---KGRRFFRTGDLGYMDEEGYFFFVDRVKRMINVSGFKVWPAEVEAK 351
|
410 420
....*....|....*....|....*.
gi 15597498 861 LLEHPAVGEAAVLT--DEADAAEPGA 884
Cdd:cd05935 352 LYKHPAI*EVCVISvpDERVGEEVKA 377
|
|
| PRK09088 |
PRK09088 |
acyl-CoA synthetase; Validated |
456-873 |
4.41e-20 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181644 [Multi-domain] Cd Length: 488 Bit Score: 96.03 E-value: 4.41e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 456 LRAALQPQAPALLDAHGSLD--FATLRARSEAVAEALLAAGVRPGQAVAVMtGRNREAIVAL-LGVMRAAAVYTPVNPEF 532
Cdd:PRK09088 3 FHARLQPQRLAAVDLALGRRwtYAELDALVGRLAAVLRRRGCVDGERLAVL-ARNSVWLVALhFACARVGAIYVPLNWRL 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 533 PAARVERMREAGGIVFALADAECAgrareafAGACLDLSTLPLAGS----GMSLPAPGGRDAAYMI-FTSGTSGQPKGVV 607
Cdd:PRK09088 82 SASELDALLQDAEPRLLLGDDAVA-------AGRTDVEDLAAFIASadalEPADTPSIPPERVSLIlFTSGTSGQPKGVM 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 608 VehaSALNLSQALARTVYANVVGEGLRVTVNAP-FSFDSSIKQILQLLSGHCLVLVPQEVrsDPQRMLGFLEERRIDVLD 686
Cdd:PRK09088 155 L---SERNLQQTAHNFGVLGRVDAHSSFLCDAPmFHIIGLITSVRPVLAVGGSILVSNGF--EPKRTLGRLGDPALGITH 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 687 --CTPSLFRLLL-QAGLDDAHPALPGRILVGGERFDEAS--WEVAAGWRrcqVFNLYGPTEATVNASLARVAEHARPTIG 761
Cdd:PRK09088 230 yfCVPQMAQAFRaQPGFDAAALRHLTALFTGGAPHAAEDilGWLDDGIP---MVDGFGMSEAGTVFGMSVDCDVIRAKAG 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 762 RA---LANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFL 838
Cdd:PRK09088 307 AAgipTPTVQTRVVDDQGNDCPAGVPGELLLRGPNLSPGYWRRPQATARAFTGDGW------FRTGDIARRDADGFFWVV 380
|
410 420 430
....*....|....*....|....*....|....*
gi 15597498 839 GRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:PRK09088 381 DRKKDMFISGGENVYPAEIEAVLADHPGIRECAVV 415
|
|
| PRK13383 |
PRK13383 |
acyl-CoA synthetase; Provisional |
458-894 |
4.89e-20 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139531 [Multi-domain] Cd Length: 516 Bit Score: 96.22 E-value: 4.89e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 458 AALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARV 537
Cdd:PRK13383 45 AARWPGRTAIIDDDGALSYRELQRATESLARRLTRDGVAPGRAVGVMCRNGRGFVTAVFAVGLLGADVVPISTEFRSDAL 124
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 538 ERMREAGGIVFALADAECAGR-AREAFAGACLDLSTLPLAGSGMSLP-APGGRdaaYMIFTSGTSGQPKGV--VVEHASA 613
Cdd:PRK13383 125 AAALRAHHISTVVADNEFAERiAGADDAVAVIDPATAGAEESGGRPAvAAPGR---IVLLTSGTTGKPKGVprAPQLRSA 201
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 614 LNLSQALARTVYANVvgeGLRVTVNAPFSFDSSIKQILQLLSGHCLVLVPQEVrsDPQRMLGFLEERRIDVLDCTP-SLF 692
Cdd:PRK13383 202 VGVWVTILDRTRLRT---GSRISVAMPMFHGLGLGMLMLTIALGGTVLTHRHF--DAEAALAQASLHRADAFTAVPvVLA 276
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 693 RLLLQAGLDDAHPALPG-RILVG---------GERFDEASWEVaagwrrcqVFNLYGPTEATVNAsLARVAE--HARPTI 760
Cdd:PRK13383 277 RILELPPRVRARNPLPQlRVVMSsgdrldptlGQRFMDTYGDI--------LYNGYGSTEVGIGA-LATPADlrDAPETV 347
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 761 GRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAagrfVEEGwpgsgrLYRSGDLVRWRADGCLEFLGR 840
Cdd:PRK13383 348 GKPVAGCPVRILDRNNRPVGPRVTGRIFVGGELAGTRYTDGGGKA----VVDG------MTSTGDMGYLDNAGRLFIVGR 417
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....
gi 15597498 841 IDEQVKINGYRIELGEIRSALLEHPAVGEAAVLtdeaDAAEPGADRRIVAFVTA 894
Cdd:PRK13383 418 EDDMIISGGENVYPRAVENALAAHPAVADNAVI----GVPDERFGHRLAAFVVL 467
|
|
| PRK06164 |
PRK06164 |
acyl-CoA synthetase; Validated |
448-904 |
2.29e-19 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235722 [Multi-domain] Cd Length: 540 Bit Score: 94.42 E-value: 2.29e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 448 ESLVAAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTP 527
Cdd:PRK06164 10 DTLASLLDAHARARPDAVALIDEDRPLSRAELRALVDRLAAWLAAQGVRRGDRVAVWLPNCIEWVVLFLACARLGATVIA 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 528 VNPEFPAARVERMREAG------------GIVFA--LADAECAGRAR-EAFAGACLDLSTLP----------LAGSGMSL 582
Cdd:PRK06164 90 VNTRYRSHEVAHILGRGrarwlvvwpgfkGIDFAaiLAAVPPDALPPlRAIAVVDDAADATPapapgarvqlFALPDPAP 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 583 PAPGGRDA------AYMIFTSGTSGQPKGVVVEHASALNLSQALARtVYAnvVGEGLRVTVNAPFSFDSSIKQILQLLSG 656
Cdd:PRK06164 170 PAAAGERAadpdagALLFTTSGTTSGPKLVLHRQATLLRHARAIAR-AYG--YDPGAVLLAALPFCGVFGFSTLLGALAG 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 657 HCLVLVpqEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGldDAHPALPGRILVGGERFDEASWEVAAgWRRCQ--- 733
Cdd:PRK06164 247 GAPLVC--EPVFDAARTARALRRHRVTHTFGNDEMLRRILDTA--GERADFPSARLFGFASFAPALGELAA-LARARgvp 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 734 VFNLYGPTE--ATVNASLARVAEHARPTIGRALAN--VDLHVVDGL-GRRKTRGASGELWIGGAGVARGYAGDAGEAAGR 808
Cdd:PRK06164 322 LTGLYGSSEvqALVALQPATDPVSVRIEGGGRPASpeARVRARDPQdGALLPDGESGEIEIRAPSLMRGYLDNPDATARA 401
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 809 FVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLtdeadAAEPGADRRI 888
Cdd:PRK06164 402 LTDDGY------FRTGDLGYTRGDGQFVYQTRMGDSLRLGGFLVNPAEIEHALEALPGVAAAQVV-----GATRDGKTVP 470
|
490
....*....|....*...
gi 15597498 889 VAFV--TAAEETADESWL 904
Cdd:PRK06164 471 VAFVipTDGASPDEAGLM 488
|
|
| PRK06188 |
PRK06188 |
acyl-CoA synthetase; Validated |
462-872 |
5.30e-19 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235731 [Multi-domain] Cd Length: 524 Bit Score: 93.13 E-value: 5.30e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 462 PQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNP-------EF-- 532
Cdd:PRK06188 26 PDRPALVLGDTRLTYGQLADRISRYIQAFEALGLGTGDAVALLSLNRPEVLMAIGAAQLAGLRRTALHPlgslddhAYvl 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 533 -----------PAARVERMREAGGIVFALADAECAGRAREAfagacLDLSTLPLAGSGMSL-PAPGGRDAAYMIFTSGTS 600
Cdd:PRK06188 106 edagistlivdPAPFVERALALLARVPSLKHVLTLGPVPDG-----VDLLAAAAKFGPAPLvAAALPPDIAGLAYTGGTT 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 601 GQPKGVVVEHASALNLSQALARTVYanvVGEGLRVTVNAPFSFDSSIKQILQLLSGHCLVLVPqevRSDPQRMLGFLEER 680
Cdd:PRK06188 181 GKPKGVMGTHRSIATMAQIQLAEWE---WPADPRFLMCTPLSHAGGAFFLPTLLRGGTVIVLA---KFDPAEVLRAIEEQ 254
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 681 RIDVLDCTPS-LFRLLLQAGLDD------------AHPALPGRILVGGERFDeaswevaagwrrcQVF-NLYGPTEATVN 746
Cdd:PRK06188 255 RITATFLVPTmIYALLDHPDLRTrdlssletvyygASPMSPVRLAEAIERFG-------------PIFaQYYGQTEAPMV 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 747 ASLARVAEHARP------TIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFvEEGWpgsgrl 820
Cdd:PRK06188 322 ITYLRKRDHDPDdpkrltSCGRPTPGLRVALLDEDGREVAQGEVGEICVRGPLVMDGYWNRPEETAEAF-RDGW------ 394
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|..
gi 15597498 821 YRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV 872
Cdd:PRK06188 395 LHTGDVAREDEDGFYYIVDRKKDMIVTGGFNVFPREVEDVLAEHPAVAQVAV 446
|
|
| FadD3 |
cd17638 |
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ... |
589-873 |
1.31e-18 |
|
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ligases, including FadD3 which is an acyl-CoA synthetase that initiates catabolism of cholesterol rings C and D in actinobacteria. The cholesterol catabolic pathway occurs in most mycolic acid-containing actinobacteria, such as Rhodococcus jostii RHA1, and is critical for Mycobacterium tuberculosis (Mtb) during infection. FadD3 catalyzes the ATP-dependent CoA thioesterification of 3a-alpha-H-4alpha(3'-propanoate)-7a-beta-methylhexahydro-1,5-indanedione (HIP) to yield HIP-CoA. Hydroxylated analogs of HIP, 5alpha-OH HIP and 1beta-OH HIP, can also be used.
Pssm-ID: 341293 [Multi-domain] Cd Length: 330 Bit Score: 89.48 E-value: 1.31e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTVYanvVGEGLRVTVNAPF--SFDSSIKQILQLLSGHclVLVPQEV 666
Cdd:cd17638 1 DVSDIMFTSGTTGRSKGVMCAHRQTLRAAAAWADCAD---LTEDDRYLIINPFfhTFGYKAGIVACLLTGA--TVVPVAV 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 667 rSDPQRMLGFLEERRIDVLDCTPSLFRLLLqaglddAHPALPgrilvggeRFDEASWEVA---------AGWRRCQ---- 733
Cdd:cd17638 76 -FDVDAILEAIERERITVLPGPPTLFQSLL------DHPGRK--------KFDLSSLRAAvtgaatvpvELVRRMRselg 140
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 734 ---VFNLYGPTEATVnASLARV---AEHARPTIGRALANVDLHVVDglgrrktrgaSGELWIGGAGVARGYAGDAGEAAG 807
Cdd:cd17638 141 fetVLTAYGLTEAGV-ATMCRPgddAETVATTCGRACPGFEVRIAD----------DGEVLVRGYNVMQGYLDDPEATAE 209
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 15597498 808 RFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:cd17638 210 AIDADGW------LHTGDVGELDERGYLRITDRLKDMYIVGGFNVYPAEVEGALAEHPGVAQVAVI 269
|
|
| C_PKS-NRPS |
cd19532 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1362-1686 |
2.54e-18 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHxxxD motif, a few such as Monascus pilosus lovastatin nonaketide synthase MokA have a non-canonical HRxxxD motif in the C-domain and are unable to catalyze amide-bond formation. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380455 [Multi-domain] Cd Length: 421 Bit Score: 89.82 E-value: 2.54e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1362 PMTSLQQGMLLQSEASGDPRLLHNVVLHEVHGRLDGELLARAWAILIGRHAILRTGF--DLHGGQvPLQWVHPATAVAAE 1439
Cdd:cd19532 3 PMSFGQSRFWFLQQYLEDPTTFNVTFSYRLTGPLDVARLERAVRAVGQRHEALRTCFftDPEDGE-PMQGVLASSPLRLE 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1440 -VPVHDLCGLDGETRRLRLRAWieeeqatpfDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYAD 1518
Cdd:cd19532 82 hVQISDEAEVEEEFERLKNHVY---------DLESGETMRIVLLSLSPTEHYLIFGYHHIAMDGVSFQIFLRDLERAYNG 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1519 llagvvaREAEAPAVGFRDYVALEREAEAN---AASALFWldylaGARYRPLPG------LAEEGPR------RMAAVRV 1583
Cdd:cd19532 153 -------QPLLPPPLQYLDFAARQRQDYESgalDEDLAYW-----KSEFSTLPEplpllpFAKVKSRppltryDTHTAER 220
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1584 DVPADSLSRLRALAERsglpLRS----LLLAAHGRALCRFSDADEVVTGFVSHGRPEEpGADRLLGLFLNTLPCRLSAS- 1658
Cdd:cd19532 221 RLDAALAARIKEASRK----LRVtpfhFYLAALQVLLARLLDVDDICIGIADANRTDE-DFMETIGFFLNLLPLRFRRDp 295
|
330 340 350
....*....|....*....|....*....|..
gi 15597498 1659 ----VDLLDSARRAFdyeRASLEHRRHPLAAI 1686
Cdd:cd19532 296 sqtfADVLKETRDKA---YAALAHSRVPFDVL 324
|
|
| LC_FACS_like |
cd17640 |
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA ... |
494-939 |
5.36e-18 |
|
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA synthetases, including an Arabidopsis gene At4g14070 that plays a role in activation and elongation of exogenous fatty acids. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341295 [Multi-domain] Cd Length: 468 Bit Score: 89.34 E-value: 5.36e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 494 GVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEfpaARVERMReaggivFALADAECAGRAREAfagacldlstl 573
Cdd:cd17640 26 GVKAGEKVALFADNSPRWLIADQGIMALGAVDVVRGSD---SSVEELL------YILNHSESVALVVEN----------- 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 574 plagsgmslpapGGRDAAYMIFTSGTSGQPKGVVVEHASAL----NLSQ------------------ALARTVYANVVGE 631
Cdd:cd17640 86 ------------DSDDLATIIYTSGTTGNPKGVMLTHANLLhqirSLSDivppqpgdrflsilpiwhSYERSAEYFIFAC 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 632 GlrvtVNAPFSFDSSIKQILQLLSGHCLVLVP-----------QEVRSDP---QRMLGFLeerridvldctpsLFRLLLQ 697
Cdd:cd17640 154 G----CSQAYTSIRTLKDDLKRVKPHYIVSVPrlweslysgiqKQVSKSSpikQFLFLFF-------------LSGGIFK 216
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 698 AGLDDAHpALPGRIlvggERFDEAswevaAGWRrcqVFNLYGPTEATVNASLARVAEHARPTIGRALANVDLHVVDGLGR 777
Cdd:cd17640 217 FGISGGG-ALPPHV----DTFFEA-----IGIE---VLNGYGLTETSPVVSARRLKCNVRGSVGRPLPGTEIKIVDPEGN 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 778 RKTR-GASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRI-DEQVKINGYRIELG 855
Cdd:cd17640 284 VVLPpGEKGIVWVRGPQVMKGYYKNPEATSKVLDSDGW------FNTGDLGWLTCGGELVLTGRAkDTIVLSNGENVEPQ 357
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 856 EIRSALLEHPAVGEAAVLtdeadaaepGADRR-----IVAFVTAAEETADESwlEVDLPSGHRVAGLNLNETEYVYQEIf 930
Cdd:cd17640 358 PIEEALMRSPFIEQIMVV---------GQDQKrlgalIVPNFEELEKWAKES--GVKLANDRSQLLASKKVLKLYKNEI- 425
|
....*....
gi 15597498 931 VDEVYSRDG 939
Cdd:cd17640 426 KDEISNRPG 434
|
|
| Cyc_NRPS |
cd19535 |
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
1395-1680 |
5.95e-18 |
|
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Cyc (heterocyclization) domains catalyze two separate reactions in the creation of heterocyclized peptide products in nonribosomal peptide synthesis: amide bond formation followed by intramolecular cyclodehydration between a Cys, Ser, or Thr side chain and a carbonyl carbon on the peptide backbone to form a thiazoline, oxazoline, or methyloxazoline ring. Cyc-domains are homologous to standard NRPS Condensation (C) domains. C-domains typically have a conserved HHxxxD motif at the active site; Cyc-domains have an alternative, conserved DxxxxD active site motif, mutation of the aspartate residues in this motif can abolish or diminish condensation activity. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and Cyc-domains. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380458 [Multi-domain] Cd Length: 423 Bit Score: 88.70 E-value: 5.95e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1395 LDGELLARAWAILIGRHAILRTGFdLHGGQvplQWVHPATAvAAEVPVHDLCGLDGETRRLRLRAWIEEEQATPFDWSRP 1474
Cdd:cd19535 37 LDPDRLERAWNKLIARHPMLRAVF-LDDGT---QQILPEVP-WYGITVHDLRGLSEEEAEAALEELRERLSHRVLDVERG 111
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1475 PLVRLAALALDERRFALgvaeHHS----VLDGWSLQSLVDELLAVYADllagvvaREAEAPAVG--FRDYVA--LEREAE 1546
Cdd:cd19535 112 PLFDIRLSLLPEGRTRL----HLSidllVADALSLQILLRELAALYED-------PGEPLPPLElsFRDYLLaeQALRET 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1547 ANAASALFWLDYLAgaryrPLPG-----LAEEgPRRMAAVRVD-----VPADSLSRLRALAERSGLPLRSLLLAAHGRAL 1616
Cdd:cd19535 181 AYERARAYWQERLP-----TLPPapqlpLAKD-PEEIKEPRFTrrehrLSAEQWQRLKERARQHGVTPSMVLLTAYAEVL 254
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 15597498 1617 CRFSDADEV---VTGFvsHGRPEEPGADRLLGLF--LNTLPCRLSASVDLLDSARRAFDYERASLEHRR 1680
Cdd:cd19535 255 ARWSGQPRFllnLTLF--NRLPLHPDVNDVVGDFtsLLLLEVDGSEGQSFLERARRLQQQLWEDLDHSS 321
|
|
| PRK12583 |
PRK12583 |
acyl-CoA synthetase; Provisional |
438-873 |
6.86e-18 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237145 [Multi-domain] Cd Length: 558 Bit Score: 89.83 E-value: 6.86e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 438 QGERVEPAPVESLVAAFDLRAALQPQAPALLDAHGSLDF--ATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVAL 515
Cdd:PRK12583 8 QGGGDKPLLTQTIGDAFDATVARFPDREALVVRHQALRYtwRQLADAVDRLARGLLALGVQPGDRVGIWAPNCAEWLLTQ 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 516 LGVMRAAAVYTPVNPEFPAARVE---RMREAGGIVFA------------------LADAECAGRAREAF----------- 563
Cdd:PRK12583 88 FATARIGAILVNINPAYRASELEyalGQSGVRWVICAdafktsdyhamlqellpgLAEGQPGALACERLpelrgvvslap 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 564 --AGACLDLSTLPLAGSGMSLPAPGGRDAAY-------MIFTSGTSGQPKGVVVEHASALNLSQALARTVYanvVGEGLR 634
Cdd:PRK12583 168 apPPGFLAWHELQARGETVSREALAERQASLdrddpinIQYTSGTTGFPKGATLSHHNILNNGYFVAESLG---LTEHDR 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 635 VTVNAPF--SFDSSIKQILQLLSGHCLVLvPQEVrSDPQRMLGFLEERRIDVLDCTPSLFrlllQAGLDdaHP------- 705
Cdd:PRK12583 245 LCVPVPLyhCFGMVLANLGCMTVGACLVY-PNEA-FDPLATLQAVEEERCTALYGVPTMF----IAELD--HPqrgnfdl 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 706 -ALPGRILVGGERFDEASWEVAAGWRRCQVFNLYGPTEA-------TVNASLARVAEharpTIGRALANVDLHVVDGLGR 777
Cdd:PRK12583 317 sSLRTGIMAGAPCPIEVMRRVMDEMHMAEVQIAYGMTETspvslqtTAADDLERRVE----TVGRTQPHLEVKVVDPDGA 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 778 RKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEI 857
Cdd:PRK12583 393 TVPRGEIGELCTRGYSVMKGYWNNPEATAESIDEDGW------MHTGDLATMDEQGYVRIVGRSKDMIIRGGENIYPREI 466
|
490
....*....|....*.
gi 15597498 858 RSALLEHPAVGEAAVL 873
Cdd:PRK12583 467 EEFLFTHPAVADVQVF 482
|
|
| E_NRPS |
cd19534 |
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
1384-1773 |
1.05e-17 |
|
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Epimerization (E) domains of nonribosomal peptide synthetases (NRPS) flip the chirality of the end amino acid of a peptide being manufactured by the NRPS. E-domains are homologous to the Condensation (C) domains. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Specialized tailoring NRPS domains such as E-domains greatly increase the range of possible peptide products created by the NRPS machinery. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the E-domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380457 [Multi-domain] Cd Length: 428 Bit Score: 88.08 E-value: 1.05e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1384 HNVVLHeVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQVpLQWVHPATAVAAEVPVHDLcglDGETRRLRLRAWIEE 1463
Cdd:cd19534 24 QSVLLR-VPQGLDPDALRQALRALVEHHDALRMRFRREDGGW-QQRIRGDVEELFRLEVVDL---SSLAQAAAIEALAAE 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1464 EQATpFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLLAGvvaREAEAPAVG-FRDYVALE 1542
Cdd:cd19534 99 AQSS-LDLEEGPLLAAALFDGTDGGDRLLLVIHHLVVDGVSWRILLEDLEAAYEQALAG---EPIPLPSKTsFQTWAELL 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1543 REA---EANAASALFWLDyLAGARYRPLPG--LAEEGPRRMAAVRVDVpadslSRLRALAERSGLPLRS----LLLAAHG 1613
Cdd:cd19534 175 AEYaqsPALLEELAYWRE-LPAADYWGLPKdpEQTYGDARTVSFTLDE-----EETEALLQEANAAYRTeindLLLAALA 248
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1614 RALCRFSDADEVVTGFVSHGR-PEEPGAD--RLLGLFLNTLPCRL--SASVDLLDS------ARRA-----FDY------ 1671
Cdd:cd19534 249 LAFQDWTGRAPPAIFLEGHGReEIDPGLDlsRTVGWFTSMYPVVLdlEASEDLGDTlkrvkeQLRRipnkgIGYgilryl 328
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1672 -ERASLEHRRHPLAAIrrrnrelrldsLFNFV-DFHQDDAAPAGVRHGGILDQVVVDVDVPLAVDFE----VAGERLEVG 1745
Cdd:cd19534 329 tPEGTKRLAFHPQPEI-----------SFNYLgQFDQGERDDALFVSAVGGGGSDIGPDTPRFALLDinavVEGGQLVIT 397
|
410 420
....*....|....*....|....*...
gi 15597498 1746 FQYAAGRFPAERAEALAGAYREALLALL 1773
Cdd:cd19534 398 VSYSRNMYHEETIQQLADSYKEALEALI 425
|
|
| OSB_CoA_lg |
cd05912 |
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA ... |
473-901 |
1.59e-17 |
|
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA synthetase, or MenE); O-succinylbenzoic acid-CoA synthase catalyzes the coenzyme A (CoA)- and ATP-dependent conversion of o-succinylbenzoic acid to o-succinylbenzoyl-CoA. The reaction is the fourth step of the biosynthesis pathway of menaquinone (vitamin K2). In certain bacteria, menaquinone is used during fumarate reduction in anaerobic respiration. In cyanobacteria, the product of the menaquinone pathway is phylloquinone (2-methyl-3-phytyl-1,4-naphthoquinone), a molecule used exclusively as an electron transfer cofactor in Photosystem 1. In green sulfur bacteria and heliobacteria, menaquinones are used as loosely bound secondary electron acceptors in the photosynthetic reaction center.
Pssm-ID: 341238 [Multi-domain] Cd Length: 411 Bit Score: 87.40 E-value: 1.59e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 473 SLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARvermreaggIVFALAD 552
Cdd:cd05912 1 SYTFAELFEEVSRLAEHLAALGVRKGDRVALLSKNSIEMILLIHALWLLGAEAVLLNTRLTPNE---------LAFQLKD 71
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 553 AECAgrareafagacLDlstlplagsgmslpapggrDAAYMIFTSGTSGQPKGVvvehasalnlsQALARTVYANVVGEG 632
Cdd:cd05912 72 SDVK-----------LD-------------------DIATIMYTSGTTGKPKGV-----------QQTFGNHWWSAIGSA 110
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 633 LRVTVNA--------PFSFDSSIKQIL-QLLSGHCLVLVPqevRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDA 703
Cdd:cd05912 111 LNLGLTEddnwlcalPLFHISGLSILMrSVIYGMTVYLVD---KFDAEQVLHLINSGKVTIISVVPTMLQRLLEILGEGY 187
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 704 HPALPGrILVGGERFDEASWEVAAGwRRCQVFNLYGPTE-----ATVNASLArvaeHARP-TIGRALANVDLHVVDGLGR 777
Cdd:cd05912 188 PNNLRC-ILLGGGPAPKPLLEQCKE-KGIPVYQSYGMTEtcsqiVTLSPEDA----LNKIgSAGKPLFPVELKIEDDGQP 261
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 778 RKTrgaSGELWIGGAGVARGYAGDAgEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEI 857
Cdd:cd05912 262 PYE---VGEILLKGPNVTKGYLNRP-DATEESFENGW------FKTGDIGYLDEEGFLYVLDRRSDLIISGGENIYPAEI 331
|
410 420 430 440
....*....|....*....|....*....|....*....|....*.
gi 15597498 858 RSALLEHPAVGEAAV--LTDEADAAEPgadrriVAFVTAAEETADE 901
Cdd:cd05912 332 EEVLLSHPAIKEAGVvgIPDDKWGQVP------VAFVVSERPISEE 371
|
|
| PRK05605 |
PRK05605 |
long-chain-fatty-acid--CoA ligase; Validated |
434-899 |
2.42e-17 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235531 [Multi-domain] Cd Length: 573 Bit Score: 88.13 E-value: 2.42e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 434 YQAWQGERVEPaPVESLVAAFDLRAALQPQAPAL-----------LDAHGSLDFATLRArseavaeallaAGVRPGQAVA 502
Cdd:PRK05605 19 YAPWTPHDLDY-GDTTLVDLYDNAVARFGDRPALdffgatttyaeLGKQVRRAAAGLRA-----------LGVRPGDRVA 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 503 VMTGRNREAIVALLGVMRAAAV-------YTPVNPEFP---------------AARVERMREAGG---IV---------- 547
Cdd:PRK05605 87 IVLPNCPQHIVAFYAVLRLGAVvvehnplYTAHELEHPfedhgarvaivwdkvAPTVERLRRTTPletIVsvnmiaampl 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 548 ---FAL---------ADAECAGRAREAFAGACLDLSTLPLAGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVVEHASAL- 614
Cdd:PRK05605 167 lqrLALrlpipalrkARAALTGPAPGTVPWETLVDAAIGGDGSDVSHPRPTPDDVALILYTSGTTGKPKGAQLTHRNLFa 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 615 NLSQALA---------RTVYA-----NVVGeglrVTVNAPFSfdssikqilqLLSGHCLVLVPqevRSDPQRMLGFLEER 680
Cdd:PRK05605 247 NAAQGKAwvpglgdgpERVLAalpmfHAYG----LTLCLTLA----------VSIGGELVLLP---APDIDLILDAMKKH 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 681 RIDVLDCTPSLFRLLLQA----GLD--------DAHPALPGRILvggerfdeASWEVAAGWRrcqVFNLYGPTEATVNAS 748
Cdd:PRK05605 310 PPTWLPGVPPLYEKIAEAaeerGVDlsgvrnafSGAMALPVSTV--------ELWEKLTGGL---LVEGYGLTETSPIIV 378
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 749 LARVAEHARP-TIGRALANVDLHVVD--GLGRRKTRGASGELWIGGAGVARGYAGDAgEAAGRFVEEGWpgsgrlYRSGD 825
Cdd:PRK05605 379 GNPMSDDRRPgYVGVPFPDTEVRIVDpeDPDETMPDGEEGELLVRGPQVFKGYWNRP-EETAKSFLDGW------FRTGD 451
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 15597498 826 LVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL-TDEADAAEpgadrRIVAFVTAAEETA 899
Cdd:PRK05605 452 VVVMEEDGFIRIVDRIKELIITGGFNVYPAEVEEVLREHPGVEDAAVVgLPREDGSE-----EVVAAVVLEPGAA 521
|
|
| PRK07787 |
PRK07787 |
acyl-CoA synthetase; Validated |
495-901 |
2.90e-17 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236096 [Multi-domain] Cd Length: 471 Bit Score: 87.35 E-value: 2.90e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 495 VRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALADA--ECAGRAREAfagacLDLSt 572
Cdd:PRK07787 42 VAGARRVAVLATPTLATVLAVVGALIAGVPVVPVPPDSGVAERRHILADSGAQAWLGPApdDPAGLPHVP-----VRLH- 115
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 573 lplAGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVV-EHASALN---LSQALARTVyANVVGEGLrvtvnapfsfdssik 648
Cdd:PRK07787 116 ---ARSWHRYPEPDPDAPALIVYTSGTTGPPKGVVLsRRAIAADldaLAEAWQWTA-DDVLVHGL--------------- 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 649 qilQLLSGHCLVL-----------VPQEVRSDPQRMLGFLEeRRIDVLDCTPSLFRLLlqAGLDDAHPAL-PGRILVGGE 716
Cdd:PRK07787 177 ---PLFHVHGLVLgvlgplrignrFVHTGRPTPEAYAQALS-EGGTLYFGVPTVWSRI--AADPEAARALrGARLLVSGS 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 717 rfdeASWEVAAGWRRC-----QVFNLYGPTEATVNASlARVAEHARP-TIGRALANVDLHVVDGLGRRKTRGAS--GELW 788
Cdd:PRK07787 251 ----AALPVPVFDRLAaltghRPVERYGMTETLITLS-TRADGERRPgWVGLPLAGVETRLVDEDGGPVPHDGEtvGELQ 325
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 789 IGGAGVARGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRID-EQVKINGYRIELGEIRSALLEHPAV 867
Cdd:PRK07787 326 VRGPTLFDGYLNRPDATAAAFTADGW------FRTGDVAVVDPDGMHRIVGREStDLIKSGGYRIGAGEIETALLGHPGV 399
|
410 420 430
....*....|....*....|....*....|....*.
gi 15597498 868 GEAAVLtdeadaAEPGAD--RRIVAFVTAAEETADE 901
Cdd:PRK07787 400 REAAVV------GVPDDDlgQRIVAYVVGADDVAAD 429
|
|
| PRK07514 |
PRK07514 |
malonyl-CoA synthase; Validated |
456-872 |
3.04e-17 |
|
malonyl-CoA synthase; Validated
Pssm-ID: 181011 [Multi-domain] Cd Length: 504 Bit Score: 87.24 E-value: 3.04e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 456 LRAALQ-PQAPALLDAHGS-LDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFP 533
Cdd:PRK07514 9 LRAAFAdRDAPFIETPDGLrYTYGDLDAASARLANLLVALGVKPGDRVAVQVEKSPEALALYLATLRAGAVFLPLNTAYT 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 534 AARVER-MREAGGIVFALADAECAGRAREAFAGACLDLSTLPLAGSGmSL------------PAP-GGRDAAYMIFTSGT 599
Cdd:PRK07514 89 LAELDYfIGDAEPALVVCDPANFAWLSKIAAAAGAPHVETLDADGTG-SLleaaaaapddfeTVPrGADDLAAILYTSGT 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 600 SGQPKGVVVEHAsalNL-SQALARTVYANVVGE-------------GLRVTVNapfsfdssikqiLQLLSGHCLVLVPqe 665
Cdd:PRK07514 168 TGRSKGAMLSHG---NLlSNALTLVDYWRFTPDdvlihalpifhthGLFVATN------------VALLAGASMIFLP-- 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 666 vRSDPQRMLGFLeeRRIDVLDCTPSLF-RLLLQAGLDDAHPAlPGRILVGG------ERFDEasWEVAAGWRrcqVFNLY 738
Cdd:PRK07514 231 -KFDPDAVLALM--PRATVMMGVPTFYtRLLQEPRLTREAAA-HMRLFISGsapllaETHRE--FQERTGHA---ILERY 301
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 739 GPTEATVNASLARVAEHARPTIGRALANVDLHVVD-GLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgs 817
Cdd:PRK07514 302 GMTETNMNTSNPYDGERRAGTVGFPLPGVSLRVTDpETGAELPPGEIGMIEVKGPNVFKGYWRMPEKTAEEFRADGF--- 378
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*
gi 15597498 818 grlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV 872
Cdd:PRK07514 379 ---FITGDLGKIDERGYVHIVGRGKDLIISGGYNVYPKEVEGEIDELPGVVESAV 430
|
|
| AAS_C |
cd05909 |
C-terminal domain of the acyl-acyl carrier protein synthetase (also called ... |
589-901 |
9.97e-17 |
|
C-terminal domain of the acyl-acyl carrier protein synthetase (also called 2-acylglycerophosphoethanolamine acyltransferase, Aas); Acyl-acyl carrier protein synthase (Aas) is a membrane protein responsible for a minor pathway of incorporating exogenous fatty acids into membrane phospholipids. Its in vitro activity is characterized by the ligation of free fatty acids between 8 and 18 carbons in length to the acyl carrier protein sulfydryl group (ACP-SH) in the presence of ATP and Mg2+. However, its in vivo function is as a 2-acylglycerophosphoethanolamine (2-acyl-GPE) acyltransferase. The reaction occurs in two steps: the acyl chain is first esterified to acyl carrier protein (ACP) via a thioester bond, followed by a second step where the acyl chain is transferred to a 2-acyllysophospholipid, thus completing the transacylation reaction. This model represents the C-terminal domain of the enzyme, which belongs to the class I adenylate-forming enzyme family, including acyl-CoA synthetases.
Pssm-ID: 341235 [Multi-domain] Cd Length: 490 Bit Score: 85.85 E-value: 9.97e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTVYAN---VVGEGLrvtvnaPF--SFDSSIKQILQLLSGHCLVLVP 663
Cdd:cd05909 148 DPAVILFTSGSEGLPKGVVLSHKNLLANVEQITAIFDPNpedVVFGAL------PFfhSFGLTGCLWLPLLSGIKVVFHP 221
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 664 QEVrsDPQRMLGFLEERRIDVLDCTPSLFRLLLQAglddAHPA-LPG-R-ILVGGERFDEASWEVAAGWRRCQVFNLYGP 740
Cdd:cd05909 222 NPL--DYKKIPELIYDKKATILLGTPTFLRGYARA----AHPEdFSSlRlVVAGAEKLKDTLRQEFQEKFGIRILEGYGT 295
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 741 TEATVNASLARVAEHARP-TIGRALANVDLHVVDGLGRRKTR-GASGELWIGGAGVARGYAGDAgEAAGRFVEEGWpgsg 818
Cdd:cd05909 296 TECSPVISVNTPQSPNKEgTVGRPLPGMEVKIVSVETHEEVPiGEGGLLLVRGPNVMLGYLNEP-ELTSFAFGDGW---- 370
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 819 rlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEH--PAVGEAAVLTDEADAAEpgadrRIVAFVTAAE 896
Cdd:cd05909 371 --YDTGDIGKIDGEGFLTITGRLSRFAKIAGEMVSLEAIEDILSEIlpEDNEVAVVSVPDGRKGE-----KIVLLTTTTD 443
|
....*
gi 15597498 897 ETADE 901
Cdd:cd05909 444 TDPSS 448
|
|
| MACS_euk |
cd05928 |
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step ... |
494-874 |
1.79e-16 |
|
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes. MACS enzymes are localized to mitochondria. Two murine MACS family proteins are found in liver and kidney. In rodents, a MACS member is detected particularly in the olfactory epithelium and is called O-MACS. O-MACS demonstrates substrate preference for the fatty acid lengths of C6-C12.
Pssm-ID: 341251 [Multi-domain] Cd Length: 530 Bit Score: 85.21 E-value: 1.79e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 494 GVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVE---RMREAGGIVfalADAECAGRArEAFAGACLDL 570
Cdd:cd05928 63 GLQRGDRVAVILPRVPEWWLVNVACIRTGLVFIPGTIQLTAKDILyrlQASKAKCIV---TSDELAPEV-DSVASECPSL 138
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 571 ST------------------LPLAGSGMSLPAPGGRDAAYMIFTSGTSGQPKgvVVEHasalnlSQALArtvyanvvgeG 632
Cdd:cd05928 139 KTkllvseksrdgwlnfkelLNEASTEHHCVETGSQEPMAIYFTSGTTGSPK--MAEH------SHSSL----------G 200
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 633 LRVTVNAPFSFDSSIKQILQLLS------------------GHClVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRL 694
Cdd:cd05928 201 LGLKVNGRYWLDLTASDIMWNTSdtgwiksawsslfepwiqGAC-VFVHHLPRFDPLVILKTLSSYPITTFCGAPTVYRM 279
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 695 LLQAGLDDAH-PALPgRILVGGERFDEaswEVAAGWRR---CQVFNLYGPTEATVNASLARVAEHARPTIGRALANVDLH 770
Cdd:cd05928 280 LVQQDLSSYKfPSLQ-HCVTGGEPLNP---EVLEKWKAqtgLDIYEGYGQTETGLICANFKGMKIKPGSMGKASPPYDVQ 355
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 771 VVDGLGRRKTRGASGELWI-----GGAGVARGYAGDAGEAAGRFveegwpgSGRLYRSGDLVRWRADGCLEFLGRIDEQV 845
Cdd:cd05928 356 IIDDNGNVLPPGTEGDIGIrvkpiRPFGLFSGYVDNPEKTAATI-------RGDFYLTGDRGIMDEDGYFWFMGRADDVI 428
|
410 420
....*....|....*....|....*....
gi 15597498 846 KINGYRIELGEIRSALLEHPAVGEAAVLT 874
Cdd:cd05928 429 NSSGYRIGPFEVESALIEHPAVVESAVVS 457
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
1192-1616 |
1.80e-16 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 86.45 E-value: 1.80e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRRALLAALAAEAAAQTLEAPANATEAALLEIWKSVLKRp 1271
Cdd:COG1020 924 GAAAAAALLRLALALLLPPYMVPAAVVLLLPLPLTGNGKLDRLALPAPAAAAAAAAAAPPAEEEEEEAALALLLLLVVV- 1002
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1272 aIGVSDNFFQVGGDSIRLIQMQVMAREAGLAFTLRDVFNHQSIRELARLLAAPASPADALGTSAPQSLEPFALLSAAERK 1351
Cdd:COG1020 1003 -VGDDDFFFFGGGLGLLLLLALARAARLLLLLLLLLLLFLAAAAAAAAAAAAAAAAAAAAPLAAAAAPLPLPPLLLSLLA 1081
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1352 RLPEGLDDAYPMTSLQQGMLLQSEASGDPRLLHNVVLHEVHgrldgellarawailigRHAILRTGFDLHGGQVPLQWVH 1431
Cdd:COG1020 1082 LLLALLLLLALLALLALLLLLLLLLLLLALLLLLALLLALL-----------------AALRARRAVRQEGPRLRLLVAL 1144
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1432 PATAVAAEVPVHDLCGLDGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDE 1511
Cdd:COG1020 1145 AAALALAALLALLLAAAAAAAELLAAAALLLLLALLLLALLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL 1224
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1512 LLAVYADLLAGVVAREAEAPAVGFRDYVALEREAEANAASALFWLDYLAGARYRPLPGLAEEGPRRMAAVRVDVPADSLS 1591
Cdd:COG1020 1225 AAAAAALLALALLLALLALAALLALAALAALAAALLALALALLALALLLLALALLLPALARARAARTARALALLLLLALL 1304
|
410 420
....*....|....*....|....*
gi 15597498 1592 RLRALAERSGLPLRSLLLAAHGRAL 1616
Cdd:COG1020 1305 LLLALALALLLLLLLLLALLLLALL 1329
|
|
| PRK06155 |
PRK06155 |
crotonobetaine/carnitine-CoA ligase; Provisional |
442-881 |
2.00e-16 |
|
crotonobetaine/carnitine-CoA ligase; Provisional
Pssm-ID: 235719 [Multi-domain] Cd Length: 542 Bit Score: 85.20 E-value: 2.00e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 442 VEPAPV--ESLVAAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVM 519
Cdd:PRK06155 13 VDPLPPseRTLPAMLARQAERYPDRPLLVFGGTRWTYAEAARAAAAAAHALAAAGVKRGDRVALMCGNRIEFLDVFLGCA 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 520 RAAAVYTPVNPEFPAARVERMREAGGIVFALADAECAGRAREAFAGAC-----------------LDLSTLPLAGSGMSL 582
Cdd:PRK06155 93 WLGAIAVPINTALRGPQLEHILRNSGARLLVVEAALLAALEAADPGDLplpavwlldapasvsvpAGWSTAPLPPLDAPA 172
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 583 PA--PGGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTVYanvVGEGLRVTVNAPFSFDSSIKQILQ-LLSGHCL 659
Cdd:PRK06155 173 PAaaVQPGDTAAILYTSGTTGPSKGVCCPHAQFYWWGRNSAEDLE---IGADDVLYTTLPLFHTNALNAFFQaLLAGATY 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 660 VLVPQ--------EVRSDpQRMLGFLEERRIDVLDCTPSLFRlllqaglDDAH-------PALPGRILVG-GERFDeasw 723
Cdd:PRK06155 250 VLEPRfsasgfwpAVRRH-GATVTYLLGAMVSILLSQPARES-------DRAHrvrvalgPGVPAALHAAfRERFG---- 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 724 evaagwrrCQVFNLYGPTEAtvNASLARVAEHARP-TIGRALANVDLHVVDGLGRRKTRGASGELWIGGA---GVARGYA 799
Cdd:PRK06155 318 --------VDLLDGYGSTET--NFVIAVTHGSQRPgSMGRLAPGFEARVVDEHDQELPDGEPGELLLRADepfAFATGYF 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 800 GDAGEAAgrfveEGWpgSGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLTDEADA 879
Cdd:PRK06155 388 GMPEKTV-----EAW--RNLWFHTGDRVVRDADGWFRFVDRIKDAIRRRGENISSFEVEQVLLSHPAVAAAAVFPVPSEL 460
|
..
gi 15597498 880 AE 881
Cdd:PRK06155 461 GE 462
|
|
| X-Domain_NRPS |
cd19546 |
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to ... |
1358-1682 |
2.20e-16 |
|
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to the non-ribosomal peptide synthetase (NRPS); The X-domain is a catalytically inactive member of the Condensation (C) domain family of non-ribosomal peptide synthetase (NRPS). It has been shown to recruit oxygenases to the NRPS to perform side-chain crosslinking in the production of glycopeptide antibiotics. C-domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as this X-domain, the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, and dual E/C (epimerization and condensation) domains. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity; members of this X-domain subfamily lack the second H of this motif.
Pssm-ID: 380468 [Multi-domain] Cd Length: 440 Bit Score: 84.07 E-value: 2.20e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1358 DDAYPMTSLQQGMLLQSEASGDPRLLHNVVLHEVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQVpLQWVHPATAVA 1437
Cdd:cd19546 2 PDEVPATAGQLRTWLLARLDEETRGRHLSVALRLRGRLDRDALEAALGDVAARHEILRTTFPGDGGDV-HQRILDADAAR 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1438 AEVPVhdlcgldGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYA 1517
Cdd:cd19546 81 PELPV-------VPATEEELPALLADRAAHLFDLTRETPWRCTLFALSDTEHVLLLVVHRIAADDESLDVLVRDLAAAYG 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1518 DLLAGVVAREAEAPaVGFRDYVALERE--AEANAASAL------FWLDYLAGARY-------RPLPGLAEegpRRMAAVR 1582
Cdd:cd19546 154 ARREGRAPERAPLP-LQFADYALWEREllAGEDDRDSLigdqiaYWRDALAGAPDelelptdRPRPVLPS---RRAGAVP 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1583 VDVPADSLSRLRALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPEEPGADRLLGLFLNTLPCRLSASVD-- 1660
Cdd:cd19546 230 LRLDAEVHARLMEAAESAGATMFTVVQAALAMLLTRLGAGTDVTVGTVLPRDDEEGDLEGMVGPFARPLALRTDLSGDpt 309
|
330 340
....*....|....*....|....*
gi 15597498 1661 ---LLDSARRAFdyerasLEHRRHP 1682
Cdd:cd19546 310 freLLGRVREAV------REARRHQ 328
|
|
| AACS_like |
cd05968 |
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This ... |
473-871 |
2.77e-16 |
|
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This uncharacterized acyl-CoA synthetase family (EC 6.2.1.16, or acetoacetate#CoA ligase or acetoacetate:CoA ligase (AMP-forming)) is highly homologous to acetoacetyl-CoA synthetase. However, the proteins in this family exist in only bacteria and archaea. AACS is a cytosolic ligase that specifically activates acetoacetate to its coenzyme A ester by a two-step reaction. Acetoacetate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is the first step of the mevalonate pathway of isoprenoid biosynthesis via isopentenyl diphosphate. Isoprenoids are a large class of compounds found in all living organisms.
Pssm-ID: 341272 [Multi-domain] Cd Length: 610 Bit Score: 84.85 E-value: 2.77e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 473 SLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEF-PAARVERMREAGGIVFALA 551
Cdd:cd05968 91 TLTYGELLYEVKRLANGLRALGVGKGDRVGIYLPMIPEIVPAFLAVARIGGIVVPIFSGFgKEAAATRLQDAEAKALITA 170
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 552 DA--------ECAGRAREAFAGACLDLSTLPLAGSGMSLPAPGGRDAAY---------------------MIFTSGTSGQ 602
Cdd:cd05968 171 DGftrrgrevNLKEEADKACAQCPTVEKVVVVRHLGNDFTPAKGRDLSYdeeketagdgaertesedplmIIYTSGTTGK 250
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 603 PKGVVVEHAS-ALNLSQALArtvYANVVGEGLRVT-------VNAPFSFDSSikqilqLLSGHCLVL---VPQEvrSDPQ 671
Cdd:cd05968 251 PKGTVHVHAGfPLKAAQDMY---FQFDLKPGDLLTwftdlgwMMGPWLIFGG------LILGATMVLydgAPDH--PKAD 319
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 672 RMLGFLEERRIDVLDCTPSLFRLLLQAGLD--DAHPALPGRILVG-GERFDEASWE---VAAGWRRCQVFNLYGPTEATV 745
Cdd:cd05968 320 RLWRMVEDHEITHLGLSPTLIRALKPRGDApvNAHDLSSLRVLGStGEPWNPEPWNwlfETVGKGRNPIINYSGGTEISG 399
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 746 NASLARVAEHARP-TIGRALANVDLHVVDGLGRRkTRGASGEL-----WIGgagVARGYAGDAGeaagRFVEEGWPGSGR 819
Cdd:cd05968 400 GILGNVLIKPIKPsSFNGPVPGMKADVLDESGKP-ARPEVGELvllapWPG---MTRGFWRDED----RYLETYWSRFDN 471
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|..
gi 15597498 820 LYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAA 871
Cdd:cd05968 472 VWVHGDFAYYDEEGYFYILGRSDDTINVAGKRVGPAEIESVLNAHPAVLESA 523
|
|
| PRK06839 |
PRK06839 |
o-succinylbenzoate--CoA ligase; |
457-873 |
2.86e-16 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 168698 [Multi-domain] Cd Length: 496 Bit Score: 84.14 E-value: 2.86e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 457 RAALQPQAPALLDAHGSLDFATLRAR-SEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAA 535
Cdd:PRK06839 11 RAYLHPDRIAIITEEEEMTYKQLHEYvSKVAAYLIYELNVKKGERIAILSQNSLEYIVLLFAIAKVECIAVPLNIRLTEN 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 536 RVERMREAGGIVFALADAECAGRAREAFAGACLD--LSTLPLAGSGMSLPA---PGGRDAAYMI-FTSGTSGQPKGVVVE 609
Cdd:PRK06839 91 ELIFQLKDSGTTVLFVEKTFQNMALSMQKVSYVQrvISITSLKEIEDRKIDnfvEKNESASFIIcYTSGTTGKPKGAVLT 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 610 HASAlnLSQALARTVYANVVGEGLRVTVNAPFSFDSSIKQILQLLSGHCLVLVPQevRSDPQRMLGFLEERRIDVLDCTP 689
Cdd:PRK06839 171 QENM--FWNALNNTFAIDLTMHDRSIVLLPLFHIGGIGLFAFPTLFAGGVIIVPR--KFEPTKALSMIEKHKVTVVMGVP 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 690 SLFRLLLQAgLDDAHPALPG-RILVGG---------ERFDEASWEVAAGwrrcqvfnlYGPTEA--TVNASLARVAEHAR 757
Cdd:PRK06839 247 TIHQALINC-SKFETTNLQSvRWFYNGgapcpeelmREFIDRGFLFGQG---------FGMTETspTVFMLSEEDARRKV 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 758 PTIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAgEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEF 837
Cdd:PRK06839 317 GSIGKPVLFCDYELIDENKNKVEVGEVGELLIRGPNVMKEYWNRP-DATEETIQDGW------LCTGDLARVDEDGFVYI 389
|
410 420 430
....*....|....*....|....*....|....*.
gi 15597498 838 LGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:PRK06839 390 VGRKKEMIISGGENIYPLEVEQVINKLSDVYEVAVV 425
|
|
| Methyltransf_21 |
pfam05050 |
Methyltransferase FkbM domain; This family has members from bacteria to human, and appears to ... |
950-1147 |
5.48e-16 |
|
Methyltransferase FkbM domain; This family has members from bacteria to human, and appears to be a methyltransferase.
Pssm-ID: 428282 Cd Length: 170 Bit Score: 77.61 E-value: 5.48e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 950 DVGANIGLFSLYIAS----RAPRARVVAFEPLAPIRRRLEANLGRYApqvevfgigLSDAEREETFtyYPGYSTFSGIAE 1025
Cdd:pfam05050 1 DVGANDGVWDSVALLfekkCGGGGEVLAIEPNPNKLEKLDCTLLNLA---------LGNDVGLYEF--YLGGKGGGGYLL 69
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1026 YADasgerdvirryLSNQGEEGGANLLLDNIDEIlddrlraeahRCRLRRLDQVIGELGLERIDLLKIDVQRAEMDVLLG 1105
Cdd:pfam05050 70 FAV-----------GDPQGASTSSVLGGEEAKYI----------EVETVTLDSFLEEIKKSDIDLLKIDVEGAELEVLEG 128
|
170 180 190 200
....*....|....*....|....*....|....*....|....
gi 15597498 1106 lDDAALAKVR--QIVLEVHdKRDGATAGRADALSDLLRRHGFEV 1147
Cdd:pfam05050 129 -AEKTLKRCQpnIIVIEVH-FFHYFGGPLFDEIRQFLRECGYRL 170
|
|
| PRK09029 |
PRK09029 |
O-succinylbenzoic acid--CoA ligase; Provisional |
458-904 |
7.94e-16 |
|
O-succinylbenzoic acid--CoA ligase; Provisional
Pssm-ID: 236363 [Multi-domain] Cd Length: 458 Bit Score: 82.61 E-value: 7.94e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 458 AALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMtGRNR-EAIVALLGVMRAAAVYTPVNPEFPAAR 536
Cdd:PRK09029 13 AQVRPQAIALRLNDEVLTWQQLCARIDQLAAGFAQQGVVEGSGVALR-GKNSpETLLAYLALLQCGARVLPLNPQLPQPL 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 537 VERMREAGGIVFALADAECagrareaFAGACLDLSTLPLAGSGMSLPAPGGRDAAyMIFTSGTSGQPKGVVVEHASALnl 616
Cdd:PRK09029 92 LEELLPSLTLDFALVLEGE-------NTFSALTSLHLQLVEGAHAVAWQPQRLAT-MTLTSGSTGLPKAAVHTAQAHL-- 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 617 sqalartvyANVVGeglrvtVNAPFSFDSSIKQILQ---------------LLSGHCLVLvpqevrsdpqRMLGFLEErr 681
Cdd:PRK09029 162 ---------ASAEG------VLSLMPFTAQDSWLLSlplfhvsgqgivwrwLYAGATLVV----------RDKQPLEQ-- 214
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 682 iDVLDCT-----PS-LFRLLLQagldDAHPALPGRILVGGERFDEASWEVAAGWR-RCqvFNLYGPTEA--TVNASLArv 752
Cdd:PRK09029 215 -ALAGCThaslvPTqLWRLLDN----RSEPLSLKAVLLGGAAIPVELTEQAEQQGiRC--WCGYGLTEMasTVCAKRA-- 285
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 753 aeHARPTIGRALANVDLHVVDglgrrktrgasGELWIGGAGVARGYAGDageaaGRFV----EEGWpgsgrlYRSGDLVR 828
Cdd:PRK09029 286 --DGLAGVGSPLPGREVKLVD-----------GEIWLRGASLALGYWRQ-----GQLVplvnDEGW------FATRDRGE 341
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 15597498 829 WRaDGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLtdEADAAEPGAdrRIVAFVTAAEETADES---WL 904
Cdd:PRK09029 342 WQ-NGELTILGRLDNLFFSGGEGIQPEEIERVINQHPLVQQVFVV--PVADAEFGQ--RPVAVVESDSEAAVVNlaeWL 415
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1198-1329 |
1.07e-15 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 84.24 E-value: 1.07e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1198 QALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRRALLAALAAEAAAQTLEaPANATEAALLEIWKSVLKRPAIGVSD 1277
Cdd:PRK12316 5016 DELKAALRERLPEYMVPAHLVFLARMPLTPNGKLDRKALPQPDASLLQQAYVA-PRSELEQQVAAIWAEVLQLERVGLDD 5094
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*
gi 15597498 1278 NFFQVGGDSirLIQMQVMAR---EAGLAFTLRDVFNHQSIRELARLLAAPASPAD 1329
Cdd:PRK12316 5095 NFFELGGHS--LLAIQVTSRiqlELGLELPLRELFQTPTLAAFVELAAAAGSGDD 5147
|
|
| PRK04319 |
PRK04319 |
acetyl-CoA synthetase; Provisional |
468-872 |
1.18e-15 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 235279 [Multi-domain] Cd Length: 570 Bit Score: 82.64 E-value: 1.18e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 468 LDAHGSLD--FATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEF-PAARVERMREAG 544
Cdd:PRK04319 66 LDASRKEKytYKELKELSNKFANVLKELGVEKGDRVFIFMPRIPELYFALLGALKNGAIVGPLFEAFmEEAVRDRLEDSE 145
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 545 GIVF----ALADAECAGR-----------AREAFAGACLDLSTLpLAGSGMSLPAPGGR--DAAYMIFTSGTSGQPKGVV 607
Cdd:PRK04319 146 AKVLittpALLERKPADDlpslkhvllvgEDVEEGPGTLDFNAL-MEQASDEFDIEWTDreDGAILHYTSGSTGKPKGVL 224
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 608 VEHASALnlsQALARTVYANVVGEGLR---------VT-----VNAPfsfdssikqilqLLSGHCLVLVpqEVRSDPQRM 673
Cdd:PRK04319 225 HVHNAML---QHYQTGKYVLDLHEDDVywctadpgwVTgtsygIFAP------------WLNGATNVID--GGRFSPERW 287
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 674 LGFLEERRIDVLDCTPSLFRLLLQAGLDDA----HPALpgR-ILVGGERFD-EASWevaagWRRcQVFNL-----YGPTE 742
Cdd:PRK04319 288 YRILEDYKVTVWYTAPTAIRMLMGAGDDLVkkydLSSL--RhILSVGEPLNpEVVR-----WGM-KVFGLpihdnWWMTE 359
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 743 --ATVNASLArvAEHARP-TIGRALANVDLHVVDGLGRRKTRGASGELWI--GGAGVARGYAGDAGEAAGRFVEeGWpgs 817
Cdd:PRK04319 360 tgGIMIANYP--AMDIKPgSMGKPLPGIEAAIVDDQGNELPPNRMGNLAIkkGWPSMMRGIWNNPEKYESYFAG-DW--- 433
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*
gi 15597498 818 grlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV 872
Cdd:PRK04319 434 ---YVSGDSAYMDEDGYFWFQGRVDDVIKTSGERVGPFEVESKLMEHPAVAEAGV 485
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
1199-1332 |
1.37e-15 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 83.56 E-value: 1.37e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1199 ALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRRalLAALAAEAAAQTLEAPANATEAALLEIWKSVLKRPAIGVSDN 1278
Cdd:PRK10252 924 ALQAQLRERLPPHMVPVVLLQLDQLPLSANGKLDRK--ALPLPELKAQVPGRAPKTGTETIIAAAFSSLLGCDVVDADAD 1001
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*..
gi 15597498 1279 FFQVGGDSirLIQMQVMA---REAGLAFTLRDVFNHQSIRELARLLAAPASPADALG 1332
Cdd:PRK10252 1002 FFALGGHS--LLAMKLAAqlsRQFARQVTPGQVMVASTVAKLATLLDAEEDESRRLG 1056
|
|
| PLN02574 |
PLN02574 |
4-coumarate--CoA ligase-like |
446-899 |
1.74e-15 |
|
4-coumarate--CoA ligase-like
Pssm-ID: 215312 [Multi-domain] Cd Length: 560 Bit Score: 82.20 E-value: 1.74e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 446 PVESLVAAFDLRAAlQPQAPALLDAHG--SLDFATLRAR-SEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAA 522
Cdd:PLN02574 38 PNLDAVSFIFSHHN-HNGDTALIDSSTgfSISYSELQPLvKSMAAGLYHVMGVRQGDVVLLLLPNSVYFPVIFLAVLSLG 116
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 523 AVYTPVNPEFPAARV-ERMREAG-GIVFALADAECAGRA--------REAFAGACLDLSTLP----LAGSGMSLPAP--G 586
Cdd:PLN02574 117 GIVTTMNPSSSLGEIkKRVVDCSvGLAFTSPENVEKLSPlgvpvigvPENYDFDSKRIEFPKfyelIKEDFDFVPKPviK 196
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 587 GRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALAR---TVYANVVGEGLRVTVNAPFSFDSSIKQILQLLSGHCLVLVP 663
Cdd:PLN02574 197 QDDVAAIMYSSGTTGASKGVVLTHRNLIAMVELFVRfeaSQYEYPGSDNVYLAALPMFHIYGLSLFVVGLLSLGSTIVVM 276
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 664 QevRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPALPGRILV---GGERFDEASWEVAAGWRRCQVFNLYGP 740
Cdd:PLN02574 277 R--RFDASDMVKVIDRFKVTHFPVVPPILMALTKKAKGVCGEVLKSLKQVscgAAPLSGKFIQDFVQTLPHVDFIQGYGM 354
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 741 TEATVNASLARVAEHAR--PTIGRALANVDLHVVD-GLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgs 817
Cdd:PLN02574 355 TESTAVGTRGFNTEKLSkySSVGLLAPNMQAKVVDwSTGCLLPPGNCGELWIQGPGVMKGYLNNPKATQSTIDKDGW--- 431
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 818 grlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL-TDEADAAE-PgadrriVAFVTAA 895
Cdd:PLN02574 432 ---LRTGDIAYFDEDGYLYIVDRLKEIIKYKGFQIAPADLEAVLISHPEIIDAAVTaVPDKECGEiP------VAFVVRR 502
|
....
gi 15597498 896 EETA 899
Cdd:PLN02574 503 QGST 506
|
|
| Firefly_Luc |
cd17642 |
insect luciferase, similar to plant 4-coumarate: CoA ligases; This family contains insect ... |
589-884 |
3.08e-15 |
|
insect luciferase, similar to plant 4-coumarate: CoA ligases; This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341297 [Multi-domain] Cd Length: 532 Bit Score: 81.03 E-value: 3.08e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTVYANVVGEGLRVTVNAPFSFDSSIKQIL-QLLSGHCLVLVPqevR 667
Cdd:cd17642 185 QVALIMNSSGSTGLPKGVQLTHKNIVARFSHARDPIFGNQIIPDTAILTVIPFHHGFGMFTTLgYLICGFRVVLMY---K 261
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 668 SDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHP-ALPGRILVGGERFDEASWEVAAgwRRcqvFNL------YGP 740
Cdd:cd17642 262 FEEELFLRSLQDYKVQSALLVPTLFAFFAKSTLVDKYDlSNLHEIASGGAPLSKEVGEAVA--KR---FKLpgirqgYGL 336
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 741 TEATvNASLARVAEHARP-TIGRALANVDLHVVDgLGRRKTRGAS--GELWIGGAGVARGYAGDAGEAAGRFVEEGWpgs 817
Cdd:cd17642 337 TETT-SAILITPEGDDKPgAVGKVVPFFYAKVVD-LDTGKTLGPNerGELCVKGPMIMKGYVNNPEATKALIDKDGW--- 411
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 15597498 818 grlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV--LTDEADAAEPGA 884
Cdd:cd17642 412 ---LHSGDIAYYDEDGHFFIVDRLKSLIKYKGYQVPPAELESILLQHPKIFDAGVagIPDEDAGELPAA 477
|
|
| C_PKS-NRPS_PksJ-like |
cd20484 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1393-1654 |
3.11e-15 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs), similar to Bacillus subtilis PksJ; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily have the typical C-domain HHxxxD motif. PksJ is involved in some intermediate steps for the synthesis of the antibiotic polyketide bacillaene which is important in secondary metabolism. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380472 [Multi-domain] Cd Length: 430 Bit Score: 80.44 E-value: 3.11e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1393 GRLDGELLARAWAILIGRHAILRTGFDLHGGqVPLQWVHPATAVAaeVPVHDLCGLDGEtrrlRLRAWIEEEQATPFDWS 1472
Cdd:cd20484 34 SKLDVEKFKQACQFVLEQHPILKSVIEEEDG-VPFQKIEPSKPLS--FQEEDISSLKES----EIIAYLREKAKEPFVLE 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1473 RPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLLAGVVAREAEAPAVgFRDYVALEREAEANAASA 1552
Cdd:cd20484 107 NGPLMRVHLFSRSEQEHFVLITIHHIIFDGSSSLTLIHSLLDAYQALLQGKQPTLASSPAS-YYDFVAWEQDMLAGAEGE 185
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1553 ---LFWLDYLAGAryrpLPGLAEEGPRRMAAVRVD--------VPADSLSRLRALAERSGLPLRSLLLAAHGRALCRFSD 1621
Cdd:cd20484 186 ehrAYWKQQLSGT----LPILELPADRPRSSAPSFegqtytrrLPSELSNQIKSFARSQSINLSTVFLGIFKLLLHRYTG 261
|
250 260 270
....*....|....*....|....*....|...
gi 15597498 1622 ADEVVTGFVSHGRPEEpGADRLLGLFLNTLPCR 1654
Cdd:cd20484 262 QEDIIVGMPTMGRPEE-RFDSLIGYFINMLPIR 293
|
|
| PRK13382 |
PRK13382 |
bile acid CoA ligase; |
452-899 |
3.57e-15 |
|
bile acid CoA ligase;
Pssm-ID: 172019 [Multi-domain] Cd Length: 537 Bit Score: 80.96 E-value: 3.57e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 452 AAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPE 531
Cdd:PRK13382 47 SGFAIAAQRCPDRPGLIDELGTLTWRELDERSDALAAALQALPIGEPRVVGIMCRNHRGFVEALLAANRIGADILLLNTS 126
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 532 F--PAARVERMREAGGIVF-----------ALADAECAGRArEAFAGACLDLSTLPL-AGSGMSLPAPGGRDAAYMIFTS 597
Cdd:PRK13382 127 FagPALAEVVTREGVDTVIydeefsatvdrALADCPQATRI-VAWTDEDHDLTVEVLiAAHAGQRPEPTGRKGRVILLTS 205
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 598 GTSGQPKGVV-VEHASALNLSQALARTVYanvvgEGLRVTV-NAPFSFDSSIKQILQLLSGHCLVLVPQevRSDPQRMLG 675
Cdd:PRK13382 206 GTTGTPKGARrSGPGGIGTLKAILDRTPW-----RAEEPTViVAPMFHAWGFSQLVLAASLACTIVTRR--RFDPEATLD 278
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 676 FLEERRIDVLDCTPSLFRLLLqagldDAHPALPGRILVGGERFDEASWE------VAAGWRRCQ--VFNLYGPTEATVNA 747
Cdd:PRK13382 279 LIDRHRATGLAVVPVMFDRIM-----DLPAEVRNRYSGRSLRFAAASGSrmrpdvVIAFMDQFGdvIYNNYNATEAGMIA 353
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 748 SLARVAEHARP-TIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGY-AGDAGEAAGRFVEegwpgsgrlyrSGD 825
Cdd:PRK13382 354 TATPADLRAAPdTAGRPAEGTEIRILDQDFREVPTGEVGTIFVRNDTQFDGYtSGSTKDFHDGFMA-----------SGD 422
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 15597498 826 LVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLTdeADAAEPGadRRIVAFVTAAEETA 899
Cdd:PRK13382 423 VGYLDENGRLFVVGRDDEMIVSGGENVYPIEVEKTLATHPDVAEAAVIG--VDDEQYG--QRLAAFVVLKPGAS 492
|
|
| PRK06145 |
PRK06145 |
acyl-CoA synthetase; Validated |
449-896 |
4.23e-15 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 102207 [Multi-domain] Cd Length: 497 Bit Score: 80.70 E-value: 4.23e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 449 SLVAAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTgRNREAIVAL-LGVMRAAAVYTP 527
Cdd:PRK06145 3 NLSASIAFHARRTPDRAALVYRDQEISYAEFHQRILQAAGMLHARGIGQGDVVALLM-KNSAAFLELaFAASYLGAVFLP 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 528 VNPEFPAARVERMREAGGIVFALADAE----CAGRAREAFAGACLDLSTLPLAGSGMSLPAPGGR---DAAYMIFTSGTS 600
Cdd:PRK06145 82 INYRLAADEVAYILGDAGAKLLLVDEEfdaiVALETPKIVIDAAAQADSRRLAQGGLEIPPQAAVaptDLVRLMYTSGTT 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 601 GQPKGVVVEHAsalNLSQALARTVYANVVGEGLRVTVNAPF----SFDssIKQILQLLSGHCLVLvpqEVRSDPQRMLGF 676
Cdd:PRK06145 162 DRPKGVMHSYG---NLHWKSIDHVIALGLTASERLLVVGPLyhvgAFD--LPGIAVLWVGGTLRI---HREFDPEAVLAA 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 677 LEERRIDVLDCTPSLFRLLLqaglddahpALPGRilvggERFDEAS--WEVAAG--------------WRRCQVFNLYGP 740
Cdd:PRK06145 234 IERHRLTCAWMAPVMLSRVL---------TVPDR-----DRFDLDSlaWCIGGGektpesrirdftrvFTRARYIDAYGL 299
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 741 TEATVNASL---ARVAEHARPTiGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVeEGWpgs 817
Cdd:PRK06145 300 TETCSGDTLmeaGREIEKIGST-GRALAHVEIRIADGAGRWLPPNMKGEICMRGPKVTKGYWKDPEKTAEAFY-GDW--- 374
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 15597498 818 grlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLtdeaDAAEPGADRRIVAFVTAAE 896
Cdd:PRK06145 375 ---FRSGDVGYLDEEGFLYLTDRKKDMIISGGENIASSEVERVIYELPEVAEAAVI----GVHDDRWGERITAVVVLNP 446
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
1354-1688 |
4.77e-15 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 81.63 E-value: 4.77e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1354 PEGLDDAYPMTSLQQGMLLQSEASGDPRLLHNVVLHEVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQvPLQWVHPA 1433
Cdd:PRK10252 1 AEPMSQHLPLVAAQPGIWMAEKLSPLPSAWSVAHYVELTGELDAPLLARAVVAGLAEADTLRMRFTEDNGE-VWQWVDPA 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1434 tAVAAEVPVHDLCGLDGETRRLRlrAWIEEEQATPFDWSR-PPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDEL 1512
Cdd:PRK10252 80 -LTFPLPEIIDLRTQPDPHAAAQ--ALMQADLQQDLRVDSgKPLVFHQLIQLGDNRWYWYQRYHHLLVDGFSFPAITRRI 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1513 LAVYADLLAGvvAREAEAPAVGFRDYVALE---REAEANAASALFWLdylagARYRPLPGLAEEGPRRMAA-------VR 1582
Cdd:PRK10252 157 AAIYCAWLRG--EPTPASPFTPFADVVEEYqryRASEAWQRDAAFWA-----EQRRQLPPPASLSPAPLPGrsasadiLR 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1583 VDVPADSLSRLRALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPEEPGAdRLLGLFLNTLPCRLS--ASVD 1660
Cdd:PRK10252 230 LKLEFTDGAFRQLAAQASGVQRPDLALALVALWLGRLCGRMDYAAGFIFMRRLGSAAL-TATGPVLNVLPLRVHiaAQET 308
|
330 340
....*....|....*....|....*...
gi 15597498 1661 LLDSARRAFDYERASLEHRRHPLAAIRR 1688
Cdd:PRK10252 309 LPELATRLAAQLKKMRRHQRYDAEQIVR 336
|
|
| PRK07529 |
PRK07529 |
AMP-binding domain protein; Validated |
446-872 |
4.89e-15 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236043 [Multi-domain] Cd Length: 632 Bit Score: 80.77 E-value: 4.89e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 446 PVESLVAAFDLRAALQPQAPAL--------LDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLG 517
Cdd:PRK07529 23 LPASTYELLSRAAARHPDAPALsflldadpLDRPETWTYAELLADVTRTANLLHSLGVGPGDVVAFLLPNLPETHFALWG 102
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 518 VMrAAAVYTPVNPEF-PAARVERMREAGG-IVFALA---DAECAGRAREAFAgACLDLSTLPLAGSGMSLPAP------- 585
Cdd:PRK07529 103 GE-AAGIANPINPLLePEQIAELLRAAGAkVLVTLGpfpGTDIWQKVAEVLA-ALPELRTVVEVDLARYLPGPkrlavpl 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 586 ------------------------------GGRDAAYMIFTSGTSGQPKGVVVEHA--------SALNLSQALARTVYAN 627
Cdd:PRK07529 181 irrkaharildfdaelarqpgdrlfsgrpiGPDDVAAYFHTGGTTGMPKLAQHTHGnevanawlGALLLGLGPGDTVFCG 260
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 628 V----VGeGLRVTVNAPFSfdssikqilqllSG-HCLVLVPQEVRsDPQRMLGF---LEERRIDVLDCTPSLFRLLLQAG 699
Cdd:PRK07529 261 LplfhVN-ALLVTGLAPLA------------RGaHVVLATPQGYR-GPGVIANFwkiVERYRINFLSGVPTVYAALLQVP 326
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 700 LDDAH-----------PALPGRIlvgGERFDEASwevaaGWRrcqVFNLYGPTEATVNASLARVAEHARP-TIGRAL--A 765
Cdd:PRK07529 327 VDGHDisslryalcgaAPLPVEV---FRRFEAAT-----GVR---IVEGYGLTEATCVSSVNPPDGERRIgSVGLRLpyQ 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 766 NVDLHVVDGLGRRK---TRGASGELWIGGAGVARGYAgDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRID 842
Cdd:PRK07529 396 RVRVVILDDAGRYLrdcAVDEVGVLCIAGPNVFSGYL-EAAHNKGLWLEDGW------LNTGDLGRIDADGYFWLTGRAK 468
|
490 500 510
....*....|....*....|....*....|
gi 15597498 843 EQVKINGYRIELGEIRSALLEHPAVGEAAV 872
Cdd:PRK07529 469 DLIIRGGHNIDPAAIEEALLRHPAVALAAA 498
|
|
| PRK06178 |
PRK06178 |
acyl-CoA synthetase; Validated |
458-901 |
8.25e-15 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235724 [Multi-domain] Cd Length: 567 Bit Score: 80.09 E-value: 8.25e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 458 AALQPQAPALlDAHGS-LDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAAR 536
Cdd:PRK06178 43 ARERPQRPAI-IFYGHvITYAELDELSDRFAALLRQRGVGAGDRVAVFLPNCPQFHIVFFGILKLGAVHVPVSPLFREHE 121
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 537 VE-RMREAGGIVF----ALAD------AECAGR-------------------------AREAFAGACLDLSTLPLAGSGM 580
Cdd:PRK06178 122 LSyELNDAGAEVLlaldQLAPvveqvrAETSLRhvivtsladvlpaeptlplpdslraPRLAAAGAIDLLPALRACTAPV 201
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 581 SLPAPGGRDAAYMIFTSGTSGQPKGVVVEH-------ASALNLSQALAR-TVYAN------VVGEGLRVtvnapfsfdss 646
Cdd:PRK06178 202 PLPPPALDALAALNYTGGTTGMPKGCEHTQrdmvytaAAAYAVAVVGGEdSVFLSflpefwIAGENFGL----------- 270
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 647 ikqILQLLSGHCLVLVpqeVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQaglddaHPALPGRILVGGERFDEAS---- 722
Cdd:PRK06178 271 ---LFPLFSGATLVLL---ARWDAVAFMAAVERYRVTRTVMLVDNAVELMD------HPRFAEYDLSSLRQVRVVSfvkk 338
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 723 --------WEVAAGwrrCQVFNL-YGPTEATVNASLARVAE------HARPT-IGRALANVDLHVVD-GLGRRKTRGASG 785
Cdd:PRK06178 339 lnpdyrqrWRALTG---SVLAEAaWGMTETHTCDTFTAGFQdddfdlLSQPVfVGLPVPGTEFKICDfETGELLPLGAEG 415
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 786 ELWIGGAGVARGYAGDAgEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHP 865
Cdd:PRK06178 416 EIVVRTPSLLKGYWNKP-EATAEALRDGW------LHTGDIGKIDEQGFLHYLGRRKEMLKVNGMSVFPSEVEALLGQHP 488
|
490 500 510 520
....*....|....*....|....*....|....*....|.
gi 15597498 866 AVGEAAVL--TDEADAAEPgadrriVAFVT---AAEETADE 901
Cdd:PRK06178 489 AVLGSAVVgrPDPDKGQVP------VAFVQlkpGADLTAAA 523
|
|
| FADD10 |
cd17635 |
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain ... |
588-876 |
9.56e-15 |
|
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain fatty acid CoA ligases, including FadD10 which is involved in the synthesis of a virulence-related lipopeptide. FadD10 is a fatty acyl-AMP ligase (FAAL) that transfers fatty acids to an acyl carrier protein. Structures of FadD10 in apo- and complexed form with dodecanoyl-AMP, show a novel open conformation, facilitated by its unique inter-domain and intermolecular interactions, which is critical for the enzyme to carry out the acyl transfer onto the acyl carrier protein (Rv0100) rather than coenzyme A.
Pssm-ID: 341290 [Multi-domain] Cd Length: 340 Bit Score: 78.07 E-value: 9.56e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 588 RDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTVYANVVGEGLRVTVNAPFSFDSSIKQILQLLSGHCLVLVPqevR 667
Cdd:cd17635 1 EDPLAVIFTSGTTGEPKAVLLANKTFFAVPDILQKEGLNWVVGDVTYLPLPATHIGGLWWILTCLIHGGLCVTGGE---N 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 668 SDPQRMLGFLEERRIDVLDCTPSLFRLLLQAgLDDAHPALPGR--ILVGGERFDEASWEVAAGWRRCQVFNLYGPTEATV 745
Cdd:cd17635 78 TTYKSLFKILTTNAVTTTCLVPTLLSKLVSE-LKSANATVPSLrlIGYGGSRAIAADVRFIEATGLTNTAQVYGLSETGT 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 746 NASL--ARVAEHARpTIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVeEGWpgsgrlYRS 823
Cdd:cd17635 157 ALCLptDDDSIEIN-AVGRPYPGVDVYLAATDGIAGPSASFGTIWIKSPANMLGYWNNPERTAEVLI-DGW------VNT 228
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*
gi 15597498 824 GDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV--LTDE 876
Cdd:cd17635 229 GDLGERREDGFLFITGRSSESINCGGVKIAPDEVERIAEGVSGVQECACyeISDE 283
|
|
| ACS |
cd05966 |
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); ... |
589-893 |
9.92e-15 |
|
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); Acetyl-CoA synthetase (ACS, EC 6.2.1.1, acetate#CoA ligase or acetate:CoA ligase (AMP-forming)) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is widely present in all living organisms. The activity of this enzyme is crucial for maintaining the required levels of acetyl-CoA, a key intermediate in many important biosynthetic and catabolic processes. Acetyl-CoA is used in the biosynthesis of glucose, fatty acids, and cholesterol. It can also be used in the production of energy in the citric acid cycle. Eukaryotes typically have two isoforms of acetyl-CoA synthetase, a cytosolic form involved in biosynthetic processes and a mitochondrial form primarily involved in energy generation.
Pssm-ID: 341270 [Multi-domain] Cd Length: 608 Bit Score: 79.91 E-value: 9.92e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVveHASALNLSQALARTVYAnvvgeglrvtvnapfsFD----------SSIKQIlqllSGHC 658
Cdd:cd05966 232 DPLFILYTSGSTGKPKGVV--HTTGGYLLYAATTFKYV----------------FDyhpddiywctADIGWI----TGHS 289
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 659 LVL---------------VPqeVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLD--DAHPALPGRIL--VGgERFD 719
Cdd:cd05966 290 YIVygplangattvmfegTP--TYPDPGRYWDIVEKHKVTIFYTAPTAIRALMKFGDEwvKKHDLSSLRVLgsVG-EPIN 366
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 720 EASW----EVAaGWRRCQVFNLYGPTE--ATVNASLARVAEhARP-TIGRALANVDLHVVDGLGRRKTRGASGELWIGGA 792
Cdd:cd05966 367 PEAWmwyyEVI-GKERCPIVDTWWQTEtgGIMITPLPGATP-LKPgSATRPFFGIEPAILDEEGNEVEGEVEGYLVIKRP 444
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 793 --GVARGYAGDAGeaagRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEA 870
Cdd:cd05966 445 wpGMARTIYGDHE----RYEDTYFSKFPGYYFTGDGARRDEDGYYWITGRVDDVINVSGHRLGTAEVESALVAHPAVAEA 520
|
330 340
....*....|....*....|....*....
gi 15597498 871 AV------LTDEAdaaepgadrrIVAFVT 893
Cdd:cd05966 521 AVvgrphdIKGEA----------IYAFVT 539
|
|
| A_NRPS_TubE_like |
cd05906 |
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) ... |
476-867 |
1.23e-14 |
|
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) synthesizing toxins and antitumor agents; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPSs that synthesize toxins and antitumor agents; for example, TubE for Tubulysine, CrpA for cryptophycin, TdiA for terrequinone A, KtzG for kutzneride, and Vlm1/Vlm2 for Valinomycin. Nonribosomal peptide synthetases are large multifunctional enzymes which synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341232 [Multi-domain] Cd Length: 540 Bit Score: 79.25 E-value: 1.23e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 476 FATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNP----EFPAARVERMREA-----GGI 546
Cdd:cd05906 42 YQDLLEDARRLAAGLRQLGLRPGDSVILQFDDNEDFIPAFWACVLAGFVPAPLTVpptyDEPNARLRKLRHIwqllgSPV 121
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 547 VFALADAECAGRAREAFAGAC----LDLSTLPLAGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVVEHAsalnlsQALAR 622
Cdd:cd05906 122 VLTDAELVAEFAGLETLSGLPgirvLSIEELLDTAADHDLPQSRPDDLALLMLTSGSTGFPKAVPLTHR------NILAR 195
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 623 TVYANVVGEGLR--VTVN-APFSFDSSIKQI-LQLLSGHCL-VLVP-QEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLL 696
Cdd:cd05906 196 SAGKIQHNGLTPqdVFLNwVPLDHVGGLVELhLRAVYLGCQqVHVPtEEILADPLRWLDLIDRYRVTITWAPNFAFALLN 275
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 697 QA--GLDDAHPALPG--RILVGGE--------RFDE-------------ASW---EVAAGWRRCQVFNLYGPTEATVNAS 748
Cdd:cd05906 276 DLleEIEDGTWDLSSlrYLVNAGEavvaktirRLLRllepyglppdairPAFgmtETCSGVIYSRSFPTYDHSQALEFVS 355
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 749 LarvaeharptiGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVr 828
Cdd:cd05906 356 L-----------GRPIPGVSMRIVDDEGQLLPEGEVGRLQVRGPVVTKGYYNNPEANAEAFTEDGW------FRTGDLG- 417
|
410 420 430
....*....|....*....|....*....|....*....
gi 15597498 829 WRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAV 867
Cdd:cd05906 418 FLDNGNLTITGRTKDTIIVNGVNYYSHEIEAAVEEVPGV 456
|
|
| FACL_like_2 |
cd05917 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
589-872 |
6.73e-14 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341241 [Multi-domain] Cd Length: 349 Bit Score: 75.39 E-value: 6.73e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHASALNlsqalartvYANVVGEGLRVTVN------APF--SFDSSIKQILQLLSGHCLV 660
Cdd:cd05917 3 DVINIQFTSGTTGSPKGATLTHHNIVN---------NGYFIGERLGLTEQdrlcipVPLfhCFGSVLGVLACLTHGATMV 73
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 661 LVpqEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQaglddaHPALPgrilvggeRFDEASWE--VAAGW--------R 730
Cdd:cd05917 74 FP--SPSFDPLAVLEAIEKEKCTALHGVPTMFIAELE------HPDFD--------KFDLSSLRtgIMAGApcppelmkR 137
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 731 RCQVFNL------YGPTEAT-------VNASLARVAEharpTIGRALANVDLHVVDGLGRRK-TRGASGELWIGGAGVAR 796
Cdd:cd05917 138 VIEVMNMkdvtiaYGMTETSpvstqtrTDDSIEKRVN----TVGRIMPHTEAKIVDPEGGIVpPVGVPGELCIRGYSVMK 213
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 15597498 797 GYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV 872
Cdd:cd05917 214 GYWNDPEKTAEAIDGDGW------LHTGDLAVMDEDGYCRIVGRIKDMIIRGGENIYPREIEEFLHTHPKVSDVQV 283
|
|
| FACL_like_1 |
cd05910 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
474-871 |
1.02e-13 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341236 [Multi-domain] Cd Length: 457 Bit Score: 75.96 E-value: 1.02e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 474 LDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERmreaggivfALADA 553
Cdd:cd05910 3 LSFRELDERSDRIAQGLTAYGIRRGMRAVLMVPPGPDFFALTFALFKAGAVPVLIDPGMGRKNLKQ---------CLQEA 73
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 554 EcagraREAFAGacldlstLPLAGsgmslpapggrDAAYMIFTSGTSGQPKGVVVEHASALNLSQALaRTVYANVVGEGL 633
Cdd:cd05910 74 E-----PDAFIG-------IPKAD-----------EPAAILFTSGSTGTPKGVVYRHGTFAAQIDAL-RQLYGIRPGEVD 129
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 634 RVTVnAPFSfdssikqILQLLSGHCLVLVPQE----VRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPaLPG 709
Cdd:cd05910 130 LATF-PLFA-------LFGPALGLTSVIPDMDptrpARADPQKLVGAIRQYGVSIVFGSPALLERVARYCAQHGIT-LPS 200
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 710 --RILVGGERFDEAsweVAAGWRR-----CQVFNLYGPTEA---TVNASLARVAEHARPT-------IGRALANVDLHVV 772
Cdd:cd05910 201 lrRVLSAGAPVPIA---LAARLRKmlsdeAEILTPYGATEAlpvSSIGSRELLATTTAATsggagtcVGRPIPGVRVRII 277
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 773 D---------GLGRRKTRGASGELWIGGAGVARGYAGDagEAAGRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRIDE 843
Cdd:cd05910 278 EiddepiaewDDTLELPRGEIGEITVTGPTVTPTYVNR--PVATALAKIDDNSEGFWHRMGDLGYLDDEGRLWFCGRKAH 355
|
410 420
....*....|....*....|....*...
gi 15597498 844 QVKINGYRIELGEIRSALLEHPAVGEAA 871
Cdd:cd05910 356 RVITTGGTLYTEPVERVFNTHPGVRRSA 383
|
|
| PRK08314 |
PRK08314 |
long-chain-fatty-acid--CoA ligase; Validated |
446-872 |
2.00e-13 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236235 [Multi-domain] Cd Length: 546 Bit Score: 75.38 E-value: 2.00e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 446 PVESLVAAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAE-ALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAV 524
Cdd:PRK08314 8 PETSLFHNLEVSARRYPDKTAIVFYGRAISYRELLEEAERLAGyLQQECGVRKGDRVLLYMQNSPQFVIAYYAILRANAV 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 525 YTPVNPEFPAARVERMREAGGIVFALADAECAGRAREAFAGACLD-------LSTLPlAGSGMSLPA------------- 584
Cdd:PRK08314 88 VVPVNPMNREEELAHYVTDSGARVAIVGSELAPKVAPAVGNLRLRhvivaqySDYLP-AEPEIAVPAwlraepplqalap 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 585 --------------------PGGRDAAYMIFTSGTSGQPKGVVVEHasalnlsqalaRTVYANVVGEGLRVTVNA----- 639
Cdd:PRK08314 167 ggvvawkealaaglappphtAGPDDLAVLPYTSGTTGVPKGCMHTH-----------RTVMANAVGSVLWSNSTPesvvl 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 640 ---PF--------SFDSSIkqilqlLSGHCLVLVPqevRSDPQRMLGFLEERRIDVLDCTPS-LFRLLLQAGLDDAHpaL 707
Cdd:PRK08314 236 avlPLfhvtgmvhSMNAPI------YAGATVVLMP---RWDREAAARLIERYRVTHWTNIPTmVVDFLASPGLAERD--L 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 708 PGRILVGGerfDEASWEVAAGWRRCQVFNL-----YGPTEaTVNASLARVAEHARPT-IGRALANVDLHVVD-GLGRRKT 780
Cdd:PRK08314 305 SSLRYIGG---GGAAMPEAVAERLKELTGLdyvegYGLTE-TMAQTHSNPPDRPKLQcLGIPTFGVDARVIDpETLEELP 380
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 781 RGASGELWIGGAGVARGYAGDAGEAAGRFVE-EGwpgsGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRS 859
Cdd:PRK08314 381 PGEVGEIVVHGPQVFKGYWNRPEATAEAFIEiDG----KRFFRTGDLGRMDEEGYFFITDRLKRMINASGFKVWPAEVEN 456
|
490
....*....|...
gi 15597498 860 ALLEHPAVGEAAV 872
Cdd:PRK08314 457 LLYKHPAIQEACV 469
|
|
| LCL_NRPS |
cd19538 |
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; ... |
1393-1683 |
2.33e-13 |
|
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380461 [Multi-domain] Cd Length: 432 Bit Score: 74.61 E-value: 2.33e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1393 GRLDGELLARAWAILIGRHAILRTGFDLHGGqVPLQWVHPATAvaAEVPVHDLcgldgETRRLRLRAWIEEEQATPFDWS 1472
Cdd:cd19538 34 GKLDVQALQQALYDVVERHESLRTVFPEEDG-VPYQLILEEDE--ATPKLEIK-----EVDEEELESEINEAVRYPFDLS 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1473 RPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLLAGVVAREAEAPaVGFRDYVALERE---AEANA 1549
Cdd:cd19538 106 EEPPFRATLFELGENEHVLLLLLHHIAADGWSLAPLTRDLSKAYRARCKGEAPELAPLP-VQYADYALWQQEllgDESDP 184
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1550 ASAL-----FWLDYLAGaryrpLPGLAE---EGPRRMAA------VRVDVPADSLSRLRALAERSGLPLRSLLLAAHGRA 1615
Cdd:cd19538 185 DSLIarqlaYWKKQLAG-----LPDEIElptDYPRPAESsyeggtLTFEIDSELHQQLLQLAKDNNVTLFMVLQAGFAAL 259
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1616 LCRFSDADEVVTGFVSHGRPEEpGADRLLGLFLNTLPCRLSASVD-----LLDSARR----AFDYERASLEH-------- 1678
Cdd:cd19538 260 LTRLGAGTDIPIGSPVAGRNDD-SLEDLVGFFVNTLVLRTDTSGNpsfreLLERVKEtnleAYEHQDIPFERlvealnpt 338
|
....*...
gi 15597498 1679 ---RRHPL 1683
Cdd:cd19538 339 rsrSRHPL 346
|
|
| PRK12406 |
PRK12406 |
long-chain-fatty-acid--CoA ligase; Provisional |
473-872 |
2.54e-13 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 183506 [Multi-domain] Cd Length: 509 Bit Score: 75.12 E-value: 2.54e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 473 SLDFATLRARSEAVAEALLAAGVRPGQAVAVMTgRNREA-IVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALA 551
Cdd:PRK12406 11 RRSFDELAQRAARAAGGLAALGVRPGDCVALLM-RNDFAfFEAAYAAMRLGAYAVPVNWHFKPEEIAYILEDSGARVLIA 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 552 DAECAGRAREAFAGAC--LDLSTLP-------LAGSGMSLPA-----------------PGGRDAAYMIFTSGTSGQPKG 605
Cdd:PRK12406 90 HADLLHGLASALPAGVtvLSVPTPPeiaaayrISPALLTPPAgaidwegwlaqqepydgPPVPQPQSMIYTSGTTGHPKG 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 606 V-----VVEHASAlnlSQALARTVYAnvVGEGLRVTVN------APFSFDssikqILQLLSGHCLVLVPqevRSDPQRML 674
Cdd:PRK12406 170 VrraapTPEQAAA---AEQMRALIYG--LKPGIRALLTgplyhsAPNAYG-----LRAGRLGGVLVLQP---RFDPEELL 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 675 GFLEERRIDVLDCTPSLFRLLLQaglddahpaLPGRIlvgGERFDEAS--WEVAAG-------------WRRCQVFNLYG 739
Cdd:PRK12406 237 QLIERHRITHMHMVPTMFIRLLK---------LPEEV---RAKYDVSSlrHVIHAAapcpadvkramieWWGPVIYEYYG 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 740 PTEATVNASLARVAEHARP-TIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVAR-GYAGDAGEAAGrfveegwPGS 817
Cdd:PRK12406 305 STESGAVTFATSEDALSHPgTVGKAAPGAELRFVDEDGRPLPQGEIGEIYSRIAGNPDfTYHNKPEKRAE-------IDR 377
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*
gi 15597498 818 GRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV 872
Cdd:PRK12406 378 GGFITSGDVGYLDADGYLFLCDRKRDMVISGGVNIYPAEIEAVLHAVPGVHDCAV 432
|
|
| ACLS-CaiC |
cd17637 |
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ... |
589-872 |
3.14e-13 |
|
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized, but may be similar to Carnitine-CoA ligase (CaiC) which catalyzes the transfer of CoA to carnitine. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341292 [Multi-domain] Cd Length: 333 Bit Score: 73.07 E-value: 3.14e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHAsalNLSQALARTVYANVVGEGLRVTVNAPFSFDSSIKQILQLL-SGHCLVLVPqevR 667
Cdd:cd17637 1 DPFVIIHTAAVAGRPRGAVLSHG---NLIAANLQLIHAMGLTEADVYLNMLPLFHIAGLNLALATFhAGGANVVME---K 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 668 SDPQRMLGFLEERRIDVL-DCTPSLFRLLLQAgldDAHPALPG--RILVGGErfdeaSWEVAAGWRRC---QVFNLYGPT 741
Cdd:cd17637 75 FDPAEALELIEEEKVTLMgSFPPILSNLLDAA---EKSGVDLSslRHVLGLD-----APETIQRFEETtgaTFWSLYGQT 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 742 EATVNASLARVAEhaRP-TIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFvEEGWpgsgrl 820
Cdd:cd17637 147 ETSGLVTLSPYRE--RPgSAGRPGPLVRVRIVDDNDRPVPAGETGEIVVRGPLVFQGYWNLPELTAYTF-RNGW------ 217
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....
gi 15597498 821 YRSGDLVRWRADGCLEFLGRIDEQ--VKINGYRIELGEIRSALLEHPAVGEAAV 872
Cdd:cd17637 218 HHTGDLGRFDEDGYLWYAGRKPEKelIKPGGENVYPAEVEKVILEHPAIAEVCV 271
|
|
| PrpE |
cd05967 |
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or ... |
589-873 |
3.35e-13 |
|
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or propionate#CoA ligase (PrpE) catalyzes the first step of the 2-methylcitric acid cycle for propionate catabolism. It activates propionate to propionyl-CoA in a two-step reaction, which proceeds through a propionyl-AMP intermediate and requires ATP and Mg2+. In Salmonella enterica, the PrpE protein is required for growth of Salmonella enterica on propionate and can substitute for the acetyl-CoA synthetase (Acs) enzyme during growth on acetate. PrpE can also activate acetate, 3HP, and butyrate to their corresponding CoA-thioesters, although with less efficiency.
Pssm-ID: 341271 [Multi-domain] Cd Length: 617 Bit Score: 75.04 E-value: 3.35e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVE---HASALNLSQalaRTVYAN--------------VVGEGLrvTVNAPfsfdssikqil 651
Cdd:cd05967 231 DPLYILYTSGTTGKPKGVVRDnggHAVALNWSM---RNIYGIkpgdvwwaasdvgwVVGHSY--IVYGP----------- 294
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 652 qLLSGHCLVLVP-QEVRS-DPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHpalpGR---------ILVGGERFDE 720
Cdd:cd05967 295 -LLHGATTVLYEgKPVGTpDPGAFWRVIEKYQVNALFTAPTAIRAIRKEDPDGKY----IKkydlsslrtLFLAGERLDP 369
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 721 ASWEVAAGWRRCQVFNLYGPTEA--TVNASLARVAEHARP--TIGRALANVDLHVVDGLGRRKTRGASGELWIGGA---G 793
Cdd:cd05967 370 PTLEWAENTLGVPVIDHWWQTETgwPITANPVGLEPLPIKagSPGKPVPGYQVQVLDEDGEPVGPNELGNIVIKLPlppG 449
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 794 VARGYAGDAGeaagRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:cd05967 450 CLLTLWKNDE----RFKKLYLSKFPGYYDTGDAGYKDEDGYLFIMGRTDDVINVAGHRLSTGEMEESVLSHPAVAECAVV 525
|
|
| PRK03640 |
PRK03640 |
o-succinylbenzoate--CoA ligase; |
457-901 |
4.00e-13 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 235146 [Multi-domain] Cd Length: 483 Bit Score: 74.23 E-value: 4.00e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 457 RAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNRE---AIVAL--LGV------------- 518
Cdd:PRK03640 11 RAFLTPDRTAIEFEEKKVTFMELHEAVVSVAGKLAALGVKKGDRVALLMKNGMEmilVIHALqqLGAvavllntrlsree 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 519 -----MRAAAVYTPVNPEFPAarvermREAGGIVFALADAEcAGRAREAFAgacldLSTLPLagsgmslpapggRDAAYM 593
Cdd:PRK03640 91 llwqlDDAEVKCLITDDDFEA------KLIPGISVKFAELM-NGPKEEAEI-----QEEFDL------------DEVATI 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 594 IFTSGTSGQPKGVVV---EH-----ASALNLsqalartvyanvvgeGLR------VTVnaPFsFDSSIKQIL--QLLSGH 657
Cdd:PRK03640 147 MYTSGTTGKPKGVIQtygNHwwsavGSALNL---------------GLTeddcwlAAV--PI-FHISGLSILmrSVIYGM 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 658 CLVLVPqevRSDPQRMLGFLEERRIDVLDCTPS-LFRLLLQAGLDDAHPALPGrILVGGERFDEASWEVAAGwRRCQVFN 736
Cdd:PRK03640 209 RVVLVE---KFDAEKINKLLQTGGVTIISVVSTmLQRLLERLGEGTYPSSFRC-MLLGGGPAPKPLLEQCKE-KGIPVYQ 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 737 LYGPTE-ATVNASLArvAEHARPTIGRA---LANVDLHVVDGlGRRKTRGASGELWIGGAGVARGYAG--DAGEAAgrfV 810
Cdd:PRK03640 284 SYGMTEtASQIVTLS--PEDALTKLGSAgkpLFPCELKIEKD-GVVVPPFEEGEIVVKGPNVTKGYLNreDATRET---F 357
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 811 EEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV--LTDEADAAEPgadrri 888
Cdd:PRK03640 358 QDGW------FKTGDIGYLDEEGFLYVLDRRSDLIISGGENIYPAEIEEVLLSHPGVAEAGVvgVPDDKWGQVP------ 425
|
490
....*....|....
gi 15597498 889 VAFVTAAEE-TADE 901
Cdd:PRK03640 426 VAFVVKSGEvTEEE 439
|
|
| FAAL |
cd05931 |
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and ... |
457-901 |
4.26e-13 |
|
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and is homologous to fatty acyl-coenzyme A (CoA) ligases (FACLs). However, FAALs produce only the acyl adenylate and are unable to perform the thioester-forming reaction, while FACLs perform a two-step catalytic reaction; AMP ligation followed by CoA ligation using ATP and CoA as cofactors. FAALs have insertion motifs between the N-terminal and C-terminal subdomains that distinguish them from the FACLs. This insertion motif precludes the binding of CoA, thus preventing CoA ligation. It has been suggested that the acyl adenylates serve as substrates for multifunctional polyketide synthases to permit synthesis of complex lipids such as phthiocerol dimycocerosate, sulfolipids, mycolic acids, and mycobactin.
Pssm-ID: 341254 [Multi-domain] Cd Length: 547 Bit Score: 74.58 E-value: 4.26e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 457 RAALQPQAPAL--LDAHGSLD----FATLRARSEAVAEALLAAGvRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNP 530
Cdd:cd05931 2 RAAARPDRPAYtfLDDEGGREetltYAELDRRARAIAARLQAVG-KPGDRVLLLAPPGLDFVAAFLGCLYAGAIAVPLPP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 531 EFPAARVERMREA---GGIVFALADAECAGRAREAFAGAC-------LDLSTLPLAGSGMSL-PAPGGRDAAYMIFTSGT 599
Cdd:cd05931 81 PTPGRHAERLAAIladAGPRVVLTTAAALAAVRAFAASRPaagtprlLVVDLLPDTSAADWPpPSPDPDDIAYLQYTSGS 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 600 SGQPKGVVVEHASALNLSQALARTVYANvvgEGLRVTVNAPFSFDSSIKQ-ILQ-LLSGHCLVLV-PQEVRSDPQRMLGF 676
Cdd:cd05931 161 TGTPKGVVVTHRNLLANVRQIRRAYGLD---PGDVVVSWLPLYHDMGLIGgLLTpLYSGGPSVLMsPAAFLRRPLRWLRL 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 677 LEERRIdvlDCTPS---LFRLLLQAGLDDAHPALP----GRILVGGERFDEASWEV------AAGWRRCQVFNLYGPTEA 743
Cdd:cd05931 238 ISRYRA---TISAApnfAYDLCVRRVRDEDLEGLDlsswRVALNGAEPVRPATLRRfaeafaPFGFRPEAFRPSYGLAEA 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 744 TVNASLAR---------------------VAEHARPTI-----GRALANVDLHVVDGLGRRKTR-GASGELWIGGAGVAR 796
Cdd:cd05931 315 TLFVSGGPpgtgpvvlrvdrdalagravaVAADDPAARelvscGRPLPDQEVRIVDPETGRELPdGEVGEIWVRGPSVAS 394
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 797 GYAGDAGEAAGRFVEEGWPGSGRLYRSGDLvRWRADGCLEFLGRIDEQVKING-----YRIElgeiRSALLEHPAVGEAA 871
Cdd:cd05931 395 GYWGRPEATAETFGALAATDEGGWLRTGDL-GFLHDGELYITGRLKDLIIVRGrnhypQDIE----ATAEEAHPALRPGC 469
|
490 500 510
....*....|....*....|....*....|
gi 15597498 872 VltdeADAAEPGADRRIVAFVTAAEETADE 901
Cdd:cd05931 470 V----AAFSVPDDGEERLVVVAEVERGADP 495
|
|
| PRK05677 |
PRK05677 |
long-chain-fatty-acid--CoA ligase; Validated |
584-871 |
6.48e-13 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 168170 [Multi-domain] Cd Length: 562 Bit Score: 74.03 E-value: 6.48e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 584 APGGRDAAYMIFTSGTSGQPKGVVVEHASAL-NLSQAlaRTVYANVVGEGLRVTVnAP------FSFdsSIKQILQLLSG 656
Cdd:PRK05677 203 NPQADDVAVLQYTGGTTGVAKGAMLTHRNLVaNMLQC--RALMGSNLNEGCEILI-APlplyhiYAF--TFHCMAMMLIG 277
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 657 HCLVLVPqevrsDPQRMLGFLEERR------------IDVLDCTPSLFRLLLQAGLDdahpalpgRILVGGERFDEAswe 724
Cdd:PRK05677 278 NHNILIS-----NPRDLPAMVKELGkwkfsgfvglntLFVALCNNEAFRKLDFSALK--------LTLSGGMALQLA--- 341
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 725 VAAGWRR---CQVFNLYGPTE----ATVNAslarvAEHARP-TIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVAR 796
Cdd:PRK05677 342 TAERWKEvtgCAICEGYGMTEtspvVSVNP-----SQAIQVgTIGIPVPSTLCKVIDDDGNELPLGEVGELCVKGPQVMK 416
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 15597498 797 GYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAA 871
Cdd:PRK05677 417 GYWQRPEATDEILDSDGW------LKTGDIALIQEDGYMRIVDRKKDMILVSGFNVYPNELEDVLAALPGVLQCA 485
|
|
| FACL_like_5 |
cd05924 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
589-901 |
6.88e-13 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341248 [Multi-domain] Cd Length: 364 Bit Score: 72.41 E-value: 6.88e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHA---SALNLSQALARTVYANVVGEGLRVTVNAPFSF---------DSSIKQILQLLSG 656
Cdd:cd05924 4 DDLYILYTGGTTGMPKGVMWRQEdifRMLMGGADFGTGEFTPSEDAHKAAAAAAGTVMfpapplmhgTGSWTAFGGLLGG 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 657 HCLVLVpqEVRSDPQRMLGFLEERRIDVLDCTPSLF-RLLLQAgLDDAHPA-LPGRILV--GGERFdeaSWEVAAGWRRC 732
Cdd:cd05924 84 QTVVLP--DDRFDPEEVWRTIEKHKVTSMTIVGDAMaRPLIDA-LRDAGPYdLSSLFAIssGGALL---SPEVKQGLLEL 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 733 Q----VFNLYGPTEATVNASlARVAEHARPTIGRALANVDLHVVDGLGRRKTRGASGELWIGGAG-VARGYAGDAGEAAG 807
Cdd:cd05924 158 VpnitLVDAFGSSETGFTGS-GHSAGSGPETGPFTRANPDTVVLDDDGRVVPPGSGGVGWIARRGhIPLGYYGDEAKTAE 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 808 RFVEEGwpgSGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV--LTDEADAAEPGAd 885
Cdd:cd05924 237 TFPEVD---GVRYAVPGDRATVEADGTVTLLGRGSVCINTGGEKVFPEEVEEALKSHPAVYDVLVvgRPDERWGQEVVA- 312
|
330
....*....|....*.
gi 15597498 886 rrIVAFVTAAEETADE 901
Cdd:cd05924 313 --VVQLREGAGVDLEE 326
|
|
| PLN02330 |
PLN02330 |
4-coumarate--CoA ligase-like 1 |
494-897 |
1.21e-12 |
|
4-coumarate--CoA ligase-like 1
Pssm-ID: 215189 [Multi-domain] Cd Length: 546 Bit Score: 73.09 E-value: 1.21e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 494 GVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALADAECAGRAR-----------EA 562
Cdd:PLN02330 76 GLRKGQVVVVVLPNVAEYGIVALGIMAAGGVFSGANPTALESEIKKQAEAAGAKLIVTNDTNYGKVKglglpvivlgeEK 155
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 563 FAGAC---LDLSTLPLAGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVVEHASAL-NLSQALArTVYANVVGEGLRVTVn 638
Cdd:PLN02330 156 IEGAVnwkELLEAADRAGDTSDNEEILQTDLCALPFSSGTTGISKGVMLTHRNLVaNLCSSLF-SVGPEMIGQVVTLGL- 233
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 639 APFSFDSSIKQILQLL---SGHCLV------------LVPQEVRSDP---QRMLGFLEERRIDVLDctpsLFRLLLQAGL 700
Cdd:PLN02330 234 IPFFHIYGITGICCATlrnKGKVVVmsrfelrtflnaLITQEVSFAPivpPIILNLVKNPIVEEFD----LSKLKLQAIM 309
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 701 DDAHPALPGRILVGGERFDEAswevaagwrrcQVFNLYGPTEATvnaslARVAEHARPTIGRALA----------NVDLH 770
Cdd:PLN02330 310 TAAAPLAPELLTAFEAKFPGV-----------QVQEAYGLTEHS-----CITLTHGDPEKGHGIAkknsvgfilpNLEVK 373
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 771 VVD-GLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKING 849
Cdd:PLN02330 374 FIDpDTGRSLPKNTPGELCVRSQCVMQGYYNNKEETDRTIDEDGW------LHTGDIGYIDDDGDIFIVDRIKELIKYKG 447
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|
gi 15597498 850 YRIELGEIRSALLEHPAVGEAAV--LTDEADAAEPGADRRIVAFVTAAEE 897
Cdd:PLN02330 448 FQVAPAELEAILLTHPSVEDAAVvpLPDEEAGEIPAACVVINPKAKESEE 497
|
|
| PRK13390 |
PRK13390 |
acyl-CoA synthetase; Provisional |
458-901 |
1.57e-12 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139538 [Multi-domain] Cd Length: 501 Bit Score: 72.35 E-value: 1.57e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 458 AALQPQAPALLDAHG--SLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAA 535
Cdd:PRK13390 7 AQIAPDRPAVIVAETgeQVSYRQLDDDSAALARVLYDAGLRTGDVVALLSDNSPEALVVLWAALRSGLYITAINHHLTAP 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 536 RVERMREAGGIVFALADAECAGRAREAFAGACLDLS-----------TLPLAGSGMSLP-APGGrdaAYMIFTSGTSGQP 603
Cdd:PRK13390 87 EADYIVGDSGARVLVASAALDGLAAKVGADLPLRLSfggeidgfgsfEAALAGAGPRLTeQPCG---AVMLYSSGTTGFP 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 604 KGVVVEhASALNLSQ------ALARTVY----ANVVGEGLRVTVNAPFSFDSSIKQIlqllsGHCLVLVPqevRSDPQRM 673
Cdd:PRK13390 164 KGIQPD-LPGRDVDApgdpivAIARAFYdiseSDIYYSSAPIYHAAPLRWCSMVHAL-----GGTVVLAK---RFDAQAT 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 674 LGFLEERRIDVLDCTPSLFRLLLQagLDDA--------------HPALPGRILVGGERFDeaswevaagWRRCQVFNLYG 739
Cdd:PRK13390 235 LGHVERYRITVTQMVPTMFVRLLK--LDADvrtrydvsslraviHAAAPCPVDVKHAMID---------WLGPIVYEYYS 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 740 PTEA---TVNASLARVAEHArpTIGRALANvDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAgrfvEEGWPG 816
Cdd:PRK13390 304 STEAhgmTFIDSPDWLAHPG--SVGRSVLG-DLHICDDDGNELPAGRIGTVYFERDRLPFRYLNDPEKTA----AAQHPA 376
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 817 SGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL--TDEADAAEPGADRRIVAFVTA 894
Cdd:PRK13390 377 HPFWTTVGDLGSVDEDGYLYLADRKSFMIISGGVNIYPQETENALTMHPAVHDVAVIgvPDPEMGEQVKAVIQLVEGIRG 456
|
....*..
gi 15597498 895 AEETADE 901
Cdd:PRK13390 457 SDELARE 463
|
|
| caiC |
PRK08008 |
putative crotonobetaine/carnitine-CoA ligase; Validated |
589-896 |
3.99e-12 |
|
putative crotonobetaine/carnitine-CoA ligase; Validated
Pssm-ID: 181195 [Multi-domain] Cd Length: 517 Bit Score: 71.25 E-value: 3.99e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHAsalNLSQALARTVYANVVGEGLR-VTVNAPFSFDSSIKQILQLLS-GHCLVLVpqEV 666
Cdd:PRK08008 174 DTAEILFTSGTTSRPKGVVITHY---NLRFAGYYSAWQCALRDDDVyLTVMPAFHIDCQCTAAMAAFSaGATFVLL--EK 248
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 667 RSdPQRMLGFLEERRIDVLDCTPSLFR-LLLQaglddahPALPGrilvggER----------FDEASWEVAAGWRRCQV- 734
Cdd:PRK08008 249 YS-ARAFWGQVCKYRATITECIPMMIRtLMVQ-------PPSAN------DRqhclrevmfyLNLSDQEKDAFEERFGVr 314
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 735 -FNLYGPTEATVNASLARVAEHAR-PTIGRALANVDLHVVDGLGRRKTRGASGELWIGG-AG--VARGYAGDAGEAAGRF 809
Cdd:PRK08008 315 lLTSYGMTETIVGIIGDRPGDKRRwPSIGRPGFCYEAEIRDDHNRPLPAGEIGEICIKGvPGktIFKEYYLDPKATAKVL 394
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 810 VEEGWpgsgrLYrSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLtdeaDAAEPGADRRIV 889
Cdd:PRK08008 395 EADGW-----LH-TGDTGYVDEEGFFYFVDRRCNMIKRGGENVSCVELENIIATHPKIQDIVVV----GIKDSIRDEAIK 464
|
....*..
gi 15597498 890 AFVTAAE 896
Cdd:PRK08008 465 AFVVLNE 471
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1193-1318 |
7.98e-12 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 71.35 E-value: 7.98e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1193 GELSEQaLRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRRALLAALAAEAAAQTLEAPANATEAALLEIWKSVLKRPA 1272
Cdd:PRK05691 4180 GALLER-IKQRLRAELPDYMVPLHWLWLDRLPLNANGKLDRKALPALDIGQLQSQAYLAPRNELEQTLATIWADVLKVER 4258
|
90 100 110 120
....*....|....*....|....*....|....*....|....*..
gi 15597498 1273 IGVSDNFFQVGGDSIRLIQMQVMAREA-GLAFTLRDVFNHQSIRELA 1318
Cdd:PRK05691 4259 VGVHDNFFELGGHSLLATQIASRVQKAlQRNVPLRAMFECSTVEELA 4305
|
|
| LC_FACS_euk1 |
cd17639 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The ... |
732-892 |
1.48e-11 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The members of this family are eukaryotic fatty acid CoA synthetases (EC 6.2.1.3) that activate fatty acids with chain lengths of 12 to 20 and includes fungal proteins. They act on a wide range of long-chain saturated and unsaturated fatty acids, but the enzymes from different tissues show some variation in specificity. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. In Schizosaccharomyces pombe, lcf1 gene encodes a new fatty acyl-CoA synthetase that preferentially recognizes myristic acid as a substrate.
Pssm-ID: 341294 [Multi-domain] Cd Length: 507 Bit Score: 69.17 E-value: 1.48e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 732 CQVFNLYGPTEATVNASLARVAEHARPTIGRALANVDLHVVD---GLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGR 808
Cdd:cd17639 275 CPVIQGYGLTETCAGGTVQDPGDLETGRVGPPLPCCEIKLVDweeGGYSTDKPPPRGEILIRGPNVFKGYYKNPEKTKEA 354
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 809 FVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKI-NGYRIELGEIRSALLEHPAVGEAAVLtdeADAAEPgadrR 887
Cdd:cd17639 355 FDGDGW------FHTGDIGEFHPDGTLKIIDRKKDLVKLqNGEYIALEKLESIYRSNPLVNNICVY---ADPDKS----Y 421
|
....*
gi 15597498 888 IVAFV 892
Cdd:cd17639 422 PVAIV 426
|
|
| MenH |
COG0596 |
2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase MenH and related esterases, ... |
1873-2111 |
1.57e-11 |
|
2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase MenH and related esterases, alpha/beta hydrolase fold [Coenzyme transport and metabolism, General function prediction only]; 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase MenH and related esterases, alpha/beta hydrolase fold is part of the Pathway/BioSystem: Menaquinone biosynthesis
Pssm-ID: 440361 [Multi-domain] Cd Length: 221 Bit Score: 66.18 E-value: 1.57e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1873 LWLQRSGSAQPRLrlIALPPAGGNAGTFRGWDARLPADVELLAIQYPGRQERQDEPFVTDVEAMLCAIDDALLPLLDRPF 1952
Cdd:COG0596 14 LHYREAGPDGPPV--VLLHGLPGSSYEWRPLIPALAAGYRVIAPDLRGHGRSDKPAGGYTLDDLADDLAALLDALGLERV 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1953 ALIGASLGGMLAYELAARleslHGLRARQLFVISsrapgpdleyprfhamgdaELLRTLREYDVLPlevlddpelrEISL 2032
Cdd:COG0596 92 VLVGHSMGGMVALELAAR----HPERVAGLVLVD-------------------EVLAALAEPLRRP----------GLAP 138
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 2033 ATLRADSRLAADYRYRPR-EPLAIPITAILGEQDPGVSRVAIDGWRRHASRYELETLAG-GHGLVVTAAEEVCAILRQRL 2110
Cdd:COG0596 139 EALAALLRALARTDLRERlARITVPTLVIWGEKDPIVPPALARRLAELLPNAELVVLPGaGHFPPLEQPEAFAAALRDFL 218
|
.
gi 15597498 2111 A 2111
Cdd:COG0596 219 A 219
|
|
| PRK07798 |
PRK07798 |
acyl-CoA synthetase; Validated |
454-872 |
2.67e-11 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236100 [Multi-domain] Cd Length: 533 Bit Score: 68.76 E-value: 2.67e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 454 FDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMtGRNR-EAIVALLGVMRAAAVYTPVN--- 529
Cdd:PRK07798 9 FEAVADAVPDRVALVCGDRRLTYAELEERANRLAHYLIAQGLGPGDHVGIY-ARNRiEYVEAMLGAFKARAVPVNVNyry 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 530 --------------------PEFpAARVERMR-EAGGI--VFALADaecaGRAREAFAGAcLDLSTLPLAGSGMSLPAPG 586
Cdd:PRK07798 88 vedelryllddsdavalvyeREF-APRVAEVLpRLPKLrtLVVVED----GSGNDLLPGA-VDYEDALAAGSPERDFGER 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 587 GRDAAYMIFTSGTSGQPKGVVVEH---------------ASALNLSQALARTVYAnvvGEGLRVTVNAPFSFDSSIKQIL 651
Cdd:PRK07798 162 SPDDLYLLYTGGTTGMPKGVMWRQedifrvllggrdfatGEPIEDEEELAKRAAA---GPGMRRFPAPPLMHGAGQWAAF 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 652 Q-LLSGHCLVLVPqEVRSDPQRMLGFLEERRIDVLDCTPSLF-RLLLQAgLDDAHPA-LPGRILV--GGERFdeaSWEVA 726
Cdd:PRK07798 239 AaLFSGQTVVLLP-DVRFDADEVWRTIEREKVNVITIVGDAMaRPLLDA-LEARGPYdLSSLFAIasGGALF---SPSVK 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 727 AGWRR----CQVFNLYGPTEATVNASlARVAEHARPTIG-RALANVDLHVVDGLGRRKTRGASGELWIGGAG-VARGYAG 800
Cdd:PRK07798 314 EALLEllpnVVLTDSIGSSETGFGGS-GTVAKGAVHTGGpRFTIGPRTVVLDEDGNPVEPGSGEIGWIARRGhIPLGYYK 392
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 15597498 801 DAGEAAGRFVEEGwpgsGRLYR-SGDLVRWRADGCLEFLGRiDEQVkIN--GYRIELGEIRSALLEHPAVGEAAV 872
Cdd:PRK07798 393 DPEKTAETFPTID----GVRYAiPGDRARVEADGTITLLGR-GSVC-INtgGEKVFPEEVEEALKAHPDVADALV 461
|
|
| PRK08276 |
PRK08276 |
long-chain-fatty-acid--CoA ligase; Validated |
473-872 |
2.76e-11 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236215 [Multi-domain] Cd Length: 502 Bit Score: 68.39 E-value: 2.76e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 473 SLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERM-REAGGIVFaLA 551
Cdd:PRK08276 11 VVTYGELEARSNRLAHGLRALGLREGDVVAILLENNPEFFEVYWAARRSGLYYTPINWHLTAAEIAYIvDDSGAKVL-IV 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 552 DAECAGRAREAFAGACLDLSTLPLAGSG----MSLPAPGGRDAAY----------MIFTSGTSGQPKGVVVE------HA 611
Cdd:PRK08276 90 SAALADTAAELAAELPAGVPLLLVVAGPvpgfRSYEEALAAQPDTpiadetagadMLYSSGTTGRPKGIKRPlpgldpDE 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 612 SALNLSQALARTVYAnvvGEGLRVTVNAPF------SFDSSIKQIlqllsGHCLVLVPqevRSDPQRMLGFLEERRIDVL 685
Cdd:PRK08276 170 APGMMLALLGFGMYG---GPDSVYLSPAPLyhtaplRFGMSALAL-----GGTVVVME---KFDAEEALALIERYRVTHS 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 686 DCTPSLFRLLLqaglddahpALPGRILvggERFDEASWEVAA---------------GWRRCQVFNLYGPTEA---TVnA 747
Cdd:PRK08276 239 QLVPTMFVRML---------KLPEEVR---ARYDVSSLRVAIhaaapcpvevkramiDWWGPIIHEYYASSEGggvTV-I 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 748 SLARVAEHaRPTIGRALANVdLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLV 827
Cdd:PRK08276 306 TSEDWLAH-PGSVGKAVLGE-VRILDEDGNELPPGEIGTVYFEMDGYPFEYHNDPEKTAAARNPHGW------VTVGDVG 377
|
410 420 430 440
....*....|....*....|....*....|....*....|....*
gi 15597498 828 RWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV 872
Cdd:PRK08276 378 YLDEDGYLYLTDRKSDMIISGGVNIYPQEIENLLVTHPKVADVAV 422
|
|
| PRK13295 |
PRK13295 |
cyclohexanecarboxylate-CoA ligase; Reviewed |
454-872 |
2.76e-11 |
|
cyclohexanecarboxylate-CoA ligase; Reviewed
Pssm-ID: 171961 [Multi-domain] Cd Length: 547 Bit Score: 68.54 E-value: 2.76e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 454 FDLRAALQPQAPALLDA---HGS---LDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTP 527
Cdd:PRK13295 30 LDACVASCPDKTAVTAVrlgTGAprrFTYRELAALVDRVAVGLARLGVGRGDVVSCQLPNWWEFTVLYLACSRIGAVLNP 109
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 528 VNPEFpaarveRMREAGgivFALADAEC--------------AGRARE-----------AFAGACLDLS----------- 571
Cdd:PRK13295 110 LMPIF------RERELS---FMLKHAESkvlvvpktfrgfdhAAMARRlrpelpalrhvVVVGGDGADSfeallitpawe 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 572 TLPLAGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVveHAsalnlsqalARTVYANVV--------GEGLRVTVNAPFSF 643
Cdd:PRK13295 181 QEPDAPAILARLRPGPDDVTQLIYTSGTTGEPKGVM--HT---------ANTLMANIVpyaerlglGADDVILMASPMAH 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 644 DSS--IKQILQLLSGHCLVLvpQEVRsDPQRMLGFLEERRID-VLDCTPSLFRLLlQAGLDDAHPALPGRI-LVGGERFD 719
Cdd:PRK13295 250 QTGfmYGLMMPVMLGATAVL--QDIW-DPARAAELIRTEGVTfTMASTPFLTDLT-RAVKESGRPVSSLRTfLCAGAPIP 325
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 720 EASWEVAAGWRRCQVFNLYGPTE--ATVNASLARVAEHARPTIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARG 797
Cdd:PRK13295 326 GALVERARAALGAKIVSAWGMTEngAVTLTKLDDPDERASTTDGCPLPGVEVRVVDADGAPLPAGQIGRLQVRGCSNFGG 405
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 798 YAG-------DAgeaagrfveEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEA 870
Cdd:PRK13295 406 YLKrpqlngtDA---------DGW------FDTGDLARIDADGYIRISGRSKDVIIRGGENIPVVEIEALLYRHPAIAQV 470
|
..
gi 15597498 871 AV 872
Cdd:PRK13295 471 AI 472
|
|
| PRK06087 |
PRK06087 |
medium-chain fatty-acid--CoA ligase; |
457-906 |
3.92e-11 |
|
medium-chain fatty-acid--CoA ligase;
Pssm-ID: 180393 [Multi-domain] Cd Length: 547 Bit Score: 68.24 E-value: 3.92e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 457 RAALQPQAPALLDAHG-SLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAA 535
Cdd:PRK06087 32 TARAMPDKIAVVDNHGaSYTYSALDHAASRLANWLLAKGIEPGDRVAFQLPGWCEFTIIYLACLKVGAVSVPLLPSWREA 111
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 536 R-VERMREAGGIVF--------------ALADAE-------CAGRAREAFAGACLDLSTLPLAGSGMSLPAP-GGRDAAY 592
Cdd:PRK06087 112 ElVWVLNKCQAKMFfaptlfkqtrpvdlILPLQNqlpqlqqIVGVDKLAPATSSLSLSQIIADYEPLTTAITtHGDELAA 191
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 593 MIFTSGTSGQPKGVVVEHASALNLSQALARtvyanvvgeGLRVTVNAPFSFDSSIKQ--------ILQLLSGHCLVLvpq 664
Cdd:PRK06087 192 VLFTSGTEGLPKGVMLTHNNILASERAYCA---------RLNLTWQDVFMMPAPLGHatgflhgvTAPFLIGARSVL--- 259
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 665 EVRSDPQRMLGFLEERRID-VLDCTPSLFRLLLQagLDDAHPALPGR--ILVGG----ERFDEASWEvaAGWRRCQVfnl 737
Cdd:PRK06087 260 LDIFTPDACLALLEQQRCTcMLGATPFIYDLLNL--LEKQPADLSALrfFLCGGttipKKVARECQQ--RGIKLLSV--- 332
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 738 YGPTEATVNA--SLARVAEHARPTIGRALANVDLHVVDGlgRRKT--RGASGELWIGGAGVARGYAGDAGEAAGRFVEEG 813
Cdd:PRK06087 333 YGSTESSPHAvvNLDDPLSRFMHTDGYAAAGVEIKVVDE--ARKTlpPGCEGEEASRGPNVFMGYLDEPELTARALDEEG 410
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 814 WPGSgrlyrsGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLtdeadaAEPGaDR---RIVA 890
Cdd:PRK06087 411 WYYS------GDLCRMDEAGYIKITGRKKDIIVRGGENISSREVEDILLQHPKIHDACVV------AMPD-ERlgeRSCA 477
|
490
....*....|....*.
gi 15597498 891 FVTAAEETADESWLEV 906
Cdd:PRK06087 478 YVVLKAPHHSLTLEEV 493
|
|
| PRK12492 |
PRK12492 |
long-chain-fatty-acid--CoA ligase; Provisional |
576-873 |
4.07e-11 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 171539 [Multi-domain] Cd Length: 562 Bit Score: 67.92 E-value: 4.07e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 576 AGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVVEHASAL-NLSQALA-----RTVYANVVGEGLRVTVnAP------FSF 643
Cdd:PRK12492 195 RGLSLKPVPVGLDDIAVLQYTGGTTGLAKGAMLTHGNLVaNMLQVRAclsqlGPDGQPLMKEGQEVMI-APlplyhiYAF 273
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 644 DSSIkqILQLLSGHCLVLVpqevrSDPQRMLGFLEER---RIDVLDCTPSLFRLLLQ----AGLDDAHPALPGRilvGGE 716
Cdd:PRK12492 274 TANC--MCMMVSGNHNVLI-----TNPRDIPGFIKELgkwRFSALLGLNTLFVALMDhpgfKDLDFSALKLTNS---GGT 343
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 717 RFDEASWEVAAGWRRCQVFNLYGPTEATVNASLARVAEHAR-PTIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVA 795
Cdd:PRK12492 344 ALVKATAERWEQLTGCTIVEGYGLTETSPVASTNPYGELARlGTVGIPVPGTALKVIDDDGNELPLGERGELCIKGPQVM 423
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 15597498 796 RGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:PRK12492 424 KGYWQQPEATAEALDAEGW------FKTGDIAVIDPDGFVRIVDRKKDLIIVSGFNVYPNEIEDVVMAHPKVANCAAI 495
|
|
| entE |
PRK10946 |
(2,3-dihydroxybenzoyl)adenylate synthase; |
461-871 |
4.65e-11 |
|
(2,3-dihydroxybenzoyl)adenylate synthase;
Pssm-ID: 236803 [Multi-domain] Cd Length: 536 Bit Score: 67.71 E-value: 4.65e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 461 QPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVytPVNPEFPAARVERM 540
Cdd:PRK10946 36 ASDAIAVICGERQFSYRELNQASDNLACSLRRQGIKPGDTALVQLGNVAEFYITFFALLKLGVA--PVNALFSHQRSELN 113
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 541 REAGGIVFAL--ADAECAGRAREAFA------------------GACLDLSTLPLAGSGMSLPAPGGRD-AAYMIFTSGT 599
Cdd:PRK10946 114 AYASQIEPALliADRQHALFSDDDFLntlvaehsslrvvlllndDGEHSLDDAINHPAEDFTATPSPADeVAFFQLSGGS 193
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 600 SGQPKGVVVEH--------ASAlNLSQALARTVYANvvgeGLRVTVNAPFSfdsSIKQILQLLSGHCLVLVPqevrsDPQ 671
Cdd:PRK10946 194 TGTPKLIPRTHndyyysvrRSV-EICGFTPQTRYLC----ALPAAHNYPMS---SPGALGVFLAGGTVVLAP-----DPS 260
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 672 RMLGF--LEERRIDVLDCTPSLFRLLLQAGLDDAHPALPGR---ILVGGERFDEAsweVAagwRR------CQVFNLYGP 740
Cdd:PRK10946 261 ATLCFplIEKHQVNVTALVPPAVSLWLQAIAEGGSRAQLASlklLQVGGARLSET---LA---RRipaelgCQLQQVFGM 334
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 741 TEATVNAS-LARVAEHARPTIGRALANVD-LHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgsg 818
Cdd:PRK10946 335 AEGLVNYTrLDDSDERIFTTQGRPMSPDDeVWVADADGNPLPQGEVGRLMTRGPYTFRGYYKSPQHNASAFDANGF---- 410
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|...
gi 15597498 819 rlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAA 871
Cdd:PRK10946 411 --YCSGDLVSIDPDGYITVVGREKDQINRGGEKIAAEEIENLLLRHPAVIHAA 461
|
|
| PRK05857 |
PRK05857 |
fatty acid--CoA ligase; |
457-902 |
7.11e-11 |
|
fatty acid--CoA ligase;
Pssm-ID: 180293 [Multi-domain] Cd Length: 540 Bit Score: 67.34 E-value: 7.11e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 457 RAALQPQAPAL--LDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPA 534
Cdd:PRK05857 23 QARQQPEAIALrrCDGTSALRYRELVAEVGGLAADLRAQSVSRGSRVLVISDNGPETYLSVLACAKLGAIAVMADGNLPI 102
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 535 ARVERMREAGGIVFALADAECAGRAREAFAGACLDLSTLPLAGSGMSL-------------PAPGGRDAAYMIFTSGTSG 601
Cdd:PRK05857 103 AAIERFCQITDPAAALVAPGSKMASSAVPEALHSIPVIAVDIAAVTREsehsldaaslagnADQGSEDPLAMIFTSGTTG 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 602 QPKGVVVEHASALNLSQALARTVYA---NVVGEglrvTVNAPFSFD--SSIKQILQLL--SGHCL-----------VLVP 663
Cdd:PRK05857 183 EPKAVLLANRTFFAVPDILQKEGLNwvtWVVGE----TTYSPLPAThiGGLWWILTCLmhGGLCVtggenttslleILTT 258
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 664 QEVRSD---PQRMLGFLEERRIDVLDcTPSLfRLLLQAGlddahpalpGRILVGGERFDEaswevAAGWRRCQVfnlYGP 740
Cdd:PRK05857 259 NAVATTclvPTLLSKLVSELKSANAT-VPSL-RLVGYGG---------SRAIAADVRFIE-----ATGVRTAQV---YGL 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 741 TEA--------TVNASLARVAEHArptIGRALANVDLHVV--DGLGRRKTRGAS----GELWIGGAGVARGYAGDAgEAA 806
Cdd:PRK05857 320 SETgctalclpTDDGSIVKIEAGA---VGRPYPGVDVYLAatDGIGPTAPGAGPsasfGTLWIKSPANMLGYWNNP-ERT 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 807 GRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLtdEADAAEPGAdr 886
Cdd:PRK05857 396 AEVLIDGW------VNTGDLLERREDGFFYIKGRSSEMIICGGVNIAPDEVDRIAEGVSGVREAACY--EIPDEEFGA-- 465
|
490
....*....|....*.
gi 15597498 887 rIVAFVTAAEETADES 902
Cdd:PRK05857 466 -LVGLAVVASAELDES 480
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
1793-1971 |
1.37e-10 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 66.99 E-value: 1.37e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1793 RVLKVLSRVLGR-PLAADQGFASAGGHSLLGVQAIAELRRLTGRQLSLGLLQGDPDAREVVRRCHAADAPPLPPATERAR 1871
Cdd:PRK10252 982 IIAAAFSSLLGCdVVDADADFFALGGHSLLAMKLAAQLSRQFARQVTPGQVMVASTVAKLATLLDAEEDESRRLGFGTIL 1061
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1872 ALwlqRSGSAQPrlrLIALPPAGGNAGTFRGWDARLPADVELLAIQYPGRQERQDEPfvTDVEAMlcaIDDALLPLLDR- 1950
Cdd:PRK10252 1062 PL---REGDGPT---LFCFHPASGFAWQFSVLSRYLDPQWSIYGIQSPRPDGPMQTA--TSLDEV---CEAHLATLLEQq 1130
|
170 180
....*....|....*....|....
gi 15597498 1951 ---PFALIGASLGGMLAYELAARL 1971
Cdd:PRK10252 1131 phgPYHLLGYSLGGTLAQGIAARL 1154
|
|
| PRK07786 |
PRK07786 |
long-chain-fatty-acid--CoA ligase; Validated |
458-873 |
1.44e-10 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 169098 [Multi-domain] Cd Length: 542 Bit Score: 66.34 E-value: 1.44e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 458 AALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARV 537
Cdd:PRK07786 27 ALMQPDAPALRFLGNTTTWRELDDRVAALAGALSRRGVGFGDRVLILMLNRTEFVESVLAANMLGAIAVPVNFRLTPPEI 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 538 E---RMREAGGIVFALADAECAGRARE-------------AFAGACLDLSTLPLAGSGMSLPAPGGRDAAYMI-FTSGTS 600
Cdd:PRK07786 107 AflvSDCGAHVVVTEAALAPVATAVRDivpllstvvvaggSSDDSVLGYEDLLAEAGPAHAPVDIPNDSPALImYTSGTT 186
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 601 GQPKGVVVEHAsalNLSQALARTVYANVVGEGLRVT-VNAPFSFDSSIKQILQ-LLSGHCLVLVPQEVrSDPQRMLGFLE 678
Cdd:PRK07786 187 GRPKGAVLTHA---NLTGQAMTCLRTNGADINSDVGfVGVPLFHIAGIGSMLPgLLLGAPTVIYPLGA-FDPGQLLDVLE 262
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 679 ERRIDVLDCTPSLFrlllQAGLDDAHP---ALPGRILVGGE--RFDEASWEVAAGWRRCQVFNLYGPTEAT-VNASL-AR 751
Cdd:PRK07786 263 AEKVTGIFLVPAQW----QAVCAEQQArprDLALRVLSWGAapASDTLLRQMAATFPEAQILAAFGQTEMSpVTCMLlGE 338
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 752 VAEHARPTIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFvEEGWpgsgrlYRSGDLVRWRA 831
Cdd:PRK07786 339 DAIRKLGSVGKVIPTVAARVVDENMNDVPVGEVGEIVYRAPTLMSGYWNNPEATAEAF-AGGW------FHSGDLVRQDE 411
|
410 420 430 440
....*....|....*....|....*....|....*....|..
gi 15597498 832 DGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:PRK07786 412 EGYVWVVDRKKDMIISGGENIYCAEVENVLASHPDIVEVAVI 453
|
|
| FACL_like_4 |
cd05944 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
586-873 |
2.04e-10 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341266 [Multi-domain] Cd Length: 359 Bit Score: 64.81 E-value: 2.04e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 586 GGRDAAYMiFTSGTSGQPKGVVVEHASALNLSQALARTVyanVVGEGLRVTVNAP-FSFDSSIKQILQLLS--GHCLVLV 662
Cdd:cd05944 1 SDDVAAYF-HTGGTTGTPKLAQHTHSNEVYNAWMLALNS---LFDPDDVLLCGLPlFHVNGSVVTLLTPLAsgAHVVLAG 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 663 PQEVRsDP---QRMLGFLEERRIDVLDCTPSLFRLLLQ----AGLDDAHPALPGRILVGGERFdeASWEVAAGWRRCQVf 735
Cdd:cd05944 77 PAGYR-NPglfDNFWKLVERYRITSLSTVPTVYAALLQvpvnADISSLRFAMSGAAPLPVELR--ARFEDATGLPVVEG- 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 736 nlYGPTEATVNASLARVAEHARP-TIGRAL--ANVDLHVVDGLGRRKTRGAS---GELWIGGAGVARGYAGDAGeAAGRF 809
Cdd:cd05944 153 --YGLTEATCLVAVNPPDGPKRPgSVGLRLpyARVRIKVLDGVGRLLRDCAPdevGEICVAGPGVFGGYLYTEG-NKNAF 229
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 15597498 810 VEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:cd05944 230 VADGW------LNTGDLGRLDADGYLFITGRAKDLIIRGGHNIDPALIEEALLRHPAVAFAGAV 287
|
|
| C_NRPS-like |
cd19537 |
Condensation family domain with an atypical active site motif; Condensation (C) domains of ... |
1385-1678 |
2.19e-10 |
|
Condensation family domain with an atypical active site motif; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily typically have a non-canonical conserved SHXXXDX(14)Y motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380460 [Multi-domain] Cd Length: 395 Bit Score: 64.90 E-value: 2.19e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1385 NV-VLHEVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQvplqwvhPATAVAAEVP-VHDLCGLDgetrrlrlrawIE 1462
Cdd:cd19537 25 NVsFACRLSGDVDRDRLASAWNTVLARHRILRSRYVPRDGG-------LRRSYSSSPPrVQRVDTLD-----------VW 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1463 EEQATPFDWSRPPLVRlaalALDERRFALGVAeHHSVLDGWSLQSLVDELLAVYA-DLLAGVVAREAEAPavgfrdyvAL 1541
Cdd:cd19537 87 KEINRPFDLEREDPIR----VFISPDTLLVVM-SHIICDLTTLQLLLREVSAAYNgKLLPPVRREYLDST--------AW 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1542 EREAEANAASalFWLDYLAGARYRPLPGLAEEGPRRMAAVRVDVPADSLSRLRALAERSGLPLRSLLLAAHGRALCRFSD 1621
Cdd:cd19537 154 SRPASPEDLD--FWSEYLSGLPLLNLPRRTSSKSYRGTSRVFQLPGSLYRSLLQFSTSSGITLHQLALAAVALALQDLSD 231
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 15597498 1622 ADEVVTGFVSHGRPEEpGADRLLGLFLNTLPCRL-------SASVDLLDSARRAFdyeRASLEH 1678
Cdd:cd19537 232 RTDIVLGAPYLNRTSE-EDMETVGLFLEPLPIRIrfpsssdASAADFLRAVRRSS---QAALAH 291
|
|
| PRK08751 |
PRK08751 |
long-chain fatty acid--CoA ligase; |
589-871 |
3.14e-10 |
|
long-chain fatty acid--CoA ligase;
Pssm-ID: 181546 [Multi-domain] Cd Length: 560 Bit Score: 65.28 E-value: 3.14e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHASAL-NLSQALARTVYANVVGEGLRVTVNA-PFS--FDSSIKQILQLLSGHCLVLVpq 664
Cdd:PRK08751 209 DIAFLQYTGGTTGVAKGAMLTHRNLVaNMQQAHQWLAGTGKLEEGCEVVITAlPLYhiFALTANGLVFMKIGGCNHLI-- 286
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 665 evrSDPQRMLGFLEE---RRIDVLDCTPSLFRLLLQA-GLDDAHPALPGRILVGGERFDEAsweVAAGWRRCQVFNL--- 737
Cdd:PRK08751 287 ---SNPRDMPGFVKElkkTRFTAFTGVNTLFNGLLNTpGFDQIDFSSLKMTLGGGMAVQRS---VAERWKQVTGLTLvea 360
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 738 YGPTEATVNASL--ARVAEHaRPTIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWP 815
Cdd:PRK08751 361 YGLTETSPAACInpLTLKEY-NGSIGLPIPSTDACIKDDAGTVLAIGEIGELCIKGPQVMKGYWKRPEETAKVMDADGWL 439
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*.
gi 15597498 816 GSgrlyrsGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAA 871
Cdd:PRK08751 440 HT------GDIARMDEQGFVYIVDRKKDMILVSGFNVYPNEIEDVIAMMPGVLEVA 489
|
|
| A_NRPS |
cd05930 |
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain ... |
1192-1234 |
3.76e-10 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341253 [Multi-domain] Cd Length: 444 Bit Score: 64.47 E-value: 3.76e-10
10 20 30 40
....*....|....*....|....*....|....*....|...
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd05930 400 GGELDEEELRAHLAERLPDYMVPSAFVVLDALPLTPNGKVDRK 442
|
|
| PRK08974 |
PRK08974 |
long-chain-fatty-acid--CoA ligase FadD; |
587-873 |
1.05e-09 |
|
long-chain-fatty-acid--CoA ligase FadD;
Pssm-ID: 236359 [Multi-domain] Cd Length: 560 Bit Score: 63.53 E-value: 1.05e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 587 GRDAAYMIFTSGTSGQPKGVVVEHASAL-NLSQALArtVYANVVGEGLRVTVNApfsfdssikqiLQL-----LSGHCLV 660
Cdd:PRK08974 205 PEDLAFLQYTGGTTGVAKGAMLTHRNMLaNLEQAKA--AYGPLLHPGKELVVTA-----------LPLyhifaLTVNCLL 271
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 661 LVPQEVRS----DPQRMLGFLEE---RRIDVLDCTPSLFRLLLQ----AGLDDAHPalpgRILVGG----ERFDEASWEV 725
Cdd:PRK08974 272 FIELGGQNllitNPRDIPGFVKElkkYPFTAITGVNTLFNALLNneefQELDFSSL----KLSVGGgmavQQAVAERWVK 347
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 726 AAGwrrCQVFNLYGPTEAT--VNASLARVAEHArPTIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAg 803
Cdd:PRK08974 348 LTG---QYLLEGYGLTECSplVSVNPYDLDYYS-GSIGLPVPSTEIKLVDDDGNEVPPGEPGELWVKGPQVMLGYWQRP- 422
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 804 EAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:PRK08974 423 EATDEVIKDGW------LATGDIAVMDEEGFLRIVDRKKDMILVSGFNVYPNEIEDVVMLHPKVLEVAAV 486
|
|
| ttLC_FACS_AEE21_like |
cd12118 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This ... |
458-872 |
1.06e-09 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This family includes fatty acyl-CoA synthetases that can activate medium to long-chain fatty acids. These enzymes catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family has been shown to catalyze the long-chain fatty acid, myristoyl acid. Also included in this family are acyl activating enzymes from Arabidopsis, which contains a large number of proteins from this family with up to 63 different genes, many of which are uncharacterized.
Pssm-ID: 341283 [Multi-domain] Cd Length: 486 Bit Score: 63.47 E-value: 1.06e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 458 AALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMtGRNREAIVAL-LGVMRAAAVYTPVNPEFPAAR 536
Cdd:cd12118 14 AAVYPDRTSIVYGDRRYTWRQTYDRCRRLASALAALGISRGDTVAVL-APNTPAMYELhFGVPMAGAVLNALNTRLDAEE 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 537 VERMREAGGIVFALADAEcagrareaFAGACLDLSTLPLAGSgmsLPAPGGRDAAYMIFTSGTSGQPKGVVVEHASA-LN 615
Cdd:cd12118 93 IAFILRHSEAKVLFVDRE--------FEYEDLLAEGDPDFEW---IPPADEWDPIALNYTSGTTGRPKGVVYHHRGAyLN 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 616 -LSQALA-----RTVY--------AN-------VVGEG-----LRvTVNAPfsfdssikQILQLLSGHclvlvpqevrsd 669
Cdd:cd12118 162 aLANILEwemkqHPVYlwtlpmfhCNgwcfpwtVAAVGgtnvcLR-KVDAK--------AIYDLIEKH------------ 220
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 670 pqrmlgfleerRIDVLDCTPSLFRLLLQAGLDDAHPaLPGRI--LVGGERFDEASWEVAA--GWRRCQVFNL---YGPte 742
Cdd:cd12118 221 -----------KVTHFCGAPTVLNMLANAPPSDARP-LPHRVhvMTAGAPPPAAVLAKMEelGFDVTHVYGLtetYGP-- 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 743 ATVNASLArvAEHARPTIGRALAN----VDLHVVDGLGRRKTRGAS---------GELWIGGAGVARGYAGDAgEAAGRF 809
Cdd:cd12118 287 ATVCAWKP--EWDELPTEERARLKarqgVRYVGLEEVDVLDPETMKpvprdgktiGEIVFRGNIVMKGYLKNP-EATAEA 363
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 15597498 810 VEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV 872
Cdd:cd12118 364 FRGGW------FHSGDLAVIHPDGYIEIKDRSKDIIISGGENISSVEVEGVLYKHPAVLEAAV 420
|
|
| AFD_YhfT-like |
cd17633 |
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, ... |
592-873 |
1.22e-09 |
|
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, as well as long-chain fatty acid-CoA ligase VraA, all of which are as yet to be characterized. These proteins belong to the adenylate-forming enzymes which catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain
Pssm-ID: 341288 [Multi-domain] Cd Length: 320 Bit Score: 62.04 E-value: 1.22e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 592 YMIFTSGTSGQPKGVVVEHASALNlSQALARTVYaNVVGEGlRVTVNAPFSFDSSIKQILQLL-SGHCLVLVPQevrSDP 670
Cdd:cd17633 4 YIGFTSGTTGLPKAYYRSERSWIE-SFVCNEDLF-NISGED-AILAPGPLSHSLFLYGAISALyLGGTFIGQRK---FNP 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 671 QRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPALpgrILVGGERFDEASWE-VAAGWRRCQVFNLYGPTEATVNASL 749
Cdd:cd17633 78 KSWIRKINQYNATVIYLVPTMLQALARTLEPESKIKS---IFSSGQKLFESTKKkLKNIFPKANLIEFYGTSELSFITYN 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 750 ARVAEHARPTIGRALANVDLHVVDGLGrrktrGASGELWIGGAGVARGYAgdageAAGRFVEEGWpgsgrlYRSGDLVRW 829
Cdd:cd17633 155 FNQESRPPNSVGRPFPNVEIEIRNADG-----GEIGKIFVKSEMVFSGYV-----RGGFSNPDGW------MSVGDIGYV 218
|
250 260 270 280
....*....|....*....|....*....|....*....|....
gi 15597498 830 RADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:cd17633 219 DEEGYLYLVGRESDMIIIGGINIFPTEIESVLKAIPGIEEAIVV 262
|
|
| EntF2 |
COG3319 |
Thioesterase domain of type I polyketide synthase or non-ribosomal peptide synthetase ... |
1288-2002 |
1.43e-09 |
|
Thioesterase domain of type I polyketide synthase or non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442548 [Multi-domain] Cd Length: 855 Bit Score: 63.57 E-value: 1.43e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1288 RLIQMQVMAREAGLAFTLRDVFNHQSIRELARLLAAPASPADALGTSAPQSLEPFALLSAAERKRLPEGLDDAYPMTSLQ 1367
Cdd:COG3319 12 AAAAAAAAAAAAAAALAAAAAAAAAAALLLLAAALLVALAALALAALALAALLAVALLAAALALAALAALAALALALAAA 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1368 QGMLLQSEASGDPRLLHNVVLHEVHGRLDGELLARAWAILIGRHAILRTGFDLHGGQVPLQWVHPATAVAAEVPVHDLCG 1447
Cdd:COG3319 92 AAALLLAALALLLALLAALALALLALLLAALLLALAALAAAAAAAALAAAAAAAAALAAAAGLGGGGGGAGVLVLVLAAL 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1448 LDGETRRLRLRAWIEEEQATPFDWSRPPLVRLAALALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLLAGVVARE 1527
Cdd:COG3319 172 LALLLAALLALALALAALLLLALAAALALALLLLLALLLLLLLLLALLLLLLLALLAAAALLALLLALLLLLLAALLLLL 251
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1528 AEAPAVGFRDYVALEREAEANAASALFWLDYLAGARYRPLPGLAEEGPRRMAAVRVDVPADSLSRLRALAERSGLPLRSL 1607
Cdd:COG3319 252 ALALLLLLALLLLLGLLALLLALLLLLALLLLAAAAALAAGGTATTAAVTTTAAAAAPGVAGALGPIGGGPGLLVLLVLL 331
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1608 LLAAHGRALCRFSDADEVVTGFVSHGRPEEPGADRLLGLFLNTLPCRLSASVDLLDSARRAFDYERASLEHRRHPLAAIR 1687
Cdd:COG3319 332 VLLLPLLLGVGGGGGGGGGGGGAGGLAGRGLRAAAALRDPAGAGARGRLRRGGDRGRRLGGGLLLGLGRLRLQRLRRGLR 411
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1688 RRNRELRLDSLFNFVDFHQDDAAPAGVRHGGILDQVVVDVDVPLAVDFEVAGERLEVGFQYAAGRFPAERAEALAGAYRE 1767
Cdd:COG3319 412 EELEEAEAALAEAAAVAAAVAAAAAAAAAAAALAAAVVAAAALAAAALLLLLLLLLLPPPLPPALLLLLLLLLLLLLAAL 491
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1768 ALLALLGDPVQPPAAAQAEDSVELRRVLKVLSRVLGRPLAADQGFASAGGHSLLGVQAIAELRRLTGRQLSLGLLQGDPD 1847
Cdd:COG3319 492 LLAAAAPAAAAAAAAAPAPAAALELALALLLLLLLGLGLVGDDDDFFGGGGGSLLALLLLLLLLALLLRLLLLLALLLAP 571
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1848 AREVVRRchaaDAPPLPPATERARALWLQRSGSAQPrlrLIALPPAGGNAGTFRGWDARLPADVELLAIQYPGRQERQDE 1927
Cdd:COG3319 572 TLAALAA----ALAAAAAAAALSPLVPLRAGGSGPP---LFCVHPAGGNVLCYRPLARALGPDRPVYGLQAPGLDGGEPP 644
|
650 660 670 680 690 700 710
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 15597498 1928 PfvTDVEAMLCAIDDALLPLL-DRPFALIGASLGGMLAYELAARLESLhGLRARQLFVISSRAPGPDLEYPRFHAM 2002
Cdd:COG3319 645 P--ASVEEMAARYVEAIRAVQpEGPYHLLGWSFGGLVAYEMARQLEAQ-GEEVALLVLLDSYAPGALARLDEAELL 717
|
|
| PRK00174 |
PRK00174 |
acetyl-CoA synthetase; Provisional |
761-901 |
1.59e-09 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 234677 [Multi-domain] Cd Length: 637 Bit Score: 63.24 E-value: 1.59e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 761 GRALANVDLHVVDGLGRRKTRGASGEL-----WiggAGVARGYAGDAGeaagRFVEEGWPGSGRLYRSGDLVRWRADGCL 835
Cdd:PRK00174 427 TRPLPGIQPAVVDEEGNPLEGGEGGNLvikdpW---PGMMRTIYGDHE----RFVKTYFSTFKGMYFTGDGARRDEDGYY 499
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 15597498 836 EFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV------LTDEAdaaepgadrrIVAFVT--AAEETADE 901
Cdd:PRK00174 500 WITGRVDDVLNVSGHRLGTAEIESALVAHPKVAEAAVvgrpddIKGQG----------IYAFVTlkGGEEPSDE 563
|
|
| alpha_am_amid |
TIGR03443 |
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ... |
1200-1362 |
1.67e-09 |
|
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.
Pssm-ID: 274582 [Multi-domain] Cd Length: 1389 Bit Score: 63.55 E-value: 1.67e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1200 LRGFLEARLPAYMLPSRIARVERLPLTAEGKLDR-------RALLAALAAEAAAQTLEAPANATEAALLEIWKSVL-KRP 1271
Cdd:TIGR03443 786 IREYLKKKLPSYAIPTVIVPLKKLPLNPNGKVDKpalpfpdTAQLAAVAKNRSASAADEEFTETEREIRDLWLELLpNRP 865
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1272 A-IGVSDNFFQVGGDSIRLIQMqvmareaglAFTLRD----------VFNHQSIRELAR---LLAAPASPADALGTSAPQ 1337
Cdd:TIGR03443 866 AtISPDDSFFDLGGHSILATRM---------IFELRKklnvelplglIFKSPTIKGFAKevdRLKKGEELADEGDSEIEE 936
|
170 180
....*....|....*....|....*
gi 15597498 1338 SLEPFALLSAAERKRLPEGLDDAYP 1362
Cdd:TIGR03443 937 EETVLELDYAKDAKTLVDSLPKSYP 961
|
|
| PRK13391 |
PRK13391 |
acyl-CoA synthetase; Provisional |
455-892 |
2.00e-09 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 184022 [Multi-domain] Cd Length: 511 Bit Score: 62.40 E-value: 2.00e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 455 DLRAALQPQAPALLDAHG--SLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVN--- 529
Cdd:PRK13391 4 GIHAQTTPDKPAVIMASTgeVVTYRELDERSNRLAHLFRSLGLKRGDHVAIFMENNLRYLEVCWAAERSGLYYTCVNshl 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 530 --PEfpAARVERMREAGGIVFALADAECAGRAREAFAG--ACLDL---STLP----LAGSGMSLPAPGGRD---AAYMIF 595
Cdd:PRK13391 84 tpAE--AAYIVDDSGARALITSAAKLDVARALLKQCPGvrHRLVLdgdGELEgfvgYAEAVAGLPATPIADeslGTDMLY 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 596 TSGTSGQPKGVVVEHASaLNLSQALART-VYANVVG--EGLRVTVNAPF--SFDSSIKQILQLLSGHCLVLvpqeVRSDP 670
Cdd:PRK13391 162 SSGTTGRPKGIKRPLPE-QPPDTPLPLTaFLQRLWGfrSDMVYLSPAPLyhSAPQRAVMLVIRLGGTVIVM----EHFDA 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 671 QRMLGFLEERRIDVLDCTPSLFRLLLQaglddahpaLPGRILvggERFDEASWEVAA---------------GWRRCQVF 735
Cdd:PRK13391 237 EQYLALIEEYGVTHTQLVPTMFSRMLK---------LPEEVR---DKYDLSSLEVAIhaaapcppqvkeqmiDWWGPIIH 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 736 NLYGPTEAtVNASLARVAEH-ARP-TIGRALANvDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEG 813
Cdd:PRK13391 305 EYYAATEG-LGFTACDSEEWlAHPgTVGRAMFG-DLHILDDDGAELPPGEPGTIWFEGGRPFEYLNDPAKTAEARHPDGT 382
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 814 WPgsgrlyRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV--LTDE------------ADA 879
Cdd:PRK13391 383 WS------TVGDIGYVDEDGYLYLTDRAAFMIISGGVNIYPQEAENLLITHPKVADAAVfgVPNEdlgeevkavvqpVDG 456
|
490
....*....|....*
gi 15597498 880 AEPGAD--RRIVAFV 892
Cdd:PRK13391 457 VDPGPAlaAELIAFC 471
|
|
| PP-binding |
pfam00550 |
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ... |
1258-1316 |
2.61e-09 |
|
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.
Pssm-ID: 425746 [Multi-domain] Cd Length: 62 Bit Score: 54.88 E-value: 2.61e-09
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 15597498 1258 AALLEIWKSVLKRPA--IGVSDNFFQVGGDSIRLIQMQVMAREA-GLAFTLRDVFNHQSIRE 1316
Cdd:pfam00550 1 ERLRELLAEVLGVPAeeIDPDTDLFDLGLDSLLAVELIARLEEEfGVEIPPSDLFEHPTLAE 62
|
|
| PtmA |
cd17636 |
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, ... |
738-873 |
3.50e-09 |
|
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341291 [Multi-domain] Cd Length: 331 Bit Score: 60.78 E-value: 3.50e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 738 YGPTEATVNASLARVAEHARPTIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVeEGWpgs 817
Cdd:cd17636 143 YGQTEVMGLATFAALGGGAIGGAGRPSPLVQVRILDEDGREVPDGEVGEIVARGPTVMAGYWNRPEVNARRTR-GGW--- 218
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*.
gi 15597498 818 grlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:cd17636 219 ---HHTNDLGRREPDGSLSFVGPKTRMIKSGAENIYPAEVERCLRQHPAVADAAVI 271
|
|
| PRK06710 |
PRK06710 |
long-chain-fatty-acid--CoA ligase; Validated |
458-898 |
1.11e-08 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 180666 [Multi-domain] Cd Length: 563 Bit Score: 60.05 E-value: 1.11e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 458 AALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARV 537
Cdd:PRK06710 34 ASRYPEKKALHFLGKDITFSVFHDKVKRFANYLQKLGVEKGDRVAIMLPNCPQAVIGYYGTLLAGGIVVQTNPLYTEREL 113
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 538 E-RMREAGG-------IVFA-LADAECAGRAREAFAGACLDLSTLPL--------------------------------- 575
Cdd:PRK06710 114 EyQLHDSGAkvilcldLVFPrVTNVQSATKIEHVIVTRIADFLPFPKnllypfvqkkqsnlvvkvsesetihlwnsveke 193
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 576 AGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTVYANVVGEGLRVTVnAPFSFDSSIKQILQL-- 653
Cdd:PRK06710 194 VNTGVEVPCDPENDLALLQYTGGTTGFPKGVMLTHKNLVSNTLMGVQWLYNCKEGEEVVLGV-LPFFHVYGMTAVMNLsi 272
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 654 LSGHCLVLVPqevRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPALPGRILVGG---------ERFDeaswE 724
Cdd:PRK06710 273 MQGYKMVLIP---KFDMKMVFEAIKKHKVTLFPGAPTIYIALLNSPLLKEYDISSIRACISGsaplpvevqEKFE----T 345
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 725 VAAGwrrcQVFNLYGPTEATVNASLARVAEHARP-TIGRALANVDLHVVD-GLGRRKTRGASGELWIGGAGVARGYAGDA 802
Cdd:PRK06710 346 VTGG----KLVEGYGLTESSPVTHSNFLWEKRVPgSIGVPWPDTEAMIMSlETGEALPPGEIGEIVVKGPQIMKGYWNKP 421
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 803 GEAAGrFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLtdeaDAAEP 882
Cdd:PRK06710 422 EETAA-VLQDGW------LHTGDVGYMDEDGFFYVKDRKKDMIVASGFNVYPREVEEVLYEHEKVQEVVTI----GVPDP 490
|
490
....*....|....*.
gi 15597498 883 GADRRIVAFVTAAEET 898
Cdd:PRK06710 491 YRGETVKAFVVLKEGT 506
|
|
| A_NRPS_Srf_like |
cd12117 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis ... |
1192-1234 |
1.25e-08 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis termination module Surfactin (SrfA-C); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the adenylation domain of the Bacillus subtilis termination module (Surfactin domain, SrfA-C) which recognizes a specific amino acid building block, which is then activated and transferred to the terminal thiol of the 4'-phosphopantetheine (Ppan) arm of the downstream peptidyl carrier protein (PCP) domain.
Pssm-ID: 341282 [Multi-domain] Cd Length: 483 Bit Score: 59.91 E-value: 1.25e-08
10 20 30 40
....*....|....*....|....*....|....*....|...
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd12117 439 EGALDAAELRAFLRERLPAYMVPAAFVVLDELPLTANGKVDRR 481
|
|
| PRK06060 |
PRK06060 |
p-hydroxybenzoic acid--AMP ligase FadD22; |
586-902 |
1.82e-08 |
|
p-hydroxybenzoic acid--AMP ligase FadD22;
Pssm-ID: 180374 [Multi-domain] Cd Length: 705 Bit Score: 59.66 E-value: 1.82e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 586 GGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARtvyanvvgEGLRVT--------VNAPFSFDSSIKQILQLLSGH 657
Cdd:PRK06060 143 GGDALAYATYTSGTTGPPKAAIHRHADPLTFVDAMCR--------KALRLTpedtglcsARMYFAYGLGNSVWFPLATGG 214
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 658 CLVLVPQEVRSDPQRMLGFLEERriDVLDCTPSLFRLLLQAGLDDAHPALpgRILV-GGErfdeaSWEVAAGWRRCQVFN 736
Cdd:PRK06060 215 SAVINSAPVTPEAAAILSARFGP--SVLYGVPNFFARVIDSCSPDSFRSL--RCVVsAGE-----ALELGLAERLMEFFG 285
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 737 ----LYGPTEATVNAS-LARVAEHARP-TIGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYagdAGEAAGRFV 810
Cdd:PRK06060 286 gipiLDGIGSTEVGQTfVSNRVDEWRLgTLGRVLPPYEIRVVAPDGTTAGPGVEGDLWVRGPAIAKGY---WNRPDSPVA 362
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 811 EEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL-TDEADaaepGADRRIV 889
Cdd:PRK06060 363 NEGW------LDTRDRVCIDSDGWVTYRCRADDTEVIGGVNVDPREVERLIIEDEAVAEAAVVaVREST----GASTLQA 432
|
330
....*....|...
gi 15597498 890 AFVTAAEETADES 902
Cdd:PRK06060 433 FLVATSGATIDGS 445
|
|
| A_NRPS_ACVS-like |
cd17648 |
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV ... |
1193-1234 |
3.05e-08 |
|
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV synthetase (ACVS, EC 6.3.2.26; also known as N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase or delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase) is involved in medically important antibiotic biosynthesis. ACV synthetase is active in an early step in the penicillin G biosynthesis pathway which involves the formation of the tripeptide 6-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine (ACV); each of the constituent amino acids of the tripeptide ACV are activated as aminoacyl-adenylates with peptide bonds formed through the participation of amino acid thioester intermediates. ACV is then cyclized by the action of isopenicillin N synthase.
Pssm-ID: 341303 [Multi-domain] Cd Length: 453 Bit Score: 58.57 E-value: 3.05e-08
10 20 30 40
....*....|....*....|....*....|....*....|..
gi 15597498 1193 GELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd17648 409 GHVPESDLLSFLRAKLPRYMVPARLVRLEGIPVTINGKLDVR 450
|
|
| PRK06018 |
PRK06018 |
putative acyl-CoA synthetase; Provisional |
476-873 |
4.27e-08 |
|
putative acyl-CoA synthetase; Provisional
Pssm-ID: 235673 [Multi-domain] Cd Length: 542 Bit Score: 58.22 E-value: 4.27e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 476 FATLRARSEAVAEALLAAGVRPGQAVAVM---TGRNREaivALLGVMRAAAVYTPVNPE-FPAARVERMREAGG------ 545
Cdd:PRK06018 42 YAQIHDRALKVSQALDRDGIKLGDRVATIawnTWRHLE---AWYGIMGIGAICHTVNPRlFPEQIAWIINHAEDrvvitd 118
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 546 -----IVFALADAECAGRAREAFAG-ACLDLSTLPLAGSGMSLPAPGGRD----------AAYMIFTSGTSGQPKGVVVE 609
Cdd:PRK06018 119 ltfvpILEKIADKLPSVERYVVLTDaAHMPQTTLKNAVAYEEWIAEADGDfawktfdentAAGMCYTSGTTGDPKGVLYS 198
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 610 HASalNLSQALArTVYANVVGEGLRVTV---------NA---PFSFDSSIKQilqllsghclvLVPQEVRSDPQRMLGFL 677
Cdd:PRK06018 199 HRS--NVLHALM-ANNGDALGTSAADTMlpvvplfhaNSwgiAFSAPSMGTK-----------LVMPGAKLDGASVYELL 264
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 678 EERRIDVLDCTPSLFRLLLQAgLDDAHPALP--GRILVGG--------ERFDEASWEVAAGWrrcqvfnlyGPTE----- 742
Cdd:PRK06018 265 DTEKVTFTAGVPTVWLMLLQY-MEKEGLKLPhlKMVVCGGsamprsmiKAFEDMGVEVRHAW---------GMTEmsplg 334
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 743 --ATVNASLARVAEHARPTI----GRALANVDLHVVDGLGRRKTRG--ASGELWIGGAGVARGYAGDAGEAagrFVEEGW 814
Cdd:PRK06018 335 tlAALKPPFSKLPGDARLDVlqkqGYPPFGVEMKITDDAGKELPWDgkTFGRLKVRGPAVAAAYYRVDGEI---LDDDGF 411
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....*....
gi 15597498 815 pgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:PRK06018 412 ------FDTGDVATIDAYGYMRITDRSKDVIKSGGEWISSIDLENLAVGHPKVAEAAVI 464
|
|
| PRK08279 |
PRK08279 |
long-chain-acyl-CoA synthetase; Validated |
438-627 |
5.06e-08 |
|
long-chain-acyl-CoA synthetase; Validated
Pssm-ID: 236217 [Multi-domain] Cd Length: 600 Bit Score: 57.96 E-value: 5.06e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 438 QGERVEPAPVESLVAAFDLRAALQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTgRNR-EAIVALL 516
Cdd:PRK08279 27 RTALITPDSKRSLGDVFEEAAARHPDRPALLFEDQSISYAELNARANRYAHWAAARGVGKGDVVALLM-ENRpEYLAAWL 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 517 GVMRAAAVYTPVN-----------------------PEFpAARVERMRE----AGGIVFALADAECAGRAREAFAGACLD 569
Cdd:PRK08279 106 GLAKLGAVVALLNtqqrgavlahslnlvdakhlivgEEL-VEAFEEARAdlarPPRLWVAGGDTLDDPEGYEDLAAAAAG 184
|
170 180 190 200 210
....*....|....*....|....*....|....*....|....*....|....*...
gi 15597498 570 LSTLPLAGSGmslpAPGGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTVYAN 627
Cdd:PRK08279 185 APTTNPASRS----GVTAKDTAFYIYTSGTTGLPKAAVMSHMRWLKAMGGFGGLLRLT 238
|
|
| PRK07638 |
PRK07638 |
acyl-CoA synthetase; Validated |
592-873 |
5.07e-08 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236071 [Multi-domain] Cd Length: 487 Bit Score: 57.87 E-value: 5.07e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 592 YMIFTSGTSGQPKGVVVEHASALNLSQALARTVYanvVGEGLRVTVnaPFSFDSSI---KQILQLLSGHCLVLVPQEVrs 668
Cdd:PRK07638 147 YMGFTSGSTGKPKAFLRAQQSWLHSFDCNVHDFH---MKREDSVLI--AGTLVHSLflyGAISTLYVGQTVHLMRKFI-- 219
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 669 dPQRMLGFLEERRIDVLDCTPSLFRLLLQAgldDAHPALPGRILVGGerfdeASWE------VAAGWRRCQVFNLYGPTE 742
Cdd:PRK07638 220 -PNQVLDKLETENISVMYTVPTMLESLYKE---NRVIENKMKIISSG-----AKWEaeakekIKNIFPYAKLYEFYGASE 290
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 743 ATVNASLARVAEHARPT-IGRALANVDLHVVDGLGRRKTRGASGELWIGGAGVARGYAGDaGEAAGRFVEEGWpgsgrlY 821
Cdd:PRK07638 291 LSFVTALVDEESERRPNsVGRPFHNVQVRICNEAGEEVQKGEIGTVYVKSPQFFMGYIIG-GVLARELNADGW------M 363
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|..
gi 15597498 822 RSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:PRK07638 364 TVRDVGYEDEEGFIYIVGREKNMILFGGINIFPEEIESVLHEHPAVDEIVVI 415
|
|
| PLN02246 |
PLN02246 |
4-coumarate--CoA ligase |
494-896 |
5.23e-08 |
|
4-coumarate--CoA ligase
Pssm-ID: 215137 [Multi-domain] Cd Length: 537 Bit Score: 58.07 E-value: 5.23e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 494 GVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVERMREAGGIVFALADAECAGRAREAFAG-------- 565
Cdd:PLN02246 71 GIRQGDVVMLLLPNCPEFVLAFLGASRRGAVTTTANPFYTPAEIAKQAKASGAKLIITQSCYVDKLKGLAEDdgvtvvti 150
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 566 -----ACLDLSTLPLAGSGmSLPAP--GGRDAAYMIFTSGTSGQPKGVVVEHASalnlsqaLARTVYANVVGEglrvtvN 638
Cdd:PLN02246 151 ddppeGCLHFSELTQADEN-ELPEVeiSPDDVVALPYSSGTTGLPKGVMLTHKG-------LVTSVAQQVDGE------N 216
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 639 APFSFDS--------------SIKQIL--QLLSGHCLVLVPqevRSDPQRMLGFLEERRIDVLDCTP------------- 689
Cdd:PLN02246 217 PNLYFHSddvilcvlpmfhiySLNSVLlcGLRVGAAILIMP---KFEIGALLELIQRHKVTIAPFVPpivlaiakspvve 293
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 690 ----SLFRLLLQAG------LDDAHPA-LPGRILVGGerfdeaswevaagwrrcqvfnlYGPTEA-TVNA-SLArVAEHA 756
Cdd:PLN02246 294 kydlSSIRMVLSGAaplgkeLEDAFRAkLPNAVLGQG----------------------YGMTEAgPVLAmCLA-FAKEP 350
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 757 RPT----IGRALANVDLHVVD-GLGRRKTRGASGELWIGGAGVARGYAGDAgEAAGRFV-EEGWpgsgrlYRSGDLVRWR 830
Cdd:PLN02246 351 FPVksgsCGTVVRNAELKIVDpETGASLPRNQPGEICIRGPQIMKGYLNDP-EATANTIdKDGW------LHTGDIGYID 423
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 15597498 831 ADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLT--DEADAAEPgadrriVAFVTAAE 896
Cdd:PLN02246 424 DDDELFIVDRLKELIKYKGFQVAPAELEALLISHPSIADAAVVPmkDEVAGEVP------VAFVVRSN 485
|
|
| AcpP |
COG0236 |
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the ... |
1252-1323 |
5.76e-08 |
|
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440006 [Multi-domain] Cd Length: 80 Bit Score: 51.78 E-value: 5.76e-08
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 15597498 1252 PANATEAALLEIWKSVLKRPA--IGVSDNFFQV-GGDSIRLIQMQVMAREA-GLAFTLRDVFNHQSIRELARLLAA 1323
Cdd:COG0236 2 PREELEERLAEIIAEVLGVDPeeITPDDSFFEDlGLDSLDAVELIAALEEEfGIELPDTELFEYPTVADLADYLEE 77
|
|
| PRK08633 |
PRK08633 |
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated |
589-910 |
7.05e-08 |
|
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated
Pssm-ID: 236315 [Multi-domain] Cd Length: 1146 Bit Score: 58.01 E-value: 7.05e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTVYANvvgEGLRVTVNAPF--SFDSSIKQILQLLSGHCLVLVPqev 666
Cdd:PRK08633 783 DTATIIFSSGSEGEPKGVMLSHHNILSNIEQISDVFNLR---NDDVILSSLPFfhSFGLTVTLWLPLLEGIKVVYHP--- 856
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 667 rsDPQ--RMLGFL-EERRIDVLDCTPSLFRLLLQAglDDAHPALPG--RILV-GGERFDEaswEVAAGWRrcQVFNL--- 737
Cdd:PRK08633 857 --DPTdaLGIAKLvAKHRATILLGTPTFLRLYLRN--KKLHPLMFAslRLVVaGAEKLKP---EVADAFE--EKFGIril 927
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 738 --YGPTE----ATVNASLARVAE------HARPTIGRALANVDLHVVD--GLGRRKTrGASGELWIGGAGVARGYAGDAG 803
Cdd:PRK08633 928 egYGATEtspvASVNLPDVLAADfkrqtgSKEGSVGMPLPGVAVRIVDpeTFEELPP-GEDGLILIGGPQVMKGYLGDPE 1006
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 804 EAAGRFVE---EGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEhpAVGEAAVLTdeADAA 880
Cdd:PRK08633 1007 KTAEVIKDidgIGW------YVTGDKGHLDEDGFLTITDRYSRFAKIGGEMVPLGAVEEELAK--ALGGEEVVF--AVTA 1076
|
330 340 350
....*....|....*....|....*....|....*
gi 15597498 881 EPGADR--RIVAFVTAAEETADESW---LEVDLPS 910
Cdd:PRK08633 1077 VPDEKKgeKLVVLHTCGAEDVEELKraiKESGLPN 1111
|
|
| PLN02860 |
PLN02860 |
o-succinylbenzoate-CoA ligase |
589-873 |
1.59e-07 |
|
o-succinylbenzoate-CoA ligase
Pssm-ID: 215464 [Multi-domain] Cd Length: 563 Bit Score: 56.35 E-value: 1.59e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHaSALnLSQALARTVyanVVGEG-----LRVtvnAPFSFDSSIKQIL-QLLSGHCLVLV 662
Cdd:PLN02860 173 DAVLICFTSGTTGRPKGVTISH-SAL-IVQSLAKIA---IVGYGeddvyLHT---APLCHIGGLSSALaMLMVGACHVLL 244
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 663 PqevRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQ----AGLDDAHPALPgRILVGG-----ERFDEASwevaAGWRRCQ 733
Cdd:PLN02860 245 P---KFDAKAALQAIKQHNVTSMITVPAMMADLISltrkSMTWKVFPSVR-KILNGGgslssRLLPDAK----KLFPNAK 316
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 734 VFNLYGPTEATVNASLARVAEHARPTIGRALANVDL-------------------HVVDGLGRRKTrGASGELWIGGAGV 794
Cdd:PLN02860 317 LFSAYGMTEACSSLTFMTLHDPTLESPKQTLQTVNQtksssvhqpqgvcvgkpapHVELKIGLDES-SRVGRILTRGPHV 395
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 15597498 795 ARGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:PLN02860 396 MLGYWGQNSETASVLSNDGW------LDTGDIGWIDKAGNLWLIGRSNDRIKTGGENVYPEEVEAVLSQHPGVASVVVV 468
|
|
| PRK07867 |
PRK07867 |
acyl-CoA synthetase; Validated |
574-872 |
1.75e-07 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236120 [Multi-domain] Cd Length: 529 Bit Score: 56.23 E-value: 1.75e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 574 PLAGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALAR--------TVY-------ANVVGEGLRVTVN 638
Cdd:PRK07867 138 AHRDAEPPFRVADPDDLFMLIFTSGTSGDPKAVRCTHRKVASAGVMLAQrfglgpddVCYvsmplfhSNAVMAGWAVALA 217
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 639 ApfsfdssikqilqllsGHCLVLVPQEVRSdpqrmlGFLEE-RRIDVLDCT----PSLFRLLLQAGLDDAHPALpgRILV 713
Cdd:PRK07867 218 A----------------GASIALRRKFSAS------GFLPDvRRYGATYANyvgkPLSYVLATPERPDDADNPL--RIVY 273
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 714 GGErfdEASWEVAAGWRR--CQVFNLYGPTEATVnaSLARVAEHARPTIGRALANVDLH-----------VVDGLGRRKT 780
Cdd:PRK07867 274 GNE---GAPGDIARFARRfgCVVVDGFGSTEGGV--AITRTPDTPPGALGPLPPGVAIVdpdtgtecppaEDADGRLLNA 348
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 781 RGASGELW-IGGAGVARGYAGDAgEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRS 859
Cdd:PRK07867 349 DEAIGELVnTAGPGGFEGYYNDP-EADAERMRGGV------YWSGDLAYRDADGYAYFAGRLGDWMRVDGENLGTAPIER 421
|
330
....*....|...
gi 15597498 860 ALLEHPAVGEAAV 872
Cdd:PRK07867 422 ILLRYPDATEVAV 434
|
|
| LC-FACS_euk |
cd05927 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are ... |
589-840 |
2.78e-07 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are eukaryotic fatty acid CoA synthetases that activate fatty acids with chain lengths of 12 to 20. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells.
Pssm-ID: 341250 [Multi-domain] Cd Length: 545 Bit Score: 55.68 E-value: 2.78e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTV-YANVVGEGL-------------RVTVNAPFSFDSSI------- 647
Cdd:cd05927 115 DLATICYTSGTTGNPKGVMLTHGNIVSNVAGVFKILeILNKINPTDvyisylplahifeRVVEALFLYHGAKIgfysgdi 194
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 648 KQI---LQLLSGHCLVLVPqevrsdpqRMLGFLEERRIDVLDCTPSLFRLL-----------LQAGLDDAHP-------- 705
Cdd:cd05927 195 RLLlddIKALKPTVFPGVP--------RVLNRIYDKIFNKVQAKGPLKRKLfnfalnyklaeLRSGVVRASPfwdklvfn 266
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 706 ----ALPGR---ILVGG-------ERFdeasWEVAAGwrrCQVFNLYGPTEATVNASLARVAEHARPTIGRALANVDLHV 771
Cdd:cd05927 267 kikqALGGNvrlMLTGSaplspevLEF----LRVALG---CPVLEGYGQTECTAGATLTLPGDTSVGHVGGPLPCAEVKL 339
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 15597498 772 VD----GLGRRKTRGAsGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGR 840
Cdd:cd05927 340 VDvpemNYDAKDPNPR-GEVCIRGPNVFSGYYKDPEKTAEALDEDGW------LHTGDIGEWLPNGTLKIIDR 405
|
|
| A_NRPS_Ta1_like |
cd12116 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A ... |
1195-1234 |
3.39e-07 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A polyketide synthase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the myxovirescin (TA) antibiotic biosynthetic gene in Myxococcus xanthus; TA production plays a role in predation. It also includes the salinosporamide A polyketide synthase which is involved in the biosynthesis of salinosporamide A, a marine microbial metabolite whose chlorine atom is crucial for potent proteasome inhibition and anticancer activity.
Pssm-ID: 341281 [Multi-domain] Cd Length: 470 Bit Score: 55.38 E-value: 3.39e-07
10 20 30 40
....*....|....*....|....*....|....*....|
gi 15597498 1195 LSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd12116 429 PDAAALRAHLRATLPAYMVPSAFVRLDALPLTANGKLDRK 468
|
|
| LC_FACS_bac |
cd05932 |
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter ... |
583-876 |
3.87e-07 |
|
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase; The members of this family are bacterial long-chain fatty acid CoA synthetase. Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase in this family is involved in the synthesis of isoprenoid wax ester storage compounds when grown on phytol as the sole carbon source. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341255 [Multi-domain] Cd Length: 508 Bit Score: 55.17 E-value: 3.87e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 583 PAPGGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTVYanvVGEGLRVTVNAP--------FSFDSSIKQILQLL 654
Cdd:cd05932 132 PTRFPEQLATLIYTSGTTGQPKGVMLTFGSFAWAAQAGIEHIG---TEENDRMLSYLPlahvtervFVEGGSLYGGVLVA 208
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 655 SGHCLVLVPQEV-RSDP--------------QRMLGFLEERRIDVLDCTPSLFRL----LLQA-GLDDAhpalpgRILVG 714
Cdd:cd05932 209 FAESLDTFVEDVqRARPtlffsvprlwtkfqQGVQDKIPQQKLNLLLKIPVVNSLvkrkVLKGlGLDQC------RLAGC 282
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 715 GER---FDEASWEVAAGWRRCQVfnlYGPTEATVNASLARVAEHARPTIGRALANVDLHVVDglgrrktrgaSGELWIGG 791
Cdd:cd05932 283 GSApvpPALLEWYRSLGLNILEA---YGMTENFAYSHLNYPGRDKIGTVGNAGPGVEVRISE----------DGEILVRS 349
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 792 AGVARGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKIN-GYRIELGEIRSALLEHPAVgEA 870
Cdd:cd05932 350 PALMMGYYKDPEATAEAFTADGF------LRTGDKGELDADGNLTITGRVKDIFKTSkGKYVAPAPIENKLAEHDRV-EM 422
|
....*.
gi 15597498 871 AVLTDE 876
Cdd:cd05932 423 VCVIGS 428
|
|
| PRK09274 |
PRK09274 |
peptide synthase; Provisional |
458-870 |
4.08e-07 |
|
peptide synthase; Provisional
Pssm-ID: 236443 [Multi-domain] Cd Length: 552 Bit Score: 55.29 E-value: 4.08e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 458 AALQPQAPALLDAHG----------SLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVytP 527
Cdd:PRK09274 16 AQERPDQLAVAVPGGrgadgklaydELSFAELDARSDAIAHGLNAAGIGRGMRAVLMVTPSLEFFALTFALFKAGAV--P 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 528 V------------------NPE----FPAARVERmreaggIVFALADAE-----CAGRaREAFAGACLDLSTLPLAGSGM 580
Cdd:PRK09274 94 VlvdpgmgiknlkqclaeaQPDafigIPKAHLAR------RLFGWGKPSvrrlvTVGG-RLLWGGTTLATLLRDGAAAPF 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 581 SLPAPGGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALaRTVYANVVGEglrvtvnapfsFDSSIKQILQLLS---GH 657
Cdd:PRK09274 167 PMADLAPDDMAAILFTSGSTGTPKGVVYTHGMFEAQIEAL-REDYGIEPGE-----------IDLPTFPLFALFGpalGM 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 658 CLVLVPQE----VRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAGLDDAHPaLPG--RILVGG--------ERFDEASW 723
Cdd:PRK09274 235 TSVIPDMDptrpATVDPAKLFAAIERYGVTNLFGSPALLERLGRYGEANGIK-LPSlrRVISAGapvpiaviERFRAMLP 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 724 EVAagwrrcQVFNLYGPTEA------TVNASLARVAEHARP----TIGRALANVDLHVV---DGLG------RRKTRGAS 784
Cdd:PRK09274 314 PDA------EILTPYGATEAlpissiESREILFATRAATDNgagiCVGRPVDGVEVRIIaisDAPIpewddaLRLATGEI 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 785 GELWIGGAGVARGYAGDAGEAAGRFVEEgwPGSGRLYRSGDLVRWRADGCLEFLGRIDEQVKING---YRIELGEI---- 857
Cdd:PRK09274 388 GEIVVAGPMVTRSYYNRPEATRLAKIPD--GQGDVWHRMGDLGYLDAQGRLWFCGRKAHRVETAGgtlYTIPCERIfnth 465
|
490
....*....|....*..
gi 15597498 858 ----RSALLEHPAVGEA 870
Cdd:PRK09274 466 pgvkRSALVGVGVPGAQ 482
|
|
| PLN02654 |
PLN02654 |
acetate-CoA ligase |
803-896 |
5.00e-07 |
|
acetate-CoA ligase
Pssm-ID: 215353 [Multi-domain] Cd Length: 666 Bit Score: 54.90 E-value: 5.00e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 803 GEAAGRF-VEEGWPGSGR-------------------LYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALL 862
Cdd:PLN02654 477 GECSGYLcVKKSWPGAFRtlygdheryettyfkpfagYYFSGDGCSRDKDGYYWLTGRVDDVINVSGHRIGTAEVESALV 556
|
90 100 110
....*....|....*....|....*....|....
gi 15597498 863 EHPAVGEAAVLTDEADAAEPGadrrIVAFVTAAE 896
Cdd:PLN02654 557 SHPQCAEAAVVGIEHEVKGQG----IYAFVTLVE 586
|
|
| AcpA |
COG3433 |
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites ... |
1192-1323 |
6.07e-07 |
|
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442659 [Multi-domain] Cd Length: 295 Bit Score: 53.60 E-value: 6.07e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRRALLAALAAEAAAQTLEAPA---NATEAALLEIWKSVL 1268
Cdd:COG3433 153 LDGLAAAAALAALDKVPPDVVAASAVVALDALLLLALKVVARAAPALAAAEALLAAASPAPAletALTEEELRADVAELL 232
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*..
gi 15597498 1269 KRPA--IGVSDNFFQVGGDSIRLIQMQVMAREAGLAFTLRDVFNHQSIRELARLLAA 1323
Cdd:COG3433 233 GVDPeeIDPDDNLFDLGLDSIRLMQLVERWRKAGLDVSFADLAEHPTLAAWWALLAA 289
|
|
| PRK06334 |
PRK06334 |
long chain fatty acid--[acyl-carrier-protein] ligase; Validated |
589-864 |
7.28e-07 |
|
long chain fatty acid--[acyl-carrier-protein] ligase; Validated
Pssm-ID: 180533 [Multi-domain] Cd Length: 539 Bit Score: 54.44 E-value: 7.28e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHASALNLSQALARtvYANVVGEGLRVTVNAPF---SFDSSikQILQLLSGHCLVLVPQE 665
Cdd:PRK06334 184 DVAVILFTSGTEKLPKGVPLTHANLLANQRACLK--FFSPKEDDVMMSFLPPFhayGFNSC--TLFPLLSGVPVVFAYNP 259
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 666 VRsdPQRMLGFLEERRIDVLDCTPSLFRLLLQAGlDDAHPALPGR--ILVGGERF-DEASWEVAAGWRRCQVFNLYGPTE 742
Cdd:PRK06334 260 LY--PKKIVEMIDEAKVTFLGSTPVFFDYILKTA-KKQESCLPSLrfVVIGGDAFkDSLYQEALKTFPHIQLRQGYGTTE 336
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 743 A----TVNASLARVAEHArptIGRALANVDLHVVDglgrRKTR-----GASGELWIGGAGVARGYAG-DAGEAAGRFVEE 812
Cdd:PRK06334 337 CspviTINTVNSPKHESC---VGMPIRGMDVLIVS----EETKvpvssGETGLVLTRGTSLFSGYLGeDFGQGFVELGGE 409
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|..
gi 15597498 813 GWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEH 864
Cdd:PRK06334 410 TW------YVTGDLGYVDRHGELFLKGRLSRFVKIGAEMVSLEALESILMEG 455
|
|
| PksD |
COG3321 |
Acyl transferase domain in polyketide synthase (PKS) enzymes [Secondary metabolites ... |
1560-2096 |
9.20e-07 |
|
Acyl transferase domain in polyketide synthase (PKS) enzymes [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442550 [Multi-domain] Cd Length: 1386 Bit Score: 54.49 E-value: 9.20e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1560 AGARYRPLPGLAEEgpRRMAAVRVDVPAdslsrLRALAERSGLPLRSLLLAAHGRALCRFSDADEVVTGFVSHGRPEEPG 1639
Cdd:COG3321 856 RGRRRVPLPTYPFQ--REDAAAALLAAA-----LAAALAAAAALGALLLAALAAALAAALLALAAAAAAALALAAAALAA 928
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1640 ADRLLGLFLNTLPCRLSASVDLLDSARRAFDYERASLEHRRHPLAAIRRRNRELRLDSLFNFVDFHQDDAAPAGVRHGGI 1719
Cdd:COG3321 929 LLALVALAAAAAALLALAAAAAAAAAALAAAEAGALLLLAAAAAAAAAAAAAAAAAAAAAAAAAAAALAAAAALALLAAA 1008
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1720 LDQVVVDVDVPLAVDFEVAGERLEVGFQYAAGRFPAERAEALAGAYREALLALLGDPVQPPAAAQAEDSVELRRVLKVLS 1799
Cdd:COG3321 1009 ALLLAAAAAAAALLALAALLAAAAAALAAAAAAAAAAAALAALAAAAAAAAALALALAALLLLAALAELALAAAALALAA 1088
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1800 RVLGRPLAADQGFASAGGHSLLGVQAIAELRRLTGRQLSLGLLQGDPDAREVVRRCHAADAPPLPPATERARALWLQRSG 1879
Cdd:COG3321 1089 ALAAAALALALAALAAALLLLALLAALALAAAAAALLALAALLAAAAAAAALAAAAAAAAALALAAAAAALAAALAAALL 1168
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1880 SAQPRLRLIALPPAGGNAGTFRGWDARLPADVELLAIQYPGRQERQDEPFVTDVEAMLCAIDDALLPLLDRPFALIGASL 1959
Cdd:COG3321 1169 AAAALLLALALALAAALAAALAGLAALLLAALLAALLAALLALALAALAAAAAALLAAAAAAAALALLALAAAAAAVAAL 1248
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1960 GGMLAYELAARLESLHGLRARQLFVISSRAPGPDLEYPRFHAMGDAELLRTLREYDVLPLEVLDDPELREISLATLRADS 2039
Cdd:COG3321 1249 AAAAAALLAALAALALLAAAAGLAALAAAAAAAAAALALAAAAAAAAAALAALLAAAAAAAAAAAAAAAAAALAAALLAA 1328
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*..
gi 15597498 2040 RLAADYRYRPREPLAIPITAILGEQDPGVSRVAIDGWRRHASRYELETLAGGHGLVV 2096
Cdd:COG3321 1329 ALAALAAAVAAALALAAAAAAAAAAAAAAAAAAALAAAAGAAAAAAALALAALAAAV 1385
|
|
| A_NRPS_VisG_like |
cd17651 |
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) ... |
1199-1234 |
1.09e-06 |
|
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes virginiamycin S synthetase (VisG) in Streptomyces virginiae; VisG is involved in virginiamycin S (VS) biosynthesis as the provider of an L-pheGly molecule, a highly specific substrate for the last condensation step by VisF. This family also includes linear gramicidin synthetase B (LgrB) in Brevibacillus brevis. Substrate specificity analysis using residues of the substrate-binding pockets of all 16 adenylation domains has shown good agreement of the substrate amino acids predicted with the sequence of linear gramicidin. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341306 [Multi-domain] Cd Length: 491 Bit Score: 53.50 E-value: 1.09e-06
10 20 30
....*....|....*....|....*....|....*.
gi 15597498 1199 ALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd17651 453 ELRAALATHLPEYMVPSAFVLLDALPLTPNGKLDRR 488
|
|
| PRK08315 |
PRK08315 |
AMP-binding domain protein; Validated |
589-872 |
1.30e-06 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236236 [Multi-domain] Cd Length: 559 Bit Score: 53.66 E-value: 1.30e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHASALNlsqalartvYANVVGEGLRVTVN------APF--SFDSSIKQILQLLSGHCLV 660
Cdd:PRK08315 200 DPINIQYTSGTTGFPKGATLTHRNILN---------NGYFIGEAMKLTEEdrlcipVPLyhCFGMVLGNLACVTHGATMV 270
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 661 lVPQEvRSDPQRMLGFLEERRidvldCT-----PSLFrlllQAGLDdaHPALPgrilvggeRFDEASWE--VAAG----- 728
Cdd:PRK08315 271 -YPGE-GFDPLATLAAVEEER-----CTalygvPTMF----IAELD--HPDFA--------RFDLSSLRtgIMAGspcpi 329
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 729 --WRRCQ-------VFNLYGPTEAT-------VNASLA-RVAeharpTIGRALANVDLHVVD-GLGRRKTRGASGELWIG 790
Cdd:PRK08315 330 evMKRVIdkmhmseVTIAYGMTETSpvstqtrTDDPLEkRVT-----TVGRALPHLEVKIVDpETGETVPRGEQGELCTR 404
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 791 GAGVARGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEA 870
Cdd:PRK08315 405 GYSVMKGYWNDPEKTAEAIDADGW------MHTGDLAVMDEEGYVNIVGRIKDMIIRGGENIYPREIEEFLYTHPKIQDV 478
|
..
gi 15597498 871 AV 872
Cdd:PRK08315 479 QV 480
|
|
| PRK06814 |
PRK06814 |
acyl-[ACP]--phospholipid O-acyltransferase; |
579-901 |
2.05e-06 |
|
acyl-[ACP]--phospholipid O-acyltransferase;
Pssm-ID: 235865 [Multi-domain] Cd Length: 1140 Bit Score: 53.43 E-value: 2.05e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 579 GMSLPAPGGRDAAYMIFTSGTSGQPKGVVVEHASAL-NLSQALARTVY--ANVVGEGLRVtvnapF-SFDSSIKQILQLL 654
Cdd:PRK06814 784 LVYFCNRDPDDPAVILFTSGSEGTPKGVVLSHRNLLaNRAQVAARIDFspEDKVFNALPV-----FhSFGLTGGLVLPLL 858
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 655 SGHCLVLVPQ--EVRSDPQR--------MLG---FLE--ERRIDVLDctpslFRLLLqaglddahpalpgRILVGGERFD 719
Cdd:PRK06814 859 SGVKVFLYPSplHYRIIPELiydtnatiLFGtdtFLNgyARYAHPYD-----FRSLR-------------YVFAGAEKVK 920
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 720 EASWEVAAGWRRCQVFNLYGPTEAT----VNASLarvaeHARP-TIGRALANVD--LHVVDGLgrrktrGASGELWIGGA 792
Cdd:PRK06814 921 EETRQTWMEKFGIRILEGYGVTETApviaLNTPM-----HNKAgTVGRLLPGIEyrLEPVPGI------DEGGRLFVRGP 989
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 793 GVARGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLE-HPAVGEAA 871
Cdd:PRK06814 990 NVMLGYLRAENPGVLEPPADGW------YDTGDIVTIDEEGFITIKGRAKRFAKIAGEMISLAAVEELAAElWPDALHAA 1063
|
330 340 350
....*....|....*....|....*....|
gi 15597498 872 VLTDEADAAEpgadrRIVAFVTAAEETADE 901
Cdd:PRK06814 1064 VSIPDARKGE-----RIILLTTASDATRAA 1088
|
|
| A_NRPS_Bac |
cd17655 |
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of ... |
1194-1234 |
2.23e-06 |
|
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetases 1, 2, and 3 (BA1, also known as ATP-dependent cysteine adenylase or cysteine activase, BA2, also known as ATP-dependent lysine adenylase or lysine activase, and BA3, also known as ATP-dependent isoleucine adenylase or isoleucine activase) in Bacilli. Bacitracin is a mixture of related cyclic peptides used as a polypeptide antibiotic. This family also includes gramicidin synthetase 1 involved in synthesis of the cyclic peptide antibiotic gramicidin S via activation of phenylalanine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341310 [Multi-domain] Cd Length: 490 Bit Score: 52.72 E-value: 2.23e-06
10 20 30 40
....*....|....*....|....*....|....*....|.
gi 15597498 1194 ELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd17655 444 ELPVAQLREFLARELPDYMIPSYFIKLDEIPLTPNGKVDRK 484
|
|
| PRK07824 |
PRK07824 |
o-succinylbenzoate--CoA ligase; |
761-900 |
2.28e-06 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 236108 [Multi-domain] Cd Length: 358 Bit Score: 51.97 E-value: 2.28e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 761 GRALANVDLHVVDGlgrrktrgasgELWIGGAGVARGYAGdaGEAAGRFVEEGWpgsgrlYRSGDLVRWrADGCLEFLGR 840
Cdd:PRK07824 195 GVPLDGVRVRVEDG-----------RIALGGPTLAKGYRN--PVDPDPFAEPGW------FRTDDLGAL-DDGVLTVLGR 254
|
90 100 110 120 130 140
....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 841 IDEQVKINGYRIELGEIRSALLEHPAVGEAAVLtdeaDAAEPGADRRIVAFVTAAEETAD 900
Cdd:PRK07824 255 ADDAISTGGLTVLPQVVEAALATHPAVADCAVF----GLPDDRLGQRVVAAVVGDGGPAP 310
|
|
| A_NRPS_AB3403-like |
cd17646 |
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or ... |
1192-1234 |
3.28e-06 |
|
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341301 [Multi-domain] Cd Length: 488 Bit Score: 51.89 E-value: 3.28e-06
10 20 30 40
....*....|....*....|....*....|....*....|...
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd17646 444 AAGPDTAALRAHLAERLPEYMVPAAFVVLDALPLTANGKLDRA 486
|
|
| A_NRPS_Cytc1-like |
cd17643 |
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation ... |
1199-1234 |
3.36e-06 |
|
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Streptomyces sp. cytotrienin synthetase (CytC1), a relatively promiscuous adenylation enzyme that installs the aminoacyl moieties on the phosphopantetheinyl arm of the holo carrier protein CytC2. Also included are Streptomyces sp Thr1, involved in the biosynthesis of 4-chlorothreonine, Pseudomonas aeruginosa pyoverdine synthetase D (PvdD), involved in the biosynthesis of the siderophore pyoverdine and Pseudomonas syringae syringopeptin synthetase, where syringpeptin is a necrosis-inducing phytotoxin that functions as a virulence determinant in the plant-pathogen interaction. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341298 [Multi-domain] Cd Length: 450 Bit Score: 51.92 E-value: 3.36e-06
10 20 30
....*....|....*....|....*....|....*.
gi 15597498 1199 ALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd17643 413 ELRALLKELLPDYMVPARYVPLDALPLTVNGKLDRA 448
|
|
| A_NRPS_PvdJ-like |
cd17649 |
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal ... |
1198-1234 |
3.76e-06 |
|
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes pyoverdine biosynthesis protein PvdJ involved in the synthesis of pyoverdine, which consists of a chromophore group attached to a variable peptide chain and comprises around 6-12 amino acids that are specific for each Pseudomonas species, and for which the peptide might be first synthesized before the chromophore assembly. Also included is ornibactin biosynthesis protein OrbI; ornibactin is a tetrapeptide siderophore with an l-ornithine-d-hydroxyaspartate-l-serine-l-ornithine backbone. The adenylation domain at the N-terminal of OrbI possibly initiates the ornibactin with the binding of N5-hydroxyornithine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341304 [Multi-domain] Cd Length: 450 Bit Score: 51.60 E-value: 3.76e-06
10 20 30
....*....|....*....|....*....|....*..
gi 15597498 1198 QALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd17649 411 AQLRTALRASLPDYMVPAHLVFLARLPLTPNGKLDRK 447
|
|
| MenE/FadK |
COG0318 |
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid ... |
1192-1234 |
3.98e-06 |
|
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) is part of the Pathway/BioSystem: Menaquinone biosynthesis
Pssm-ID: 440087 [Multi-domain] Cd Length: 452 Bit Score: 51.73 E-value: 3.98e-06
10 20 30 40
....*....|....*....|....*....|....*....|...
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:COG0318 397 GAELDAEELRAFLRERLARYKVPRRVEFVDELPRTASGKIDRR 439
|
|
| C_NRPS-like |
cd19066 |
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ... |
22-415 |
4.40e-06 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380453 [Multi-domain] Cd Length: 427 Bit Score: 51.64 E-value: 4.40e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 22 FPLSPLQTRAWRRHAERPENTV----VGVRLHAPADpvatLERLRRALDGEAQLRVAYRT--MPGMSLPVQVLDGRAADL 95
Cdd:cd19066 2 IPLSPMQRGMWFLKKLATDPSAfnvaIEMFLTGSLD----LARLKQALDAVMERHDVLRTrfCEEAGRYEQVVLDKTVRF 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 96 LVE--RLPGDGDWAGRFARESARLAASPLGGEGQPVLALGLLLDAAGETLqgLLLAAPAFVVDAASLVALLRRGLGPAGQ 173
Cdd:cd19066 78 RIEiiDLRNLADPEARLLELIDQIQQTIYDLERGPLVRVALFRLADERDV--LVVAIHHIIVDGGSFQILFEDISSVYDA 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 174 ASADEGDEALLFQHFSEWA---NEALAGEDGESASGYWREQ----------------AAVAAESPLALADDLGEGEWtar 234
Cdd:cd19066 156 AERQKPTLPPPVGSYADYAawlEKQLESEAAQADLAYWTSYlhglppplplpkakrpSQVASYEVLTLEFFLRSEET--- 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 235 rllpRALLERLAANGL-PEAAALLAWTQVAGQFQGDEGLPLEMArlVSGRLFNEFAELAGPFAGVAPLCLENVRAGSVGE 313
Cdd:cd19066 233 ----KRLREVARESGTtPTQLLLAAFALALKRLTASIDVVIGLT--FLNRPDEAVEDTIGLFLNLLPLRIDTSPDATFPE 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 314 RLDALQAAILAQEEAAAL----------RDPFAPDWPLAELGFAWLA-----GELDGAGVAELDCR---QPPLGGFLELQ 375
Cdd:cd19066 307 LLKRTKEQSREAIEHQRVpfielvrhlgVVPEAPKHPLFEPVFTFKNnqqqlGKTGGFIFTTPVYTsseGTVFDLDLEAS 386
|
410 420 430 440
....*....|....*....|....*....|....*....|
gi 15597498 376 VLPHGEGRLASLRVRRDHDGTLAGRLLDAWVECLESIAAD 415
Cdd:cd19066 387 EDPDGDLLLRLEYSRGVYDERTIDRFAERYMTALRQLIEN 426
|
|
| PRK07008 |
PRK07008 |
long-chain-fatty-acid--CoA ligase; Validated |
588-901 |
5.29e-06 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235908 [Multi-domain] Cd Length: 539 Bit Score: 51.63 E-value: 5.29e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 588 RDAAYMIFTSGTSGQPKGVVVEHAS------------ALNLSqalARTVYANVVGeglRVTVNA---PFSFDssikqilq 652
Cdd:PRK07008 176 NQASSLCYTSGTTGNPKGALYSHRStvlhaygaalpdAMGLS---ARDAVLPVVP---MFHVNAwglPYSAP-------- 241
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 653 lLSGHCLVLVPQEVrsDPQRMLGFLEERRIDVLDCTPSLFRLLLQ----AGLDDAHPAlpgRILVGGERFDEASWEVAAG 728
Cdd:PRK07008 242 -LTGAKLVLPGPDL--DGKSLYELIEAERVTFSAGVPTVWLGLLNhmreAGLRFSTLR---RTVIGGSACPPAMIRTFED 315
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 729 WRRCQVFNLYGPTEATVNASLARV--AEHARP---------TIGRALANVDLHVVDGLGRRKTRG--ASGELWIGGAGVA 795
Cdd:PRK07008 316 EYGVEVIHAWGMTEMSPLGTLCKLkwKHSQLPldeqrklleKQGRVIYGVDMKIVGDDGRELPWDgkAFGDLQVRGPWVI 395
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 796 RGYagdageaagrFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLTd 875
Cdd:PRK07008 396 DRY----------FRGDASPLVDGWFPTGDVATIDADGFMQITDRSKDVIKSGGEWISSIDIENVAVAHPAVAEAACIA- 464
|
330 340
....*....|....*....|....*....
gi 15597498 876 eadAAEPGADRR-IVAFVT--AAEETADE 901
Cdd:PRK07008 465 ---CAHPKWDERpLLVVVKrpGAEVTREE 490
|
|
| A_NRPS_ApnA-like |
cd17644 |
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the ... |
1194-1234 |
5.53e-06 |
|
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Planktothrix agardhii anabaenopeptin synthetase (ApnA A1), which is capable of activating two chemically distinct amino acids (Arg and Tyr). Structural studies show that the architecture of the active site forces Arg to adopt a Tyr-like conformation, thus explaining the bispecificity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341299 [Multi-domain] Cd Length: 465 Bit Score: 51.28 E-value: 5.53e-06
10 20 30 40
....*....|....*....|....*....|....*....|.
gi 15597498 1194 ELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd17644 422 SPSTVELRQFLKAKLPDYMIPSAFVVLEELPLTPNGKIDRR 462
|
|
| BACL_like |
cd05929 |
Bacterial Bile acid CoA ligases and similar proteins; Bile acid-Coenzyme A ligase catalyzes ... |
546-872 |
7.67e-06 |
|
Bacterial Bile acid CoA ligases and similar proteins; Bile acid-Coenzyme A ligase catalyzes the formation of bile acid-CoA conjugates in a two-step reaction: the formation of a bile acid-AMP molecule as an intermediate, followed by the formation of a bile acid-CoA. This ligase requires a bile acid with a free carboxyl group, ATP, Mg2+, and CoA for synthesis of the final bile acid-CoA conjugate. The bile acid-CoA ligation is believed to be the initial step in the bile acid 7alpha-dehydroxylation pathway in the intestinal bacterium Eubacterium sp.
Pssm-ID: 341252 [Multi-domain] Cd Length: 473 Bit Score: 50.84 E-value: 7.67e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 546 IVFALADAECAGRA--REAFAGACLDLSTLPLAGSGMSLPAPGGRD---------AAYMIFTSGTSGQPKGVVVEH---- 610
Cdd:cd05929 72 KSSRAPRAEACAIIeiKAAALVCGLFTGGGALDGLEDYEAAEGGSPetpiedeaaGWKMLYSGGTTGRPKGIKRGLpggp 151
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 611 ------ASALNLSQALARTVYANVVgeglRVTVNAPFSFDSSIkqilqLLSGHCLVLVPqevRSDPQRMLGFLEERRIDV 684
Cdd:cd05929 152 pdndtlMAAALGFGPGADSVYLSPA----PLYHAAPFRWSMTA-----LFMGGTLVLME---KFDPEEFLRLIERYRVTF 219
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 685 LDCTPSLFRLLLqaglddahpALPGrilVGGERFDEAS----WEVAA-----------GWRRCQVFNLYGPTEAtvNASL 749
Cdd:cd05929 220 AQFVPTMFVRLL---------KLPE---AVRNAYDLSSlkrvIHAAApcppwvkeqwiDWGGPIIWEYYGGTEG--QGLT 285
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 750 ARVAE----HaRPTIGRALANvDLHVVDGLGRRKTRGASGELWIGGAGvARGYAGDAGEAAGRFVEEGWpgsgrlyRS-G 824
Cdd:cd05929 286 IINGEewltH-PGSVGRAVLG-KVHILDEDGNEVPPGEIGEVYFANGP-GFEYTNDPEKTAAARNEGGW-------STlG 355
|
330 340 350 360
....*....|....*....|....*....|....*....|....*...
gi 15597498 825 DLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV 872
Cdd:cd05929 356 DVGYLDEDGYLYLTDRRSDMIISGGVNIYPQEIENALIAHPKVLDAAV 403
|
|
| PRK09192 |
PRK09192 |
fatty acyl-AMP ligase; |
448-622 |
8.24e-06 |
|
fatty acyl-AMP ligase;
Pssm-ID: 236403 [Multi-domain] Cd Length: 579 Bit Score: 50.77 E-value: 8.24e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 448 ESLVAAFDLrAALQPQAPALLDAHGSL----DFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAA 523
Cdd:PRK09192 21 PTLVEALDY-AALGEAGMNFYDRRGQLeealPYQTLRARAEAGARRLLALGLKPGDRVALIAETDGDFVEAFFACQYAGL 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 524 VytPVNPEFPAA---------RVERMREAGGIVFALADAECAGRAREA-------FAGACLDLSTLPLAgsGMSLPAPGG 587
Cdd:PRK09192 100 V--PVPLPLPMGfggresyiaQLRGMLASAQPAAIITPDELLPWVNEAthgnpllHVLSHAWFKALPEA--DVALPRPTP 175
|
170 180 190
....*....|....*....|....*....|....*
gi 15597498 588 RDAAYMIFTSGTSGQPKGVVVEHASALNLSQALAR 622
Cdd:PRK09192 176 DDIAYLQYSSGSTRFPRGVIITHRALMANLRAISH 210
|
|
| A_NRPS_Sfm_like |
cd12115 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene ... |
1192-1234 |
1.03e-05 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene cluster from Streptomyces lavendulae; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the saframycin A gene cluster from Streptomyces lavendulae which implicates the NRPS system for assembling the unusual tetrapeptidyl skeleton in an iterative manner. It also includes saframycin Mx1 produced by Myxococcus xanthus NRPS.
Pssm-ID: 341280 [Multi-domain] Cd Length: 447 Bit Score: 50.39 E-value: 1.03e-05
10 20 30 40
....*....|....*....|....*....|....*....|...
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd12115 403 GAAGLVEDLRRHLGTRLPAYMVPSRFVRLDALPLTPNGKIDRS 445
|
|
| DltA |
cd05945 |
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes ... |
1199-1234 |
1.06e-05 |
|
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes D-alanyl carrier protein ligase DltA and aliphatic beta-amino acid adenylation enzymes IdnL1 and CmiS6. DltA incorporates D-ala in techoic acids in gram-positive bacteria via a two-step process, starting with adenylation of D-alanine that transfers D-alanine to the D-alanyl carrier protein. IdnL1, a short-chain aliphatic beta-amino acid adenylation enzyme, recognizes 3-aminobutanoic acid, and is involved in the synthesis of the macrolactam antibiotic incednine. CmiS6 is a medium-chain beta-amino acid adenylation enzyme that recognizes 3-aminononanoic acid, and is involved in the synthesis of cremimycin, also a macrolactam antibiotic. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341267 [Multi-domain] Cd Length: 449 Bit Score: 50.32 E-value: 1.06e-05
10 20 30
....*....|....*....|....*....|....*.
gi 15597498 1199 ALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd05945 412 AIKAELAERLPPYMIPRRFVYLDELPLNANGKIDRK 447
|
|
| PLN03102 |
PLN03102 |
acyl-activating enzyme; Provisional |
595-873 |
1.21e-05 |
|
acyl-activating enzyme; Provisional
Pssm-ID: 215576 [Multi-domain] Cd Length: 579 Bit Score: 50.40 E-value: 1.21e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 595 FTSGTSGQPKGVVVEHA----SALNLSQALARTVYANVVGEGLRVTVNA-PFSFDSSIKQILQLLSGHclVLVPQEVRSd 669
Cdd:PLN03102 193 YTSGTTADPKGVVISHRgaylSTLSAIIGWEMGTCPVYLWTLPMFHCNGwTFTWGTAARGGTSVCMRH--VTAPEIYKN- 269
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 670 pqrmlgfLEERRIDVLDCTPSLFRLLLQAG-LDDAHPALPGRILVGGerfdeaSWEVAAGWRRC-----QVFNLYGPTEA 743
Cdd:PLN03102 270 -------IEMHNVTHMCCVPTVFNILLKGNsLDLSPRSGPVHVLTGG------SPPPAALVKKVqrlgfQVMHAYGLTEA 336
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 744 T-------VNASLARVAEH------ARPTIGR-ALANVDLHVVDGLGRRKTRGAS-GELWIGGAGVARGYAGDAgEAAGR 808
Cdd:PLN03102 337 TgpvlfceWQDEWNRLPENqqmelkARQGVSIlGLADVDVKNKETQESVPRDGKTmGEIVIKGSSIMKGYLKNP-KATSE 415
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 15597498 809 FVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVL 873
Cdd:PLN03102 416 AFKHGW------LNTGDVGVIHPDGHVEIKDRSKDIIISGGENISSVEVENVLYKYPKVLETAVV 474
|
|
| Abhydrolase_6 |
pfam12697 |
Alpha/beta hydrolase family; This family contains alpha/beta hydrolase enzymes of diverse ... |
1895-2100 |
1.36e-05 |
|
Alpha/beta hydrolase family; This family contains alpha/beta hydrolase enzymes of diverse specificity.
Pssm-ID: 463673 [Multi-domain] Cd Length: 211 Bit Score: 48.24 E-value: 1.36e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1895 GNAGTFRGWDARLPADVELLAIQYPGRQERQDEPF----VTDVEAMLCAIDDAllplldRPFALIGASLGGMLAYELAar 1970
Cdd:pfam12697 6 GAGLSAAPLAALLAAGVAVLAPDLPGHGSSSPPPLdladLADLAALLDELGAA------RPVVLVGHSLGGAVALAAA-- 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1971 leslHGLRARQLFVISSRAPGPDL--EYPRFHAMGDAELLRTLREYDVLPLEVLDDPELREISLATLRADSRLAADYRYR 2048
Cdd:pfam12697 78 ----AAALVVGVLVAPLAAPPGLLaaLLALLARLGAALAAPAWLAAESLARGFLDDLPADAEWAAALARLAALLAALALL 153
|
170 180 190 200 210
....*....|....*....|....*....|....*....|....*....|....
gi 15597498 2049 PREPLA--IPITAILGEQDPGVSRVAIDGWRRHASRYELETLAGGHGLVVTAAE 2100
Cdd:pfam12697 154 PLAAWRdlPVPVLVLAEEDRLVPELAQRLLAALAGARLVVLPGAGHLPLDDPEE 207
|
|
| A_NRPS_SidN3_like |
cd05918 |
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); ... |
1198-1234 |
1.40e-05 |
|
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family of siderophore-synthesizing NRPS includes the third adenylation domain of SidN from the endophytic fungus Neotyphodium lolii, ferrichrome siderophore synthetase, HC-toxin synthetase, and enniatin synthase. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341242 [Multi-domain] Cd Length: 481 Bit Score: 49.85 E-value: 1.40e-05
10 20 30
....*....|....*....|....*....|....*..
gi 15597498 1198 QALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd05918 435 AELRSKLRQRLPSYMVPSVFLPLSHLPLTASGKIDRR 471
|
|
| A_NRPS_CmdD_like |
cd17652 |
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) ... |
1192-1234 |
2.26e-05 |
|
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes phosphinothricin tripeptide (PTT, phosphinothricylalanylalanine) synthetase, where PTT is a natural-product antibiotic and potent herbicide that is produced by Streptomyces hygroscopicus. This adenylation domain has been confirmed to directly activate beta-tyrosine, and fluorinated chondramides are produced through precursor-directed biosynthesis. Also included in this family is chondramide synthase D (also known as ATP-dependent phenylalanine adenylase or phenylalanine activase or tyrosine activase). Chondramides A-D are depsipeptide antitumor and antifungal antibiotics produced by C. crocatus, are a class of mixed peptide/polyketide depsipeptides comprised of three amino acids (alanine, N-methyltryptophan, plus the unusual amino acid beta-tyrosine or alpha-methoxy-beta-tyrosine) and a polyketide chain ([E]-7-hydroxy-2,4,6-trimethyloct-4-enoic acid).
Pssm-ID: 341307 [Multi-domain] Cd Length: 436 Bit Score: 49.17 E-value: 2.26e-05
10 20 30 40
....*....|....*....|....*....|....*....|...
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd17652 391 GAAPTAAELRAHLAERLPGYMVPAAFVVLDALPLTPNGKLDRR 433
|
|
| PRK13388 |
PRK13388 |
acyl-CoA synthetase; Provisional |
572-872 |
2.41e-05 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237374 [Multi-domain] Cd Length: 540 Bit Score: 49.25 E-value: 2.41e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 572 TLPLAGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQALAR--------TVY-------ANVVGEGLRVT 636
Cdd:PRK13388 134 LVAAAGALTPHREVDAMDPFMLIFTSGTTGAPKAVRCSHGRLAFAGRALTErfgltrddVCYvsmplfhSNAVMAGWAPA 213
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 637 VNApfsfdssikqilqllsGHCLVLVPQEVRSdpqrmlGFLEE-RRIDVLDCT---PSLFRLLLQAGLDDAHpALPGRIL 712
Cdd:PRK13388 214 VAS----------------GAAVALPAKFSAS------GFLDDvRRYGATYFNyvgKPLAYILATPERPDDA-DNPLRVA 270
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 713 VGGERFDEaswEVAAGWRR--CQVFNLYGPTEATVNASLARVAEH---ARPTIGRALANVDLHVVDGLGRRKTRG----- 782
Cdd:PRK13388 271 FGNEASPR---DIAEFSRRfgCQVEDGYGSSEGAVIVVREPGTPPgsiGRGAPGVAIYNPETLTECAVARFDAHGallna 347
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 783 --ASGELW-IGGAGVARGYAGDAGEAAGRfVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRS 859
Cdd:PRK13388 348 deAIGELVnTAGAGFFEGYYNNPEATAER-MRHGM------YWSGDLAYRDADGWIYFAGRTADWMRVDGENLSAAPIER 420
|
330
....*....|...
gi 15597498 860 ALLEHPAVGEAAV 872
Cdd:PRK13388 421 ILLRHPAINRVAV 433
|
|
| A_NRPS_TlmIV_like |
cd12114 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including ... |
1192-1234 |
3.46e-05 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Streptoalloteichus tallysomycin biosynthesis genes; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the TLM biosynthetic gene cluster from Streptoalloteichus that consists of nine NRPS genes; the N-terminal module of TlmVI (NRPS-5) and the starter module of BlmVI (NRPS-5) are comprised of the acyl CoA ligase (AL) and acyl carrier protein (ACP)-like domains, which are thought to be involved in the biosynthesis of the beta-aminoalaninamide moiety.
Pssm-ID: 341279 [Multi-domain] Cd Length: 477 Bit Score: 48.81 E-value: 3.46e-05
10 20 30 40
....*....|....*....|....*....|....*....|...
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd12114 433 GTPIAPDALRAFLAQTLPAYMIPSRVIALEALPLTANGKVDRA 475
|
|
| A_NRPS_GliP_like |
cd17653 |
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of ... |
1199-1234 |
4.38e-05 |
|
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of nonribosomal peptide synthases (NRPS) gliotoxin biosynthesis protein P (GliP), thioclapurine biosynthesis protein P (tcpP) and Sirodesmin biosynthesis protein P (SirP). In the filamentous fungus Aspergillus fumigatus, NRPS GliP is involved in the biosynthesis of gliotoxin, which is initiated by the condensation of serine and phenylalanine. Studies show that GliP is not required for invasive aspergillosis, suggesting that the principal targets of gliotoxin are neutrophils or other phagocytes. SirP is a phytotoxin produced by the fungus Leptosphaeria maculans, which causes blackleg disease of canola (Brassica napus). In the fungus Claviceps purpurea, NRPS tcpP catalyzes condensation of tyrosine and glycine, part of biosynthesis of an unusual class of epipolythiodioxopiperazines (ETPs) that lacks the reactive thiol group for toxicity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341308 [Multi-domain] Cd Length: 433 Bit Score: 48.46 E-value: 4.38e-05
10 20 30
....*....|....*....|....*....|....*.
gi 15597498 1199 ALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd17653 394 GLRSELAKHLPSYAVPDRIIALDSFPLTANGKVDRK 429
|
|
| A_NRPS_ProA |
cd17656 |
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the ... |
1194-1234 |
7.60e-05 |
|
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains gramicidin S synthase 2 (also known as ATP-dependent proline adenylase or proline activase or ProA). ProA is a multifunctional enzyme involved in synthesis of the cyclic peptide antibiotic gramicidin S and able to activate and polymerize the amino acids proline, valine, ornithine and leucine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341311 [Multi-domain] Cd Length: 479 Bit Score: 47.47 E-value: 7.60e-05
10 20 30 40
....*....|....*....|....*....|....*....|.
gi 15597498 1194 ELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd17656 436 ELNISQLREYLAKQLPEYMIPSFFVPLDQLPLTPNGKVDRK 476
|
|
| PRK09294 |
PRK09294 |
phthiocerol/phthiodiolone dimycocerosyl transferase; |
1391-1631 |
8.50e-05 |
|
phthiocerol/phthiodiolone dimycocerosyl transferase;
Pssm-ID: 181765 [Multi-domain] Cd Length: 416 Bit Score: 47.40 E-value: 8.50e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1391 VHGRLDGELLARAWAILIGRHAILRTGFDLHGGQVPLqwvhpatAVAAEVPVHDLCGLDGETRRlrlrawieEEQATPFD 1470
Cdd:PRK09294 30 LRGVLDIDALSDAFDALLRAHPVLAAHLEQDSDGGWE-------LVADDLLHPGIVVVDGDAAR--------PLPELQLD 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1471 WSRPpLVRLAaLALDERRFALGVAEHHSVLDGWSLQSLVDELLAVYADLL-AGVVAREAEAPAVGFRDYVALEREAEANA 1549
Cdd:PRK09294 95 QGVS-LLALD-VVPDDGGARVTLYIHHSIADAHHSASLLDELWSRYTDVVtTGDPGPIRPQPAPQSLEAVLAQRGIRRQA 172
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 1550 ASALFWLD-----YLAGARYRPLPGLAEEGPRRMAAVRVDVPADSLSRLRALAERSGLPLRSLLLAAHGRALCRFSDADE 1624
Cdd:PRK09294 173 LSGAERFMpamyaYELPPTPTAAVLAKPGLPQAVPVTRCRLSKAQTSSLAAFGRRHRLTVNALVSAAILLAEWQLRRTPH 252
|
....*..
gi 15597498 1625 VVTGFVS 1631
Cdd:PRK09294 253 VPLPYVY 259
|
|
| PRK06187 |
PRK06187 |
long-chain-fatty-acid--CoA ligase; Validated |
1192-1234 |
8.83e-05 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235730 [Multi-domain] Cd Length: 521 Bit Score: 47.49 E-value: 8.83e-05
10 20 30 40
....*....|....*....|....*....|....*....|...
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:PRK06187 469 GATLDAKELRAFLRGRLAKFKLPKRIAFVDELPRTSVGKILKR 511
|
|
| PRK03640 |
PRK03640 |
o-succinylbenzoate--CoA ligase; |
1192-1234 |
1.31e-04 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 235146 [Multi-domain] Cd Length: 483 Bit Score: 46.88 E-value: 1.31e-04
10 20 30 40
....*....|....*....|....*....|....*....|...
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:PRK03640 432 SGEVTEEELRHFCEEKLAKYKVPKRFYFVEELPRNASGKLLRH 474
|
|
| PksD |
COG3321 |
Acyl transferase domain in polyketide synthase (PKS) enzymes [Secondary metabolites ... |
384-917 |
1.54e-04 |
|
Acyl transferase domain in polyketide synthase (PKS) enzymes [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442550 [Multi-domain] Cd Length: 1386 Bit Score: 47.17 E-value: 1.54e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 384 LASLRVRRDHDGTLAGRLLDAWVECLE----SIAADRQLPLAGLPLigaaereryQAWQGERVEPAPVESLVAAFDLRAA 459
Cdd:COG3321 820 LPSLRRGEDELAQLLTALAQLWVAGVPvdwsALYPGRGRRRVPLPT---------YPFQREDAAAALLAAALAAALAAAA 890
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 460 LQPQAPALLDAHGSLDFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAARVER 539
Cdd:COG3321 891 ALGALLLAALAAALAAALLALAAAAAAALALAAAALAALLALVALAAAAAALLALAAAAAAAAAALAAAEAGALLLLAAA 970
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 540 MREAGGIVFALADAECAGRAREAFAGACLDLSTLPLAGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVVEHASALNLSQA 619
Cdd:COG3321 971 AAAAAAAAAAAAAAAAAAAAAAAAALAAAAALALLAAAALLLAAAAAAAALLALAALLAAAAAALAAAAAAAAAAAALAA 1050
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 620 LARTVYANVVGEGLRVTVNAPFSFDSsikqiLQLLSGHCLVLVPQEVRSDPQRMLGFLEERRIDVLDCTPSLFRLLLQAG 699
Cdd:COG3321 1051 LAAAAAAAAALALALAALLLLAALAE-----LALAAAALALAAALAAAALALALAALAAALLLLALLAALALAAAAAALL 1125
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 700 LDDAHPALPGRILVGGERFDEASWEVAAGWRRCQVFNLYGPTEATVNASLARVAEHARPTIGRALANVDLHVVDGLGRRK 779
Cdd:COG3321 1126 ALAALLAAAAAAAALAAAAAAAAALALAAAAAALAAALAAALLAAAALLLALALALAAALAAALAGLAALLLAALLAALL 1205
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 780 TRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRS 859
Cdd:COG3321 1206 AALLALALAALAAAAAALLAAAAAAAALALLALAAAAAAVAALAAAAAALLAALAALALLAAAAGLAALAAAAAAAAAAL 1285
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*...
gi 15597498 860 ALLEHPAVGEAAVLTDEADAAEPGADRRIVAFVTAAEETADESWLEVDLPSGHRVAGL 917
Cdd:COG3321 1286 ALAAAAAAAAAALAALLAAAAAAAAAAAAAAAAAALAAALLAAALAALAAAVAAALAL 1343
|
|
| PTZ00237 |
PTZ00237 |
acetyl-CoA synthetase; Provisional |
821-869 |
1.67e-04 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 240325 [Multi-domain] Cd Length: 647 Bit Score: 46.66 E-value: 1.67e-04
10 20 30 40
....*....|....*....|....*....|....*....|....*....
gi 15597498 821 YRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGE 869
Cdd:PTZ00237 494 YNSGDLGFKDENGYYTIVSRSDDQIKISGNKVQLNTIETSILKHPLVLE 542
|
|
| PRK04813 |
PRK04813 |
D-alanine--poly(phosphoribitol) ligase subunit DltA; |
1198-1233 |
1.71e-04 |
|
D-alanine--poly(phosphoribitol) ligase subunit DltA;
Pssm-ID: 235313 [Multi-domain] Cd Length: 503 Bit Score: 46.43 E-value: 1.71e-04
10 20 30
....*....|....*....|....*....|....*.
gi 15597498 1198 QALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDR 1233
Cdd:PRK04813 459 KAIKKELKERLMEYMIPRKFIYRDSLPLTPNGKIDR 494
|
|
| FCS |
cd05921 |
Feruloyl-CoA synthetase (FCS); Feruloyl-CoA synthetase is an essential enzyme in the feruloyl ... |
494-861 |
1.98e-04 |
|
Feruloyl-CoA synthetase (FCS); Feruloyl-CoA synthetase is an essential enzyme in the feruloyl acid degradation pathway and enables some proteobacteria to grow on media containing feruloyl acid as the sole carbon source. It catalyzes the transfer of CoA to the carboxyl group of ferulic acid, which then forms feruloyl-CoA in the presence of ATP and Mg2. The resulting feruloyl-CoA is further degraded to vanillin and acetyl-CoA. Feruloyl-CoA synthetase (FCS) is a subfamily of the adenylate-forming enzymes superfamily.
Pssm-ID: 341245 [Multi-domain] Cd Length: 561 Bit Score: 46.27 E-value: 1.98e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 494 GVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPA-----ARVERMRE--AGGIVFA-----LADA-------- 553
Cdd:cd05921 46 GLSAERPLLILSGNSIEHALMALAAMYAGVPAAPVSPAYSLmsqdlAKLKHLFEllKPGLVFAqdaapFARAlaaifplg 125
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 554 --------ECAGRAREAFAGaclDLSTLPLAGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVVEHAsALNLSQALARTVY 625
Cdd:cd05921 126 tplvvsrnAVAGRGAISFAE---LAATPPTAAVDAAFAAVGPDTVAKFLFTSGSTGLPKAVINTQR-MLCANQAMLEQTY 201
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 626 ANVVGEGLRVTVNAPFS--FDSSIKQILQLLSGHCLVLvpQEVRSDPQRM---LGFLEERRIDVLDCTPSLFRLLLQAGL 700
Cdd:cd05921 202 PFFGEEPPVLVDWLPWNhtFGGNHNFNLVLYNGGTLYI--DDGKPMPGGFeetLRNLREISPTVYFNVPAGWEMLVAALE 279
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 701 DDahPALPGR-------ILVGGERFDEASWE------VAAGWRRCQVFNLYGPTEaTVNASLARVAEHARP-TIGRALAN 766
Cdd:cd05921 280 KD--EALRRRffkrlklMFYAGAGLSQDVWDrlqalaVATVGERIPMMAGLGATE-TAPTATFTHWPTERSgLIGLPAPG 356
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 767 VDLHVVdglgrrkTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgsgrlYRSGDLVRWrADGC-----LEFLGRI 841
Cdd:cd05921 357 TELKLV-------PSGGKYEVRVKGPNVTPGYWRQPELTAQAFDEEGF------YCLGDAAKL-ADPDdpakgLVFDGRV 422
|
410 420
....*....|....*....|.
gi 15597498 842 DEQVKIN-GYRIELGEIRSAL 861
Cdd:cd05921 423 AEDFKLAsGTWVSVGPLRARA 443
|
|
| AMP-binding_C |
pfam13193 |
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to ... |
1192-1230 |
2.13e-04 |
|
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to pfam00501. It has a central beta sheet core that is flanked by alpha helices.
Pssm-ID: 463804 [Multi-domain] Cd Length: 76 Bit Score: 41.76 E-value: 2.13e-04
10 20 30
....*....|....*....|....*....|....*....
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGK 1230
Cdd:pfam13193 38 GVELLEEELVAHVREELGPYAVPKEVVFVDELPKTRSGK 76
|
|
| PP-binding |
pfam00550 |
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ... |
1792-1850 |
2.14e-04 |
|
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.
Pssm-ID: 425746 [Multi-domain] Cd Length: 62 Bit Score: 41.01 E-value: 2.14e-04
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 15597498 1792 RRVLKVLSRVLGRP---LAADQGFASAGGHSLLGVQAIAELRRLTGRQLSLGLLQGDPDARE 1850
Cdd:pfam00550 1 ERLRELLAEVLGVPaeeIDPDTDLFDLGLDSLLAVELIARLEEEFGVEIPPSDLFEHPTLAE 62
|
|
| PKS_TE |
smart00824 |
Thioesterase; Peptide synthetases are involved in the non-ribosomal synthesis of peptide ... |
1926-1991 |
2.22e-04 |
|
Thioesterase; Peptide synthetases are involved in the non-ribosomal synthesis of peptide antibiotics. Next to the operons encoding these enzymes, in almost all cases, are genes that encode proteins that have similarity to the type II fatty acid thioesterases of vertebrates. There are also modules within the peptide synthetases that also share this similarity. With respect to antibiotic production, thioesterases are required for the addition of the last amino acid to the peptide antibiotic, thereby forming a cyclic antibiotic. Thioesterases (non-integrated) have molecular masses of 25-29 kDa.
Pssm-ID: 214835 [Multi-domain] Cd Length: 212 Bit Score: 44.52 E-value: 2.22e-04
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 15597498 1926 DEPFVTDVEAMLCAIDDALLPLL-DRPFALIGASLGGMLAYELAARLESlHGLRARQLFVISSRAPG 1991
Cdd:smart00824 39 GEPLPASADALVEAQAEAVLRAAgGRPFVLVGHSSGGLLAHAVAARLEA-RGIPPAAVVLLDTYPPG 104
|
|
| A_NRPS_PpsD_like |
cd17650 |
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation ... |
1199-1234 |
2.58e-04 |
|
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetase 1 (BacA) in Bacillus licheniformis, tyrocidine synthetase in Brevibacillus brevis, plipastatin synthase (PpsD, an important antifungal protein) in Bacillus subtilis and mannopeptimycin peptide synthetase (MppB) in Streptomyces hygroscopicus. Plipastatin has strong fungitoxic activity and is involved in inhibition of phospholipase A2 and biofilm formation. Bacitracin, a mixture of related cyclic peptides, is used as a polypeptide antibiotic while function of tyrocidine is thought to be regulation of sporulation. MppB is involved in biosynthetic pathway of mannopeptimycin, a novel class of mannosylated lipoglycopeptides. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341305 [Multi-domain] Cd Length: 447 Bit Score: 45.92 E-value: 2.58e-04
10 20 30
....*....|....*....|....*....|....*.
gi 15597498 1199 ALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd17650 410 ELRAFLAKELPSYMIPSYYVQLDALPLTPNGKVDRR 445
|
|
| PRK12582 |
PRK12582 |
acyl-CoA synthetase; Provisional |
490-894 |
2.64e-04 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237144 [Multi-domain] Cd Length: 624 Bit Score: 46.19 E-value: 2.64e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 490 LLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEF----------------------------PAARVERMR 541
Cdd:PRK12582 97 LLDLGLDPGRPVMILSGNSIEHALMTLAAMQAGVPAAPVSPAYslmshdhaklkhlfdlvkprvvfaqsgaPFARALAAL 176
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 542 EAGGIVFALADAECAGRAREAFAGAcldLSTLPLAGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVVEHasalnlsqala 621
Cdd:PRK12582 177 DLLDVTVVHVTGPGEGIASIAFADL---AATPPTAAVAAAIAAITPDTVAKYLFTSGSTGMPKAVINTQ----------- 242
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 622 RTVYANVVG-EGLRvtvnaPFSFDSSIKQILQ-----------------LLSGHCLVLvpqevrsDPQR-MLGFLEERRI 682
Cdd:PRK12582 243 RMMCANIAMqEQLR-----PREPDPPPPVSLDwmpwnhtmggnanfnglLWGGGTLYI-------DDGKpLPGMFEETIR 310
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 683 DVLDCTPSLF-----RLLLQAGLDDAHPALP-------GRILVGGERFDEASWE------VAAGWRRCQVFNLYGPTEAT 744
Cdd:PRK12582 311 NLREISPTVYgnvpaGYAMLAEAMEKDDALRrsffknlRLMAYGGATLSDDLYErmqalaVRTTGHRIPFYTGYGATETA 390
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 745 VNASLARVAEHARPTIGRALANVDLHVVdglgrrkTRGASGELWIGGAGVARGYAGDAGEAAGRFVEEGWpgsgrlYRSG 824
Cdd:PRK12582 391 PTTTGTHWDTERVGLIGLPLPGVELKLA-------PVGDKYEVRVKGPNVTPGYHKDPELTAAAFDEEGF------YRLG 457
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 15597498 825 DLVRW----RADGCLEFLGRIDEQVKI-NGYRIELGEIRSALLehpavgeAAVLTDEADAAEPGADRrivAFVTA 894
Cdd:PRK12582 458 DAARFvdpdDPEKGLIFDGRVAEDFKLsTGTWVSVGTLRPDAV-------AACSPVIHDAVVAGQDR---AFIGL 522
|
|
| ttLC_FACS_AlkK_like |
cd12119 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes ... |
1192-1234 |
2.89e-04 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes fatty acyl-CoA synthetases that can activate medium-chain to long-chain fatty acids. They catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family catalyzes the long-chain fatty acid, myristoyl acid, while another member in this family, the AlkK protein identified from Pseudomonas oleovorans, targets medium chain fatty acids. This family also includes uncharacterized FACS proteins.
Pssm-ID: 341284 [Multi-domain] Cd Length: 518 Bit Score: 45.70 E-value: 2.89e-04
10 20 30 40
....*....|....*....|....*....|....*....|...
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd12119 472 GATVTAEELLEFLADKVAKWWLPDDVVFVDEIPKTSTGKIDKK 514
|
|
| FATP_chFAT1_like |
cd05937 |
Uncharacterized subfamily of bifunctional fatty acid transporter/very-long-chain acyl-CoA ... |
589-872 |
3.04e-04 |
|
Uncharacterized subfamily of bifunctional fatty acid transporter/very-long-chain acyl-CoA synthetase in fungi; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis. Members of this family are fungal FATPs, including FAT1 from Cochliobolus heterostrophus.
Pssm-ID: 341260 [Multi-domain] Cd Length: 468 Bit Score: 45.50 E-value: 3.04e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHASALNLSQALARTVyanVVGEGLRVTVNAPF--SFDSSIKQILQLLSGHCLVLVPQ-- 664
Cdd:cd05937 88 DPAILIYTSGTTGLPKAAAISWRRTLVTSNLLSHDL---NLKNGDRTYTCMPLyhGTAAFLGACNCLMSGGTLALSRKfs 164
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 665 ------EVRSDPQRMLGFLEErridvldctpsLFRLLLQAGL---DDAHPAlpgRILVG-GERFDeaSWEvaagwRRCQV 734
Cdd:cd05937 165 asqfwkDVRDSGATIIQYVGE-----------LCRYLLSTPPspyDRDHKV---RVAWGnGLRPD--IWE-----RFRER 223
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 735 FN------LYGPTEAT-------VNASLARVAEHARPTIGRALAN------VDLHVVDGLGRRKT-------RGASGE-- 786
Cdd:cd05937 224 FNvpeigeFYAATEGVfaltnhnVGDFGAGAIGHHGLIRRWKFENqvvlvkMDPETDDPIRDPKTgfcvrapVGEPGEml 303
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 787 --LWIGGAGVARGYAGDAGEAAGRFVEEGWPGSGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEH 864
Cdd:cd05937 304 grVPFKNREAFQGYLHNEDATESKLVRDVFRKGDIYFRTGDLLRQDADGRWYFLDRLGDTFRWKSENVSTTEVADVLGAH 383
|
....*...
gi 15597498 865 PAVGEAAV 872
Cdd:cd05937 384 PDIAEANV 391
|
|
| PRK08043 |
PRK08043 |
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase; |
589-900 |
3.32e-04 |
|
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase;
Pssm-ID: 181207 [Multi-domain] Cd Length: 718 Bit Score: 45.86 E-value: 3.32e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHASALnlsqalartvyANVvgEGLRV----TVNAPF--------SFDSSIKQILQLLSG 656
Cdd:PRK08043 366 DAALILFTSGSEGHPKGVVHSHKSLL-----------ANV--EQIKTiadfTPNDRFmsalplfhSFGLTVGLFTPLLTG 432
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 657 HCLVLVPQEV--RSDPQrmlgFLEERRIDVLDCTpSLFrllLQAGLDDAHPALPGR---ILVGGERFDEAS---WEVAAG 728
Cdd:PRK08043 433 AEVFLYPSPLhyRIVPE----LVYDRNCTVLFGT-STF---LGNYARFANPYDFARlryVVAGAEKLQESTkqlWQDKFG 504
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 729 WRrcqVFNLYGPTE----ATVNASLArvaehARP-TIGRALANVD--LHVVDGL---GRRKTRGAS---GELWIGGAGVA 795
Cdd:PRK08043 505 LR---ILEGYGVTEcapvVSINVPMA-----AKPgTVGRILPGMDarLLSVPGIeqgGRLQLKGPNimnGYLRVEKPGVL 576
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 796 RGYAGDAGEAAgrfVEEGWpgsgrlYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRS-ALLEHPAVGEAAVLT 874
Cdd:PRK08043 577 EVPTAENARGE---MERGW------YDTGDIVRFDEQGFVQIQGRAKRFAKIAGEMVSLEMVEQlALGVSPDKQHATAIK 647
|
330 340
....*....|....*....|....*.
gi 15597498 875 DEADAAEPgadrrIVAFVTAAEETAD 900
Cdd:PRK08043 648 SDASKGEA-----LVLFTTDSELTRE 668
|
|
| EntE |
COG1021 |
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase ... |
1192-1234 |
4.10e-04 |
|
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440644 [Multi-domain] Cd Length: 533 Bit Score: 45.52 E-value: 4.10e-04
10 20 30 40
....*....|....*....|....*....|....*....|....
gi 15597498 1192 GGELSEQALRGFLEAR-LPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:COG1021 482 GEPLTLAELRRFLRERgLAAFKLPDRLEFVDALPLTAVGKIDKK 525
|
|
| PRK05850 |
PRK05850 |
acyl-CoA synthetase; Validated |
449-610 |
7.55e-04 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235624 [Multi-domain] Cd Length: 578 Bit Score: 44.55 E-value: 7.55e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 449 SLVAAFDLRAALQPQAPALL---------DAHGSLDFATLRARSEAVAEALLAAGVrPGQAVAVMTGRNREAIVALLGVM 519
Cdd:PRK05850 2 SVPSLLRERASLQPDDAAFTfidyeqdpaGVAETLTWSQLYRRTLNVAEELRRHGS-TGDRAVILAPQGLEYIVAFLGAL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 520 RAAAVYTPVNPEFPAARVER----MREAGGIVF----ALAD--AECAGRAREAFAGACLDLSTLPL-AGSGMSLPAPGGR 588
Cdd:PRK05850 81 QAGLIAVPLSVPQGGAHDERvsavLRDTSPSVVlttsAVVDdvTEYVAPQPGQSAPPVIEVDLLDLdSPRGSDARPRDLP 160
|
170 180
....*....|....*....|..
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEH 610
Cdd:PRK05850 161 STAYLQYTSGSTRTPAGVMVSH 182
|
|
| A_NRPS_LgrA-like |
cd17645 |
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This ... |
1194-1234 |
9.18e-04 |
|
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes linear gramicidin synthetase (LgrA) in Brevibacillus brevis. LgrA has a formylation domain fused to the N-terminal end that formylates its substrate for linear gramicidin synthesis to proceed. This formyl group is essential for the clinically important antibacterial activity of gramicidin by enabling head-to-head gramicidin dimers to make a beta-helical pore in gram-positive bacterial membranes, allowing free passage of monovalent cations, destroying the ion gradient and killing bacteria. This family also includes bacitracin synthetase 1 (known as ATP-dependent cysteine adenylase or BA1); it activates cysteine, incorporates two D-amino acids, releases and cyclizes the mature bacitracin, an antibiotic that is a mixture of related cyclic peptides that disrupt gram positive bacteria by interfering with cell wall and peptidoglycan synthesis. Also included is surfactin synthetase which activates and polymerizes the amino acids Leu, Glu, Asp, and Val to form the antibiotic surfactin.
Pssm-ID: 341300 [Multi-domain] Cd Length: 440 Bit Score: 44.08 E-value: 9.18e-04
10 20 30 40
....*....|....*....|....*....|....*....|.
gi 15597498 1194 ELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd17645 397 EIPHEELREWLKNDLPDYMIPTYFVHLKALPLTANGKVDRK 437
|
|
| PRK08308 |
PRK08308 |
acyl-CoA synthetase; Validated |
817-914 |
1.19e-03 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236231 [Multi-domain] Cd Length: 414 Bit Score: 43.49 E-value: 1.19e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 817 SGRLYRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAVLTdeadAAEPGADRRIVAFVTAAE 896
Cdd:PRK08308 289 GDKEIFTKDLGYKSERGTLHFMGRMDDVINVSGLNVYPIEVEDVMLRLPGVQEAVVYR----GKDPVAGERVKAKVISHE 364
|
90 100
....*....|....*....|.
gi 15597498 897 ETADES---WLEVDLPSgHRV 914
Cdd:PRK08308 365 EIDPVQlreWCIQHLAP-YQV 384
|
|
| V_cholerae_RfbT |
pfam05575 |
Vibrio cholerae RfbT protein; This family consists of several RfbT proteins from Vibrio ... |
945-1042 |
1.21e-03 |
|
Vibrio cholerae RfbT protein; This family consists of several RfbT proteins from Vibrio cholerae. It has been found that genetic alteration of the rfbT gene is responsible for serotype conversion of Vibrio cholerae O1 and determines the difference between the Ogawa and Inaba serotypes, in that the presence of rfbT is sufficient for Inaba-to-Ogawa serotype conversion.
Pssm-ID: 114305 Cd Length: 286 Bit Score: 43.13 E-value: 1.21e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 945 DAVVLDVGANIGLFSLYIASRAPRARVVAFEPLAPIRRRLEANLGRYAPQVEV--FGIGLSDAEREETFTYYPGYSTFSG 1022
Cdd:pfam05575 80 DTTYIDIGANVGTFCGIAARHITQGKIIAIEPLTEMENSIRMNVQLNNPLVEFhhFGCAIGENEGENIFEVYEFDNRVSS 159
|
90 100
....*....|....*....|....*
gi 15597498 1023 I-----AEYADASGERDVIRRYLSN 1042
Cdd:pfam05575 160 LyfkknTDIADKVKNSQVLVRKLSS 184
|
|
| PRK08162 |
PRK08162 |
acyl-CoA synthetase; Validated |
458-621 |
1.43e-03 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236169 [Multi-domain] Cd Length: 545 Bit Score: 43.78 E-value: 1.43e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 458 AALQPQAPALLdaHGSL--DFATLRARSEAVAEALLAAGVRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPVNPEFPAA 535
Cdd:PRK08162 28 AEVYPDRPAVI--HGDRrrTWAETYARCRRLASALARRGIGRGDTVAVLLPNIPAMVEAHFGVPMAGAVLNTLNTRLDAA 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 536 RVERMREAGGIVFALADAECAGRAREAFagACLDLSTLPLAGSGMSlPAPGGR--------------------------- 588
Cdd:PRK08162 106 SIAFMLRHGEAKVLIVDTEFAEVAREAL--ALLPGPKPLVIDVDDP-EYPGGRfigaldyeaflasgdpdfawtlpadew 182
|
170 180 190
....*....|....*....|....*....|....*
gi 15597498 589 DAAYMIFTSGTSGQPKGVVVEHASA-LN-LSQALA 621
Cdd:PRK08162 183 DAIALNYTSGTTGNPKGVVYHHRGAyLNaLSNILA 217
|
|
| AFD_YhfT-like |
cd17633 |
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, ... |
1192-1233 |
1.92e-03 |
|
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, as well as long-chain fatty acid-CoA ligase VraA, all of which are as yet to be characterized. These proteins belong to the adenylate-forming enzymes which catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain
Pssm-ID: 341288 [Multi-domain] Cd Length: 320 Bit Score: 42.78 E-value: 1.92e-03
10 20 30 40
....*....|....*....|....*....|....*....|..
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDR 1233
Cdd:cd17633 279 GDKLTYKQLKRFLKQKLSRYEIPKKIIFVDSLPYTSSGKIAR 320
|
|
| PLN02387 |
PLN02387 |
long-chain-fatty-acid-CoA ligase family protein |
785-867 |
2.72e-03 |
|
long-chain-fatty-acid-CoA ligase family protein
Pssm-ID: 215217 [Multi-domain] Cd Length: 696 Bit Score: 42.80 E-value: 2.72e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 785 GELWIGGAGVARGYAGDagEAAGRFV----EEGWpgsgRLYRSGDLVRWRADGCLEFLGRIDEQVKI-NGYRIELGEIRS 859
Cdd:PLN02387 503 GEIVIGGPSVTLGYFKN--QEKTDEVykvdERGM----RWFYTGDIGQFHPDGCLEIIDRKKDIVKLqHGEYVSLGKVEA 576
|
....*...
gi 15597498 860 ALLEHPAV 867
Cdd:PLN02387 577 ALSVSPYV 584
|
|
| OSB_CoA_lg |
cd05912 |
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA ... |
1193-1234 |
3.24e-03 |
|
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA synthetase, or MenE); O-succinylbenzoic acid-CoA synthase catalyzes the coenzyme A (CoA)- and ATP-dependent conversion of o-succinylbenzoic acid to o-succinylbenzoyl-CoA. The reaction is the fourth step of the biosynthesis pathway of menaquinone (vitamin K2). In certain bacteria, menaquinone is used during fumarate reduction in anaerobic respiration. In cyanobacteria, the product of the menaquinone pathway is phylloquinone (2-methyl-3-phytyl-1,4-naphthoquinone), a molecule used exclusively as an electron transfer cofactor in Photosystem 1. In green sulfur bacteria and heliobacteria, menaquinones are used as loosely bound secondary electron acceptors in the photosynthetic reaction center.
Pssm-ID: 341238 [Multi-domain] Cd Length: 411 Bit Score: 42.33 E-value: 3.24e-03
10 20 30 40
....*....|....*....|....*....|....*....|..
gi 15597498 1193 GELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDRR 1234
Cdd:cd05912 366 RPISEEELIAYCSEKLAKYKVPKKIYFVDELPRTASGKLLRH 407
|
|
| A_NRPS_alphaAR |
cd17647 |
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as ... |
1200-1233 |
3.47e-03 |
|
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as alpha-aminoadipate reductase (EC 1.2.1.95) or alpha-AR or L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), which catalyzes the activation of alpha-aminoadipate by ATP-dependent adenylation and the reduction of activated alpha-aminoadipate by NADPH. The activated alpha-aminoadipate is bound to the phosphopantheinyl group of the enzyme itself before it is reduced to (S)-2-amino-6-oxohexanoate.
Pssm-ID: 341302 [Multi-domain] Cd Length: 520 Bit Score: 42.50 E-value: 3.47e-03
10 20 30
....*....|....*....|....*....|....
gi 15597498 1200 LRGFLEARLPAYMLPSRIARVERLPLTAEGKLDR 1233
Cdd:cd17647 481 IREFLKKRLASYAIPSLIVVLDKLPLNPNGKVDK 514
|
|
| AFD_class_I |
cd04433 |
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as ... |
1192-1232 |
4.07e-03 |
|
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as the ANL (acyl-CoA synthetases, the NRPS adenylation domains, and the Luciferase enzymes) superfamily. It includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases.The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341228 [Multi-domain] Cd Length: 336 Bit Score: 41.89 E-value: 4.07e-03
10 20 30 40
....*....|....*....|....*....|....*....|.
gi 15597498 1192 GGELSEQALRGFLEARLPAYMLPSRIARVERLPLTAEGKLD 1232
Cdd:cd04433 296 GADLDAEELRAHVRERLAPYKVPRRVVFVDALPRTASGKID 336
|
|
| COG3903 |
COG3903 |
Predicted ATPase [General function prediction only]; |
52-465 |
4.57e-03 |
|
Predicted ATPase [General function prediction only];
Pssm-ID: 443109 [Multi-domain] Cd Length: 933 Bit Score: 42.31 E-value: 4.57e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 52 ADPVATLERLRRALDGEAQLRVAYRTMPGMSLPVQVLDGRAADLLVERLPGDGDWAGRFARESARLAAsplggeGQPVLA 131
Cdd:COG3903 526 DNLRAALRWALAHGDAELALRLAAALAPFWFLRGLLREGRRWLERALAAAGEAAAALAAAAALAAAAA------AARAAA 599
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 132 LGLLLDAAGETLQGLLLAAPAFVVDAASLVALLRRGLGPAGQASADEGDEALLFQHFSEWANEALAGEDGESASGYWREQ 211
Cdd:COG3903 600 AAAAAAAAAAAAAAAAAAAAAAALLLLAALAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAALAAAAAAAAAAAAA 679
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 212 AAVAAESPLALADDLGEGEWTARRLLPRALLERLAANGLPEAAALLAWTQVAGQFQGDEGLPLEMARLVSGRLFNEFAEL 291
Cdd:COG3903 680 AAAAAAALAAAAAALAAAAAAAALAAAAAAALAAAAAAAAAAAAAAALLAAAAAAALAAAAAAAALALAAAAAAAAAAAA 759
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 292 AGPFAGVAPLCLENVRAGSVGERLDALQAAILAQEEAAALRDPFAPDWPLAELGFAWLAGELDGAGVAELDCRQPPLGGF 371
Cdd:COG3903 760 AAALAAAAAAAALAALLLALAAAAAALAAAAAAAAAAAAAAAAAAAAAAAAAAAAALAAAAAAAAAAAAALAAALAAAAA 839
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 372 LELQVLPHGEGRLASLRVRRDHDGTLAGRLLDAWVECLESIAADRQLPLAGLPLIGAAERERYQAWQGERVEPAPVESLV 451
Cdd:COG3903 840 AAAAAAAAAAAAAALAAALAAAAAAAAAAALAAAAAAAAAAAAALLAAAAAAAAAAAAAAAAAAALAAAAAAAAAAALAA 919
|
410
....*....|....
gi 15597498 452 AAFDLRAALQPQAP 465
Cdd:COG3903 920 AAAAAAAAAAAAAA 933
|
|
| PRK12476 |
PRK12476 |
putative fatty-acid--CoA ligase; Provisional |
495-849 |
6.11e-03 |
|
putative fatty-acid--CoA ligase; Provisional
Pssm-ID: 171527 [Multi-domain] Cd Length: 612 Bit Score: 41.65 E-value: 6.11e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 495 VRPGQAVAVMTGRNREAIVALLGVMRAAAVYTPV-NPEFPaARVERMREaggivfALADAECA-----GRAREAFAGACL 568
Cdd:PRK12476 89 AGPGDRVAILAPQGIDYVAGFFAAIKAGTIAVPLfAPELP-GHAERLDT------ALRDAEPTvvlttTAAAEAVEGFLR 161
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 569 DLSTL--PL----------AGSGMSLPAPGGRDAAYMIFTSGTSGQPKGVVVEH-ASALNLSQALartVYANVVGEGLRV 635
Cdd:PRK12476 162 NLPRLrrPRviaidaipdsAGESFVPVELDTDDVSHLQYTSGSTRPPVGVEITHrAVGTNLVQMI---LSIDLLDRNTHG 238
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 636 TVNAPFSFDSSIKQIL--QLLSGHCLVLVPQEVRSDPQRMLGFLEE--RRIDVLDCTPSL-FRLLLQAGLDDAHPALPGR 710
Cdd:PRK12476 239 VSWLPLYHDMGLSMIGfpAVYGGHSTLMSPTAFVRRPQRWIKALSEgsRTGRVVTAAPNFaYEWAAQRGLPAEGDDIDLS 318
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 711 ---ILVGGERFDEASWEV--AA----GWRRCQVFNLYGPTEATVnaSLARVAEHARPTI----------GRALA------ 765
Cdd:PRK12476 319 nvvLIIGSEPVSIDAVTTfnKAfapyGLPRTAFKPSYGIAEATL--FVATIAPDAEPSVvyldreqlgaGRAVRvaadap 396
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 15597498 766 NVDLHV-------------VD-GLGRRKTRGASGELWIGGAGVARGYAGDAGEAAGRFVE------------EGWPGSGR 819
Cdd:PRK12476 397 NAVAHVscgqvarsqwaviVDpDTGAELPDGEVGEIWLHGDNIGRGYWGRPEETERTFGAklqsrlaegshaDGAADDGT 476
|
410 420 430
....*....|....*....|....*....|
gi 15597498 820 LYRSGDLVRWRaDGCLEFLGRIDEQVKING 849
Cdd:PRK12476 477 WLRTGDLGVYL-DGELYITGRIADLIVIDG 505
|
|
| prpE |
PRK10524 |
propionyl-CoA synthetase; Provisional |
808-872 |
6.35e-03 |
|
propionyl-CoA synthetase; Provisional
Pssm-ID: 182517 [Multi-domain] Cd Length: 629 Bit Score: 41.47 E-value: 6.35e-03
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 15597498 808 RFVEEGWPGSGRL-YRSGDLVRWRADGCLEFLGRIDEQVKINGYRIELGEIRSALLEHPAVGEAAV 872
Cdd:PRK10524 461 RFVKTYWSLFGRQvYSTFDWGIRDADGYYFILGRTDDVINVAGHRLGTREIEESISSHPAVAEVAV 526
|
|
| BCL_like |
cd05919 |
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate ... |
1198-1233 |
6.44e-03 |
|
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate CoA ligase (BCL) and related ligases that catalyze the acylation of benzoate derivatives, 2-aminobenzoate and 4-hydroxybenzoate. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Xenobiotic aromatic compounds are also a major class of man-made pollutants. Some bacteria use benzoate as the sole source of carbon and energy through benzoate degradation. Benzoate degradation starts with its activation to benzoyl-CoA by benzoate CoA ligase. The reaction catalyzed by benzoate CoA ligase proceeds via a two-step process; the first ATP-dependent step forms an acyl-AMP intermediate, and the second step forms the acyl-CoA ester with release of the AMP.
Pssm-ID: 341243 [Multi-domain] Cd Length: 436 Bit Score: 41.29 E-value: 6.44e-03
10 20 30
....*....|....*....|....*....|....*.
gi 15597498 1198 QALRGFLEARLPAYMLPSRIARVERLPLTAEGKLDR 1233
Cdd:cd05919 397 RDIHRHLLERLSAHKVPRRIAFVDELPRTATGKLQR 432
|
|
|